0001213900-23-041268.txt : 20230519 0001213900-23-041268.hdr.sgml : 20230519 20230518183930 ACCESSION NUMBER: 0001213900-23-041268 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 77 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230519 DATE AS OF CHANGE: 20230518 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Evergreen Sustainable Enterprises, Inc. CENTRAL INDEX KEY: 0001527102 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 263119496 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-55019 FILM NUMBER: 23937478 BUSINESS ADDRESS: STREET 1: 8533 MIDWAY RD. CITY: DALLAS STATE: TX ZIP: 75209 BUSINESS PHONE: (469) 209-6154 MAIL ADDRESS: STREET 1: P.O. BOX 540308 CITY: DALLAS STATE: TX ZIP: 75354 FORMER COMPANY: FORMER CONFORMED NAME: Generation Hemp, Inc. DATE OF NAME CHANGE: 20191209 FORMER COMPANY: FORMER CONFORMED NAME: Home Treasure Finders, Inc. DATE OF NAME CHANGE: 20110801 10-K 1 f10k2022_evergreen.htm ANNUAL REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

FORM 10-K

 

   ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For Fiscal Year Ended December 31, 2022

 

Commission File Number 000-55019

 

Evergreen Sustainable Enterprises, Inc.

(formerly Generation Hemp, Inc.)

(Exact name of registrant as specified in its charter)

 

Delaware   26-3119496
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)
     
8533 Midway Road, Dallas, Texas   75209
(Address of principal executive offices)   (Zip code)

 

(469) 209-6154

(Registrant’s telephone number, including area code)

 

Securities Registered under Section 12(b) of the Exchange Act:

None

 

Securities Registered under Section 12(g) of the Exchange Act:

Class: Common Stock, par value $0.00001 per share

Ticker: EGSE

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐   No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ☐   No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐   No

 

Indicate by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes    No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or, an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company”, in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐  Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b).  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b 2 of the Exchange Act). Yes ☐   No

 

As of June 30, 2022, the last business day of the registrant’s most recently completed second fiscal quarter, the aggregate market value of common stock held by non-affiliates of the registrant was $18,658,253

 

At May 18, 2023, the registrant had 113,254,002 shares of common stock outstanding.

 

 

 

 

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Annual Report on Form 10-K, the other reports, statements, and information that the Company has previously filed with or furnished to, or that we may subsequently file with or furnish to, the SEC and public announcements that we have previously made or may subsequently make include, may include, or may incorporate by reference certain statements that may be deemed to be “forward- looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and that are intended to enjoy the protection of the safe harbor for forward-looking statements provided by that Act. To the extent that any statements made in this report contain information that is not historical, these statements are essentially forward-looking. Forward-looking statements can be identified by the use of words such as “anticipate”, “estimate”, “plan”, “project”, “continuing”, “ongoing”, “expect”, “believe”, “intend”, “may”, “will”, “should”, “could”, or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. Forward looking statements contained in this Annual Report on Form 10-K include, but are not limited to statements about:

 

  the marketability of our products;

 

  financial condition and liquidity of our customers;

 

  competition in the hemp markets;

 

  conditions in the cryptocurrency mining industry, including any prolonged substantial reduction in cryptocurrency prices, and specifically, the value of bitcoin, which could cause a decline in the demand for the Company’s services;
     
  competition among the various providers of data mining services;
     
  industry and market conditions;

 

  purchases by major customers and our ability to renew sales contracts;

 

  credit and performance risks associated with customers, suppliers, banks and other financial counterparties;

 

  availability, timing of delivery and costs of key supplies, capital equipment or commodities;

 

  our future capital requirements and our ability to raise additional capital to finance our activities;

 

  the future trading of our common stock;

 

  legal and regulatory risks associated with OTC Markets;

 

  our ability to operate as a public company;

 

  our ability to protect our proprietary information;

 

  general economic and business conditions; the volatility of our operating results and financial condition;

 

  our ability to attract or retain qualified senior management personnel and research and development staff;

 

  timing for completion of major acquisitions or capital projects;

 

  our ability to obtain additional financing on favorable terms, if required, to complete acquisitions as currently contemplated or to fund the operations and growth of our business;

 

  operating or other expenses or changes in the timing thereof;

 

  compliance with stringent laws and regulations, as well as changes in the regulatory environment, the adoption of new or revised laws, regulations and permitting requirements;

 

  potential legal proceedings and regulatory inquiries against us; and

 

  other risks identified in this Quarterly Report that are not historical. 

 

You should not rely upon forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Annual Report on Form 10-K primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, results of operations and prospects. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors described in the section titled “Risk Factors” and elsewhere in this Annual Report on Form 10-K. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Annual Report on Form 10-K. We cannot assure you that the results, events and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements.

 

The forward-looking statements made in this Annual Report on Form 10-K relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements to reflect events or circumstances or to reflect new information or the occurrence of unanticipated events, except as required by law.

 

i

 

 

SUMMARY RISK FACTORS

 

The risk factors described below are a summary of the principal risk factors associated with an investment in us. These are not the only risks we face. The below summary is qualified in its entirety by that more complete discussion of such risks and uncertainties. You should carefully consider these risk factors, together with the risk factors set forth in “Item 1A. Risk Factors” of this Report and the other reports and documents filed by us with the U.S. Securities and Exchange Commission (“SEC”).

 

Risks Related to Our Business 

 

  There is substantial doubt that we will be able to continue as a going concern.
     
  We have a history of significant losses, which could continue in the future, and we may never achieve nor maintain profitability.
     
  Unfavorable global economic or political conditions could adversely affect our business, financial condition or results of operations.
     
  We have a limited operating history in two new sectors and operate under the professional guidance of our Chairman and CEO.
     
  We may be unable to manage our growth or implement our expansion strategy, especially in the bitcoin industry.
     
  The issuance of additional shares of our common stock may be necessary for the implementation of our growth strategy.
     
  The loss of our current chief executive officer or key management personnel or inability to attract and retain the necessary personnel could have a material adverse effect upon our business, financial condition or results of operations.
     
  Our Chief Executive Officer has significant influence over our operations.
     
  It is likely that conflicts of interest may arise in the day-to- day operations of our business. Such conflicts, if not properly resolved, could have a material negative impact on our business.
     
  Adverse outcomes in any future legal proceedings could subject us to substantial damages and adversely affect our results of operations and profitability.
     
  We will seek to expand through acquisitions of and investments in various brands, businesses, and assets in the Hemp sector. These acquisition activities may be unsuccessful or divert management’s attention.
     
  We risk insolvency if revenues decline sharply and we are unable pay our bills and unable to timely locate and negotiate a suitable business combination or capital injection.
     
  We are subject to certain corporate governance and internal control reporting requirements, and our costs related to compliance with, or our failure to comply with existing and future requirements, could adversely affect our business.
     
  Natural and other disasters, information technology system failures and network disruptions and cybersecurity breaches and attacks could adversely affect our business.
     
  Failure to comply with U.S. federal, state and international laws and regulations relating to privacy or data protection, or the expansion of current or the enactment of new laws or regulations relating to privacy or data protection, could adversely affect our business and our financial condition.

 

ii

 

 

  Hemp prices have historically been very volatile and can directly affect the desire or willingness of farmers to grow new hemp crops each year, which is necessary for us to maintain consistent drying operations.

 

Risks Related to our Activities in the Legal Hemp Industry

 

  We will be subject to a myriad of different laws and regulations governing hemp and bitcoin. Our inability to comply with such laws in a cost-effective manner may have an adverse effect on our business and result of operations.
     
  We have limited operating history in the legal hemp or cannabis industry, which makes it difficult to accurately assess our future growth prospects.
     
  Negative press from being in the hemp and/or bitcoin space could have a material adverse effect on our business, financial condition, and results of operations.

 

Risks Related to Ownership of Our Common Stock

 

  Our stock price has been and may continue to be volatile, and you could lose all or part of your investment.
     
  Our operating results will be subject to fluctuations and our stock price may decline significantly.
     
  There are restrictions on the transferability of certain of our securities.
     
  If the Company uses its stock in acquisitions of other entities, there may be substantial dilution at the time of a transaction.
     
  Trading on the OTC Markets can be volatile and sporadic, which could depress the market price of our common stock and make it difficult for our stockholders to resell their shares.
     
  The Company currently plans move to a more advantageous trading market and then potentially uplist, to a national exchange, however, there is no assurance that we will be able to successfully move trading markets or uplist to a national exchange.
     
  Because we do not expect to pay any dividends for the foreseeable future, investors may be forced to sell their stock to realize a return on their investment.
     
  Our common stock is presently subject to the “Penny Stock” rules of the SEC.
     
  If we fail to remain current on our reporting requirements, we could be removed from the OTCQB which would limit the ability of broker-dealers to sell our securities in the secondary market.
     
  If we ultimately decide to implement a reverse stock split in order to meet certain minimum stock prices required on a national exchange, the liquidity of the shares of our common stock will likely decrease accordingly.

 

iii

 

 

EVERGREEN SUSTAINABLE ENTERPRISES, INC.

(FORMERLY GENERATION HEMP, INC.)

 

FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2022

 

TABLE OF CONTENTS

 

  Page
PART I  
   
Item 1. Description of Business 1
Item 1A. Risk Factors 8
Item 1B. Unresolved Staff Comments 26
Item 2. Properties 26
Item 3. Legal Proceedings 26
Item 4. Mine Safety Disclosures 26
   
PART II  
   
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 27
Item 6. Reserved 28
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 28
Item 7A. Quantitative and Qualitative Disclosures about Market Risk 32
Item 8. Financial Statements and Supplementary Data F-1
Item 9. Changes In and Disagreements with Accountants on Accounting and Financial Disclosure 33
Item 9A. Controls and Procedures 33
Item 9B. Other Information 33
Item 9C. Disclosures Regarding Foreign Jurisdiction that Prevent Inspections 33
   
PART III  
   
Item 10. Directors, Executive Officers and Corporate Governance 34
Item 11. Executive Compensation 38
Item 12. Security Ownership of Certain Beneficial Owners and Management And Related Stockholder Matters 40
Item 13. Certain Relationships and Related Transactions and Director Independence 41
Item 14. Principal Accountant Fees and Services 42
Item 15. Exhibits and Financial Statement Schedules 43
Signatures 48

 

iv

 

 

PART I

 

Item 1. Business

 

Overview

 

Evergreen Sustainable Enterprises, Inc. (formerly Generation Hemp, Inc.) (the “Company” or “Evergreen Sustainable”), was incorporated on August 21, 2021 in the State of Delaware. The Company was originally incorporated on July 28, 2008 in the State of Colorado. On November 27, 2019, Home Treasure Finders, Inc. (“HTF”) acquired approximately 94% of the common stock of Energy Hunter Resources, Inc. (“EHR”) in a series of transactions accounted for as a reverse merger (the “Transaction”). Upon closing of the Transaction, HTF changed its name to Generation Hemp, Inc. In March 2023, the Company changed its name to Evergreen Sustainable Enterprises, Inc.

 

On January 11, 2021, we completed the acquisition of certain assets of Halcyon Thruput, LLC (“Halcyon”). With this acquisition, we commenced providing post-harvest and midstream services to growers by drying, processing, cleaning and stripping harvested hemp directly from the field and wetbaled at our 48,000 square foot leased facility located in Hopkinsville, Kentucky. Additionally, the Company offers safe storage services for processed hemp, which enables farmers to maximize strategic market timing. In September 2021, the Company launched its small animal bedding consumer goods product line (“Rowdy Rooster”) made from the hemp hurd byproduct that is produced from its hemp processing operations. In September of 2022, the Company launched its industrial absorbent consumer goods product line (Gas Monkey Spill-Jack), also made from the hemp hurd byproduct produced from its hemp processing operations. This second product line is marketed under a branding agreement with Gas Monkey Garage, a well-known brand in the automotive and entertainment sector.

 

 We also generate revenue from rental of our “Cannabis Zoned” (Hemp) warehouse property located in Denver, Colorado currently leased to an unaffiliated hemp seed company.

 

As of December 31, 2022, EHR held an approximate 8% working interest in an oil & gas property located in Cochran County, Texas within the Slaughter-Levelland Field of the San Andres formation in the Northwest Shelf of West Texas. EHR’s oil & gas activities are currently held for sale and are presented in these consolidated financial statements as discontinued operations for each of the periods presented.

 

Our management team has been and continues to actively review acquisition candidates involved in the hemp industry that operate within a number of vertical businesses, predominantly within the midstream sector that are attractive to us and are within the hemp supply chain.

 

To fund our business activities, we have historically completed a number of private placements of equity and debt. We continue to seek additional public or private placements of our stock and debt. Our common shares are quoted on the OTCQB Markets under the symbol “EGSE.”

 

Subsequent Events

 

In January 2023, the Company announced a new strategic direction into sustainable energy projects, starting with bitcoin mining. The Company’s name was changed to Evergreen Sustainable Enterprises, Inc. (“EGSE”) in March 2023. The Company’s existing hemp operations will continue to be maintained as a fully operating wholly-owned subsidiary.

 

On January 9, 2023, the Company purchased 80% of Toro Energía Sociedad Anonima (“Toro”), a Costa Rican corporation with ownership of a hydroelectric dam in Costa Rica. The source of approximately one megawatt of power produced from the hydroelectric dam (six generators) will be used to power new Bitcoin mining machines at an extremely low cost. The transaction was completed based on a total enterprise value for Toro of $2,750,000, including seller-financed debt of $985,000. The seller-financed debt has a term of 10 years and a 9.5% per annum variable interest rate (based on the prime rate) with straight line amortization.

 

The purchase price for 80% of Toro’s equity was $1,412,000. These amounts were paid in cash from proceeds of a Secured Promissory Note (“Secured Note”) with Gary C. Evans, CEO of the Company (‘Evans”). Under the terms of the Secured Note, (a) the Company and Evans restructured (i) the Subordinated Promissory Note, dated November 20, 2020 and (ii) Convertible Promissory Note, dated July 20, 2021, such that all accrued and unpaid interest on each note were rolled into a new Secured Note, (b) Evans lent the Company $500,000 on January 9, 2023 and $969,000 on January 10, 2023. The Secured Note has a maturity date of July 15, 2023 and bears interest at the rate of 10.00% per annum. The Secured Note has a conversion feature which permits Evans to convert at the Maturity Date then outstanding principal and interest at a conversion price of $0.275 (the closing price of the Company’s stock on January 9, 2023).

  

1

 

 

The Toro Dam is located approximately 25 miles from San Jose between two volcano craters. The site generates all its energy from green resources with a proven 98% run time over the many years it has been in operation and has a full-time staff in place under a new Operating & Maintenance Agreement.

 

Hydroelectric power is a clean and renewable energy source that is used to generate electricity by harnessing the energy of falling water and can provide a reliable and a very cost-effective source of energy for bitcoin mining operations. Hydroelectric power can help reduce the carbon footprint of cryptocurrency mining, as many cryptocurrencies are produced using fossil fuels, which continues to contribute to greenhouse gas emissions and climate change. By using hydroelectric power, bitcoin mining can be made more environmentally friendly and sustainable and can help improve the stability and reliability of cryptocurrency networks. Hydroelectric power is a relatively stable and reliable source of energy, compared to other sources such as coal or fossil fuels, which can be prone to price fluctuations and supply disruptions. The Company has committed to acquire and made financial payments for the purchase of 240 new Bitmain S19J Pro+ ASIC miners that will be deployed at the Toro Dam sometime in the first quarter of 2023.

 

Corporate Structure

 

The Company’s business operations are conducted through several operating subsidiaries with its core operational and business activities directed through Evergreen Sustainable. These subsidiaries are listed below:

 

GENH Halcyon Acquisition, LLC– Hemp midstream processing operations and hemp consumer goods products

 

CryptoRica, LLC –Bitcoin mining operations located in Costa Rica

 

Razorback I, LLC –Bitcoin mining operations located in Arkansas

 

Bluegrass I, LLC– Bitcoin mining operations located in Kentucky

 

Energy Hunter Resources, Inc.– Energy operations

 

Principal Services and their Markets

 

The Company has diversified itself to take advantage of the two developing industries of industrial hemp and bitcoin mining. Within both industries, there are vast opportunities to embody and drive environmental, social, and corporate governance (“ESG”) advancements. Within its hemp operations and product lines, the Company continues to be a leader in building out the infrastructure to support the fiber and hurd hemp supply chain for industrial applications. Within its bitcoin mining operations and developing bitcoin mining operations, the Company is primarily utilizing diversified green energy sources to power modular bitcoin mining arrays and targeting rural or remote areas that benefit both residents and local utilities.

 

In addition to our hydroelectric powered bitcoin operations in Costa Rica, the Company is in development on several bitcoin mining arrays in several rural or remote U.S. locations. We have two bitcoin mining arrays in development in Arkansas, an eight (8) megawatt array in south central Arkansas. We also have three bitcoin mining arrays located in Kentucky, a five (5) megawatt array in Carter County and two additional sites in various stages of development in Greenup County and again in Carter County that will potentially be a total of an additional eighteen (18) megawatts, including a site that is in-part powered with hydroelectricity.

 

Our hemp processing operations provide post-harvest and midstream services to growers by drying, processing, cleaning, stripping harvested hemp directly from the field and wetbaled at our leased 48,000 square foot facility located in Hopkinsville, Kentucky. The drying services technology greatly increases efficiency and capacity during harvest for farmers who need to quickly move harvested hemp while preserving the cannabinoid potency by providing scalable infrastructure essential to receive and process hemp with high moisture content (“wet”) quickly. Additionally, the Company offers safe storage services for processed hemp, which enables farmers to maximize strategic market timing. The midstream business is fee income oriented, based upon a price per pound of material handled, and therefore is more protected from significant commodity price variations. The facility is able to process approximately 10,000 wet pounds per hour and the potential to scale up to 20,000 wet pounds per hour in order to meet market demands as licensed and harvested hemp acreage continues to increase across Kentucky, Tennessee, Ohio, Alabama and other states.

 

We also own one industrial warehouse located in Denver, Colorado and lease 100% of this space within that project to aid a licensed hemp seed grower. We exercise appropriate and reasonable care to screen our tenants, require and verify that our tenants maintain proper licenses and operate in compliance with all applicable rules and regulations at the federal, state, and local level.

 

We may own properties for our own investment account and as such are solely at financial risk in connection with our investments. In the event we utilize funds loaned to us by third party groups, they may in some circumstances share certain risks.

 

We do not grow, distribute or sell any form of cannabis. We have no present plan to engage in such activities or obtain a license to do so, now, or in the future. We currently plan to only operate in the hemp space. We are in the process of expanding our operations into other states, predominantly Kentucky and North Carolina.

 

2

 

 

Marketing of our Services

 

The market, clients, customers and distribution methods for hemp services and hemp-based products are large and diverse. These markets range from hemp mid-stream services for hemp growers/farmers, to hemp derived products like bioplastics, textiles, building materials, food additives, and dietary supplements.  Awareness and demand continue to grow for “green,” environmentally-friendly products derived from hemp, and the consumer market has already begun to integrate hemp products and products that contain hemp derivatives to existing product lines.  The distribution system is constantly evolving as small retailers, retail chains, and big box stores become increasingly educated on and familiar/comfortable with hemp and its derivatives.  The current market is focused on one of the cannabinoids derived from hemp called cannabidiol (“CBD”) and consumer goods that contain CBD. Additionally, consumer awareness followed by increased demand continues to drive and even force companies to make room on their shelves for hemp and products with hemp derivatives.  For products with hemp derivatives like CBD, direct to consumer Ecommerce through online store sales remains the main source of revenue for consumer goods companies, accounting for reported percentages of approximately 70-80% of sales.  

 

The Company continues to implement a plan to become more diversified within the midstream market.  Our marketing efforts began with a grass roots approach in order to meet with farmers, growers, and seed operations that would benefit from midstream services.  To supplement the grass roots outreach, we built our online web presence to reflect our desire to educate, to become a contributor and part of the hemp community, and also to act as a pioneer company to connect investors in the U.S. public markets to a hemp education and platform that is dually informed. 

 

We maintain and update our website and engage on social media platforms to market our ongoing hemp sector efforts.  We use globally distributed YouTube video ad campaigns to increase our brand awareness and encourage markets and the investment community to learn more about the hemp space. These videos have been played on several business sites such as CNBC, MSNBC, Fox News, Fox Business, Yahoo Finance, among others.  We have also begun to market a version of “Fireside Chats” from our Chairman and CEO to talk about various topics of interest in the hemp space.  These video segments will post on our social media platforms and they will also be used to create awareness campaigns that should have a global outreach.  In order to reach region specific growers/farmers in hemp, we have teed up direct mail marketing materials which prove effective for service markets within a specified radius.  These materials will serve as invitations to the farmers and growers in areas that the midstream services which we are acquiring will reach.  These are designed to add an identity to the midstream facility and provide an offer of help and partnership.  As we continue to become involved with additional verticals in the hemp supply chain, we will expand and tailor these marketing and advertising efforts to the specific needs of each segment. To-date all marketing, ad creation, ad campaigns, and creative work has been done internally and with a minimal budget. The Company has consistently presented at, and/or exhibited in a number of industry tradeshows, and conferences and small cap investor conferences.

 

In 2021, we increased our marketing efforts by engaging several industry and investor media platforms by providing or collaborating on sponsored content in the form of articles, interviews, and podcasts in order to continue to educate the public and investors on the hemp industry and our company’s various products, services, and business plan. We have been featured on USA Today, Small Caps Daily, Benzinga, Reddit, and Cannabis Wealth Magazine. Gary C. Evans has also been a guest on KRLD News Radio Dallas to discuss the Company, along with several podcasts and webinars. We have also continued to build out our social media presence on Instagram, TikTok, Facebook (Meta), Twitter, LinkedIn, and YouTube. We are attempting to post video and/or static posts at least twice per week and designing content based on statistical data of engagement metrics – what content is trending, what users are most responsive to, and what times receive the most user reach and engagement. For reference, when comparing social media engagement from October 18, 2021 – December 28, 2021 to the same period for 2020, reach increased by 4,912% and engagement increased by 420% due to these efforts by management and the social media team.

 

On February 17, 2022, we executed a merchandise licensing agreement with world-renowned brand, Gas Monkey Garage. The Company will manufacture a USA grown hemp hurd spill absorbent and market this new product under the Gas Monkey brand name to consumers, retailers, and distributors as an environmentally sustainable, USA made, ultra-absorbent spill clean-up material. This will be our second environmentally sustainable consumer goods product line made from U.S. grown hemp hurd. Spill absorbents are typically used in garages, factories, or industrial settings to quickly contain spills of oil and other liquids. Spill absorbents are also used at the site of auto accidents to quickly contain leaks of oil and other fluids due to collisions.

 

Richard Rawlings, owner and founder of Gas Monkey Garage, is the star of the international hit series’ “Fast N’ Loud” & “Garage Rehab” spanning 17+ seasons and 200+ episodes. Mr. Rawlings and Gas Monkey have migrated the show to an online platform and consistently produce new episodes that premiere every week on YouTube and Facebook. With his experience of owning and running a garage for over 18 years, Richard Rawlings found the sustainable spill absorbent to be of great significance.

 

3

 

 

There are several types of spill absorbents with varying characteristics. These are in three general categories – mineral based, animal or vegetable based, and synthetic or organic polymers. The challenge in choosing an absorbent is finding an effective absorbent that does not pose a threat to health or the environment, whether that threat is posed when that material is procured or used. For example, a widely used spill absorbent material in products is Bentonite Clay. This is often a very dusty material and has warnings of containing unsafe levels of lead (FDA) and is associated with a number of health complaints in humans.

 

The Company tested its U.S. grown and milled hemp hurd against currently used absorbents on the market and the findings showed it to have as effective or more effective absorbency and ability to contain spills.

 

In February of 2023, the Company began working with iHeart Media, one of the most influential media companies with several different marketing and advertising channels (radio, television, digital, etc.). iHeart Media agreed to drastically reduce their typical budget requirements in order to foster a growth relationship with the Company. The first campaigns, called OTT (Over-The-Top), are targeting specific consumers, and will air before streaming television and film content played on various internet streaming digital platforms. Initially, these campaigns are advertising the Company’s consumer goods products.

  

Competition

 

The hemp industry and hemp-based consumer product industry is highly competitive and fragmented in its nascency with numerous companies, consisting of publicly (mostly Canadian) and privately-owned companies. There are also large, well-funded companies beginning to emerge in the U.S. with a similar intention as the Company; to consolidate and vertically integrate along the hemp supply chain through acquisitions. These companies have indicated their intention to compete in the hemp industry and hemp-based product category. However, certain holding companies such as Acreage Holdings (domiciled in British Columbia) also include cannabis companies in their portfolio, whereas the Company is currently hemp only. We routinely evaluate internal and external opportunities to optimize value for shareholders through market research, strategic relationships and/or partnerships, and by asset acquisitions. Based upon our management team experience, we believe we are well-positioned to capitalize in the growing hemp industry and hemp-based product industry. 

 

There are several companies developing hemp-based products and materials that will potentially displace existing products and materials sourced from less sustainable or less environmentally friendly sources. These hemp-based products are developing in the markets of textiles, building materials, biofuels, as food additives, skin care topicals and other therapeutics, and dietary supplements. Also, it is thought that cannabinoids derived from hemp can be used as therapeutics for a range of medical indications. The hemp-derived cannabinoid therapeutic market currently includes extracts of the hemp plant in several formulations, including proprietary formulations from several companies. These formulations include CBD and other cannabinoid such as,” CBG”, “CBC”, and “CBN” or a combination of several cannabinoids as the active ingredients. There are over one hundred different cannabinoids, therefore the market potential is only beginning to be realized. The therapeutics and supplement market are flooded with competition for hemp-based cannabinoid therapeutics. There are also companies that are using hemp-based cannabinoids as active ingredients in pharmaceutical formulations.

 

Bitcoin mining is an increasingly competitive industry comprised of companies and organizations of varying scale and sophistication. There has been a significant increase in the number of commercial bitcoin miners attempting to expand and scale their mining operations, which in turn has contributed to increasing the global network’s total hash power. As more hashing capability is added to the bitcoin network, the revenue generating potential of the Company’s miners could be negatively affected. Additionally, as more bitcoin miners enter the industry, The Company may experience additional pressure on profitability and ability to scale operations, due to greater competition for access to miners, mining locations, and infrastructure components.

 

Our Competitive Strengths

 

We believe that we have the following competitive strengths:

 

  Experienced and Committed Management Team. Gary C. Evans, our CEO, and other anticipated members of our senior management team have substantial experience in all aspects of growing a public company in a highly competitive sector, including acquisitions, dispositions, construction, development, management, finance and capital markets. Mr. Evans has previously been the Chairman and CEO of three different public companies that obtained financial success on the New York Stock Exchange. Additionally, he previously served as Chairman, CEO, and Lead Director of a NASDAQ listed company in the biopharmaceutical space for 24 years, having just resigned in 2021.
     
  Focus on Consolidating Atomized Industry. Our focus on revenue generating and positive cash flow businesses is a key part of our growth strategy. Moreover, we believe the beginning of an entire new industry creates numerous opportunities to evaluate and consolidate very fragmented businesses. Our ultimate goal of being a more fully integrated enterprise within the midstream sector will eventually give us control of very profitable values chain and separate us from most of our competition.
     
  Demonstrated Investment and Capital Raising Acumen. We will continue to utilize rigorous underwriting standards for evaluating acquisitions and potential tenants to ensure that they meet our strategic and financial criteria. Our management team’s extensive experience and relationships established in mergers and acquisitions over the past 40 years and over 100 separate transactions should enable us to identify, negotiate and close on acquisitions cost effectively, efficiently, and with shareholder interest first in mind.

 

4

 

 

Intellectual Property

 

As a company within the hemp industry, our current effort is to protect and distinguish our company and brand identity amidst other entities currently operating within and entering the space.

 

The Company uses specific hardware and software for its bitcoin mining operations. In certain cases, source code and other software assets may be subject to an open-source license due to the fact that the majority of the technology in the blockchain and cryptocurrency sectors is open source For these works, we adhere to the terms of any license agreements that may be in place. The Company does not currently own, and does not have any current plans to seek, any patents in connection with its existing and planned blockchain and cryptocurrency related operations. The Company expects to rely upon trade secrets, trademarks, service marks, trade names, copyrights and other intellectual property rights and to license the use of intellectual property rights owned and controlled by others.

 

Governmental Regulation

 

Hemp Industry

 

We are subject to local and federal laws in our operating jurisdictions. We will hold required licenses for product production and distribution to the extent that our business requires and will monitor changes in laws, regulations, treaties and agreements.

 

The Agriculture Improvement Act of 2018 known as the “2018 Farm Bill,” is United States federal legislation signed into law on December 20, 2018, which provides much of the legal framework for the hemp-based CBD product category. The 2018 Farm Bill permanently removed “hemp” from the purview of the Controlled Substances Act, and accordingly, the Drug Enforcement Administration (“DEA”) no longer has any claim to interfere with the interstate commerce of hemp products. Some of the immediate impact from this legislation includes the ability for farmers to access crop insurance and U.S. Department of Agriculture programs for certification and competitive grants. While the DEA is now officially not involved in hemp regulation, the FDA retains its authority to regulate ingestible and topical products, including those that contain hemp and hemp extracts such as CBD.

 

A range of federal regulations govern any potential product development, manufacturing, distribution, sales and marketing, including the Dietary Supplement Health and Education Act of 1994 (the “DSHEA”). Under DSHEA, supplements are effectively regulated by the FDA for Good Manufacturing Practices under 21 CFR Part 111. DSHEA defines a “dietary supplement” as a product intended to supplement the diet that contains one or more of the following: (a) a vitamin; (b) a mineral; (c) an herb or other botanical; (d) an amino acid; (e) a dietary substance for use by man to supplement the diet by increasing the total dietary intake; or (f) a concentrate, metabolite, constituent, extract, or combination of any ingredient described in clause (a) through (e). Thus, the law permits a wide range of dietary ingredients in dietary supplements, including CBD which is an extract of a botanical (Cannabis sativa L. plant). CBD also falls under clause (e) as it is a dietary substance for use by man to supplement the diet by increasing the total dietary intake.

 

Blockchain and Cryptomining

 

Government regulation of blockchain and cryptocurrency mining industries is being actively considered by the United States federal government via several agencies and regulatory bodies as well as similar entities in other countries. State government regulations also may apply to the Company’s activities and other activities in which the Company participates or may participate in the future. Other regulatory bodies are governmental or semi-governmental and have shown an interest in regulating or investigating companies engaged in the blockchain or cryptocurrency mining business.

 

Businesses that are engaged in the transmission and custody of bitcoin and other digital assets, including brokers and custodians, can be subject to the regulations of the U.S. Department of the Treasury (the “Treasury”) as money services businesses as well as state money transmitter licensing requirements. Bitcoin and other digital assets are subject to anti-fraud regulations under federal and state commodity laws, and digital asset derivative instruments are substantively regulated by the Commodity Futures Trading Commission. Certain jurisdictions, including, among others, the State of New York and a number of countries outside the United States, have developed regulatory requirements specifically for digital assets and companies that transact in them.

 

5

 

 

Regulations may change substantially in the future, and it is presently not possible to know how regulations will apply to the Company’s business or when they will become effective. As the regulatory and legal environments evolve, The Company may become subject to new laws and further regulation by the SEC and other agencies, which may affect its mining and other activities. For instance, various bills have been proposed in the U.S. Congress related to The Company’s business, which may be adopted and have an impact on the Company. See “Risk Factors” for additional discussion regarding the Company’s belief about the potential risks that existing and future regulations pose to its business.

 

On March 2, 2022, the United States announced plans to establish a unified federal regulatory regime for cryptocurrency, and a group of United States Senators sent a letter to the United States Treasury Department asking Treasury Secretary Yellen to investigate Treasury’s ability to monitor and restrict the use of cryptocurrencies to evade sanctions imposed by the United States.

 

In September 2022, the White House issued a report regarding the Climate and Energy Implications of Crypto-Assets in the United States. The report states that the Department of Energy and Environmental Protection Agency should initiate a process to solicit data and develop environmental performance and energy conservation standards for crypto-asset technologies, including mining equipment. Should such measures prove ineffective at achieving the Administration’s environmental goals, the report calls for the Administration to explore executive actions and legislation to limit or eliminate the use of high energy intensity consensus mechanisms for crypto-asset mining.

 

We are unable to predict the impact that any new standards, legislation, or regulations may have on our business at the time of filing this Annual Report. We continue to monitor and proactively engage in dialogue on regulatory and legislative matters related to our industry.

 

Further, in December 2022 the SEC’s Division of Corporation Finance issued guidance advising companies to disclose exposure and risk to the cryptocurrency market. While the focus is on digital asset managers and exchanges, and not bitcoin miners, the failure of such large asset managers and exchanges may create increased price volatility of bitcoin. the Company does not store our bitcoin on such exchanges; however, we may be impacted by such failures.

 

In January 2023, the Federal Reserve, Office of the Comptroller of the Currency, and Federal Deposit Insurance Corporation issued a joint statement discouraging banks from doing business with clients in crypto-asset industries. In January 2023, the Federal Reserve also issued a policy statement broadening its authority to cover state-chartered banks.

 

Also in January 2023, the House of Representatives announced its first ever Financial Services Subcommittee on Digital Assets and the intention to develop a regulatory framework for the digital asset industry. The bipartisan leadership of the Senate Banking Committee announced that goal as well.

 

As the regulatory and legal environment evolves, we may become subject to new laws, such as further regulation by the SEC and other agencies, which may affect our mining and other activities. For additional discussion regarding our belief about the potential risks existing and future regulation pose to our business, see Part I, Item 1A. “Risk Factors” of this Annual Report.

 

Additionally, we are subject to numerous federal, state and local environmental laws and regulations. Numerous governmental agencies, such as the U.S. Environmental Protection Agency and analogous state and provincial agencies issue regulations to implement and enforce these laws, which often require stringent and costly compliance measures. These laws and regulations may, among other things, require the acquisition of permits; govern the amounts and types of substances that may be released into the environment in connection with our operations; restrict the way we handle or dispose of our materials and wastes; or require investigatory and remedial actions. Failure to comply with these laws and regulations may result in the assessment of substantial administrative, civil and criminal penalties, the imposition of investigatory, remedial or corrective action obligations, or the possible issuance of injunctions limiting or prohibiting our activities. In addition, some laws and regulations relating to the protection of the environment may, in certain circumstances, impose liability for environmental damages and cleanup costs without regard to negligence or fault. Complying with these regulatory requirements may increase our cost of doing business and consequently affect our profitability. Moreover, environmental laws and regulations have been subject to frequent changes over the years, and the imposition of more stringent requirements could have a material adverse effect upon our capital expenditures, earnings or our competitive position. We believe that our existing environmental control procedures are adequate and we have no current plans for substantial capital expenditures in this area that would materially and adversely affect our business, financial condition or results of operations.

 

6

 

 

Environmental Matters

 

Compliance with federal, state and local requirements regulating the discharge of materials into the environment, or otherwise relating to the protection of the environment, have not had, nor are they expected to have, any material effect on the capital expenditures, earnings or competitive position of the Company.

 

Employees

 

We had 11 employees as of December 31, 2022, including our named executive officers. None of our employees are covered by collective bargaining agreements, and we have not experienced any strikes or work stoppages related to labor relation issues. We believe we have good relations with our employees. We also utilize seasonal part-time employees during peak hemp processing season and contractors to provide certain specialized skills and expertise that may be required from time to time.

 

Where You Can Find More Information

 

We file annual, quarterly and current reports, proxy statements and other information required by the Securities Exchange Act of 1934, as amended (the “Exchange Act”), with the Securities and Exchange Commission (the “SEC”). You may read and copy any document we file with the SEC at the SEC’s public reference room located at 100 F Street, N.E., Washington, D.C. 20549, U.S.A. Please call the SEC at 1-800-SEC-0330 for further information on the public reference room. Our SEC filings are also available to the public from the SEC’s internet site at http://www.sec.gov.

 

On our Internet website, http://www.genhempinc.com, we post the following recent filings as soon as reasonably practicable after they are electronically filed with or furnished to the SEC: our annual reports on Form 10-K, our quarterly reports on Form 10-Q, our current reports on Form 8-K, and any amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act.

 

7

 

 

Item 1A. Risk Factors

 

Our business involves certain risks and uncertainties. The following is a description of significant risks that might cause our future financial condition or results of operations to differ materially from those expected. In addition to the risks and uncertainties described below, we may face other risks and uncertainties, some of which may be unknown to us and some of which we may deem immaterial. If one or more of these risks or uncertainties occur, our business, financial condition or results of operations may be materially and adversely affected.

 

Risks Related to Our Business

 

There is substantial doubt that we will be able to continue as a going concern.

 

Our independent registered public accounting firm’s auditors’ report includes an explanatory paragraph stating that there is substantial doubt about our ability to continue as a going concern. We have had substantial losses since inception and as of December 31, 2022, and the date of this report we have minimal cash reserves. While we are beginning to generate increasing revenue and a positive cash flow, our ability to build significant cash reserves and continue as a going concern over the long term remains unproven. In the event that we are forced to reduce operations or seriously curtail our business, an investor will lose all money invested.

 

We have a history of significant losses, which we expect to continue, and we may never achieve nor maintain profitability.

 

We have incurred significant net losses since our formation and may continue to incur net losses for the foreseeable future as we complete our acquisition efforts. We incurred net losses of $7.0 million and $9.8 million for the years ended December 31, 2022 and 2021, respectively. To date, we have not generated any significant revenues from the hemp business. If we are unsuccessful in implementing our strategic plan we may never become profitable.

 

Business interruptions resulting from the coronavirus disease (COVID-19) outbreak or similar public health crises could cause a disruption of the development of our product candidates and adversely impact our business.

 

In March 2020, the World Health Organization declared the novel coronavirus disease (COVID-19) outbreak a global pandemic. To limit the spread of COVID-19, governments have taken various actions including the issuance of stay-at-home orders and physical distancing guidelines. Accordingly, businesses have adjusted, reduced or suspended operating activities. We may experience disruptions as a result of COVID-19 that could severely impact our business and planned acquisition strategy, including:

 

  challenges related to ongoing and increased operational expenses related to the COVID-19 pandemic;

 

  delays, difficulties or increased costs to comply with COVID-19 protocols;

 

  limitations in resources that would otherwise be focused on the conduct of our business, including because of sickness or the desire to avoid contact with large groups of people or as a result of government-imposed “Stay-at-Home” orders or similar working restrictions;

 

  delays in receiving the supplies and materials needed to operate our business;

 

  interruption in global shipping that may affect the transport of materials or our supply chain;

 

  changes in regulations as part of a response to the COVID-19 pandemic which may require us to change the ways in which our business may be conducted, or which may result in unexpected costs;

 

  delays in necessary interactions with regulators and other important governmental agencies and contractors due to limitations in employee resources or forced furlough of personnel; and

 

  increased competition for suppliers and vendors.

 

We will continue to assess the impact that COVID-19 may have on our ability to effectively conduct our business operations as planned and there can be no assurance that we will be able to avoid a material impact on our business from the spread of COVID-19 or its consequences, including disruption to our business and downturns in business sentiment generally or in our industry. Should COVID-19 cases in USA increase, the country or states may institute stricter social distancing protocols.

 

8

 

 

The global outbreak of COVID-19 continues to rapidly evolve. The extent to which the COVID-19 pandemic impacts our business will depend on future developments such as the rate of the spread of the disease, travel restrictions and social distancing in the United States and other countries, business closures or business disruptions and the effectiveness of actions taken in the United States and other countries to contain and treat the disease and to address its impact, including on financial markets or otherwise. Further, a lack of coordinated response on risk mitigation and vaccination deployment with respect to the COVID-19 pandemic on a local or federal level could result in significant increases to the duration and severity of the pandemic in the United States as compared to the rest of the world and could have a corresponding negative impact on our business. While the extent of the impact of the current COVID-19 pandemic on our business and financial results is uncertain, a continued and prolonged public health crisis such as the COVID-19 pandemic could have a material negative impact on our business, financial condition and operating results.

 

To the extent the COVID-19 pandemic adversely affects our business, financial condition and operating results, it may also have the effect of heightening many of the risks described in this “Risk Factors” section.

 

Unfavorable global economic or political conditions could adversely affect our business, financial condition or results of operations.

 

Our results of operations could be adversely affected by general conditions in the global economy and in the global financial markets. A global financial crisis or a global or regional political disruption could cause extreme volatility in the capital and credit markets. For example, outbreaks of epidemic, pandemic, or contagious diseases, such as the recent COVID-19 outbreak, could disrupt our business. Business disruptions could include disruptions to the productivity of our employees working remotely and restrictions on their travel may hinder their ability to meet with potential customers and close transactions, as well as temporary closures of the facilities of suppliers or contract growers as we try to develop our supply chain. In addition, the COVID-19 outbreak may result in a severe economic downturn and has already significantly affected the financial markets of many countries. A severe or prolonged economic downturn or political disruption could result in a variety of risks to our business, including our ability to raise capital when needed on acceptable terms, if at all. A weak or declining economy or political disruption could also strain our operations, possibly resulting in a future supply disruption, or cause our future customers to delay making payments for our services. Any of the foregoing could harm our business and we cannot anticipate all of the ways in which the political or economic climate and financial market conditions could adversely impact our business.

 

We have a limited operating history and operate under the professional guidance of our Chairman and CEO.

 

Our ability to achieve consistent cash flow and profitability depends upon the continued service of Gary C. Evans. Mr. Evans is our Chairman and CEO, largest shareholder, and the primary management level executive.

 

Our business plan provides that we will grow the Company’s asset base and revenues rapidly and ultimately deliver a positive cash flow generating company.

 

We may not be able to generate predictable and continuous revenue in the future. Further, there is no assurance that we will ever grow operations in the manner contemplated.

 

We may incur significant operating losses in the future, due to the expansion of our operations or other factors. There is no assurance that we can expand under terms that permit profitable operations over the long term. Failure to generate sufficient revenue to pay expenses as they come due may make us unable to continue as a going concern and result in the failure of our company and the complete loss of any money invested to purchase our shares.

 

We may be unable to manage our growth or implement our expansion strategy, especially in the bitcoin industry.

 

As a public company, our expenses include, but are not limited to, annual audits, legal costs, SEC reporting costs, costs of a transfer agent and the costs associated with fees and compliance. Further, our management will need to invest significant time and energy to stay current with the public company responsibilities of our business and may from time to time have diminished time available to apply to other tasks necessary to our survival and growth.

 

It is therefore possible that the financial and time burdens of operating as a public company will cause us to fail to achieve profitability. If we exhaust our funds, our business will fail and our investors will lose all money invested in our stock.

 

If we fail to pay public company costs, as such costs are incurred; we could become delinquent in our reporting obligations and face the delisting of our shares.

 

It is essential that we grow our overall business, achieve significant profits and maintain adequate cash flow in order to pay the cost of remaining a public entity which includes but is not limited the costs of remaining current with SEC reporting obligations.

 

9

 

 

The issuance of additional shares of our common stock may be necessary for the implementation of our growth strategy.

 

Limited private placement of restricted shares of our common stock has been completed from time to time when deemed necessary. Cash generated in prior years was used to acquire cannabis zoned real property, finance our office space and provide working capital.  Issuance of any additional securities pursuant to future fundraising activities undertaken may significantly dilute the ownership of existing shareholders and may reduce the price of our common stock.

 

We acquired, improved and leased our Denver warehouse to a licensed third party hemp seed grower. Rental payments are current and the warehouse is presently reflecting positive cash flow.

 

While we have been able to acquire a warehouse in Denver, Colorado with owner financing, future acquisitions may require financial resources well in excess of our present balance sheet. Failure to successfully obtain additional funding would likely jeopardize our ability to expand our hemp business and related operations.

 

The loss of our chief executive officer or key management personnel or inability to attract and retain the necessary personnel could have a material adverse effect upon our business, financial condition or results of operations.

 

Our success is heavily dependent on the continued active participation of our chief executive officer, largest shareholder, and sole director listed under “Management.” Loss of the services of Mr. Evans, would have a material adverse effect upon our business, financial condition or results of operations. Further, our success and achievement of our growth plans depend on our ability to recruit, hire, train and retain other highly qualified technical, professional, clerical, administrative and managerial personnel. Inability to attract and retain the necessary personnel, consultants and advisors could have a material adverse effect on our business, financial condition or results of operations.

 

Our Chief Executive Officer has significant influence over us.

 

Our Chief Executive Officer has the ability to influence all of our business affairs.

  

It is likely that conflicts of interest may arise in the day-to- day operations of our business.  Such conflicts, if not properly resolved, could have a material negative impact on our business.

 

In the past, the Company has issued shares for cash and services at prices which were solely determined by prior management. At that time, management made a determination of both the value of the exchange for our shares, and, as well, the price per share used in the capital raising effort. Transactions of this nature were not made at arm’s length and were made without input from a knowledgeable and non-interested third party.  Future transactions of a like nature could dilute the percentage ownership of the company owned by a given investor. While the company believes its past transactions were appropriate, and plans to act in good faith in the future, an investor in our shares will have no ability to alter such transactions as they may occur in the future and, further, will not be consulted by the company in advance of any such transactions. An investor who is unwilling to endure such potential dilution should not purchase our shares.

 

Adverse outcomes in any future legal proceedings could subject us to substantial damages and adversely affect our results of operations and profitability.

 

We may become party to legal proceedings, including matters involving personnel and employment issues, personal injury, environmental matters, and other proceedings. Some of these potential proceedings could result in substantial damages or payment awards that exceed our insurance coverage. We will estimate our exposure to any future legal proceedings and establish provisions for the estimated liabilities where it is reasonably possible to estimate and where an adverse outcome is probable. Assessing and predicting the outcome of these matters will involve substantial uncertainties. Furthermore, even if the outcome is ultimately in our favor, our costs associated with such litigation may be material. Adverse outcomes in future legal proceedings or the costs and expenses associated therewith could have an adverse effect on our results of operations.

 

10

 

 

We will seek to expand through acquisitions of and investments in various brands, businesses, and assets in the Hemp sector. These acquisition activities may be unsuccessful or divert management’s attention.

 

We will consider strategic and complementary acquisitions of and investments in other brands, businesses or other assets in the hemp sector, and such acquisitions or investments are subject to risks that could affect our business, including risks related to:

 

  the necessity of coordinating geographically disparate organizations;
     
  implementing common systems and controls;
     
  integrating personnel with diverse business and cultural backgrounds;
     
  integrating acquired manufacturing and production facilities, technology and products;
     
  unanticipated expenses related to integration, including technical and operational integration;
     
  increased costs and unanticipated liabilities, including with respect to registration, environmental, health and safety matters, that may affect sales and operating results;
     
  retaining key employees;
     
  obtaining required government and third-party approvals;
     
  legal limitations in new jurisdictions;
     
  installing effective internal controls and audit procedures;
     
  issuing common stock that could dilute the interests of our existing stockholders;
     
  spending cash and incurring debt;
     
  assuming contingent liabilities; and
     
  creating additional expenses.

 

We may not be able to identify opportunities or complete transactions on commercially reasonable terms, or at all, or actually realize any anticipated benefits from such acquisitions or investments. Similarly, we may not be able to obtain financing for acquisitions or investments on attractive terms. In addition, the success of any acquisitions or investments also will depend, in part, on our ability to integrate the acquisition or investment with our then existing operations.

 

We risk insolvency if revenues decline sharply and we are unable pay our bills and unable to timely locate and negotiate a suitable business combination or capital injection.

 

Management is always concerned over potentially unfavorable events and related sharp reductions in revenues. If such problems occur, we will first reduce expenses, conserve cash and endeavor to replace lost revenue. In anticipation of possible problems of this nature, and alternatively to grow our business when opportunity presents, management has continued its negotiations in connection with potential business combinations and continues to explore other means of raising cash. Our goal is to develop cash reserves, either for expansion, or to cover shortfalls in revenue. Management believes that ultimately, consummation of one or more such transactions would serve the best interests of shareholders; however, there is no assurance that we can locate or consummate a suitable business combination or otherwise provide for liquidity, expanded working capital and a stronger balance sheet.

 

We are subject to corporate governance and internal control reporting requirements, and our costs related to compliance with, or our failure to comply with existing and future requirements, could adversely affect our business.

 

We face corporate governance requirements under the Sarbanes-Oxley Act of 2002, as well as new rules and regulations subsequently adopted by the SEC and the Public Company Accounting Oversight Board. These laws, rules and regulations continue to evolve and may become increasingly stringent in the future. In particular, under new SEC rules we will be required to include management’s report on internal controls as part of our annual report pursuant to Section 404 of the Sarbanes-Oxley Act. Furthermore, under the proposed rules, an attestation report on our internal controls from our independent registered public accounting firm will be required as part of our annual report. We are in the process of evaluating our control structure to help ensure that we will be able to comply with Section 404 of the Sarbanes-Oxley Act. The financial cost of compliance with these laws, rules and regulations is expected to be substantial. We cannot assure you that we will be able to fully comply with these laws, rules and regulations that address corporate governance, internal control reporting and similar matters. Failure to comply with these laws, rules and regulations could materially adversely affect our reputation, financial condition and the value of our securities.

 

11

 

 

Management identified a material weakness in our internal control over financial reporting related to the accounting for complex transactions. The Company has begun the process of designing and implementing measures to improve its internal controls over financial reporting and remediate this material weakness. The Company’s efforts include implementing additional reviews of business combination transactions and modifying the Company’s instructions to valuation specialists and reviews of their workproduct. This will include staffing additions as appropriate. We will consider the material weakness remediated after the applicable controls operate for a sufficient period of time, and management has concluded, through testing, that the controls are operating effectively. However, our remedial actions may not prevent this or similar weaknesses from occurring in the future.

 

Natural and other disasters, information technology system failures and network disruptions and cybersecurity breaches and attacks could adversely affect our business.

 

Our business and results of operations could be negatively affected by certain factors beyond our control, such as natural disasters and/or climate change-related events (such as hurricanes, earthquakes, fires, and floods); civil unrest; negative geopolitical conditions and developments; war, terrorism, or other man-made disasters; and information technology system failures, network disruptions and cybersecurity breaches and attacks. Any of these events could result in, among other things, damage to or the temporary closure of our facilities; a temporary lack of an adequate work force in one or more markets; an interruption in power supply; a temporary or long-term disruption in our supply chain; and short- or long-term damage to our prospective customers’ businesses (which would adversely impact demand for our products and services). ∙ We rely on our own information systems, as well as those of our third-party business partners and suppliers. Despite the introduction of system backup measures and engage in information system redundancy planning and processes, such measures, planning and processes may be ineffective or inadequate to address all eventualities.

 

Further, our information systems and our business partners’ and suppliers’ information systems may be vulnerable to attacks by hackers and other security breaches, including computer viruses and malware, through the internet (including via devices and applications connected to the internet), email attachments and persons with access to these information systems, such as our employees or third parties with whom we do business. As information systems and the use of software and related applications by us, our business partners, suppliers, and customers become more cloud-based and connected to the internet, there has been an increase in global cybersecurity vulnerabilities and threats, including more sophisticated and targeted cyber-related attacks that pose a risk to the security of our information systems and networks and the confidentiality, availability and integrity of data and information. Any such attack or breach could compromise our networks and the information stored thereon could be accessed, publicly disclosed, lost, or stolen.

 

If we or our business partners or suppliers were to experience a system disruption, attack or security breach that impacts any of our critical functions, or our customers were to experience a system disruption, attack or security breach via any of our connected products and services, it could result in a period of shutdown of information systems during which we may not be able to operate, the loss of sales and customers, financial misstatement, potential liability for damages to our customers, reputational damage and significant incremental costs, which could adversely affect our business, results of operations and profitability. Furthermore, any access to, public disclosure of, or other loss of data or information (including any of our confidential or proprietary information or personal data or information) as a result of an attack or security breach could result in governmental actions or private claims or proceedings, which could damage our reputation, cause a loss of confidence in our products and services, damage our ability to develop (and protect our rights to) our proprietary technologies and adversely affect our business.

 

Failure to comply with U.S. federal, state and international laws and regulations relating to privacy or data protection, or the expansion of current or the enactment of new laws or regulations relating to privacy or data protection, could adversely affect our business and our financial condition.

 

Failure to comply with U.S. federal, state and international laws and regulations relating to privacy or data protection, or the expansion of current or the enactment of new laws or regulations relating to privacy or data protection, could adversely affect our business and our financial condition. A variety of U.S. federal, state and international laws and regulations govern the collection, use, retention, sharing and security of data. Laws and regulations relating to privacy and data protection are evolving and subject to potentially differing interpretations. These requirements may be interpreted and applied in a manner that is inconsistent from one jurisdiction to another or may conflict with other rules or our practices. As a result, our practices may not have complied or may not comply in the future with all such laws, regulations, requirements and obligations. Any failure, or perceived failure, by us to comply with our posted privacy policies or with any federal, state or international privacy or data protection related laws, regulations, industry self-regulatory principles, industry standards or codes of conduct, regulatory guidance, orders to which we may be subject or other legal obligations relating to privacy or data protection could adversely affect our reputation and business, and may result in claims, proceedings or actions against us by governmental entities or others or other liabilities or require us to change our operations and/or cease using certain data sets. Any such claim, proceeding or action could hurt our reputation and business, force us to incur significant expenses in defense of such proceedings, distract our management, increase our costs of doing business, result in a loss of customers.

 

12

 

 

Uncertain Economic, Social and Political Environment.

 

Consumer, corporate and financial confidence may be adversely affected by current or future tensions around the world, fear of terrorist activity and/or military conflicts, localized or global financial crises or other sources of political, social or economic unrest. Such erosion of confidence may lead to or extend a localized or global economic downturn. A climate of uncertainty may reduce the availability of potential investment opportunities, and increases the difficulty of modeling market conditions, potentially reducing the accuracy of financial projections. In addition, limited availability of credit for consumers, homeowners and businesses, including credit used to acquire businesses, in an uncertain environment or economic downturn may have an adverse effect on the economy generally and on our ability to make acquisitions. This may slow or halt our rate of growth and materially and adversely affect our business and/or stock price.

 

The Company will incur expenses in connection with its SEC filing requirements and may not be able to meet such costs, which could jeopardize its filing status with the SEC.

 

As a public reporting company, the Company is required to meet the filing requirements of the SEC. The Company may see an increase in its legal, accounting, auditing and fees and expenses as a result of such requirements. Our costs will increase significantly as the Company expands operations. Our filings are subject to comment from the SEC on its filings and/or it is required to file supplemental filings for transactions and activities. If the Company is not compliant in meeting the filing requirements of the SEC, it could lose its status as a 1934 Act Company, which could compromise its ability to raise funds.

 

Risks Related to our Activities in the Legal Hemp Industry

 

We will be subject to a myriad of different laws and regulations governing hemp and bitcoin. Our inability to comply with such laws in a cost-effective manner may have an adverse effect on our business and result of operations.

 

Laws and regulations governing the use of hemp in the United States are broad in scope; subject to evolving interpretations; and subject to enforcement by a myriad of regulatory agencies and law enforcement entities. Under the Agriculture Improvement Act of 2018, also known as the 2018 Farm Bill, a state or Indian tribe that desires to have primary regulatory authority over the production of hemp in the state or territory of the Indian tribe must submit a plan to monitor and regulate hemp production to the Secretary of the USDA. The Secretary must then approve the state or tribal plan after determining if the plan complies with the requirements set forth in the Agriculture Improvement Act of 2018. The Secretary may also audit the state or Indian tribe’s compliance with the federally-approved plan. If the Secretary does not approve the state or Indian tribe’s plan, then the production of hemp in that state or territory of that Indian tribe will be subject to a plan established by USDA. USDA has not yet established such a plan. We anticipate that many states will seek to have primary regulatory authority over the production of hemp. States that seek such authority may create new laws and regulations that limit or restrict the use of hemp.

 

Federal and state laws and regulations on hemp may address production, monitoring, manufacturing, distribution, and laboratory testing to ensure that that the hemp has a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis. Federal laws and regulations may also address the transportation or shipment of hemp or hemp products, as the Agriculture Improvement Act of 2018 prohibits states and Indian tribes from prohibiting the transportation or shipment of hemp or hemp products produced in accordance with that law through the state or territory of the Indian tribe, as applicable. We may be subject to many different state-based regulatory regimens for hemp, all of which could require us to incur substantial costs associated with compliance requirements. Our operations will be restricted to only where such operations are legal on the local, state and federal levels.

 

In addition, it is possible that additional regulations may be enacted in the future in the United States and globally that will be directly applicable to research and development operations.

 

We cannot predict the nature of any future laws, regulations, interpretations, or applications, nor can we determine what effect additional governmental regulations or administrative policies and procedures, when and if promulgated, could have on our business.

 

We have a limited operating history in the legal hemp industry, which makes it difficult to accurately assess our future growth prospects.

 

The legal hemp and cannabis industry is an evolving industry that may not develop as expected. Furthermore, our operations will continue to evolve as we continually assess new strategic opportunities for our business within this industry. Assessing the future prospects of this industry is challenging in light of both known and unknown risks and difficulties we may encounter.

 

13

 

 

Growth prospects in the legal hemp and cannabis industry can be affected by a wide variety of factors including:

 

  Competition from other similar companies;
     
  Fluctuations in the market price of CBD oil;
     
  Regulatory limitations on the types of research and development with respect to cannabis;
     
  Other changes in the regulation of cannabis and legal hemp use; and
     
  Changes in underlying consumer behavior, which may affect the demand of our legal hemp and cannabis traits.

 

We may not be able to successfully address the above factors, which could negatively impact our intended business plans. 

 

Negative press from being in the hemp/cannabis space could have a material adverse effect on our business, financial condition, and results of operations.

 

The hemp plant and the cannabis/marijuana plant are both part of the same cannabis sativa genus/species of plant, except that hemp, by definition, has less than 0.3% THC content, but the same plant with a higher THC content is cannabis/marijuana, which is legal under certain state laws, but which is not legal under federal law. The similarities between these plants can cause confusion, and our activities with legal hemp may be incorrectly perceived as us being involved in federally illegal cannabis. Also, despite growing support for the cannabis industry and legalization of cannabis in certain U.S. states, many individuals and businesses remain opposed to the cannabis industry. Any negative press resulting from any incorrect perception that we have entered into the cannabis space could result in a loss of current or future business. It could also adversely affect the public’s perception of us and lead to reluctance by new parties to do business with us or to own our common stock. We cannot assure you that additional business partners, including but not limited to financial institutions and customers, will not attempt to end or curtail their relationships with us. Any such negative press or cessation of business could have a material adverse effect on our business, financial condition, and results of operations.

 

Risks Relating to Digital Asset Networks and Digital Assets

 

Digital assets, such as bitcoin, may become regulated as securities or investment securities.

 

Bitcoin is the oldest and most well-known form of digital asset. Bitcoin and other forms of digital assets / cryptocurrencies have been the source of much regulatory scrutiny, which has resulted in differing definitional outcomes without a single unifying statement. In the context of the offer and sale of the Initial Coin Offering (“ICO”) tokens, the SEC has determined certain digital tokens are securities under the Howey test as stated by the U.S. Supreme Court. ICO offerings of securities would require registration under the Securities Act or an available exemption therefrom for offers or sales in the United States to be lawful. Section 5(a) of the Securities Act provides that, unless a registration statement is in effect as to a security, it is unlawful for any person, directly or indirectly, to engage in the offer or sale of securities in interstate commerce. Furthermore, Section 5(c) of the Securities Act provides a similar prohibition against offers to sell, or offers to buy, unless a registration statement has been filed. Although the Company does not believe its mining activities require registration for it to conduct such activities and accumulate digital assets, the SEC, the Commodity Futures Trading Commission (the “CFTC”), Nasdaq or other governmental or quasi- governmental agency or organization may conclude that the Company’s activities involve the offer or sale of “securities,” or ownership of “investment securities,” and the Company may face regulation under the Securities Act or the Investment Company Act of 1940, as amended (the “Investment Company Act”). Such regulation or the inability to meet the requirements to continue operations would have a material adverse effect on the Company’s business, financial condition and results of operations.

 

The further development and acceptance of digital asset networks and other digital assets, which represent a new and rapidly changing industry, are subject to a variety of factors that are difficult to evaluate, and the slowing or stopping of the development or acceptance of digital asset systems may adversely affect the Company’s business, financial condition and results of operations.

 

Digital assets such as bitcoins, which may be used, among other things, to buy and sell goods and services are a new and rapidly evolving industry of which the digital asset networks are prominent, but not unique, parts. The growth of the digital asset industry in general, and the digital asset networks of bitcoin in particular, are subject to a high degree of uncertainty. The factors affecting the further development of the digital asset industry, as well as the digital asset networks, include, among others:

 

continued worldwide growth in the adoption and use of bitcoins and other digital assets;
   
government and quasi-government regulation of bitcoins and other digital assets and their use, or restrictions on or regulation of access to and operation of the digital asset network or similar digital assets systems;
   
the maintenance and development of the open-source software protocol of the bitcoin network;
   
changes in consumer demographics and public tastes and preferences;
   
the availability and popularity of other forms or methods of buying and selling goods and services, including new means of using fiat currencies;
   
general economic conditions and the regulatory environment relating to digital assets; and
   
the impact of regulators focusing on digital assets and digital securities and the costs associated with such regulatory oversight.

 

14

 

 

A decline in the popularity or acceptance of the digital asset networks of bitcoin, or similar digital asset systems, could adversely affect the Company’s business, financial condition and results of operations.

 

If demand for transactions in bitcoin declines and is replaced by new demand for other cryptocurrencies, the Company’s business, financial condition and results of operations could be adversely affected.

 

The Company’s business will be highly dependent on strong bitcoin demand relative to other cryptocurrencies in the market. As such, in addition to the factors impacting the broader crypto economy described elsewhere in this section, the Company’s business may be adversely affected, and growth in the Company’s, and therefore the Company’s, revenues may slow or decline, if market demand for bitcoin deteriorates and is supplanted by other cryptocurrencies such as ethereum and dogecoin. In addition, negative perceptions surrounding bitcoin relative to other cryptocurrencies may cause bitcoin to fall out of favor. If other cryptocurrencies, such as ethereum and dogecoin, surpass bitcoin in market demand over a sustained period of time, such a trend could harm the Company’s business. Competition from public and central bank backed digital currencies could undercut the need for other cryptocurrencies such as bitcoin. Competition from stablecoins (commodity-backed or fiat-backed) could undercut demand for other cryptocurrencies such as bitcoin.

 

Significant contributors to all or any digital asset network could propose amendments to the respective network’s protocols and software that, if accepted and authorized by such network, could adversely affect the Company’s business, financial condition and results of operations.

 

Digital asset networks are open-source projects and, although there is an influential group of leaders in, for example, the bitcoin network community known as the “Core Developers,” there is no official developer or group of developers that formally controls the bitcoin network. Any individual can download the bitcoin network software and make any desired modifications, which are proposed to users and miners on the bitcoin network through software downloads and upgrades, typically posted to the bitcoin development forum on GitHub.com. Proposals for upgrades and discussions relating thereto take place on online forums. For example, there is an ongoing debate regarding altering the blockchain by increasing the size of blocks to accommodate a larger volume of transactions. Although some proponents support an increase, other market participants oppose an increase to the block size as it may deter miners from confirming transactions and concentrate power into a smaller group of miners. To the extent that a significant majority of the users and miners on the bitcoin network install such software upgrade, the bitcoin network would be subject to new protocols and software that may adversely affect the Company’s business, financial condition and results of operations.

 

In the event a developer or group of developers proposes a modification to the bitcoin network that is not accepted by a majority of miners and users, but that is nonetheless accepted by a substantial plurality of miners and users, two or more competing and incompatible blockchain implementations could result. This is known as a “hard fork.” We may not be able to realize the economic benefit of such a “hard fork”, either immediately or ever, which could adversely affect an investment in our securities. If we hold a cryptocurrency at the time of a hard fork, industry standards would dictate that we would be expected to hold an equivalent amount of the old and new assets following the fork. However, we may not be able, or it may not be practical, to secure or realize the economic benefit of the new asset for various reasons. For instance, we may determine that there is no safe or practical way to custody the new asset, that trying to do so may pose an unacceptable risk to our holdings in the old asset, or that the costs of taking possession and/or maintaining ownership of the new cryptocurrency exceed the benefits of owning the new cryptocurrency. Additionally, laws, regulation or other factors may prevent us from benefitting from the new asset even if there is a safe and practical way to custody and secure the new asset. In such case, the “hard fork” in the blockchain could materially and adversely affect the perceived value of digital assets as reflected on one or both incompatible blockchains, which may adversely affect the Company’s business, financial condition and results of operations and, in the worst-case scenario, harm the sustainability of the bitcoin network’s economy.

 

15

 

 

The open-source structure of the bitcoin network protocol means that the contributors to the protocol are generally not directly compensated for their contributions in maintaining and developing the bitcoin network protocol, and a failure to properly monitor and upgrade the protocol could damage the bitcoin network and adversely affect the Company’s business, financial condition and results of operations.

 

The bitcoin network operates based on an open-source protocol, not represented by an official organization or authority. Instead, it is maintained by a group of core contributors, largely on the Bitcoin Core project on GitHub. As an open-source project, bitcoin is not represented by an official organization or authority. As the bitcoin network protocol is not sold and its use does not generate revenues for contributors, contributors are generally not directly compensated for maintaining and developing the bitcoin network protocol. Although the Media Lab’s Digital Currency Initiative of the Massachusetts Institute of Technology funds the current maintainer Wladimir J. van der Laan, among others, this type of financial incentive is not typical. The lack of guaranteed financial incentive for contributors to maintain or develop the bitcoin network and the lack of guaranteed resources to adequately address emerging issues with the bitcoin network may reduce incentives to address the issues adequately or in a timely manner.

 

Changes to a digital asset network which the Company is mining on may adversely affect the Company’s business, financial condition and results of operations.

 

If a malicious actor or botnet obtains control in excess of 50% of the processing power active on any digital asset network, including the bitcoin network, it is possible that such actor or botnet could manipulate the blockchain in a manner that may adversely affect the Company’s business, financial condition and results of operations.

 

If a malicious actor or botnet (a volunteer or hacked collection of computers controlled by networked software coordinating the actions of the computers) obtains a majority of the processing power dedicated to mining on any digital asset network, including the bitcoin network, it may be able to alter the blockchain by constructing alternate blocks if it is able to solve for such blocks faster than the remainder of the miners on the blockchain can add valid blocks. In such alternate blocks, the malicious actor or botnet could control, exclude or modify the ordering of transactions, though it could not generate new digital assets or transactions using such control. Using alternate blocks, the malicious actor could “double-spend” its own digital assets (i.e., spend the same digital assets in more than one transaction) and prevent the confirmation of other users’ transactions for so long as it maintains control. To the extent that such malicious actor or botnet does not yield its majority control of the processing power or the digital asset community does not reject the fraudulent blocks as malicious, reversing any changes made to the blockchain may not be possible, which may adversely affect the Company’s business, financial condition and results of operations.

 

The approach towards and possible crossing of the 50% threshold indicates a greater risk that a single mining pool could exert authority over the validation of digital asset transactions. To the extent that the digital assets ecosystems do not act to ensure greater decentralization of digital asset mining processing power, the feasibility of a malicious actor obtaining in excess of 50% of the processing power on any digital asset network (e.g., through control of a large mining pool or through hacking such a mining pool) will increase, which may adversely affect the Company’s business, financial condition and results of operations.

 

If the award of digital assets for solving blocks and transaction fees for recording transactions are not sufficiently high to cover expenses related to running data center operations, it may adversely affect the Company’s business, financial condition and results of operations.

 

Bitcoin miners record transactions when they solve for and add blocks of information to the blockchain. When a miner solves for a block, it creates such block, which includes data relating to (i) the solution to the block, (ii) a reference to the prior block in the blockchain to which the new block is being added and (iii) all transactions that have occurred but have not yet been added to the blockchain. The miner becomes aware of outstanding, unrecorded transactions through data packet transmission and propagation. Typically, bitcoin transactions will be recorded in the next chronological block if the spending party has an internet connection and at least one minute has passed between the transaction’s data packet transmission and the solution of the next block. If a transaction is not recorded in the next chronological block, it is usually recorded in the next block thereafter.

 

As the award of new digital assets for solving blocks declines, and if transaction fees are not sufficiently high, miners may not have an adequate incentive to continue mining and may cease their mining operations. For example, the current fixed reward on the bitcoin network for solving a new block is six and a quarter (6.25) bitcoins per block. The reward decreased from twelve and a half (12.5) bitcoins in May 2020. It is estimated that it will halve again in approximately May 2024. This reduction may result in a reduction in the aggregate hashrate of the bitcoin network as the incentive for miners will decrease. Moreover, miners ceasing operations would reduce the aggregate hashrate on the bitcoin network, which would adversely affect the confirmation process for transactions (i.e., temporarily decreasing the speed at which blocks are added to the blockchain until the next scheduled adjustment in difficulty for block solutions) and make the bitcoin network more vulnerable to a malicious actor obtaining control in excess of 50% of the aggregate hashrate on the bitcoin network. Periodically, the bitcoin network has adjusted the difficulty for block solutions so that solution speeds remain in the vicinity of the expected ten-minute confirmation time targeted by the bitcoin network protocol.

 

16

 

 

The Company believes that from time to time there will be further considerations and adjustments to the bitcoin network and others regarding the difficulty for block solutions. More significant reductions in aggregate hashrate on digital asset networks could result in material, though temporary, delays in block solution confirmation time. Any reduction in confidence in the confirmation process or aggregate hashrate of any digital asset network may negatively impact the value of digital assets, which may adversely affect the Company’s business, financial condition and results of operations.

 

To the extent that the profit margins of digital asset mining operations are not high, operators of digital asset mining operations are more likely to immediately sell their digital assets earned by mining in the digital asset exchange market, resulting in a reduction in the price of digital assets that may adversely affect the Company’s business, financial condition and results of operations.

 

Over the past ten years, digital asset mining operations have evolved from individual users mining with computer processors, graphics processing units and first-generation servers. Currently, new processing power brought onto the digital asset networks is predominantly added by incorporated and unincorporated “professionalized” mining operations. Professionalized mining operations may use proprietary hardware or sophisticated machines. They require the investment of significant capital for the acquisition of this hardware, the leasing of operating space (often in data centers or warehousing facilities), incurrence of electricity costs and the employment of technicians to operate the mining farms. As a result, professionalized mining operations are of a greater scale than prior miners and have more defined, regular expenses and liabilities. These regular expenses and liabilities require professionalized mining operations to more immediately sell digital assets earned from mining operations on the digital asset exchange market, whereas it is believed that individual miners in past years were more likely to hold newly mined digital assets for more extended periods. The immediate selling of newly mined digital assets greatly increases the supply of digital assets on the digital asset exchange market, creating downward pressure on the price of each digital asset.

 

The extent to which the value of digital assets mined by a professionalized mining operation exceeds the allocable capital and operating costs determines the profit margin of such operation. A professionalized mining operation may be more likely to sell a higher percentage of its newly mined digital assets rapidly if it is operating at a low profit margin and it may partially or completely cease operations if its profit margin is negative. This could create a network effect that may further reduce the price of digital assets until mining operations with higher operating costs become unprofitable and remove mining power from the respective digital asset network. The network effect of reduced profit margins resulting in greater sales of newly mined digital assets could result in a reduction in the price of digital assets that may adversely affect the Company’s business, financial condition and results of operations.

 

To the extent that any miners cease to record transactions in solved blocks, transactions that do not include the payment of a transaction fee will not be recorded on the blockchain until a block is solved by a miner who does not require the payment of transaction fees, and any widespread delays in the recording of transactions could result in a loss of confidence in that digital asset network, which may adversely affect the Company’s business, financial condition and results of operations.

 

To the extent that any miners cease to record transactions in solved blocks, such transactions will not be recorded on the blockchain. Currently, there are no known incentives for miners to elect to exclude the recording of transactions in solved blocks. However, to the extent that any such incentives arise (e.g., a collective movement among miners or one or more mining pools forcing bitcoin users to pay transaction fees as a substitute for or in addition to the award of new bitcoins upon the solving of a block), actions of miners solving a significant number of blocks could delay the recording and confirmation of transactions on the blockchain. Any systemic delays in the recording and confirmation of transactions on the blockchain could result in greater exposure to double-spending transactions, or transactions that consist of bad actors simultaneously sending two or more bitcoin to different addresses, and a loss of confidence in certain or all digital asset networks, which may adversely affect the Company’s business, financial condition and results of operations.

 

Intellectual property rights claims may adversely affect the operation of some or all digital asset networks.

 

Third parties may assert intellectual property claims relating to the holding and transfer of digital assets and their source code. Regardless of the merit of any intellectual property or other legal action, any threatened action that reduces confidence in some or all digital asset networks’ long-term viability or the ability of end-users to hold and transfer digital assets may adversely affect the Company’s business, financial condition and results of operations. In addition, a meritorious intellectual property claim could prevent the Company and other end-users from accessing some or all digital asset networks or holding or transferring their digital assets. As a result, an intellectual property claim against the Company or other large digital asset network participants may adversely affect the Company’s business, financial condition and results of operations.

 

17

 

 

To the extent that the digital asset exchanges representing a substantial portion of the volume in digital asset trading are involved in fraud or experience security failures or other operational issues, such digital asset exchanges’ failures may result in a reduction in the price of some or all digital assets and may adversely affect the Company’s business, financial condition and results of operations.

 

The digital asset exchanges on which the digital assets trade are new and, in most cases, largely unregulated. Furthermore, many digital asset exchanges (including several of the most prominent U.S. dollar denominated digital asset exchanges) do not provide the public with significant information regarding their ownership structure, management teams, corporate practices or regulatory compliance. As a result, the marketplace may lose confidence in, or may experience problems relating to, digital asset exchanges, including prominent exchanges handling a significant portion of the volume of digital asset trading. A lack of stability in the digital asset exchange market and the closure or temporary shutdown of digital asset exchanges due to fraud, business failure, hackers or malware or government-mandated regulation may reduce confidence in the digital asset networks and result in greater volatility in digital asset values. These potential consequences of a digital asset exchange’s failure may adversely affect the Company’s business, financial condition and results of operations.

 

Political or economic crises may motivate large-scale sales of digital assets, which could result in a reduction in some or all digital assets’ values and adversely affect the Company’s business, financial condition and results of operations.

 

As an alternative to fiat currencies that are backed by central governments, digital assets such as bitcoins, which are relatively new, are subject to supply and demand forces based upon the desirability of an alternative, decentralized means of buying and selling goods and services, and it is unclear how such supply and demand will be impacted by geopolitical events. Nevertheless, political or economic crises, including current or anticipated military conflicts such as the war between Russia and Ukraine, terrorism, sanctions or other geopolitical events globally, may motivate large-scale acquisitions or sales of digital assets either globally or locally. Large-scale sales of digital assets would result in a reduction in some or all digital assets’ values and may adversely affect the Company’s business, financial condition and results of operations.

 

The Company’s ability to adopt technology in response to changing security needs or trends poses a challenge to the safekeeping of the Company’s digital assets.

 

The history of digital asset exchanges has shown that exchanges and large holders of digital assets must adapt to technological change in order to secure and safeguard their digital assets. The Company will rely on enterprise cold storage solutions from third parties to safeguard the Company’s digital assets from theft, loss, destruction or other issues relating to hackers and technological attack. The Company’s digital assets may also be moved to various exchanges in order to exchange them for fiat currency during which time the Company will be relying on the security of such exchanges to safeguard the Company’s digital assets.

 

The Company believes that it may become a more appealing target of security threats as the size of the Company’s bitcoin holdings grow. To the extent that either custody providers or the Company are unable to identify and mitigate or stop new security threats, the Company’s digital assets may be subject to theft, loss, destruction or other attack, which may adversely affect the Company’s business, financial condition and results of operations.

 

Digital asset transactions are irrevocable, and stolen or incorrectly transferred digital assets may be irretrievable and, as a result, any incorrectly executed digital asset transactions may adversely affect the Company’s business, financial condition and results of operations.

 

Digital asset transactions are not, from an administrative perspective, reversible without the consent and active participation of the recipient of the transaction or, in theory, control or consent of a majority of the processing power on the respective digital asset network. Once a transaction has been verified and recorded in a block that is added to the blockchain, an incorrect transfer of digital assets or a theft of digital assets generally will not be reversible, and the Company may not be capable of seeking compensation for any such transfer or theft. Although the Company’s transfers of digital assets will regularly be made to or from various parties, it is possible that, through computer or human error, or through theft or criminal action, the Company’s digital assets could be transferred in incorrect amounts or to unauthorized third parties. To the extent that the Company is unable to seek a corrective transaction with such third party or is incapable of identifying the third party which has received the Company’s digital assets through error or theft, the Company will be unable to revert or otherwise recover incorrectly transferred digital assets. To the extent that the Company is unable to seek redress for such error or theft, such loss may adversely affect the Company’s business, financial condition and results of operations.

 

The limited rights of legal recourse against the Company, and the Company’s lack of insurance protection, expose the Company and its stockholders to the risk of loss of its digital assets for which no person is liable.

 

The digital assets held by the Company may not be insured. Therefore, a loss may be suffered with respect to the Company’s digital assets which is not covered by insurance and for which no person is liable in damages, which may adversely affect the Company’s business, financial condition and results of operations.

 

18

 

 

The Company may not have adequate sources of recovery if its digital assets are lost, stolen or destroyed.

 

If the Company’s digital assets are lost, stolen or destroyed under circumstances rendering a party liable to the Company, the responsible party may not have the financial resources sufficient to satisfy its claim. For example, as to a particular event of loss, the only source of recovery for the Company might be limited, to the extent identifiable, other responsible third parties (e.g., a thief or terrorist), any of which may not have the financial resources (including liability insurance coverage) to satisfy a valid claim by the Company.

 

Digital assets held by the Company are not subject to FDIC or SIPC protections.

 

The Company will not hold its digital assets with a banking institution or a member of the Federal Deposit Insurance Corporation (“FDIC”) or the Securities Investor Protection Corporation (“SIPC”) and, therefore, its digital assets will not be subject to the protections enjoyed by depositors with FDIC or SIPC member institutions.

 

The loss or destruction of a private key required to access a digital asset may be irreversible and, as a result, the Company’s loss of access to its private keys or its experience of a data loss relating to its digital assets may adversely affect the Company’s business, financial condition and results of operations.

 

Digital assets are controllable only by the possessor of both the unique public key and private key relating to the local or online digital wallet in which the digital assets are held. The Company is required by the operation of digital asset networks to publish the public key relating to a digital wallet in use when it first verifies a spending transaction from that digital wallet and disseminates such information into the respective network. The Company safeguards and keeps private the private keys relating to its digital assets by using enterprise cold storage custody solutions from third parties. To the extent a private key is lost, destroyed or otherwise compromised and no backup of the private key is accessible, the Company will be unable to access the digital assets held by it and the private key will not be capable of being restored by the respective digital asset network. Any loss of private keys relating to digital wallets used to store the Company’s digital assets may adversely affect the Company’s business, financial condition and results of operations.

 

Because the Company’s future digital assets may be held by digital asset exchanges, it faces heightened risks from cybersecurity attacks and financial stability of digital asset exchanges.

 

The Company may transfer digital assets from its wallet to digital asset exchanges prior to selling them. Digital assets not held in the Company’s wallet are subject to the risks encountered by digital asset exchanges including a denial-of-service attack or other malicious hacking, a sale of the digital asset exchange, loss of the digital assets by the digital asset exchange and other risks similar to those described herein. The Company may not maintain a custodian agreement with any of the digital asset exchanges that hold the Company’s digital assets. These digital asset exchanges may or may not provide insurance and may lack the resources to protect against hacking and theft. If this were to occur, the Company’s business, financial condition and results of operations may be adversely affected.

 

As the number of digital assets awarded for solving a block in the blockchain decreases, the incentive for miners to continue to contribute processing power to the respective digital asset network will transition from a set reward to transaction fees.

 

In order to incentivize miners to continue to contribute processing power to any digital asset network, such network may either formally or informally transition from a set reward to transaction fees earned upon solving for a block. This transition could be accomplished either by miners independently electing to record in the blocks they solve only those transactions that include payment of a transaction fee or by the digital asset network adopting software upgrades that require the payment of a minimum transaction fee for all transactions. If transaction fees paid for digital asset transactions become too high, the marketplace may be reluctant to accept digital assets as a means of payment and existing users may be motivated to switch from one digital asset to another digital asset or back to fiat currency. Decreased use and demand for bitcoins may adversely affect the value of the Company’s bitcoins and may adversely affect the Company’s business, financial condition and results of operations.

 

The price of bitcoin may be influenced by regulatory, commercial and technical factors that are highly uncertain resulting in the price of bitcoin being extremely volatile, which may significantly influence the market price of the Company’s common stock.

 

To the extent investors view the value of the Company’s common stock as linked to the value or change in the value of bitcoin, fluctuations in the price of bitcoin may significantly influence the market price of the Company’s common stock. In addition, the Company’s business operations are no longer economical below the bitcoin breakeven point, or the point at which the total cost of mining operations exceeds the total revenues generated.

 

The price of bitcoin has historically been subject to dramatic fluctuations and is highly volatile. Bitcoin has only recently become accepted as a means of payment for goods and services and has recently trended toward becoming a more actively traded instrument, however the acceptance and use of bitcoin remains limited and far from mainstream. Conversely, a significant portion of demand for bitcoin may be generated by speculators and investors seeking to profit from the short- or long-term holding of bitcoin.

 

19

 

 

In addition, some blockchain industry participants have reported that a significant percentage of bitcoin trading activity is artificial or non-economic in nature and may represent attempts to manipulate the price of bitcoin. As a result, trading platforms may seek to inflate demand for bitcoin, which could increase the volatility of the price of bitcoin and may significantly influence the market price of the Company’s common stock.

 

The development and acceptance of competing blockchain platforms or technologies may cause consumers to use alternative distributed ledgers or other alternatives.

 

The development and acceptance of competing blockchain platforms or technologies, including competing cryptocurrencies which our miners may not be able to mine, such as cryptocurrencies being developed by popular social media platforms, online retailers, or government sponsored cryptocurrencies, may cause consumers to use alternative distributed ledgers or an alternative to distributed ledgers altogether. Our business currently intends to utilize presently existent digital ledgers and blockchains and we could face difficulty adapting to emergent digital ledgers, blockchains, or alternatives thereto. This may adversely affect us and our exposure to various blockchain technologies and prevent us from realizing the anticipated profits from our investments. Such circumstances could have a material adverse effect on our business, prospects or operations and potentially the value of any bitcoin or other cryptocurrencies we mine or otherwise acquire or hold for our own account, which could materially and adversely affect investors’ investments in our securities.

 

The decentralized nature of cryptocurrency systems may lead to slow or inadequate responses to crises, which may negatively affect our business.

 

The decentralized nature of the governance of cryptocurrency systems may lead to ineffective decision making that slows development or prevents a network from overcoming emergent obstacles. Governance of many cryptocurrency systems is by voluntary consensus and open competition with no clear leadership structure or authority. To the extent lack of clarity in corporate governance of cryptocurrency systems leads to ineffective decision making that slows development and growth of such cryptocurrencies, the value of our common stock may be adversely affected.

 

Risks Relating to Regulatory Matters

 

We are subject to a highly-evolving regulatory landscape and any adverse changes to, or our failure to comply with, any laws and regulations could adversely affect our business, reputation, prospects or operations.

 

Until recently, relatively little regulatory attention has been directed toward bitcoin and the bitcoin network by U.S. federal and state governments, foreign governments and self-regulatory agencies. We currently only operate in the United States, and do not currently have any plans to expand our operations beyond the United States. As bitcoin has grown in popularity and in market size, the U.S. regulatory regime - namely the Federal Reserve Board, U.S. Congress and certain U.S. agencies (e.g., the SEC, the CFTC, FinCEN and the Federal Bureau of Investigation) have begun to examine the operations of the bitcoin network, bitcoin users and the bitcoin exchange market. The complexity and evolving nature of our business and the significant uncertainty surrounding the regulation of the cryptocurrency industry requires us to exercise our judgment as to whether certain laws, rules, and regulations apply to us, and it is possible that governmental bodies and regulators may disagree with our conclusions. To the extent we have not complied with such laws, rules, and regulations, we could be subject to significant fines, revocation of licenses, limitations on our products and services, reputational harm, and other regulatory consequences, each of which may be significant and could adversely affect our business, operating results, and financial condition.

 

Additionally, the recent bankruptcy filings of FTX, the third largest digital asset exchange by volume at the time of its filing, and its affiliated hedge fund Alameda Research LLC, in addition to other bankruptcy filings of crypto companies throughout calendar year 2022 and the first quarter of 2023, together with the recent closures of Silicon Valley Bank, SBNY and Silvergate Bank, will likely attract heightened regulatory scrutiny from U.S. regulatory agencies such as the SEC and CFTC. Increasing regulation and regulatory scrutiny may result in new costs for the Company and Company’s management having to devote increased time and attention to regulatory matters, change aspects of the Company’s business or result in limits on the utility of bitcoin. In addition, regulatory developments and/or the Company’s business activities may require the Company to comply with certain regulatory regimes. Increasingly strict legal and regulatory requirements and any regulatory investigations and enforcement may result in changes to our business, as well as increased costs, and supervision and examination for ourselves and our service providers. Moreover, new laws, regulations, or interpretations may result in additional litigation, regulatory investigations, and enforcement or other actions. Adverse hanges to, or our failure to comply with, any laws and regulations may have an adverse effect on our reputation and brand and our business, operating results, and financial condition.

 

20

 

 

Additionally, although we are not directly connected to the recent cryptocurrency market events, we may still suffer reputational harm due to our association with the cryptocurrency industry in light of the recent disruption in the crypto asset markets. Ongoing and future regulation and regulatory actions could significantly restrict or eliminate the market for or uses of bitcoin and/or may adversely affect the Company’s business, reputation, financial condition and results of operations.

 

TeraWulf may be at a higher risk of litigation and other legal proceedings due to heightened regulatory scrutiny of the cryptocurrency industry, which could ultimately be resolved against TeraWulf, requiring material future cash payments or charges, which could impair TeraWulf’s financial condition and results of operations.

 

The size, nature and complexity of the Company’s business could make it susceptible to various claims, both in litigation and binding arbitration proceedings, legal proceedings, and government investigations, due to the heightened regulatory scrutiny following the recent disruptions in the crypto asset markets. The Company believes that since cryptocurrency mining, and the digital asset industry generally, is a relatively new business sector, it is more likely subject to government investigation and regulatory determination, particularly following the recent cryptocurrency market participant bankruptcies described elsewhere herein. Any claims, regulatory proceedings or litigation that could arise in the course of the Company’s business could have a material adverse effect on the Company, its business or operations, or the industry as a whole.

 

The Company may be classified as an inadvertent investment company.

 

The Company is not engaged in the business of investing, reinvesting or trading in securities and does not hold itself out as being engaged in those activities. Under the Investment Company Act, however, a company may be deemed an investment company under Section 3(a)(1)(C) if the value of its investment securities is more than 40% of its total assets (exclusive of government securities and cash items) on a consolidated basis.

 

The Company will be engaging in digital asset mining, the outputs of which are cryptocurrencies, which may be deemed a security. In the event that the digital assets held by the Company exceed 40% of its total assets, exclusive of cash, the Company may inadvertently become an investment company. An inadvertent investment company can avoid being classified as an investment company if it can rely on one of the exclusions under the Investment Company Act. One such exclusion, namely Rule 3a-2 under the Investment Company Act, allows an inadvertent investment company a grace period of one year from the earlier of (i) the date on which an issuer owns securities and/or cash having a value exceeding 50% of the issuer’s total assets on either a consolidated or unconsolidated basis and (ii) the date on which an issuer owns or proposes to acquire investment securities having a value exceeding 40% of the value of such issuer’s total assets (exclusive of government securities and cash items) on an unconsolidated basis. The Company is putting in place policies that it expects will work to keep the digital assets held by the Company at less than 40% of its total assets, liquidating its digital assets or seeking a no-action letter from the SEC if the Company is unable to maintain sufficient total assets or liquidate sufficient digital assets in a timely manner.

 

As Rule 3a-2 is available to a company no more than once every three years, and assuming no other exclusions are available to the Company, the Company would have to keep within the 40% limit for at least three years after it ceases being an inadvertent investment company. This may limit the Company’s ability to make certain investments or enter into joint ventures that could otherwise have a positive impact on the Company’s earnings. In any event, the Company does not intend to become an investment company engaged in the business of investing and trading securities.

 

Classification as an investment company under the Investment Company Act requires registration with the SEC. If an investment company fails to register, it would have to stop doing almost all business, and its contracts would become voidable. Registration is time consuming and restrictive and would require a restructuring of the Company’s operations, and the Company would be very constrained in the kind of business it could do as a registered investment company. Furthermore, the Company would become subject to substantial regulation concerning management, operations, transactions with affiliated persons and portfolio composition, and would need to file reports under the Investment Company Act regime. The cost of such compliance would result in the Company incurring substantial additional expenses, and the failure to register if required may adversely affect the Company’s business, financial condition and results of operations.

 

It may be illegal now, or in the future, to acquire, own, hold, sell or use digital assets in one or more countries, and ownership of, holding or trading in the Company’s securities may also be considered illegal and subject to sanction.

 

Although digital assets are not currently regulated or are lightly regulated in most countries, including the United States, one or more countries, such as China and Russia, may take regulatory actions in the future that severely restricts the right to acquire, own, hold, sell or use digital assets or to exchange digital assets for fiat currency. Such an action may also result in the restriction of ownership, holding or trading in the Company’s securities and may adversely affect the Company’s business, financial condition and results of operations.

 

21

 

 

If regulatory changes or interpretations of the Company’s activities require its registration as a money services business under the regulations promulgated by FinCEN under the authority of the U.S. Bank Secrecy Act of 1970, as amended, the Company may be required to register and comply with such regulations.

 

To the extent that the activities of the Company cause it to be deemed a money service business under the regulations promulgated by FinCEN under the authority of the U.S. Bank Secrecy Act of 1970, as amended, the Company may be required to comply with FinCEN regulations, including those that would mandate the Company to implement anti-money laundering programs, make certain reports to FinCEN and maintain certain records.

 

To the extent that the activities of the Company cause it to be deemed a “money transmitter” or equivalent designation under state law of any state in which the Company operates, the Company may be required to seek a license or otherwise register with a state regulator and comply with state regulations that may include the implementation of anti-money laundering programs, maintenance of certain records and other operational requirements. Currently, the New York State Department of Financial Services has finalized its “BitLicense” framework for businesses that conduct “virtual currency business activity,” the Conference of State Bank Supervisors has proposed a model form of state level “virtual currency” regulation and additional state regulators, including those from the States of California, Idaho, Virginia, Kansas, Texas, South Dakota and Washington, have made public statements indicating that virtual currency businesses may be required to seek licenses as money transmitters. In July 2016, the State of North Carolina updated the law to define “virtual currency” and the activities that trigger licensure in a business-friendly approach that encourages companies to use virtual currency and blockchain technology. Specifically, the North Carolina law does not require miners or software providers to obtain a license for multi-signature software, smart contract platforms, smart property, colored coins and non-hosted, non-custodial wallets. Starting on January 1, 2016, the State of New Hampshire requires anyone who exchanges a digital currency for another currency must become a licensed and bonded money transmitter. In numerous other states, including the States of Connecticut and New Jersey, legislation is being proposed or has been introduced regarding the treatment of bitcoin and other digital assets. The Company will continue to monitor for developments in such legislation, guidance or regulations.

 

Such additional federal or state regulatory obligations may cause the Company to incur extraordinary expenses, possibly affecting an investment in the shares of the Company’s common stock in a material and adverse manner. Furthermore, the Company and its service providers may not be capable of complying with certain federal or state regulatory obligations applicable to money services business and money transmitters. If the Company is deemed to be subject to and is determined not to comply with such additional regulatory and registration requirements, the Company may act to dissolve and liquidate the Company.

 

Blockchain technology may expose the Company to specially designated nationals or blocked persons or cause it to violate provisions of law.

 

The Company is subject to the rules enforced by The Office of Financial Assets Control of the U.S. Department of Treasury (“OFAC”), including regarding sanctions and requirements not to conduct business with persons named on its specially designated nationals list. However, because of the pseudonymous nature of blockchain transactions, the Company may inadvertently and without its knowledge engage in transactions with persons named on OFAC’s specially designated nationals list, which may expose the Company to regulatory sanctions and adversely affect the Company’s business, financial condition and results of operations.

 

The Company may be required to register and comply with bitcoin regulations and, to the extent that the Company decides to continue operations, the required registrations and regulatory compliance steps may result in extraordinary expenses to the Company.

 

Current and future legislation, and other regulatory developments, including interpretations released by a regulatory authority, may impact the manner in which bitcoins are treated for classification and clearing purposes. In particular, bitcoin derivatives are not excluded from the definition of “commodity future” by the CFTC. The Company cannot be certain as to how future regulatory developments will impact the treatment of bitcoins under the law.

 

Bitcoins have been deemed to fall within the definition of a commodity, and the Company may be required to register and comply with additional regulation under the Commodity Exchange Act of 1936, as amended, including additional periodic report and disclosure standards and requirements. Moreover, the Company may be required to register as a commodity pool operator and to register us as a commodity pool with the CFTC through the National Futures Association. Such additional registrations may result in extraordinary expenses, thereby materially and adversely affecting the Company’s business, financial condition and results of operations. If the Company determines it will not comply with such additional regulatory and registration requirements, it may seek to cease certain of its operations. Any such action may adversely affect the Company’s business, financial condition and results of operations. As of the date of this Annual Report, the Company is not aware of any rules that have been proposed to regulate bitcoins as securities. However, the Company cannot be certain as to how future regulatory developments will impact the treatment of bitcoins under the law.

 

22

 

 

If federal or state legislatures or agencies initiate or release tax determinations that change the classification of bitcoins as property for tax purposes (in the context of when such bitcoins are held as an investment), such determination could have a negative tax consequence on the Company or its shareholders.

 

Current guidance from the Internal Revenue Service indicates that digital assets such as bitcoin should be treated and taxed as property and that transactions involving the payment of bitcoin for goods and services should be treated as barter transactions. While this treatment creates a potential tax reporting requirement for any circumstance where the ownership of a bitcoin passes from one person to another, usually by means of bitcoin transactions (including off-blockchain transactions), it would also apply capital gains treatment to those transactions which may adversely affect the Company’s business, financial condition and results of operations.

 

Under certain recently proposed legislation, substantial tax compliance burdens may be imposed on the Company relating to the tax reporting of bitcoin and bitcoin-related transactions.

 

Legislation recently passed in the Senate would impose substantial tax compliance obligations on the Company relating to the reporting of bitcoin and bitcoin-related transactions. Under this legislation, it is possible that the Company would be treated as a digital assets broker and required to deliver certain tax forms in connection with the validation of blockchain transactions. Were this legislation to be passed in the House and enacted unchanged, the Company could face tax reporting and compliance mandates that it may not have the information or resources to fully comply with. Although the current legislation may not be enacted in its current form, future legislation may impose similar tax compliance responsibilities on the Company, which may be expensive and burdensome to comply with, and which could, as a result, adversely impact the Company’s operations. The Company will continue to monitor for developments in such legislation, guidance or regulations.

 

The Company’s bitcoin holdings could subject it to regulatory scrutiny.

 

As digital assets, including bitcoin, have grown in popularity and market size, there has been increasing focus on the extent to which digital assets can be used to launder the proceeds of illegal activities or fund criminal or terrorist activities or entities subject to sanctions regimes. While the Company intends to institute risk-based procedures reasonably designed to promote compliance with applicable anti-money laundering and sanctions laws and regulations and takes care to only acquire bitcoin through entities subject to anti money laundering regulation and related compliance rules in the United States, if it is found to have purchased any bitcoin from bad actors that have used bitcoin to launder money or persons subject to sanctions, the Company is and may continue to be subject to regulatory proceedings and further transactions or dealings in bitcoin may be restricted or prohibited.

 

Due to the unregulated nature and lack of transparency surrounding the operations of many bitcoin trading venues, they may experience fraud, security failures or operational problems, which may adversely affect the value of the Company’s future bitcoin holdings.

 

Bitcoin trading venues are relatively new and, in some cases, unregulated. Furthermore, there are many bitcoin trading venues which do not provide the public with significant information regarding their ownership structure, management teams, corporate practices and regulatory compliance. As a result, the marketplace may lose confidence in bitcoin trading venues, including prominent exchanges that handle a significant volume of bitcoin trading.

 

Negative perception, a lack of stability in the broader bitcoin markets and the closure or temporary shutdown of bitcoin trading venues due to fraud, business failure, hackers or malware or government- mandated regulation may reduce confidence in bitcoin and result in greater volatility in the prices of bitcoin.

 

To the extent investors view the Company’s common stock as linked to the value of the Company’s future bitcoin holdings, these potential consequences of a bitcoin trading venue’s failure could have a material adverse effect on the market value of the Company’s common stock.

 

23

 

 

Risks Related to Ownership of Our Common Stock

 

Our stock price has been and may continue to be volatile, and you could lose all or part of your investment.

 

The market price of our common stock is subject to wide fluctuations in response to various risk factors, some of which are beyond our control and may not be related to our operating performance, including:

 

  addition or loss of significant customers, suppliers, or distributors;
     
  changes in laws or regulations applicable to our industry ;

 

  additions or departures of key personnel;
     
  the failure of securities analysts to cover our common stock after an offering;
     
  actual or anticipated changes in expectations regarding our performance by investors or securities analysts;
     
  price and volume fluctuations in the overall stock market;
     
  volatility in the market price and trading volume of companies in our industry or companies that investors consider comparable;
     
  share price and volume fluctuations attributable to inconsistent trading volume levels of our shares;
     
  our ability to protect our intellectual property and other proprietary rights;
     
  sales of our common stock by us or our stockholders;
     
  the expiration of contractual lock-up agreements;
     
  litigation involving us, our industry, or both;
     
  major catastrophic events; and
     
  general economic and market conditions and trends.

 

Further, the stock markets have experienced extreme price and volume fluctuations that have affected and continue to affect the market prices of equity securities of many companies. These fluctuations often have been unrelated or disproportionate to the operating performance of those companies. In addition, the stock prices of many cannabis-related companies have experienced wide fluctuations that have often been unrelated to the operating performance of those companies. These broad market and industry fluctuations, as well as general economic, political, and market conditions such as recessions, interest rate changes, or international currency fluctuations, may cause the market price of our common stock to decline. If the market price of our common stock fluctuates or declines, you may not realize any return on your investment and may lose some or all of your investment.

 

Our operating results are subject to fluctuations and our stock price may decline significantly.

 

Our quarterly revenue and operating results are difficult to predict from quarter to quarter. We derive revenue from our hemp processing business which is dependent upon volumes produced by farmers and is seasonal. Prices for products derived from hemp have declined significantly over the past few years resulting in many farmers exiting the industry. We derive relatively stable revenue from our property leased industrial warehouse. Nonetheless, it is possible that our net operating results in some quarters will fall below our expectations. Our quarterly operating results will be affected by a number of factors, including:

 

  Timing, availability and changes in government incentive programs;
     
  Unplanned additional expenses and/or shortfalls in anticipated rental income at our warehouse property;
     
  Logistical costs;
     
  The timing of new technology announcements or introductions by our competitors and other developments in the competitive environment;
     
  Increases or decreases in real estate appreciation rates due to changes in economic growth;
     
  Travel costs and other factors; and
     
  State and federal government regulations

 

24

 

 

If revenue for a particular quarter is lower than we expect, we may not be unable to proportionately reduce our operating expenses for that quarter, which would harm our operating results for that quarter. If we fail to meet investor expectations or our own future guidance, even by a small amount, our stock price could decline, perhaps substantially.

 

There are restrictions on the transferability of certain of our securities.

 

Until registered for resale, investors must bear the economic risk of an investment in the Shares for an indefinite period of time. Rule 144 promulgated under the Securities Act (“Rule 144”), which provides for an exemption from the registration requirements under the Securities Act under certain conditions, requires, among other conditions, a six-month holding period prior to the resale (in limited amounts) of securities acquired in a non-public offering without having to satisfy the registration requirements under the Securities Act. There can be no assurance that we will fulfill any reporting requirements in the future under the Exchange Act or disseminate to the public any current financial or other information concerning us.

 

If the Company uses its stock in acquisitions of other entities, there may be substantial dilution at the time of a transaction.

 

The offering price of the common stock we sold as a private placement of restricted shares of our common stock to raise working capital, was arbitrarily set. The price did not bear any relationship to our assets, book value, earnings or net worth and it is not an indication of actual value. You may also suffer additional dilution in the future from the sale of additional shares of common stock or other securities or if the Company’s shares are issued to purchase other assets or to raise additional working capital.

 

Trading on the OTC Markets can be volatile and sporadic, which could depress the market price of our common stock and make it difficult for our stockholders to resell their shares.

 

Our common shares are quoted on OTCQB. There is no cost of such quotation and related services from OTC Markets, Inc. Trading in stock quoted on the OTCQB Markets is often thin and characterized by wide fluctuations in trading prices due to many factors that may have little to do with our operations or business prospects. This volatility could depress the market price of our common stock for reasons unrelated to operating performance. Moreover, the OTC Markets is not a stock exchange, and trading of securities on the OTCQB Markets is often more sporadic than the trading of securities listed on a quotation system like Nasdaq or a stock exchange like the New York Stock Exchange. Accordingly, our stockholders may have difficulty reselling any of their shares. A number of brokerage houses will not trade our securities for customers because we are in the hemp business and/or because we trade on the OTC.

 

The Company currently plans to move to a more advantageous trading market via a potential uplisting, to a national exchange, and a formal application has been made. However, there is no assurance that we will be able to successfully move trading markets or uplist to a national exchange.

  

Because we do not expect to pay any dividends for the foreseeable future, investors may be forced to sell their stock to realize a return on their investment.

 

We do not anticipate that we will pay any dividends to holders of our common stock for the foreseeable future. Any payment of cash dividends will be at the discretion of our board of directors and will depend on, among other things, our results of operations, cash requirements, financial condition, contractual restrictions including compliance with covenants under our debt agreements, and other factors that our board of directors may deem relevant. Our ability to pay dividends might be restricted by the terms of any indebtedness that we incur in the future. In addition, certain of our current outstanding debt agreements prohibit us from paying cash dividends on our common stock. Consequently, you should not rely on dividends to receive a return on your investment.

 

25

 

 

Our common stock is presently subject to the “Penny Stock” rules of the SEC.

 

We are subject now to the “Penny Stock” rules since our shares of common stock sell below $5.00 per share. Penny stocks generally are equity securities with a price of less than $5.00. The penny stock rules require broker-dealers to deliver a standardized risk disclosure document prepared by the SEC which provides information about penny stocks and the nature and level of risks in the penny stock market. The broker-dealer must also provide the customer with current bid and offer quotations for the penny stock, the compensation of the broker-dealer and its salesperson, and monthly account statements showing the market value of each penny stock held in the customer’s account. The bid and offer quotations, and the broker-dealer and salesperson compensation information must be given to the customer orally or in writing prior to completing the transaction and must be given to the customer in writing before or with the customer’s confirmation. ∙ In addition, the penny stock rules require that prior to a transaction, the broker dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser’s written agreement to the transaction. The penny stock rules are burdensome and may reduce the trading activity for shares of our common stock. As long as our shares of common stock are subject to the penny stock rules, the holders of such shares of common stock may find it more difficult to sell their securities.

 

If we fail to remain current on our reporting requirements, we could be removed from the OTCQB which would limit the ability of broker-dealers to sell our securities in the secondary market.

 

Companies trading on the OTCQB must be reporting issuers under Section 12 of the Securities Exchange Act of 1934, as amended, and must be current in their reports under Section 13, in order to maintain price quotation privileges on the OTCQB. As a result, the market liquidity for our securities could be severely adversely affected by limiting the ability of broker-dealers to sell our securities and the ability of stockholders to sell their securities in the secondary market. In addition, we may be unable to get relisted on the OTCQB, which may have an adverse material effect on the Company.

 

If we decide to implement a reverse stock split, a reverse stock split may decrease the liquidity of the shares of our common stock.

 

The liquidity of the shares of our common stock may be affected adversely by a reverse stock split given the reduced number of shares that will be outstanding following a reverse stock split, especially if the market price of our common stock does not increase as a result of the reverse stock split.

 

Item 1B. Unresolved Staff Comments

 

None.

 

Item 2. Properties

 

We provide post-harvest and midstream services to growers by drying, processing, cleaning, stripping harvested hemp directly from the field and wetbaled at our leased 48,000 square foot facility located in Hopkinsville, Kentucky. We maintain significant equipment at this location including four belt dryers, augers and elevators, polishers, debearders, screening machines, dust collection systems, hammer mill, air compressors and bagging equipment.

 

Our industrial warehouse is located at 4430 Garfield Street, Denver, Colorado in an industrial neighborhood zoned for cannabis cultivation. Properties located in the 80216 zip code have recently had some of the highest appreciation rates in the Denver region due to significant infrastructure expenditures by local governmental agencies. Numerous warehouses utilized for cannabis cultivation are located in this industrial district of Denver.

 

We also lease office space located in Fort Worth, Texas for managerial offices.

 

The Company owns certain real property including land, hydroelectric dam, generators, transformers, internet towers, etc. in Costa Rica through an 80% owned subsidiary.

 

Item 3. Legal Proceedings

 

As a normal incident of the businesses in which the Company is engaged, various claims, charges and litigation may be asserted or commenced from time to time against the Company. With respect to claims and litigation currently asserted or commenced against the Company, it is the opinion of management that final judgments, if any, which might be rendered against the Company are adequately reserved for, are covered by insurance, or are not likely to have a material adverse effect on the Company’s financial condition or results of operations. Nevertheless, given the uncertainties of litigation, it is possible that certain types of claims, charges and litigation could have a material adverse impact on the Company; see Item 1A, “Risk Factors.” See Note 8 to the consolidated financial statements included in this annual report for additional information relating to legal matters.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

26

 

 

PART II

 

Item 5. Market for Registrant’s Common Equity and Related Shareholder Matters.

 

Our common stock is quoted on OTCQB under the symbol “GENH.” In the future, should we meet stringent qualifications and pay the required fee, we plan to have our shares quoted on Capital Markets tier of NASDAQ, however here is no assurance that our shares will continue to be quoted on any market.

 

Shareholders

 

As of the date of this report, there were 76 direct holders of our common shares as shown on the list maintained by our transfer agent. We may have a substantial number of additional shareholders who hold their shares in street name.

 

Dividends

 

We have not declared or paid any cash dividends on our common stock. To date we have utilized all available cash to finance our operations. Payment of cash dividends in the future will be at the discretion of our Board of Directors and will depend upon our earnings levels, capital requirements, any restrictive loan covenants and other factors the Board considers relevant.

 

Warrants

 

At December 31, 2022, there were 3,058,333 warrants outstanding for the purchase of Company common stock. Refer to Note 10 to the consolidated financial statements included in this annual report for additional information relating to outstanding warrants.

 

Equity Compensation Plans

 

The 2021 Omnibus Incentive Plan (“2021 Plan”) was adopted by our Board on July 1, 2021. The 2021 Plan provides for the initial reservation of 15 million shares of common stock for issuance, and provides that the maximum number of shares that may be issued pursuant to the exercise of ISOs is 15 million. The number of shares of common stock available for issuance under the 2021 Plan constituted approximately 13.1% of the Company’s fully diluted common shares outstanding as of the date of Board approval, including shares issuable upon the conversion of preferred shares, as calculated on an as-converted basis. On the one-year anniversary date of the 2021 Plan, the number of shares of common stock reserved for issuance thereunder shall automatically increase to 20% of the fully diluted common shares outstanding, including shares issuable upon the conversion of preferred shares, as calculated on an as-converted basis.

 

At December 31, 2022, there were 15,765,000 options outstanding for the purchase of Company common stock. Refer to Note 11 to the consolidated financial statements included in this annual report for additional information relating to outstanding options.

 

Recent Sales of Unregistered Securities

 

Since January 1, 2022, we have sold securities in private transactions without registering the securities under the Securities Act as shown below:

 

  Issuance for Extensions of Secured Note – The Company issued 110,000 common shares as consideration for extensions of the maturity of a senior note in 2022.

 

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

 

We made no purchases of our equity securities.

 

Our Transfer Agent

 

We have retained Securities Transfer Corporation (“STC”), Plano, Texas, as transfer agent for our Common shares. Shareholders are responsible to contact STC to update their address. This may be done by contacting:

 

  Securities Transfer Corporation
  2901 N. Dallas Parkway, Suite 380
  Plano, Texas 75093
  Phone: (469) 633-0101
  Fax: (469) 633-0088
  www.stctransfer.com

 

STC is responsible for all record-keeping and administrative functions in connection with our common shares.

 

27

 

 

Item 6. Reserved

 

Not applicable.

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion is intended to assist you in understanding our results of operations and our present financial condition and contains forward-looking statements that reflect our future plans, estimates, beliefs and expected performance. The forward-looking statements are dependent upon events, risks and uncertainties that may be outside our control. We caution you that our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to such differences are discussed elsewhere in this Annual Report, particularly in the “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors,” all of which are difficult to predict. In light of these risks, uncertainties and assumptions, the forward-looking events discussed may not occur. We do not undertake any obligation to publicly update any forward-looking statements except as otherwise required by applicable law.

 

There is limited historical financial information about our Company upon which to base an evaluation of our future performance.  We cannot guarantee that we will be successful in our hemp businesses. We are subject to risks inherent in a small company, including limited capital resources, delays and cost overruns due to price and cost increases. There is no assurance that future financing will be available to our company on acceptable terms. Additional equity financing could result in dilution to existing shareholders.

 

Overview

 

We are a holding company active within the “hemp” space. Beginning in 2023, we started activities in the sustainable asset space including the bitcoin industry. We were incorporated on August 21, 2021 in the State of Delaware. The Company was originally incorporated on July 28, 2008 in the State of Colorado. On November 27, 2019, HTF purchased approximately 94% of the common stock of EHR in a series of transactions accounted for as a reverse merger.

 

On January 11, 2021, we completed the acquisition of certain assets of Halcyon Thruput, LLC (“Halcyon”). With this acquisition, we commenced providing post-harvest and midstream services to growers by drying, processing, cleaning and stripping harvested hemp directly from the field and wetbaled at our 48,000 square foot leased facility located in Hopkinsville, Kentucky. Additionally, the Company offers safe storage services for processed hemp, which enables farmers to maximize strategic market timing. In September 2021, the Company launched its small animal bedding consumer goods product line (“Rowdy Rooster”) made from the hemp hurd byproduct that is produced from its hemp processing operations. In September of 2022, the Company launched its industrial absorbent consumer goods product line (Gas Monkey Spill-Jack), also made from the hemp hurd byproduct produced from its hemp processing operations. This second product line is marketed under a branding agreement with Gas Monkey Garage, a well-known brand in the automotive and entertainment sector.

 

We also generate revenue from rental of our “Cannabis Zoned” (Hemp) warehouse property located in Denver, Colorado currently leased to an unaffiliated hemp seed company.

 

Liquidity – The Company is dependent upon obtaining additional funding to continue ongoing operations and to pursue its strategy and execute its acquisition plans.

 

In the year ended December 31, 2022, the Company used $633 thousand of cash for its operating activities. At December 31, 2022, the Company’s current liabilities, including financing obligations due within one year, totaled $5.9 million as compared with its current assets of $917 thousand.

 

The Company will continue to pursue additional capital raising opportunities in order to fund future acquisitions and meet its obligations as they become due. In the event financing cannot be obtained, the Company may not be able to satisfy these plans and obligations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

28

 

 

Subsequent Events

 

In January 2023, the Company announced a new strategic direction into sustainable energy projects, starting with bitcoin mining. The Company’s name was changed to Evergreen Sustainable Enterprises, Inc. (“EGSE”) in March 2023. The Company’s existing hemp operations will continue to be maintained as a fully operating wholly-owned subsidiary.

 

On January 9, 2023, the Company purchased 80% of Toro Energía Sociedad Anonima (“Toro”), a Costa Rican corporation with ownership of a hydroelectric dam located in Costa Rica. The source of approximately one megawatt of power produced from the hydroelectric dam (six generators) will be used to power new Bitcoin mining machines at an extremely low cost. The transaction was completed based on a total enterprise value for Toro of $2.75 million, including seller-financed debt of $985 thousand. The seller-financed debt has a term of 10 years and a 9.5% per annum variable interest rate (based on the prime rate) with straight line amortization.

 

The purchase price for 80% of Toro’s equity was $1,412,000. These amounts were paid in cash from proceeds of a Secured Promissory Note (“Secured Note”) with Gary C. Evans, CEO of the Company (‘Evans”). Under the terms of the Secured Note, (a) the Company and Evans restructured (i) the Subordinated Promissory Note, dated November 20, 2020 and (ii) Convertible Promissory Note, dated July 20, 2021, such that all accrued and unpaid interest on each note were rolled into a new Secured Note, (b) Evans lent the Company $500 thousand on January 9, 2023 and $969 thousand on January 10, 2023. The Secured Note has a maturity date of July 15, 2023 and bears interest at the rate of 10.00% per annum. The Secured Note has a conversion feature which permits Evans to convert at the Maturity Date then outstanding principal and interest at a conversion price of $0.275 (the closing price of the Company’s stock on January 9, 2023).

  

The Toro Dam is located approximately 25 miles from San Jose between two volcano craters. The site generates all its energy from green resources with a proven 98% run time over the many years it has been in operation and has a full-time staff in place under a new Operating & Maintenance Agreement.

 

Hydroelectric power is a clean and renewable energy source that is used to generate electricity by harnessing the energy of falling water and can provide a reliable and a very cost-effective source of energy for bitcoin mining operations. Hydroelectric power can help reduce the carbon footprint of cryptocurrency mining, as many cryptocurrencies are produced using fossil fuels, which continues to contribute to greenhouse gas emissions and climate change. By using hydroelectric power, bitcoin mining can be made more environmentally friendly and sustainable and can help improve the stability and reliability of cryptocurrency networks. Hydroelectric power is a relatively stable and reliable source of energy, compared to other sources such as coal or fossil fuels, which can be prone to price fluctuations and supply disruptions. The Company has committed to acquire and made financial payments for the purchase of 240 new Bitmain S19J Pro+ ASIC miners that will be deployed at the Toro Dam sometime in the first quarter of 2023.

 

How the Company Generates Revenue

 

We provide post-harvest and midstream services to growers by drying, processing, cleaning and stripping harvested hemp directly from the field and wetbaled at our leased 48,000 square foot facility located in Hopkinsville, Kentucky. Additionally, the Company offers safe storage services for processed hemp, which enables farmers to maximize strategic market timing. In August 2021, the Company launched its animal bedding consumer goods product line made from the hemp hurd byproduct that is produced from its hemp processing operations.

 

We also generate revenue from rental of our “Cannabis Zoned” (Hemp) warehouse property located in Denver, Colorado currently leased to a hemp seed company.

 

We currently intend to generate revenue from Bitcoin mining.

 

Our Costs and Expenses of Conducting Business

 

The principal costs and expenses involved in conducting our business are labor, materials and overhead costs for processing services, real estate holding costs (interest, taxes, depreciation and maintenance costs) and general and administrative expenses for our management, contract labor, professional fees and other costs of being a public company. We also incur costs in seeking acquisitions and financings of our business.

 

Discontinued Oil & Gas Activities

 

As of December 31, 2022, EHR held an approximate 8% working interest in an oil & gas property located in Cochran County, Texas within the Slaughter-Levelland Field of the San Andres formation in the Northwest Shelf of West Texas. EHR’s oil & gas activities are currently held for sale and are presented in these consolidated financial statements as discontinued operations for each of the periods presented.

 

29

 

 

Results of Operations

 

Years Ended December 31, 2022 and 2021

 

The net loss attributable to Evergreen Sustainable Enterprises for the year ended December 31, 2022 was $7.0 million as compared with a net loss attributable to Evergreen Sustainable Enterprises of $9.8 million for 2021. The net loss attributable to Evergreen Sustainable Enterprises for 2022 includes $4.8 million of stock-based compensation expense, $407 thousand for a non-cash impairment charge and $1.0 million for depreciation and amortization largely due to the Halcyon acquisition. Excluding these non-cash items, the Company’s cash loss was $852 thousand in 2022 as compared with a cash loss of $3.9 million for 2021. We processed larger volumes of hemp in 2022 as compared with 2021 resulting in greater gross profits from these operations. We also received $501 thousand for settlements from two lawsuits during 2022. 

 

The Company reports its oil & gas activities as discontinued operations. Loss from discontinued operations was $60 thousand for the year ended December 31, 2022 as compared with a loss of $32 thousand in 2021.

 

Revenue. Total revenue for 2022 was $2.6 million as compared with $674 thousand for 2021.

 

Our hemp processing operations are typically limited during the first half of each year until harvest. In 2022, we commenced hemp processing in June and remained fully operational through late-December 2022. We processed 6.1 million pounds of hemp biomass for total revenues of $2.5 million. In 2021, we commenced hemp processing operations in the third quarter. We had revenues of $592 thousand for the processing of approximately 2.1 million pounds of hemp biomass.

 

In 2022, we sold about 30% of our on-hand inventory of processed hemp biomass for $100 thousand. We took this inventory in-kind from a customer in late-2021. We are holding the remaining inventory for sale at a later date.

 

Rental revenue was $90 thousand in 2022 as compared with $82 thousand in 2021. The Company’s Denver warehouse is presently leased through August 1, 2023 for $7.5 thousand per month plus certain other expenses.

 

Cost of Revenue. Cost of revenue was $1.0 million for 2022 as compared with $653 thousand for 2021 and consisted of direct labor, supplies and overhead for the Company’s post-harvest and midstream services operations. Our gross margin on post-harvest processing and midstream services was 59% in 2022 as compared with -10% for 2021. The negative margin on this business in 2021 was caused by holding costs and limited staffing needed until the annual harvest and processing commenced in August 2021. In 2022, we took steps to reduce operating costs by idling our facilities until processing commenced in June 2022.

 

Depreciation and Amortization. Depreciation and amortization expense totaled $1.0 million in 2022 as compared with $1.3 million for 2021. Intangible assets consist of customer relationships and non-compete agreements acquired in the acquisition of certain assets of Halcyon. Amortization of these intangibles was $586 thousand in 2022 and $818 thousand in 2021. Future amortization expense in each of the next five years are expected to be $419 thousand for 2023, $278 thousand for 2024, $194 thousand for 2025, $130 thousand for 2026 and $86 thousand for 2027.

 

General and Administrative Expense. General and administrative expenses totaled $7.1 million for the year ended December 31, 2022 as compared with $7.8 million in 2021. The reduction was principally a result of lower cash compensation expense in 2022. In 2021, bonus compensation totaling $610 thousand was paid to our CEO for successful completion of the Halcyon acquisition. Non-cash stock-based compensation expense was $4.8 million in 2022 as compared with $4.5 million in 2021.

 

Other Income/Expense. Interest expense was $501 thousand in 2022 and $708 thousand in 2021. Amortization of debt discounts was $327 thousand higher in 2021 than in 2022. These debt discounts were incurred from the initial issuance of debt with stock or warrants.

 

Other income for 2022 includes $501 thousand received for settlements from two lawsuits during 2022. In 2021, other income of $25 thousand was recognized for forgiveness of the Company’s PPP Loan principal and interest thereon.

 

Loss from Discontinued Operations. In 2022, we recognized a loss from discontinued operations of $60 thousand as compared with a loss of $32 thousand in 2021. The major classes of line items constituting the loss on discontinued operations is presented in Item 8 of Part II, “Financial Statements and Supplementary Data—Note 12—Discontinued Operations.” Until we fully dispose of our remaining oil & gas property interests, we expect lower future revenues and costs as production activities have declined substantially. We do not anticipate making future investment of growth capital into these properties. In 2019, the Company’s oil and gas properties became impaired and the carrying amount of the properties was expensed due to the market decline and the Company’s determination to exit the oil and gas business.

 

30

 

 

Liquidity and Capital Resources

 

Our primary source of cash from continuing operations includes post-harvest and midstream services and rental revenue. Our primary uses of cash include our operating costs, general and administrative expenses and merger and acquisition expenses.

 

Cash flow information from continuing operations for 2022 was as follows:

 

  Cash used in operating activities was $633 thousand million principally due to the net loss adjusted for non-cash items.

 

  No cash was used for investing activities in 2022.

 

  Net cash from financing activities totaled $887 thousand. This amount included $1.3 million of cash inflows from the proceeds from notes payable. We used $407 thousand of cash for repayment of outstanding indebtedness.

 

We used $3 thousand of cash for discontinued operations in 2022.

 

Funding Requirements

 

We expect to continue to incur significant expenses and operating losses for the foreseeable future. We anticipate that our overall expenses may increase significantly as we grow our hemp business.

 

We anticipate that we will require additional capital to fund operations, including hiring additional employees, completing acquisitions and funding capital expenditures during the next twelve-month period.

 

Because of the numerous risks and uncertainties associated with the development and commercialization of our business, we are unable to estimate the amounts of increased capital outlays and operating expenses. Our future capital requirements will depend on many factors, including:

 

  our success in identifying and making acquisitions of profitable operations;

 

  our ability to negotiate operating contracts with growers and others within the hemp industry on favorable terms, if at all;

 

  deriving revenue from our assets and operations; and

 

  the cost of such operations and costs of being a public company.

 

Until such time as we can generate substantial revenues, we expect to finance our cash needs through a combination of equity offerings and debt financings. We do not have any committed external source of funds. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interest of our shareholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of common shareholders. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce or terminate our growth plans and future commercialization efforts.

 

Off-Balance Sheet Arrangements

 

As of December 31, 2022, we had no off-balance sheet arrangements.

 

31

 

 

Indebtedness

 

The Company’s indebtedness at December 31, 2022 is presented in Item I, “Financial Statements – Note 5 – Notes Payable – Related Parties” and in Item I, “Financial Statements—Note 6—Other Indebtedness.”

 

 Subsequently, the Company received advances under new and existing note arrangements. Refer to Item I, “Financial Statements—Note 15 – Subsequent Events.”

 

Critical Accounting Policies and Estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the amounts of revenue and expenses reported for the period then ended.

 

Impairment of Long-lived Assets. We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. These events and circumstances include, but are not limited to, a current expectation that a long-lived asset will be disposed of significantly before the end of its previously estimated useful life, a significant adverse change in the extent or manner in which we use a long-lived asset or a change in its physical condition.

 

When such events or changes in circumstances occur, a recoverability test is performed comparing projected undiscounted cash flows from the use and eventual disposition of an asset or asset group to its carrying amount. If the projected undiscounted cash flows are less than the carrying amount, an impairment is recorded for the excess of the carrying amount over the estimated fair value.

 

We make various assumptions, including assumptions regarding future cash flows in our assessments of long-lived assets for impairment. The assumptions about future cash flows and growth rates are based on the current and long-term business plans related to the long-lived assets.

 

Stock-based Compensation – We account for employee stock-based compensation using the fair value method. Compensation cost for equity incentive awards is based on the fair value of the equity instrument generally on the date of grant and is recognized over the requisite service period. Forfeitures are recognized as they occur.

 

Recent Accounting Pronouncements. See Item 8 of Part II, “Financial Statements and Supplementary Data—Note 2—Summary of Significant Accounting Policies—Recent Accounting Pronouncements.”

 

Item 7A. Quantitative and Qualitative Disclosure About Market Risk

 

Not required for smaller reporting companies.

 

32

 

 

Item 8. Financial Statements and Supplementary Data

 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

  Page
Report of Independent Registered Public Accounting Firm (PCAOB ID Number 688) F-2
   
Consolidated Balance Sheets F-4
   
Consolidated Statements of Operations F-5
   
Consolidated Statements of Changes in Stockholders’ Equity (Deficit) F-6
   
Consolidated Statements of Cash Flows F-7
   
Notes to Consolidated Financial Statements F-8

 

F-1

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Shareholders and Board of Directors of

Evergreen Sustainable Enterprises, Inc. (formerly Generation Hemp, Inc.)

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Evergreen Sustainable Enterprises, Inc. (formerly Generation Hemp, Inc.) (the “Company”) as of December 31, 2022 and 2021, the related consolidated statements of operations, changes in stockholders’ equity (deficit) and cash flows for each of the years ended December 31, 2022 and 2021, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the years then ended, in conformity with accounting principles generally accepted in the United States of America.

 

Explanatory Paragraph – Going Concern

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described in Note 1, the Company has a significant working capital deficiency, has incurred significant losses and needs to raise additional funds to meet its obligations and sustain its operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1 to the consolidated financial statements. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matters

 

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

 

F-2

 

 

Valuation and accounting for share-based instruments

 

As described in Note 9, for the year ended December 31, 2021, the Company issued 2,558,333 warrants to investors with exercise prices of $0.500 to $0.600 per share, vesting over a period of two years. The warrants issued were attached to units of common stock sold to various investors including a related party, which are only redeemable by the warrants holders.

 

As described in Note 10, the Company issued 13,850,000 options during the year ended December 31, 2021 with a grant date fair value of $10,525,284. Additionally, the Company issued 1,915,000 options during the year ended December 31, 2022 with a grant date fair value of $576,251. Share-based compensation expense of $4,385,118 and $4,758,257 was recognized in 2021 and 2022, respectively, related to these options based on the vesting terms.

 

How we Addressed the Matter in Our Audit

 

Our audit procedures included, amongst others:

 

  We tested the agreements to determine whether management appropriately evaluated such agreements on issuance date.
     
  We tested the information that served as the basis for valuation of the shares issued to determine whether stock compensation should be recorded.
     
  We evaluated the reasonableness of the valuation method and assumptions used by management to calculate the values on issuance date by developing an independent estimate of the volatility by utilizing third party historical data of closing prices.

 

Valuation and accounting for acquisition of Halcyon assets

 

As described in Note 3, for the year ended December 31, 2021, the Company completed the acquisition of certain assets of Halcyon for a total purchase consideration of $6,100,000 consisting of 6,250,000 shares of Company common stock valued at $2.5 million, $1.75 million in cash, a promissory note for $850,000 and the assumption of approximately $1,000,000 of new indebtedness of Halcyon.

 

How we Addressed the Matter in Our Audit

 

Our audit procedures included, amongst others:

 

We tested the asset purchase agreements to determine whether appropriately evaluated such agreements on the acquisition date.

 

We tested the information that served as the basis for valuation for the asset acquired whether any valuation adjustments should be recorded.

 

We evaluated the reasonableness of the valuation method and assumptions used by management to calculate the values on the acquisition date by developing an independent estimate of the fair values by utilizing the multi-period excess earnings method for intangible assets and published cost databases for tangible assets.

 

/s/ Marcum llp

Marcum llp

 

We have served as the Company’s auditor since 2019.

 

Houston, Texas
May 18, 2023

 

F-3

 

 

Evergreen Sustainable Enterprises, Inc.

(formerly Generation Hemp, Inc.)

Consolidated Balance Sheets

 

   December 31, 
   2022   2021 
Assets        
Current Assets:        
Cash  $275,506   $20,656 
Accounts receivable   470,719    
-
 
Inventories   148,427    212,518 
Prepaid expenses   22,143    4,723 
Total current assets   916,795    237,897 
Property and equipment, net   2,161,952    2,580,662 
Operating lease right-of-use asset   161,827    263,065 
Intangible assets, net   1,271,398    1,857,908 
Goodwill   799,888    799,888 
Other assets   2,060    407,000 
Total Assets  $5,313,920   $6,146,420 
           
Liabilities and Equity (Deficit)          
Current Liabilities:          
Accounts payable  $686,297   $883,485 
Accrued liabilities   767,396    410,990 
Payables to related parties   591,574    204,007 
Operating lease liability - related party   111,839    101,238 
Notes payable – related parties   3,322,620    2,183,551 
Other indebtedness - current   250,002    501,668 
Current liabilities of discontinued operations held for sale   166,186    153,482 
Total current liabilities   5,895,914    4,438,421 
Operating lease liability - related party, net of current portion   49,988    161,827 
Long-term liabilities of discontinued operations held for sale   207,197    162,948 
Total liabilities   6,153,099    4,763,196 
           
Commitments and contingencies   
 
    
 
 
           
Series B redeemable preferred stock, no par value, $10,000 stated value, 300 shares authorized, 118 shares issued and outstanding at December 31, 2022 and 2021   591,558    591,558 
           
Equity (Deficit):          
Preferred stock, $0.00001 par value; 200,000,000 shares authorized, none outstanding   
-
    
-
 
Common stock, $0.00001 par value; 200,000,000 shares authorized, 113,204,002 and 113,094,002 shares issued and outstanding at December 31, 2022 and 2021, respectively   1,132    1,131 
Additional paid-in capital   34,029,851    29,150,258 
Accumulated deficit   (35,230,018)   (28,118,245)
Evergreen Sustainable Enterprises equity (deficit)   (1,199,035)   1,033,144 
Noncontrolling interest   (231,702)   (241,478)
Total equity (deficit)   (1,430,737)   791,666 
Total Liabilities and Equity (Deficit)  $5,313,920   $6,146,420 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4

 

 

Evergreen Sustainable Enterprises, Inc.

(formerly Generation Hemp, Inc.)

Consolidated Statements of Operations

 

   For the year ended
December 31,
 
   2022   2021 
Revenue:        
Post-harvest and midstream services  $2,505,590   $592,024 
Rental   90,000    82,500 
Total revenue   2,595,590    674,524 
           
Costs and Expenses:          
Cost of revenue (exclusive of items shown separately below)   1,016,930    652,521 
Depreciation and amortization   1,005,220    1,340,425 
Impairment expense   407,000    
-
 
General and administrative   7,128,421    7,803,196 
Total costs and expenses   9,557,571    9,796,142 
           
Operating loss   (6,961,981)   (9,121,618)
           
Other expense (income):          
Other income   (500,905)   (25,424)
Change in fair value of marketable security   
-
    (11,770)
Interest expense   501,146    708,338 
Total other expense (income)   241    671,144 
Loss from continuing operations   (6,962,222)   (9,792,762)
Income (loss) from discontinued operations   (59,773)   (32,213)
Net loss  $(7,021,995)  $(9,824,975)
Less: net income (loss) attributable to noncontrolling interests   9,776    (2,247)
Net loss attributable to Evergreen Sustainable Enterprises  $(7,031,771)  $(9,822,728)
Earnings (loss) per common share:          
Loss from continuing operations          
Basic  $(0.06)  $(0.17)
Diluted  $(0.06)  $(0.17)
Loss from discontinued operations          
Basic  $
-
   $
-
 
Diluted  $
-
   $
-
 
Earnings (loss) per share          
Basic  $(0.06)  $(0.17)
Diluted  $(0.06)  $(0.17)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5

 

 

Evergreen Sustainable Enterprises, Inc.

(formerly Generation Hemp, Inc.)

Statements of Changes in Stockholders’ Equity (Deficit)

 

   Series B
Redeemable
Preferred Stock
   Series A Preferred Stock   Common Stock   Additional
Paid-In
   Accumulated   Noncontrolling   Total Equity 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Interest   (Deficit) 
Balance at January 1, 2021   135   $729,058    6,328,948   $4,975,503    17,380,317   $6,083,480   $4,436,018   $(18,220,705)  $(239,231)  $(2,964,935)
Acquisition of Certain Assets of Halcyon Thruput, LLC   -    -    -    -    6,250,000    2,500,000    -    -    -    2,500,000 
Issuances of common stock units   -    -    -    -    1,758,333    136,717    838,283    -    -    975,000 
Warrant exercises   -    -    -    -    9,494,316    4,771,679    (1,429,679)   -    -    3,342,000 
Issuance of common shares for Convertible Promissory Note   -    -    -    -    618,660    217,769    -    -    -    217,769 
Issuance of common shares for Senior Secured Promissory Note   -    -    -    -    1,000,000    1,942,500    -    -    -    1,942,500 
Common shares issued to vendor for services   -    -    -    -    125,000    117,500    -    -    -    117,500 
Issuance of common shares for extension of secured note   -    -    -    -    20,000    18,000    -    -    -    18,000 
Change in common stock par value due to change in corporate domicile   -    -    -    -    -    (15,868,273)   15,868,273    -    -    - 
Conversion of Series A preferred stock   
 
    
 
    (6,328,948)   (4,975,503)   75,947,376    759    4,974,744    -    -    - 
Series B preferred stock redemptions   (17)   (137,500)   -    -    -    -    -    -    -    - 
Series B preferred stock dividend   -    -    -    -    -    -    -    (74,812)   -    (74,812)
Stock-based compensation   -    -    -    -    500,000    81,000    4,462,619    -    -    4,543,619 
Net loss   -    -    -    -    -    -    -    (9,822,728)   (2,247)   (9,824,975)
                                                   
Balance at December 31, 2021   118    591,558    -    -    113,094,002    1,131    29,150,258    (28,118,245)   (241,478)   791,666 
Issuance of common shares for extension of secured note   -    -    -    -    110,000    1    52,580    -    -    52,581 
Modification of warrants for extension of promissory note to investor                            
 
    68,756    
 
    
 
    68,756 
Series B preferred stock dividend   -    -    -    -    -    -    -    (80,002)   -    (80,002)
Stock-based compensation   -    -    -    -    -    -    4,758,257    -    -    4,758,257 
Net loss   -    -    -    -    -    -    -    (7,031,771)   9,776    (7,021,995)
Balance at December 31, 2022   118   $591,558    -   $-    113,204,002   $1,132   $34,029,851   $(35,230,018)  $(231,702)  $(1,430,737)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-6

 

 

Evergreen Sustainable Enterprises, Inc.

(formerly Generation Hemp, Inc.)

Consolidated Statements of Cash Flows

 

   For the year ended
December 31,
 
   2022   2021 
Cash Flows From Operating Activities          
Net loss  $(7,021,995)  $(9,824,975)
Loss from discontinued operations   (59,773)   (32,213)
Net loss from continuing operations   (6,962,222)   (9,792,762)
Adjustments to reconcile net loss from continuing operations to net cash from operating activities:          
Depreciation and amortization   1,005,220    1,340,425 
Impairment expense   407,000    
-
 
Amortization of debt discount   52,581    380,282 
Stock-based compensation   4,758,257    4,543,619 
Common shares issued to vendor for services   
-
    117,500 
Modification of warrants for extension of promissory note to investor   68,756    
-
 
Other income - PPP Loan forgiveness   
-
    (25,424)
Loss on disposal of property and equipment   
-
    6,938 
Change in fair value of marketable securities   
-
    (11,770)
Changes in operating assets and liabilities:          
Accounts receivable   (470,719)   75,470 
Inventories   64,091    (212,518)
Prepaid expenses and other assets   (19,480)   (4,723)
Accounts payable and accrued liabilities   466,783    85,939 
Net cash from operating activities – continuing operations   (629,733)   (3,497,024)
Net cash from operating activities – discontinued operations   (2,820)   
-
 
Net cash from operating activities   (632,553)   (3,497,024)
Cash Flows From Investing Activities          
Capital expenditures   
-
    (77,715)
Acquisition of certain assets of Halcyon Thruput, LLC, net of acquired cash of $224,530   
-
    (1,525,470)
Proceeds from sale of investment in common stock   
-
    34,847 
Net cash from investing activities – continuing operations    
-
    (1,568,338)
Cash Flows From Financing Activities          
Issuance of common stock units   
-
    925,000 
Redemptions of Series B preferred stock   
 
    (137,500)
Series B preferred stock dividends paid   
 
    (16,500)
Proceeds from warrant exercises   
-
    3,342,000 
Repayment of Halcyon bank note   
-
    (995,614)
Proceeds from notes payable - related parties   1,294,069    
-
 
Repayments of notes payable - related parties   (105,000)   
-
 
Proceeds from subordinated notes   
-
    410,000 
Repayment of subordinated notes   (50,000)   (1,100,000)
Payment of mortgage payable   (251,666)   (117,793)
Net cash from financing activities – continuing operations   887,403    2,309,593 
Net change in cash   254,850    (2,755,769)
Cash, beginning of period   20,656    2,776,425 
Cash, end of period  $275,506   $20,656 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-7

 

 

Evergreen Sustainable Enterprises, Inc.

(formerly Generation Hemp, Inc.)

Notes to Consolidated Financial Statements

 

1. Business

 

Evergreen Sustainable Enterprises, Inc. (formerly Generation Hemp, Inc.) (the “Company”) was incorporated on August 21, 2021 in the State of Delaware. The Company was originally incorporated as Home Treasure Finders, Inc. (“HTF”) on July 28, 2008 in the State of Colorado. On November 27, 2019, HTF purchased approximately 94% of the common stock of Energy Hunter Resources, Inc. (“EHR”) in a series of transactions accounted for as a reverse merger. Upon closing, HTF changed its name to Generation Hemp, Inc. In March 2023, the Company changed its name to Evergreen Sustainable Enterprises, Inc.

 

On January 11, 2021, we completed the acquisition of certain assets of Halcyon Thruput, LLC (“Halcyon”). With this acquisition, we commenced providing post-harvest and midstream services to hemp growers by drying, processing, cleaning and stripping harvested hemp directly from the field and wetbaled at our 48,000 square foot leased facility located in Hopkinsville, Kentucky. The Company also offers safe storage services for processed hemp, which enables farmers to maximize strategic market timing. We market two retail products, Gas Monkey Spill-Jack, an all-natural, plant-based, sustainable, and biodegradable loose absorbent, and Rowdy Rooster, an animal bedding consumer goods product, each made from the hemp hurd byproduct that is produced from our hemp processing operations.

 

We also generate revenue from rental of our “Cannabis Zoned” (Hemp) warehouse property located in Denver, Colorado currently leased to an unaffiliated hemp seed company.

 

As of December 31, 2022, EHR held an approximate 8% working interest in an oil & gas property located in Cochran County, Texas within the Slaughter-Levelland Field of the San Andres formation in the Northwest Shelf of West Texas. EHR’s oil & gas activities are currently held for sale and are presented in these consolidated financial statements as discontinued operations for each of the periods presented.

 

Our management team has been and continues to actively review acquisition candidates involved in the hemp industry that operate within a number of vertical businesses, predominantly within the midstream sector that are attractive to us and are within the hemp supply chain. Additionally, the Company has been studying the Bitcoin mining space and in January 2023 announced a new strategic initiative in this area and commenced bitcoin operations. Refer to Note 15 for more discussion.

 

Liquidity and Going Concern – The Company is dependent upon obtaining additional funding to continue ongoing operations and to pursue its strategy and execute its acquisition plans.

 

In the year ended December 31, 2022, the Company used $633 thousand of cash for its operating activities. At December 31, 2022, the Company’s current liabilities, including financing obligations due within one year, totaled $5.9 million as compared with its current assets of $917 thousand.

 

The Company will continue to pursue additional capital raising opportunities in order to fund future acquisitions and meet its obligations as they become due. We may not be successful in obtaining additional financing needed. In the event financing cannot be obtained, the Company may not be able to satisfy these plans and obligations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

2. Summary of Significant Accounting Policies

 

Basis of Presentation – The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and U.S. Securities and Exchange Commission regulations. The consolidated financial statements comprise the financial statements of the Company, its wholly-owned subsidiaries, and subsidiaries that it controls due to ownership of a majority voting interest. Subsidiaries are fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continue to be consolidated until the date when such control ceases. The financial statements of the subsidiaries are prepared for the same reporting period as the Company. All significant intercompany balances and transactions are eliminated upon consolidation.

 

F-8

 

 

Business Combinations – The Company accounts for business combinations under the acquisition method of accounting. Under this method, acquired assets, including separately identifiable intangible assets, and any assumed liabilities are recorded at their acquisition date estimated fair value. Determining the fair value of assets acquired and liabilities assumed involves the use of significant estimates and assumptions. The excess of purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents the goodwill amount resulting from the acquisition.

 

Use of Estimates – The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the (i) impairment of long-lived assets and goodwill, (ii) valuation allowances for deferred income tax assets and (iii) estimates of accrued liabilities. Actual results could differ from those estimates.

 

Revenue Recognition – Post-harvest and midstream services revenue is typically determined based on volumes processed at agreed-upon contractual prices and is recognized at the point in time when performance obligations under the terms of a contract with our customers are satisfied. This occurs when control of the product is transferred to our customers upon completion of our processing.

 

Rental revenue is recognized based on the contractual cash rental payments for the period.

 

Cash – The Company maintains its deposits of cash in financial institutions, which may at times exceed amounts covered by insurance provided by the U.S. Federal Deposit Insurance Corporation (“FDIC”). The Company has not experienced any losses related to amounts in excess of FDIC limits.

 

Inventories – Inventories consist of processed hemp product and are stated at the lower of cost or net realizable value. Cost, which includes the cost of raw materials, labor and overhead, is determined using the first-in, first-out method. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable cost of completion, disposal and transportation.

 

Property and Equipment – Property and equipment is stated at cost and depreciated using the straight-line method over the estimated useful lives of assets. Upon disposition, the cost and accumulated depreciation are removed and any gain or loss on the disposal is reflected in the statements of operations. The cost of maintenance and repairs is charged to income as incurred; significant renewals and improvements are capitalized.

 

Leases – The Company’s lease arrangements are operating leases which are capitalized on the balance sheet as right-of-use (“ROU”) assets and obligations. Right of use (“ROU”) assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. These are recognized at the lease commencement date based on the present value of payments over the lease term. If leases do not provide for an implicit rate, we use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term as the lease payments. Lease expense is recognized on a straight-line basis over the lease term.

 

Intangible Assets – Finite-lived intangible assets are amortized and are tested for impairment when an event occurs or circumstances change that indicate it is more likely than not that an impairment exists. Intangible assets consist of customer relationships and non-compete agreements acquired in the acquisition of certain assets of Halcyon.

 

Impairment of Long-Lived Assets – We review long-lived assets for potential impairment when events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. In this assessment, future pre-tax cash flows (undiscounted) resulting from the use of the asset and its eventual disposal are estimated. If the undiscounted future cash flows are less than the carrying amount of the asset, an impairment loss is recognized for the difference between its carrying value and estimated fair value.

 

Noncontrolling Interest – Noncontrolling interests represent the portion of net assets in consolidated entities that are not owned by the Company. As of December 31, 2022 and 2021, minority investors owned approximately 6% of EHR.

 

F-9

 

 

Stock-based Compensation – We account for stock-based compensation using the fair value method. Compensation cost for equity incentive awards is based on the fair value of the equity instrument generally on the date of grant and is recognized over the requisite service period. Forfeitures are recognized as they occur.

 

Income Taxes – Income taxes are accounted for using a balance sheet approach. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. In assessing the realizability of deferred tax assets, management considers whether it is more-likely-than-not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax asset (including the impact of available carryback and carryforward periods), projected future taxable income, and tax-planning strategies in making this assessment. A valuation allowance for deferred tax assets is recorded when it is more likely than not that the benefit from the deferred tax asset will not be realized.

 

The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which a change in judgment occurs. The Company had no material uncertain tax positions as of December 31, 2022 or 2021. Income tax returns we file may be routinely examined by tax authorities. The statute of limitations is currently open for tax returns filed after 2018.

 

The Company is subject to the Texas margin tax; however, tax expense was zero for the years ended December 31, 2022 and 2021.

 

Discontinued Operations – In connection with the Transaction, management determined to fully divest of EHR’s oil and gas activities. As such, these activities are presented as discontinued operations for each of the periods presented.

 

The Company follows the successful efforts method of accounting for its oil and gas properties. Costs to acquire mineral interests in oil and gas properties and to drill and equip new development wells and related asset retirement costs are capitalized. In 2019, the Company’s oil and gas properties became fully impaired and the carrying amount of the properties was expensed to the market decline and the Company’s determination to exit the oil and gas business. The oil & gas properties have limited production and operations for which the Company recognizes its share as a non-operating working interest owner. Oil & gas revenue is recognized for discontinued operations based on delivered quantities in the amount of the consideration to which the Company is entitled.

 

The Company records a liability for the plugging, abandonment and remediation of its properties at the end of their productive lives. The Company computes the liability for asset retirement obligations by calculating the present value of estimated future cash flows related to each property. This requires the Company to use significant assumptions, including current estimates of plugging and abandonment costs, annual inflation of these costs, the productive lives of wells and its risk-adjusted interest rate. Changes in any of these assumptions can result in significant revisions to the estimated asset retirement obligations.

 

Asset retirement obligations are recorded as a liability at their estimated present value at the asset’s inception, with an offsetting increase to producing properties in the accompanying balance sheet which is amortized to expense on a unit-of-production basis. Periodic accretion of the discount on asset retirement obligations is recorded as expense.

 

Fair Value Measurements – Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The three levels related to fair value measurements are as follows:

 

Level 1 —    Observable inputs such as quoted prices in active markets for identical assets or liabilities.
   
Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data.
   
Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

 

F-10

 

 

The estimated fair values of cash, accounts receivable, accounts payable and indebtedness approximate their carrying amounts due to the relatively short maturity of these instruments.

 

Earnings (loss) per Share – Basic earnings (loss) per share amounts are calculated by dividing income available to common shareholders, after deducting preferred stock dividends, by the weighted average number of shares of common stock outstanding. Diluted earnings per share amounts are calculated by dividing net income by the weighted average number of shares of common stock and common stock equivalents outstanding. Common stock equivalents represent shares issuable upon the assumed conversion of preferred stock, outstanding convertible notes and the assumed exercise of common stock options and warrants outstanding.

 

Major Customer and Concentration of Credit Risk – We estimate an allowance for doubtful accounts based on an analysis of specific customers, taking into consideration the age of past due accounts and an assessment of the customer’s ability to pay. An allowance for doubtful accounts was not needed as of December 31, 2022 or 2021.

 

During 2022, one customer accounted for approximately 96% of our post-harvest and midstream services revenue. Amounts due from this customer represented all of our accounts receivable at December 31, 2022. During 2021, one customer accounted for approximately 91% of our post-harvest and midstream services revenue. No amounts were due from this customer at December 31, 2021.

 

Our rental revenue is derived from a single lessee on a commercial warehouse owned by the Company. There were no amounts due from this customer at December 31, 2022 or 2021.

 

Recent Accounting Pronouncements – In December 2019, the FASB issued ASU 2019-12, Income Taxes, which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. We adopted this standard in the first quarter of 2021. Adoption of this ASU did not have a significant impact on our consolidated financial statements.

 

In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40). The new standard reduces the number of accounting models for convertible debt instruments and convertible preferred stock and amends the guidance for the derivatives scope exception for contracts in an entity’s own equity. The standard also amends and makes targeted improvements to the related earnings per share guidance. The ASU is effective for fiscal years beginning after December 15, 2021. The standard allows for either modified or full retrospective transition methods. The Company adopted this standard on January 1, 2022. The adoption of this ASU did not have a significant impact on our consolidated financial statements.

  

There are no other new accounting pronouncements that are expected to have a material impact on the consolidated financial statements.

 

3. Property and Equipment

 

Property and equipment consisted of the following:

 

   Useful  December 31, 
   Life (yrs)  2022   2021 
Land     $96,000   $96,000 
Warehouse  30   916,500    916,500 
Leasehold Improvements  3   473,601    473,601 
Machinery and equipment  5-7   1,506,447    1,506,447 
Vehicles  4   149,440    149,440 
Computer equipment and software  3   46,825    46,825 
Office furniture and equipment  3-5   17,294    17,294 
              
Subtotal      3,206,107    3,206,107 
Less accumulated depreciation and amortization      (1,044,155)   (625,445)
Total property and equipment, net     $2,161,952   $2,580,662 

 

F-11

 

 

4. Intangible and Other Assets

 

The following table summarizes information related to finite-lived intangible assets:

 

   December 31, 2022   December 31, 2021 
   Gross           Gross         
   Carrying   Accumulated       Carrying   Accumulated     
   Amount   Amortization   Net   Amount   Amortization   Net 
Customer relationships  $2,612,649   $(1,362,311)  $1,250,338   $2,612,649   $(796,858)  $1,815,791 
Non-competition agreements   63,176    (42,116)   21,060    63,176    (21,059)   42,117 
Total  $2,675,825   $(1,404,427)  $1,271,398   $2,675,825   $(817,917)  $1,857,908 

 

Future amortization expense for intangible assets in each of the next five years are expected to be $419 thousand for 2023, $278 thousand for 2024, $194 thousand for 2025, $130 thousand for 2026 and $86 thousand for 2027.

 

Other assets included $407,000 at December 31, 2021 for the Company’s option to purchase the facility located in Hopkinsville, Kentucky leased from Halcyon. Under this agreement, the Company had the option to purchase the facility on or before August 25, 2022, as amended, for a purchase price of $993 thousand. This agreement was not renewed upon its expiration. Impairment expense totaling $407 thousand was recognized in the third quarter of 2022 as a result.

 

5. Notes Payable – Related Parties

 

Notes payable – related parties consisted of the following:

 

   December 31, 
   2022   2021 
Subordinated Promissory Note to CEO  $523,551   $523,551 
Convertible Promissory Note to CEO   1,107,069    410,000 
Secured Promissory Note to Coventry Asset Management, LTD.   1,000,000    1,000,000 
Subordinated Promissory Note to Investor   200,000    250,000 
Promissory Note to Investment Hunter, LLC   492,000    
-
 
Total notes payable – related parties  $3,322,620   $2,183,551 

 

Subordinated Promissory Note to CEO – Our CEO made advances to the Company during 2020 under a subordinated promissory note in the amount of $524 thousand initially due September 30, 2021. This note was amended to a new maturity date of January 1, 2023. The note bore interest at 10% per annum. Accrued interest on this subordinated promissory note totaled $60 thousand at December 31, 2022. In January 2023, the amounts due under this note were restructured and rolled into a new Secured Promissory Note from our CEO (see Note 15).

 

Convertible Promissory Note to CEO – In 2021, our CEO made advances totaling $410 thousand to the Company under a convertible promissory note. Additional advances made in 2022 totaled $697 thousand. The convertible note initially matured on January 1, 2022 but was subsequently amended to extend the maturity date to January 1, 2023. The note bore interest at 10%. The principal and interest due on the convertible note were convertible, at the option of the holder, into restricted shares of the Company’s common stock at an initial conversion price of $0.50 per share but that was lowered in July 2022 to $0.30 per share. Accrued interest on this convertible promissory note totaled $107 thousand at December 31, 2022. In January 2023, the amounts due under this note were restructured and rolled into a new Secured Promissory Note from our CEO (see Note 15).

 

F-12

 

 

Secured Promissory Note and Warrants to Coventry Asset Management, LTD. – On December 30, 2020, the Company received proceeds from issuance of a secured promissory note in principal amount of $1 million to Coventry Asset Management, LTD, a Company stockholder. The promissory note is secured by the property acquired in the acquisition of certain assets of Halcyon. The unpaid balance of the secured promissory note bears interest at a rate of 14% per annum. The promissory note has been extended seven times including the issuance of 20,000 restricted common shares as extension fees each for the first five extensions and the issuance of 50,000 restricted common shares for the last two extensions. The maturity date of the promissory note is December 31, 2023, as amended. If before December 31, 2023, the Company raises new equity capital of $5 million or more, then the full amount outstanding under the promissory note is due within five days. As amended, principal payments of $250 thousand each are due June 1, 2023 and August 31, 2023. Accrued interest on this secured note totaled $200 thousand at December 31, 2022.

 

Subordinated Promissory Note and Warrants to Investor – On December 30, 2020, the Company issued a subordinated promissory note in principal amount of $500 thousand to an accredited investor who is also a Company stockholder. The Company previously made principal payment totaling $300 thousand. The unpaid balance of the Subordinated Note bears interest at a rate of 10% per annum. The subordinated note principal together with accrued and unpaid interest was due, as previously amended, on March 31, 2022 but was extended to June 30, 2022. On March 1, 2023, the Company paid $240 thousand in full repayment of this note and accrued interest thereon.

 

The holder of the subordinated note received a warrant to purchase 500 thousand shares of common stock exercisable for cash at an exercise price of $0.352 per share. As consideration for the April 2022 extension, the term of this warrant was extended by one year to December 30, 2023. The Company recognized $69 thousand of interest expense in 2022 for the modification related to this extension of the warrant term.

 

Promissory Note to Investment Hunter, LLC – In 2022, Investment Hunter, LLC, a Texas LLC controlled by our CEO, made advances totaling $492 thousand to the Company under a promissory note due January 1, 2023, as amended. If the Company raises new equity capital of $3 million or more, then the full amount outstanding under the note is due within five days. The note bears interest at 10% per annum. Accrued interest on this subordinated promissory note totaled $43 thousand at December 31, 2022.

  

6. Other Indebtedness

 

Mortgage Payable and Operating Lease –The Company is obligated under a mortgage payable dated September 15, 2014 secured by its warehouse property located in Denver, Colorado. The note has been amended a number of times to a maturity date of October 1, 2023. In the latest extension, the Company made a principal payment of $25 thousand plus accrued interest in January 2023 and agreed to make seven additional monthly principal payments of $25 thousand plus accrued interest each beginning on March 1, 2023. A final payment of $50 thousand plus accrued interest is due at maturity. The interest rate on the mortgage payable is 12%. If before the final maturity of the mortgage payable, the Company raises new equity capital of $5 million or more, then the full amount outstanding is due within ten days.

 

The Company leases the Denver warehouse property to a tenant under an operating lease which was renewed with a new tenant and extended to August 1, 2023 for a monthly rent of $7.5 thousand. The lease requires a true-up with the tenant for property taxes and insurance paid by the Company and requires the tenant to maintain the interior and exterior of the warehouse (except for the roof). The lease provides for a rent abatement in the first and last month of the contracted extension. Minimum future rents for 2023 are $52 thousand.

 

Paycheck Protection Program Loan – Congress created the Paycheck Protection Program (“PPP”) under the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) to provide forgivable loans to eligible small businesses facing economic hardship to retain U.S. employees on their payroll during the Coronavirus Disease 2019 (“COVID-19”) pandemic. PPP loan recipients may be eligible to have their loans forgiven if the funds were used for eligible expenses. On April 29, 2020, we received disbursement of an approved PPP loan in the amount of $25 thousand. The Company received notice that the PPP Loan principal and interest thereon was fully forgiven on April 20, 2021.

 

F-13

 

 

7. Leases

 

Office Space – The Company leases office space in Fort Worth, Texas for managerial offices. This lease requires monthly payments of $2 thousand and is month-to-month. Lease expense for this facility totaled $24 thousand for 2022 and $22 thousand for 2021.

 

Hemp Processing Operating Facility – The Company leases its operating facility in Kentucky from Oz Capital, LLC, a related party, under a lease expiring May 31, 2024. The lease provides for monthly payments of $10 thousand. Oz Capital, LLC is responsible for all taxes and maintenance under the lease. Lease expense for this facility totaled $123 thousand for 2022 and $119 thousand for 2021. A right-of-use asset and lease liability is recorded for this lease. As the lease does not provide an implicit rate, the Company used its estimated incremental borrowing rate of 10% in determining the present value of the lease payments.

 

Future Bitcoin Mining Premises – In 2022, the Company entered a five-year commercial lease for land and premises in Arkansas. We expect to use these premises as a future Bitcoin mining location because of its favorable power rates and land availability. The lease commences once the Company begins receiving power for its operations conducted at the location. The monthly rent will vary from a minimum of $1 thousand per megawatt of power usage monthly up to $4 thousand per megawatt monthly depending on the average power usage over a trailing 90-day period and the price of bitcoin. We anticipate commencing operations at the leased premises in 2023.

 

8. Commitments and Contingencies

 

Litigation – From time to time, we are subject to various litigation and other claims in the normal course of business. Below is a discussion of specific matters. We cannot estimate the ultimate outcome of these matters.

 

Evergreen Sustainable Enterprises, Inc. (formerly Generation Hemp, Inc.) v. Colorado Mill Equipment, LLC

 

The defendant sold to the Company a faulty piece of equipment for $16 thousand and will not refund to the Company the purchase price after repeated attempts to return their equipment. An original lawsuit filed by the Company against Colorado Mill Equipment in January 2022 in Dallas County was subsequently dismissed due to jurisdiction. A second lawsuit was subsequently filed in El Paso County, Colorado and is currently pending.

 

Halcyon Thruput, LLC, Plaintiff v. United National Insurance Company, Defendant, United States District Court for the Northern District of Texas, Dallas Division, Case No. 3:21-CV-3136-K

 

Halcyon Thruput, LLC (Halcyon) obtained an all-risks commercial insurance policy, including an Equipment Breakdown Endorsement (Policy) from United National Insurance Company (UNIC) to provide substantial coverages for Halcyon Thruput LLC’s (Halcyon) $1.2 million hemp processing dryer (Dryer) at its facility in Hopkinsville, Kentucky. During the Policy period, the Dryer caught fire due to the Dryer being defectively designed.

 

While UNIC has paid a number of Halcyon’s claims, Halcyon’s claim for the cost of the replacement Dryer of $1.5 million was denied as described below.

  

Buyer, a wholly owned subsidiary of the Company, pursuant to an Asset Purchase Agreement as twice amended, then acquired all the assets of Halcyon, except for the right to the proceeds of UNIC’s insurance policy since the Policy prohibited assignment. Halcyon and Buyer agreed that Buyer’s principal, Gary C. Evans, had the right to control the litigation, engage counsel for Halcyon and make all decisions relating to any proceeds received in the litigation by settlement or otherwise.

 

Halcyon’s suit against UNIC, which was removed to federal court, seeks over $1 million plus statutory interest on that sum from August 10, 2020 for violating the Texas Insurance Code’s requirement that claims be promptly paid, additional statutory penalties, and attorneys’ fees. Certain documents have been executed between the Company, Halcyon and legal counsel, which provide for a sharing of costs and expenses and awards, if any, against UNIC. Mediation of the case was held in April 2022 where no agreement was reached by the parties. Depositions of the Company’s expert witnesses were completed in July 2022 and of UNIC’s representatives in September 2022.

 

In August 2022, the Company received a second payment from UNIC of $357 thousand as a partial settlement of this claim, which amount was reported as other income in the consolidated financial statements.

 

F-14

 

 

JDONE, LLC v. Grand Traverse Holdings, LLC and John Gallegos, Denver District Court Case No. 2019CV33723

 

JDONE, LLC (“JDONE”), a wholly owned subsidiary of the Company and landlord of a commercial warehouse building in Denver, brought suit against Grand Traverse Holdings, LLC for default of its commercial lease of the warehouse from JDONE. This case settled in October 2022 and the Company received $122 thousand from the defendant, which amount was reported as other income in the consolidated financial statements.

 

KBSIII Tower at Lake Carolyn, LLC and Prime US-Tower at Lake Carolyn, LLC (collectively – “KBSIII”) v. Energy Hunter Resources, Inc.

 

Plaintiff/Counterdefendant KBSIII was seeking lost rent on office space for periods after EHR vacated office premises located in Las Colinas, Texas. EHR filed a counter suit alleging specific damages due to uninhabitable premises of the office space due to the intolerable conduct of other tenants located on the same floor. On December 23, 2020, the trial court entered a summary judgment against EHR for $231 thousand. The judgment provides for post-judgment interest at a rate of 5% per annum until paid and further provides for additional amounts owed should EHR pursue unsuccessful appeals to higher courts. At December 31, 2022, the Company had accrued $253 thousand for this judgment, which is exclusively an EHR obligation.

 

Ogborn-Mihm, LLP v. Evergreen Sustainable Enterprises, Inc. (formerly Generation Hemp, Inc.), JDONE, LLC and Gary C. Evans

 

The Company was recently made aware of litigation filed against it in the District Court of Denver from a law firm which was previously engaged by the Company. While none of the parties have been officially served, the alleged amount being sought from the Company is less than $50,000

 

9. Income Taxes

 

No amounts were recorded for income tax expense during the years ended December 31, 2022 or 2021. A reconciliation of the expected statutory federal tax and the total income tax expense from continuing operations was as follows:

 

   Year Ended December 31, 
   2022   2021 
Federal statutory rate  $(1,462,067)  $(2,056,480)
State income taxes, net   (141,438)   (198,940)
Change in valuation allowance   1,630,110    3,655,210 
Change in state tax rates   
-
    (178,644)
True-up of prior year deferred items   
-
    (929,450)
Other, net   (26,605)   (291,696)
Total income tax expense  $
-
   $
-
 

 

The tax effect of temporary differences that gave rise to significant components of deferred tax assets and liabilities consisted of the following:

 

   December 31, 
   2022   2021 
Assets:        
Net operating loss carryforwards  $5,471,098   $4,960,487 
Stock-based compensation   2,142,362    1,046,464 
Property and equipment   (24,310)   33,803 
Intangible assets   216,726    135,012 
Subtotal   7,805,876    6,175,766 
Valuation allowance   (7,805,876)   (6,175,766)
Net deferred tax asset  $
-
   $
-
 

 

F-15

 

 

The Company has federal net operating loss (“NOL”) carryforwards of approximately $23.8 million at December 31, 2022, of which approximately $6.5 million begin to expire in 2034 and the remainder have no expiration. The Company estimates that a majority of its NOL carryforwards are subject to annual limitations under Internal Revenue Code Section 382 as a result of ownership changes at various times including in the Transaction. These NOL carryforwards may never be utilized by the Company.

 

The Company is delinquent in filing its 2021 Federal and state tax returns.

 

10. Equity

 

Series A Preferred Stock Our Series A Preferred Stock was originally issued in connection with HTF’s acquisition of EHR in 2019. On September 8, 2021, holders of the Company’s Series A Preferred Stock elected to convert such shares into shares of the Company’s common stock. As a result, 6,328,948 shares of Series A Preferred Stock were converted into 75,947,376 shares of common stock, with each share of Series A Preferred Stock converting into 12 shares of restricted common stock pursuant to the applicable Certificate of Designations.

 

Series B Preferred Stock Units – On December 30, 2020, the Company sold to certain accredited investors, including Gary C. Evans, our Chief Executive Officer, an aggregate of 135 preferred stock units comprised of (i) one share of Series B Redeemable Convertible Preferred Stock, no par value, and (ii) one warrant exercisable for 50 thousand shares of common stock of the Company until December 30, 2022 at an exercise price of $0.352 per share.

 

The sale of the preferred stock units for $10 thousand each resulted in aggregate gross proceeds of approximately $1.35 million, before deducting estimated offering expenses payable by the Company. Substantially all of the proceeds raised in the offering were used to fund the acquisition of assets of Halcyon, expenses related thereto and for general corporate purposes.

 

Each share of Series B Preferred Stock is initially convertible into 25,000 shares of common stock, subject to adjustment. Holders of Series B Preferred Stock are entitled to receive dividends of 6.00% per annum based on the stated value equal to $10 thousand per share. Except as otherwise required by law, the Series B Preferred Stock does not have voting rights. However, as long as any shares of Series B Preferred Stock are outstanding, the Company will not, without the affirmative vote of the holders of a majority of the then outstanding shares of the Series B Preferred Stock, (a) alter or change adversely the powers, preferences or rights given to the Series B Preferred Stock, (b) alter or amend the related certificate of designation, (c) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of Series B Preferred Stock, (d) repay, repurchase or offer to repay, repurchase or otherwise acquire more than a de minimis number of shares of its common stock, (e) enter into any agreement with respect to any of the foregoing, or (f) pay cash dividends or distributions on any equity securities of the Company other than pursuant to the terms of the outstanding Series B Preferred Stock. The Series B Preferred Stock does not have a preference upon any liquidation, dissolution or winding-up of the Company.

 

Any or all of the Series B Preferred Stock may be converted, at their holder’s option, into 25,000 shares of common stock, as adjusted for any stock dividends, splits, combinations or similar events.

 

At any time after the occurrence of a “Qualifying Event,” the Company, upon 5-day written notice, shall have the right to cause each share of Series B Preferred Stock (and all accrued in-kind dividends with respect thereto) to be converted into common stock. For purposes of this automatic conversion of the Series B Preferred Stock, a “Qualifying Event” shall have occurred if (A) (1) the rolling five-trading day volume-weighted average trading price of shares of the common stock exceeds $1.00, and (2) there shall be an effective registration statement under the Securities Act of 1933, as amended covering all of the shares of common stock which would be issuable upon conversion of all of the outstanding shares of Series B Preferred Stock or (B) the Company closes a firm commitment underwriting of the common stock on a Form S-1 Registration Statement with aggregate gross proceeds of at least $5 million at a price per share equal to or greater than $1.00. In each instance, a conversion may not be made unless the Company has filed an amendment to its Articles of Incorporation effecting an increase in its authorized common stock so that the Company has a sufficient number of authorized and unissued shares of common stock so as to permit the conversion of all outstanding shares.

 

F-16

 

 

The Series B Preferred Stock may be redeemed by the Company for its stated value, plus accrued and unpaid dividends, at any time. Initially, redemption payments of 12.5% each of the total amount of Series B Preferred Stock then outstanding plus accrued dividends were due from the Company to each Holder of Series B Preferred Stock at the end of each calendar quarter of 2021. The first required redemption payments totaling $137 thousand were made in April 2021. In May, June and October of 2021, the three holders of the Series B Preferred Stock, including the Company’s chief executive officer, entered into transactions in which they accepted the mandatory redemption payment required pursuant to the Series B Preferred Stock certificate of designation in a number of Series B Units to effectively waive the redemption requirement. All other terms of the Series B Units remain unchanged and the holders’ ownership interest in the Series B Preferred Units remains the same as it was before such transactions.

 

Common Stock – At December 31, 2022, the Company had 113,204,002 common shares outstanding. Following is a discussion of common stock issuances during the periods presented:

 

  Acquisition of Certain Assets of Halcyon – In January 2021, the Company issued 6,250,000 shares of common stock valued at $2.5 million ($0.40 per share; restricted from trading for a period of up to one year) in the acquisition.
     
  2021 First Quarter Issuances of Common Stock Units – In the first quarter of 2021, the Company issued 800,000 common stock units for total proceeds of $400,000. Each common stock unit consisted of one share of common stock and a warrant for the purchase of two shares of common stock for $0.50 each. Each warrant is exercisable any time before its expiration on the second anniversary of its issuance. The Company allocated the total proceeds based on the relative fair values of the common stock and warrants. The fair value of the warrants was determined using an options valuation model with key assumptions including a risk-free interest rate of 0.11% and historical volatility of 272%. A total of $263 thousand was allocated to the warrants and reported in additional paid-in capital.  
     
  Warrant Exercises – In the first quarter of 2021, the Company received approximately $3 million for the exercise of 8,428,976 outstanding warrants. In the fourth quarter of 2021, the Company received $375 thousand for the exercise of 1,065,340 outstanding warrants.
     
  Issuances for Exchange or Conversion of Debt – The Company issued a total of 1,618,660 common shares for the exchange or conversion of outstanding indebtedness totaling $2.2 million in the first quarter of 2021.
     
  Issuance to Vendor for Services – In the third quarter of 2021, the Company issued 125,000 common shares valued at $117.5 thousand to a vendor for services performed.
     
  Issuance for Extension of Secured Note – The Company issued 20,000 common shares valued at $18 thousand as consideration to extend the maturity of a senior note in the third quarter of 2021.
     
  Issuance for Conversion of Series A Preferred Stock – As noted above, in the third quarter of 2021, the Company issued 75,947,376 common shares for the conversion of all outstanding shares of its Series A Preferred Stock.
     
  2021 Fourth Quarter Issuances of Common Stock Units – In the fourth quarter of 2021, the Company issued 958,333 common stock units to accredited investors for total proceeds of $575 thousand. Each common stock unit consists of one share of common stock and a warrant for the purchase of one share of common stock for $0.60 each. Each warrant is exercisable any time before its expiration on the second anniversary of its issuance. The Company allocated the total proceeds based on the relative fair values of the common stock and warrants. The fair value of the warrants was determined using an options valuation model with key assumptions including risk-free interest rates ranging from 0.48% to 0.70% and historical volatility ranging from 237% to 258%. A total of $277 thousand was allocated to the warrants and reported in additional paid-in capital..
     
  Issuance for Extensions of Secured Note – The Company issued 110,000 common shares valued at $52.6 thousand as consideration for extensions of the maturity of a senior note in 2022. Refer to Note 5.

 

F-17

 

 

Common Stock Warrants Outstanding – Following is a summary of warrants outstanding as of December 31, 2022:

 

   # of
Warrants
   Price
(each)
   Expiration Date  Method of Exercise
Issued in December 2020 with subordinated note to investor (1)   500,000   $0.352   December 30, 2023  Cash
Issued in Q1 2021 with common stock units (1)   1,600,000   $0.500   January-February, 2023  Cash
Issued in Q4 2021 with common stock units (1)   958,333   $0.600   October-December, 2023  Cash
Total warrants outstanding at December 31, 2022   3,058,333            

 

(1) May be redeemed for $0.0001 per warrant at the Company’s option with 30 days advanced notice should the weighted average market price of common stock exceed $1.00 for any five out of seven consecutive trading days with a minimum average daily trading volume for such seven-day period of at least 25,000 shares of common stock.

 

Following is a summary of outstanding stock warrants activity for the periods presented:

 

   # of
Warrants
   Weighted
Average
Price
 
Warrants as of January 1, 2021   22,988,632   $0.353 
Issued   2,558,333   $0.537 
Cancelled   (7,244,316)  $0.352 
Exercised   (9,494,316)  $0.352 
Warrants as of December 31, 2021   8,808,333   $0.407 
Canceled   (5,750,000)  $0.354 
Warrants as of December 31, 2022   3,058,333   $0.507 

 

11. Stock-Based Compensation

 

We award restricted stock or stock options as incentive compensation to employees and compensation to our Board of Directors for services. Generally, these awards include vesting periods of up to three years from the date of grant.

 

The 2021 Omnibus Incentive Plan (“2021 Plan”) was adopted by our Board on July 1, 2021. The 2021 Plan provides for the initial reservation of 15 million shares of common stock for issuance, and provides that the maximum number of shares that may be issued pursuant to the exercise of ISOs is 15 million. On the one-year anniversary date of the 2021 Plan, the number of shares of common stock reserved for issuance automatically increased to 20% of the fully diluted common shares outstanding, including shares issuable upon the conversion of preferred shares, as calculated on an as-converted basis.

 

In the first quarter of 2021, the Company issued 500,000 restricted shares valued at $155 thousand as incentive compensation to two executives who joined the Company. Compensation expense related to these awards totaled $155 thousand for 2021. These awards became fully vested in January 2022.

 

In the fourth quarter of 2021, the Company awarded options for 13,850,000 shares of the Company’s common stock as incentive compensation to management and the Board of Directors. One-third of the awarded options vested immediately with the remaining options vesting in two equal annual tranches over the next two years. Vested options may be exercised at any time until their expiration after 10 years at an exercise price of $0.76 per share. Unvested options are forfeited upon termination of service. The fair value of the awards at the date of grant of $10.5 million was determined using the Black-Scholes option pricing model. Key assumptions included a risk-free interest rate ranging from 1.18% to 1.28%, historical volatility ranging from 331% to 643% and an expected life of the stock options ranging from five to six years.

 

In the third quarter of 2022, the Company awarded options for 1,915,000 shares of the Company’s common stock as incentive compensation to its CEO and board of directors. The awarded options vest over the next three years. Vested options may be exercised at any time until their expiration ranging from eight to 10 years at their exercise prices ranging from $0.30 to $0.33 per share. Unvested options are forfeited upon termination of service. The fair value of the awards at the date of grant of $576 thousand was determined using the Black-Scholes option pricing model. Key assumptions included a risk-free interest rate ranging from 2.87% to 3.03%, historical volatility ranging from 251% to 408% and an expected life of the stock options ranging from four to seven years.

 

We recognized $4.7 million of compensation expense in 2022 and $1.4 million in 2021 for option awards. As of December 31, 2022, there was $2.0 million of total unrecognized compensation cost related to options to be recognized over a remaining weighted average period of 17 months.

 

F-18

 

 

The following table summarizes options outstanding, as well as activity for the periods presented:

 

   Shares   Weighted
Average
Grant Date
Fair Value
  

Weighted
Average
Exercise

Price

   Aggregate
Intrinsic
Value
 
Outstanding at January 1, 2021   
   -
   $
   -
   $
   -
    
     -
 
Granted   13,850,000   $0.76   $0.76    
-
 
Outstanding at December 31, 2021   13,850,000   $0.76   $0.76    
-
 
Granted   1,915,000   $0.30   $0.31    
-
 
Outstanding at December 31, 2022   15,765,000   $0.70   $0.71    
-
 

 

The remaining weighted average contractual life of exercisable options at December 31, 2022 was nine years.

 

12. Discontinued Operations

 

In 2019, management determined to fully divest of EHR’s oil and gas activities. As such, these activities are presented as discontinued operations for each of the periods presented. The following is a summary of the carrying amounts of major classes of assets and liabilities of the discontinued operations to assets and liabilities held for sale:

 

   December 31, 
   2022   2021 
Assets:        
Oil and natural gas properties held for sale, at cost  $1,874,849   $1,874,849 
Accumulated DD&A   (1,874,849)   (1,874,849)
Total assets of discontinued operations held for sale  $
-
   $
-
 
           
Liabilities:          
Accrued liabilities  $61,701   $48,997 
Asset retirement obligations   52,368    52,368 
Revenue payable   52,117    52,117 
Current liabilities of discontinued operations held for sale   166,186    153,482 
Asset retirement obligations -          
Long-term liabilities of discontinued operations held for sale   207,197    162,948 
Total liabilities of discontinued operations held for sale  $373,383   $316,430 

 

The following is a summary of the major classes of line items constituting loss on discontinued operations shown in the consolidated statements of operations:

 

   For the year ended
December 31,
 
   2022   2021 
Revenue -        
Oil and gas sales  $147,828   $116,710 
           
Costs and Expenses:          
Lease operating expense   163,352    134,590 
Accretion of asset retirement obligations   44,249    14,333 
Total costs and expenses   207,601    148,923 
Loss from discontinued operations  $(59,773)  $(32,213)

 

F-19

 

 

13. Supplemental Cash Flow Information

 

   For the year ended
December 31,
 
   2022   2021 
Cash paid for interest  $68,321   $138,736 
Cash paid for taxes   
-
    
-
 
           
Noncash investing and financing activities:          
Acquisition of certain assets of Halcyon Thruput, LLC          
- issuance of common shares   
-
    2,500,000 
- issuance of subordinated note   
-
    850,000 
- assumption of Halcyon bank note   
-
    995,614 
Series B preferred stock dividend payable   80,002    58,312 
Issuance of common stock units previously subscribed   
-
    50,000 
Issuances of common shares for exchange or conversion of debt   
-
    2,160,269 
Conversion of Series A preferred stock into common stock   -    4,975,503 

 

14. Earnings (Loss) per Share

 

The following is the computation of earnings (loss) per basic and diluted share:

 

   For the year ended
December 31,
 
   2022   2021 
Amounts attributable to Generation Hemp:        
Numerator        
Loss from continuing operations attributable to common stockholders  $(6,975,740)  $(9,792,532)
Income (loss) from discontinued operations   (56,031)   (30,196)
Less: preferred stock dividends   (80,002)   (74,812)
Net loss attributable to common stockholders  $(7,111,773)  $(9,897,540)
Denominator          
Weighted average shares used to compute basic EPS   113,163,591    57,159,659 
Dilutive effect of convertible note   1,164,773    1,164,773 
Dilutive effect of preferred stock   2,950,000    55,075,900 
Dilutive effect of common stock options   229,762    709,981 
Dilutive effect of common stock warrants   1,320,951    11,022,542 
Weighted average shares used to compute diluted EPS   118,829,077    125,132,855 
Earnings (loss) per share:          
Loss from continuing operations          
Basic  $(0.06)  $(0.17)
Diluted  $(0.06)  $(0.17)
Loss from discontinued operations          
Basic  $
-
   $
-
 
Diluted  $
-
   $
-
 
Earnings (loss) per share          
Basic  $(0.06)  $(0.17)
Diluted  $(0.06)  $(0.17)

 

The computation of diluted earnings per common share excludes the assumed conversion of the Series B Preferred Stock and outstanding convertible notes and exercise of common stock options and warrants in periods when we report a loss. The dilutive effect of the assumed exercise of outstanding options and warrants was calculated using the treasury stock method.

 

15. Subsequent Events

 

Issuance of common stock options – In January 2023, the Company issued options for the purchase of 100,000 shares of common stock each to our three directors as board fees for the year. The exercise price of the options is $0.30 and they have a ten year term. One-third of the options vested immediately. The remaining options vest in equal tranches over the next two years.

 

F-20

 

 

Commencement of Bitcoin Operations and Acquisition of Toro Energía Sociedad Anonima – In January 2023, the Company announced a new strategic direction into sustainable energy projects, starting with bitcoin mining. The Company’s name was changed to Evergreen Sustainable Enterprises, Inc. (“EGSE”) in March 2023. The Company’s existing operations will continue to be maintained as a fully operating wholly-owned subsidiary.

 

On January 9, 2023, the Company purchased 80% of Toro Energía Sociedad Anonima (“Toro”), a Costa Rican corporation with ownership of a hydroelectric dam in Costa Rica. The source of approximately one megawatt of power produced from the hydroelectric dam (six generators) will be used to power new Bitcoin mining machines at an extremely low cost. The transaction included seller-financed debt of $985 thousand. The seller-financed debt has a term of 10 years and a 9.5% per annum variable interest rate (based on the prime rate) with straight line amortization. The seller-financed debt is secured by pledge of the Toro Dam.

 

The purchase price for 80% of Toro’s equity was $1.4 million. These amounts were paid in cash from proceeds of a Secured Promissory Note (“Secured Note”) with the Gary C. Evans, CEO of the Company (‘Evans”). Under the terms of the Secured Note, (a) the Company and Evans restructured (i) the Subordinated Promissory Note dated November 20, 2020 and (ii) Convertible Promissory Note dated July 20, 2021, such that all accrued and unpaid interest on each note were rolled into a new Secured Note, (b) Evans lent the Company $500 thousand on January 9, 2023 and $969 thousand on January 10, 2023. The Secured Note has a maturity date of July 15, 2023 and bears interest at the rate of 10.00% per annum. The Secured Note has a conversion feature which permits Evans to convert at the Maturity Date then outstanding principal and interest at a conversion price of $0.275 (the closing price of the Company’s stock on January 9, 2023).

 

The Toro Dam is located approximately 25 miles from San Jose between two volcano craters. The site generates all its energy from green resources with a proven 98% run time over the years and has a full-time staff in place under a new Operating & Maintenance Agreement.

 

Hydroelectric power is a clean and renewable energy source that is used to generate electricity by harnessing the energy of falling water and can provide a reliable and a very cost-effective source of energy for bitcoin mining operations. Hydroelectric power can help reduce the carbon footprint of cryptocurrency mining, as many cryptocurrencies are produced using fossil fuels, which continues to contribute to greenhouse gas emissions and climate change. By using hydroelectric power, bitcoin mining can be made more environmentally friendly and sustainable and can help improve the stability and reliability of cryptocurrency networks. Hydroelectric power is a relatively stable and reliable source of energy, compared to other sources such as coal or fossil fuels, which can be prone to price fluctuations and supply disruptions. The Company has committed to acquire 240 new Bitmain S19J Pro+ ASIC miners that will be deployed at the Toro Dam in the first half of 2023.

 

Subordinated Promissory Note and Warrants to Investor – As discussed in Note 5, on March 1, 2023, the Company paid $240 thousand in full repayment of this note and accrued interest thereon.

 

Hemp Processing Operating Facility – The Company’s lease of its operating facility in Kentucky from Oz Capital, LLC, a related party, was amended in January 2023. As amended, the lease payment was increased to $20.5 thousand monthly beginning in March 2023. The lease expiration date of May 31, 2024 was not changed.

 

Issuance of Series C Preferred Units – In the first quarter of 2023, the Company issued six Series C Preferred Units in a private placement for total proceeds of $300 thousand. Each unit consists of one share of 8.50% Series C Redeemable Convertible Preferred Stock and 5,000 warrants to acquire one share of common stock. Cumulative dividends at 8.5% of the stated value of the Series C Redeemable Convertible Preferred Stock are payable each calendar quarter end in cash or additional shares of Series C Redeemable Convertible Preferred Stock, at the Company’s option.

 

Each share of Series C Redeemable Convertible Preferred Stock is convertible, at the holder’s option, into 100 thousand shares of our common stock at any time. It is subject to automatic conversion if (a) the rolling five (5)-trading day volume-weighted average trading price of shares of our common stock exceeds $0.75 and (b) there shall be an effective registration statement under the Securities Act of 1933. The conversion ratio may be adjusted for certain dilutive issuances or in the event a dividend is paid on our common stock. The Series C Redeemable Convertible Preferred Stock is redeemable at any time at the Company’s option.

 

The warrants are exercisable for a cash exercise price of $0.50 per share and expire in three years. The warrants may be redeemed at the Company’s option if after one year from issuance, the trading price of the Company’s common stock exceeds $0.875 over a ten consecutive day trading period having a minimum trading volume of 25 thousand shares daily.

 

Promissory Note to Investment Hunter, LLC – In the first quarter of 2023, Investment Hunter, LLC, a Texas LLC controlled by our CEO, made advances totaling $300 thousand to the Company.

 

Secured Promissory Note to a Director and our CEO – On April 19, 2023, Razorback I, LLC, a wholly-owned subsidiary of the Company, borrowed $300 thousand under a secured promissory note from one of our directors and our CEO. Proceeds from the note are expected to be utilized in the acquisition of land in Arkansas to expand bitcoin mining operations.

 

The promissory note matures on April 15, 2024. Interest accrues at 12% per annum and is due quarterly beginning on July 15, 2023. The holders have the option to convert the outstanding principal and interest into restricted shares at a conversion price of $0.30 per share of common stock.

 

The secured promissory note is collateralized by a pledge of 100% of the ownership interest of Razorback I, LLC and has been guaranteed by the Company as well.

 

* * * * *

 

F-21

 

 

Supplemental Oil and Gas Information

 

(Unaudited)

 

Oil and Gas Reserve Information. Proved oil and gas reserves are those quantities of crude oil, natural gas, condensate, and NGLs, which by analysis of geoscience and engineering data, can be estimated with reasonable certainty to be economically producible from a given date forward, from known reservoirs, and under existing economic conditions, operating methods, and government regulations. Estimated proved developed oil and gas reserves can be expected to be recovered through existing wells with existing equipment and operating methods. The Company reports all estimated proved reserves held under production-sharing arrangements utilizing the “economic interest” method.

 

Proved oil and gas reserves have been estimated by independent, third-party petroleum engineers, Mire & Associates, Inc. These reserve estimates have been prepared in compliance with the Securities and Exchange Commission rules and accounting standards based on the 12-month unweighted first-day-of-the-month average price for the year.

 

There are numerous uncertainties inherent in estimating quantities of proved reserves and projecting future rates of production and timing of development expenditures. The reserve data in the following tables only represent estimates and should not be construed as being exact.

 

The following reserves schedule sets forth the changes in estimated quantities of proved crude oil reserves:

 

   Crude Oil (Bbls)   Natural Gas (mcf)   Total (Boe) 
Total proved reserves:            
Balance at December 31, 2020   19,560    13,850    21,868 
Revisions of previous estimates   (10,895)   (13,247)   (13,102)
Production   (1,675)   (603)   (1,776)
Balance at December 31, 2021   6,990    -    6,990 
Revisions of previous estimates   178    47    225 
Production   (1,508)   (47)   (1,555)
Balance at December 31, 2022   5,660    -    5,660 
                
Proved developed reserves as of:               
December 31, 2020   2,660    -    2,660 
December 31, 2021   6,990    -    6,990 
December 31, 2022   5,660    -    5,660 
                
Proved undeveloped reserves as of:               
December 31, 2020   16,900    13,850    19,208 
December 31, 2021   -    -    - 
December 31, 2022   -    -    - 

 

F-22

 

 

The decrease in proved quantities for 2021 was due principally to revisions of previous reserve estimates after undeveloped reserves were determined to be non-economic. The decrease in proved quantities for 2022 was due principally to annual production.

 

Costs Incurred in Oil and Natural Gas Property Acquisitions and Development Activities. Costs incurred by the Company in oil and natural gas acquisitions and development are presented below:

 

   For the year ended
December 31,
 
 
   2022   2021 
Acquisitions:          
Proved  $       -   $      - 
Unproved   -    - 
Exploration   -    - 
Development   -    - 
Costs incurred  $-   $- 

 

Capitalized Costs. The following table sets forth the capitalized costs and associated accumulated depreciation, depletion, and amortization relating to the Company’s oil and gas acquisition, exploration, and development activities:

 

   December 31, 
   2022   2021 
Proved properties  $621,198   $621,198 
Unproved properties   1,253,651    1,253,651 
    1,874,849    1,874,849 
Accumulated DD&A and impairment   (1,874,849)   (1,874,849)
Total  $-   $- 

 

Future Net Cash Flows. Future cash inflows as of December 31, 2022 and 2021 were calculated using an unweighted arithmetic average of oil and gas prices in effect on the first day of each month in the respective year, except where prices are defined by contractual arrangements. Operating costs, production and ad valorem taxes and future development costs are based on current costs with no escalation. Future development costs include abandonment and dismantlement costs.

 

The following table sets forth unaudited information concerning future net cash flows for proved oil and gas reserves, net of income tax expense. Income tax expense has been computed using expected future tax rates and giving effect to tax deductions and credits available, under current laws, and which relate to oil and gas producing activities. This information does not purport to present the fair market value of the Company’s oil and gas assets, but does present a standardized disclosure concerning possible future net cash flows that would result under the assumptions used.

 

   December 31, 
   2022   2021 
Future cash inflows  $522,560   $454,030 
Future production costs   (296,270)   (278,870)
Future development costs   (34,280)   (34,280)
Future income tax expense   -    - 
Future net cash flows   192,010    140,880 
10% annual discount for estimated timing of cash flows   (88,800)   (72,250)
Discounted future net cash flows  $103,210   $68,630 

 

The following table sets forth the principal sources of change in the discounted future net cash flows:

 

   December 31, 
   2021   2020 
Balance, beginning of period  $68,630   $63,760 
Sales, net of production costs   15,524    17,880 
Net change in prices and production costs   9,984    245,615 
Changes in future development costs   -    (226,800)
Revision of quantities   2,209    (38,201)
Accretion of discount   6,863    6,376 
Balance, end of period  $103,210   $68,630 

 

*  *  *  *  *

 

F-23

 

 

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 

 

None.

 

Item 9A. Controls and Procedures 

 

Evaluation of Disclosure Controls and Procedures. The Company carried out an evaluation of the effectiveness of the design and operation of its disclosure controls and procedures pursuant to Exchange Act Rules. This evaluation was done as of the end of the fiscal year by and under the supervision of the Company’s principal executive officer (who is also the principal financial officer). Based upon that evaluation, the principal executive officer concluded that our disclosure controls and procedures were effective as of December 31, 2022. There have been no significant changes in our internal controls or in other factors that could significantly affect the internal controls subsequent to the date we completed the evaluation.

 

Management’s Report on Internal Control Over Financial Reporting. Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) of the 1934 Act. Management has assessed the effectiveness of our internal control over financial reporting as of December 31, 2022 based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

 

As a result of this assessment, management identified a material weakness in internal control over financial reporting related to the accounting for business combination transactions. Management has concluded that this deficiency constitutes a material weakness. As a result of the material weakness discussed above, management has concluded that the Company’s internal control over financial reporting was ineffective as of December 31, 2022. Notwithstanding the material weakness, the Company’s management has concluded that the consolidated financial statements, included in the 2022 Annual Report on Form 10-K, fairly present, in all material respects, our financial condition, results of operations and cash flows for the periods presented in conformity with generally accepted accounting standards.

 

Management Plans to Remediate Material Weakness. The Company has begun the process of designing and implementing effective internal control measures to improve its internal controls over financial reporting and remediate the reported material weakness. The Company’s efforts include implementing additional reviews of business combination transactions and modifying the Company’s instructions to valuation specialists and reviews of their workproduct. We will consider the material weakness remediated after the applicable controls operate for a sufficient period of time, and management has concluded, through testing, that the controls are operating effectively.

 

Changes in Internal Control Over Financial Reporting. We regularly review our system of internal control over financial reporting and make changes to our processes and systems to improve controls and increase efficiency, while ensuring that we maintain an effective internal control environment. Changes may include such activities as implementing new, more efficient systems, consolidating activities and migrating processes.

 

There were no changes in our internal control over financial reporting during the quarter ended December 31, 2022 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Limitations on Controls. Our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives as specified above. Management does not expect, however, that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all error and fraud. Any control system, no matter how well designed and operated, is based upon certain assumptions and can provide only reasonable, not absolute, assurance that its objectives will be met. Further, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected.

 

Item 9B. Other Information

 

None.

 

Item 9C. Disclosures Regarding Foreign Jurisdiction that Prevent Inspections

 

None.

 

33

 

 

PART III

 

Item 10. Directors, Executive Officers and Corporate Governance

 

The following persons are our executive officers and directors and hold the offices set forth opposite their names.

 

Name   Age   Position
         
Gary C. Evans   65   Chairman of the Board and Chief Executive Officer
Melissa Pagen   47   Senior Vice President, Corporate Development of the Company
Jack Sibley   38   Vice President, Operations of the Company, and Co-CEO of GENH Halcyon
Watt Stephens   38   Vice President, Corporate Development of the Company and Secretary of GENH Halcyon
Joe McClaugherty   71   Lead Director
Gary D. Elliston   69   Director
John Harris   74   Director

 

The following is a brief account of the business experience of each of our directors and executive officers:

 

Gary C. Evans, Chairman of the Board and Chief Executive Officer. Gary C. Evans is a serial entrepreneur. Mr. Evans previously led Magnum Hunter Resources Corporation for seven years, a NYSE listed public energy company specializing in unconventional resource plays predominately in the Appalachian Basin. Mr. Evans was also founder and CEO of Eureka Hunter Holdings, LLC, a mid-stream gas gathering company transporting and managing up to 1 BCF of daily natural gas volumes from wells producing in West Virginia and Ohio on approximately 200 miles of newly constructed pipeline during the similar seven-year period. Additionally, Mr. Evans previously founded and served as the Chairman and Chief Executive Officer of Magnum Hunter Resources Inc. (MHRI), a NYSE listed company, for twenty years before selling MHRI to Cimarex Energy for approximately $2.2 billion in June 2005. Later that year, Mr. Evans formed Wind Hunter Energy, LLC, a renewable energy company which was subsequently acquired in December 2006 by GreenHunter Energy, Inc., an emerging water resource company focusing on oil field water management and clean water technologies active in the Marcellus and Utica resource plays in Appalachia. As founder, Mr. Evans has served as Chairman and Chief Executive Officer of GreenHunter Energy, Inc. since December 2006 until May 2016 upon the sale of its assets to a private equity fund.

 

Throughout his career, Mr. Evans has raised various forms of capital on Wall Street that has exceeded $6 Billion. Mr. Evans serves as a Director of Novavax Inc., a NASDAQ listed clinical-stage vaccine biotechnology company (Covid-19 Vaccine) with a market capitalization of approximately $20 Billion, where he has previously served as Chairman, CEO and Lead Director. Mr. Evans was recognized by Ernst and Young as the Southwest Area 2004 Entrepreneur of the Year for the Energy Sector and was subsequently inducted into the World Hall of Fame for Ernst & Young Entrepreneurs. Mr. Evans was also recognized as the Energy Industry Leader of the year in 2013 and chosen by Finance Monthly in 2013 as one of the most respected CEO’s. Mr. Evans was chosen as the Best CEO in the “Large Company” category by Texas Top Producers in 2013. He additionally won the Deal Maker of the Year Award in 2013 by Finance Monthly. Mr. Evans presently serves on the board of directors of U.S. Antimony, a NYSE listed company. Mr. Evans serves on the Board of the Maguire Energy Institute at Southern Methodist University and speaks regularly at both hemp and energy industry conferences and on national television networks around the world on the current affairs of the energy industry.

 

Melissa Pagen, Senior Vice-President, Corporate Development of the Company. Prior to joining the Company, Melissa Pagen built over twenty years of professional and executive experience in managerial and officer positions in several industries - both in the private and public sectors. With a demonstrated history in consumer goods, business development, investor relations, and industrial technologies, Melissa brings a unique combination of talents to the company. She developed and launched start-up companies in ecommerce, nutraceuticals, and the energy sector. In June 2019, Melissa was brought on by Gary C. Evans to help launch the Company, although her working tenure with Mr. Evans first began in 2013. In October 2019, she was brought on full-time as an officer of the Company.

 

34

 

 

From 2016 - 2019 in Los Angeles, Melissa helped develop, launch, and reorganize companies in ecommerce, nutraceuticals, and medical practices through her advising company Root LLC/Root Endeavor LLC. This included working with founders and teams on branding, marketing, product development, packaging, operations, staff reorganization, and optimizing efficiencies. In mid 2013 through 2015, Melissa began working under Gary C. Evans at Green Hunter Resources, Inc., a publicly traded company, where she started as Water Treatment Specialist/Account Executive, then moved into the position of Assistant Vice President, Investor Relations, and ultimately Vice President, Business Development, where she negotiated and secured multi-million-dollar contracts with large E&P companies for water treatment and handling, then oversaw those relationships. During her time in the energy sector, Melissa did several public speaking engagements for industry organizations, which helped earn her the honor of a WING Award (Women In Natural Gas) by Shale Media Group in 2014. Before beginning work with Mr. Evans, Melissa founded her own environmental remediation business in the Bakken Shale of North Dakota from 2012 - 2013. From 2010 - 2012, Melissa worked as Vice President, Marketing and Sales for Sionix Corporation, a publicly traded company in water treatment technology. Following the Tsunami in 2011, Melissa traveled to Japan to participate in discussions to address urgent water treatment issues and potential solutions in the wake of the Fukushima disaster. In 2001, Melissa began her career in the film industry, in development for Radar Pictures, Inc. (f/k/a Interscope Communications [Pictures]). She then worked with a female television Producer from 2004 - 2009. Working alongside creative executives and teams in the Film industry, she developed skills in writing, project management, and visual storytelling that would ultimately contribute to a number of future roles in helping companies develop branding, messaging, marketing, and investor relations. Melissa earned a Bachelor of Arts degree from University of California, Los Angeles where she graduated summa cum laude.

 

Jack Sibley, Vice President, Corporate Development of the Company, and Co-CEO of GENH Halcyon. Prior to joining the Company, Jack Sibley was a founding partner of OZ Capital, LLC, an Opportunity Zone Investment fund focused on operating businesses within Opportunity Zone designations. In his roll at OZ Capital, Jack oversaw the operations of its portfolio investments, including Halcyon Thruput, an industrial hemp processing company located in Hopkinsville, Kentucky. As an executive, Jack has worked alongside management teams to implement creative, innovative solutions to complex business issues, identify growth verticals and maximize stakeholder value.  Prior to OZ Capital, Jack served as Vice President at Sovrano LLC, a Private Equity company focused in Food & Beverage. Jack also co-founded and served as President of Bamboo Juices, LLC in Atlanta, GA from 2014 - 2016.  He received an MBA from The University of Georgia’s Terry College of Business in 2014 with concentrations in Finance and Marketing.  Jack graduated with a BA in International Affairs from The University of Georgia in 2007.

 

Watt Stephens, Secretary of GENH Halcyon. Watt began his career as a credit analyst with Frost Bank in 2007, in this role he underwrote countless credit requests in various industries including commercial & industrial, energy and real estate. He then moved into a leadership position being tapped to run business development for a newly formed group focused on complex credit relationships. After almost 10 years at Frost Bank, Watt went back to school to earn his MBA and focus on his goal of launching his own business. In 2018, Watt teamed up with Jack Sibley to form OZ Capital LLC, an opportunity zone focused venture capital fund based in Fort Worth. OZ Capital founded and funded Halcyon Thruput in 2019. Watt and Jack stepped in as Co-CEO’s mid-way through 2020 and subsequently sold the business to the Company at the beginning of 2021. Watt earned his BS ’07 from SMU and MBA ’17 from SMU’s Cox School of Business.

 

Joe L. McClaughertyDirector. Mr. McClaugherty previously served as a director of Magnum Hunter Resources Corporation from 2006 through 2016 where he served as Lead Director during the last three years of his tenure. Mr. McClaugherty is a senior partner of McClaugherty & Silver, P.C., a full-service firm engaged in the practice of civil law, located in Santa Fe, New Mexico. He has practiced law for 40 years and has had a Martindale-Hubbell rating of AV Preeminent for over 20 years and is a Fellow of the International Academy of Trial Lawyers. Prior to founding McClaugherty& Silver, P.C. in 1992, he was the Managing Partner of the Santa Fe office of Kemp, Smith, Duncan & Hammond, and, earlier, of Rodey, Dickason, Sloan, Akin & Robb. Mr. McClaugherty has served on numerous boards of both international and domestic companies. He received a BBA with Honors from the University of Texas in 1973 and a JD with Honors from the University of Texas School of Law in 1976. He is admitted to the Bars of the State of New Mexico, Texas and Colorado, as well as the Federal Bars of the Districts of New Mexico and Colorado, the Tenth Circuit Court of Appeals and the United States Supreme Court. The Company believes that it benefits from Mr. McClaugherty’s business and law degrees from the University of Texas at Austin, his approximately 40 years of legal experience in a broad-based civil practice and his extensive business experience on boards of both international and domestic companies.

 

35

 

 

Gary D. Elliston, Director. Mr. Elliston is the senior founding partner of DeHay & Elliston, L.L.P. where he specializes in the areas of toxic tort, commercial litigation, and professional and product liability litigation. He graduated cum laude from Howard Payne University in 1975, and as a Hatton W. Sumners Foundation Scholar, cum laude, from Southern Methodist University Law School in 1978. In 2007, he received an Honorary Doctorate of Humanities from Howard Payne University. He has served as a member of numerous professional, community and charitable organizations He is licensed to practice law in five states and actively tries cases around the US. He has been recognized multiple years as a Texas Super Lawyer and Best Lawyers in America.

 

John Harris, Director. Mr. Harris is currently a private investor in a cannabis growing operation based in southern California. Mr. Harris previously served as a member of the senior leadership team at EDS for approximately 25 years. He is also the former President and CEO of eTelecare Global Solutions; a $300M private equity backed business process outsourcing (“BPO”) company. Prior to eTelecare, Mr. Harris was President and CEO of Seven World Wide, a $400 million private equity backed Marketing Services BPO Company with operations in North America and the United Kingdom. Mr. Harris is a graduate of the University of West Georgia where he earned both a BBA and MBA. He currently serves on the Board of Advisors to the Richardson School of Business at the University of West Georgia. Mr. Harris has held board positions with a number of public and private telecommunications and technology services companies, and currently sits on the board of The Hackett Group. Mr. Harris’s experience as a senior executive and board member at a variety of global companies coupled with his recent experience as an investor in the cannabis space makes him an important asset as we grow and expand the Company’s business.

 

Involvement in Certain Legal Proceedings

 

In March 2016, during Mr. Evans’ tenure as interim CEO of GreenHunter Resources, Inc. that company and certain of its subsidiaries (namely, GreenHunter Water, LLC; Hunter Disposal, LLC; Ritchie Hunter Water Disposal, LLC; Hunter Hauling, LLC; White Top Oilfield Construction, LLC; Blackwater Services, LLC; Virco Realty, LLC; Little Muskingum Drilling, LLC; Blue Water Energy Solutions, LLC; GreenHunter Wheeling Barge, LLC; GreenHunter Environmental Solutions, LLC; and MAG Tank Hunter, LLC) filed for bankruptcy protection under Chapter 11 of the Bankruptcy Code. GreenHunter Resources, Inc. sought protection in large part because of the cyclical downturn in the commodity prices of both oil and natural gas which had a direct effect on all oil field service companies. GreenHunter Resources, Inc.’s assets were subsequently sold to a private equity group, which allowed predominately all secured indebtedness to be fully repaid.

 

In December 2015, during Mr. Evans’ tenure as CEO of Magnum Hunter Resources Corporation, that company filed for bankruptcy protection under Chapter 11 of the Bankruptcy Code in Delaware (In re Magnum Hunter Resources Corporation, et al., included the following debtors in addition to Magnum Hunter Resources Corporation, each of which was a directly or indirectly owned subsidiary of Magnum Hunter Resources Corporation: Alpha Hunter Drilling, LLC; Bakken Hunter Canada, Inc.; Bakken Hunter, LLC; Energy Hunter Securities, Inc.; Hunter Aviation, LLC; Hunter Real Estate, LLC; Magnum Hunter Marketing, LLC; Magnum Hunter Production, Inc.; Magnum Hunter Resources GP, LLC; Magnum Hunter Resources, LP; Magnum Hunter Services, LLC; NGAS Gathering, LLC; NGAS Hunter, LLC; PRC Williston LLC; Shale Hunter, LLC; Triad Holdings, LLC; Triad Hunter, LLC; Viking International Resources Co., Inc.; and Williston Hunter ND, LLC). This filing was due in large part to the precipitous commodity cycle downturn which saw the price of natural gas and crude oil reach lows not seen for over a decade. Magnum Hunter Resources Corporation subsequently emerged from bankruptcy with no indebtedness in May 2016 under Mr. Evans’ leadership. The company has since merged with Southwestern Energy Company (NYSE: SWN).

 

Board of Directors

 

Our board of directors currently consists of four members, including our Chairman and Chief Executive Officer. In evaluating director candidates, we will assess whether a candidate possesses the integrity, judgment, knowledge, experience, skills and expertise that are likely to enhance the board of directors’ ability to manage and direct our affairs and business, including, when applicable, to enhance the ability of the committees of the board of directors to fulfill their duties. Our directors hold office until the earlier of their death, resignation, retirement, disqualification or removal or until their successors have been duly elected and qualified.

 

36

 

 

Independent Directors

 

Under NASDAQ Marketplace Rule 5605(a)(2), a director will not be considered an “independent director” if, such director at any time during the past three years was an employee of the Company, or if a director (or a director’s family member) accepted compensation from the Company (other than compensation for board or board committee service) in excess of $120,000 during any twelve-month period within the three years preceding the determination of independence. In addition, a director will not qualify as an “independent director” if, in the opinion of our Board of Directors, that person has a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. As of the Effective Date, each of Messrs. McClaugherty, Harris, and Elliston is an “independent director” within the meaning of Nasdaq Marketplace Rule 5605(a)(2). In addition, there are no family relationships among any of the directors or executive officers of the Company.

 

Committees of the Board of Directors

 

We have an audit committee, compensation committee and nominating and corporate governance committee of our board of directors and may have such other committees as the board of directors shall determine from time to time. Each of the standing committees of the board of directors has the composition and responsibilities described below.

 

Audit Committee

 

A minimum of two individuals serves as the members of our audit committee. As required by the rules of the Commission and listing standards of the NASDAQ, where we currently anticipate applying to have our Common Stock listed, the audit committee will consist solely of independent directors within one year of the listing date. Commission rules also require that a public company disclose whether or not its audit committee has an “audit committee financial expert” as a member. An “audit committee financial expert” is defined as a person who, based on his or her experience, possesses the attributes outlined in such rules. John Harris satisfies the definition of “audit committee financial expert”.

 

The audit committee oversees, reviews, acts on and reports on various auditing and accounting matters to our Board, including: the selection of our independent registered public accounting firm, the scope of our annual audits, fees to be paid to the independent registered public accounting firm, the performance of our independent registered public accounting firm and our accounting practices. In addition, the audit committee oversees our compliance programs relating to legal and regulatory requirements. We have adopted an audit committee charter defining the committee’s primary duties in a manner consistent with the rules of the Commission and the NASDAQ.

 

Compensation Committee

 

A minimum of three individuals serves as members of our compensation committee. Our compensation committee reviews and recommends policies relating to compensation and benefits of our directors and employees and is responsible for approving the compensation of our Chief Executive Officer and other executive officers. We have adopted a compensation committee charter defining the committee’s primary duties in a manner consistent with the rules of the Commission and NASDAQ.

 

Nominating and Corporate Governance

 

A minimum of three individuals serves as members of our nominating and corporate governance committee. Our nominating and corporate governance committee selects or recommends that the Board select candidates for election to our Board, develops and recommends to the Board corporate governance guidelines that will be applicable to us and oversee board of director and management evaluations. We have adopted a nominating and corporate governance committee charter defining the committee’s primary duties in a manner consistent with the rules of the Commission and NASDAQ.

 

37

 

 

Code of Business Conduct and Ethics

 

Our Board adopted a code of business conduct and ethics applicable to our employees, directors and officers, in accordance with applicable U.S. federal securities laws and the corporate governance rules of the NASDAQ. Any waiver of this code may be made only by our Board and will be promptly disclosed as required by applicable U.S. federal securities laws and the corporate governance rules of the NASDAQ. Copies of the Code of Conduct and Financial Code of Ethics are available on our website at https://www.genhempinc.com/ under “Investors.” Information on our website is not incorporated by reference into this annual report or any other filing we file with or furnish to the SEC. Shareholders may also obtain electronic or printed copies by sending a written request to 8533 Midway Road, Dallas, Texas 75209 or by emailing gevans@genhempinc.com,

 

Lead Independent Director

 

If at any time, the offices of Chairman of the Board and Chief Executive Officer are held by the same person, we intend that the independent members of the Board will elect on an annual basis with a majority vote an independent director to serve in a lead capacity (the “Lead Independent Director”). The Lead Independent Director coordinates the activities of the other independent directors and perform such other duties and responsibilities as the Board may determine. The Board has adopted a Lead Independent Director Charter defining the Lead Independent Director’s primary duties in a manner consistent with the rules of the Commission and NASDAQ. The Board has selected Mr. McClaugherty to serve as Lead Independent Director.

 

Corporate Governance Guidelines

 

After the Effective Date, we anticipate that the Board will adopt corporate governance guidelines in accordance with the corporate governance rules of the NASDAQ.

 

Item 11. Executive Compensation

 

Narrative Disclosures

 

Employment, Severance or Change in Control Agreements. We currently do not maintain any employment, severance or change in control agreements with our named executive officers. In addition, our named executive officers are not entitled to any payments or other benefits in connection with a termination of employment or a change in control.

 

Retirement Benefits. We have not maintained, and do not currently intend to maintain, a defined benefit pension plan or nonqualified deferred compensation plan.

 

Compensation of Named Executive Officers

 

The following table contains compensation data for our named executive officers for the fiscal years ending December 31, 2022 and 2021:

 

Name and Principal Position  Fiscal
Year
  Salary   Bonus   Stock
Awards
   Option
Awards
   Total
Received(1)
 
                        
Gary C. Evans  2021  $401,294    610,000       $6,079,586   $7,090,880 
Chief Executive Officer  2022   400,000            141,659    541,659 
                             
Melissa M. Pagen  2021  $117,000           $759,948   $876,948 
Managing Director, Chief Branding Officer, Corporate Secretary  2022   180,000                180,000 
                             
Jack Sibley(2)  2021  $164,904        77,500   $569,961   $812,365 
Vice President, Corporate Development of the Company, and Co-CEO of GENH Halcyon  2022   175,000                175,000 
                             
Watt Stephens(2)  2021  $164,904        77,500   $569,961   $812,365 
Managing Director, Vice President, Corporate Development of the Company and Secretary of GENH Halcyon  2022   175,000                175,000 

 

(1)Amount reflects total compensation received for calendar year.

 

(2)Mr. Sibley and Mr. Watt joined the Company on January 11, 2021. Each receive a base annual salary of $175,000.

 

38

 

 

Outstanding Equity Awards at Fiscal Year-End

 

The following table provides information relating to the unexercised stock options and the unvested stock awards for the Named Executive Officers as of December 31, 2022:

 

   Stock Option Awards  Restricted Stock Awards 
   Number of Securities Underlying          Shares of Restricted
Stock
 
   Unexercised Options   Option   Option  That Have Not Vested 
Name  Exercisable   Unvested   Exercise
Price
   Expiration
Date
  Number   Market
Value
 
                        
Gary C. Evans   5,333,334    2,666,666   $0.76   10/29/2031          —   $         — 
        475,000   $0.33   08/15/2027      $ 
Melissa M. Pagen   666,667    333,333   $0.76   10/29/2031      $ 
Jack Sibley   500,000    250,000   $0.76   10/29/2031      $ 
Watt Stephens   500,000    250,000   $0.76   10/29/2031      $ 

 

Compensation of Directors

 

Attracting and retaining qualified non-employee directors is critical to the future value growth and governance of our Company. A significant portion of the total compensation package for our non-employee directors is equity-based to align the interest of these directors with our stockholders.

 

Directors who are also our employees will not receive any additional compensation for their service on our Board.

 

Directors are reimbursed for (i) travel and miscellaneous expenses to attend meetings and activities of our Board or its committees; and (ii) travel and miscellaneous expenses related to such director’s participation in general education and orientation programs for directors.

 

The following table summarizes the compensation awarded or paid to the members of the board of directors, who were compensated for board service beginning with their election to the board of directors in the fiscal year ended December 31, 2022:

 

   Nature of Director Fees     
Director Name  Director   Committee   Option
Awards (1)
   Total 
Joe McClaugherty  $   $   $36,216   $36,216 
Gary D. Elliston           36,216    36,216 
John Harris           36,216    36,216 
Gary C. Evans                
                     
All directors as a group  $   $   $108,648   $108,648 

 

  (1) Each of the directors were granted options for the purchase of 120,000 shares of the Company’s common stock in 2022. The awarded options vested vest in three equal annual tranches over three years from issuance. Vested options may be exercised at any time until their expiration after 10 years at an exercise price of $0.30 per share.

 

The table above does not include the amount of any expense reimbursements paid to the above directors. Mr. Evans does not receive any additional compensation for serving on the Board of Directors other than the compensation described in the Summary Executive Compensation Table, above.

 

39

 

 

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

The following table sets forth information regarding beneficial ownership of our Common Stock, as of February 28, 2022. We have determined beneficial ownership in accordance with Commission rules. The information does not necessarily indicate beneficial ownership for any other purpose.

 

Except as indicated in the footnotes to the following table, the persons named in the table has sole voting and investment power with respect to all shares of common stock and preferred stock beneficially owned. Except as otherwise indicated, the address of each of the stockholders listed below is: C/O Evergreen Sustainable Enterprises, Inc., 8533 Midway Road, Dallas, Texas 75209.

 

Name of Beneficial Owner  Amount and
Nature of
Ownership
(1)
   Percent of
Voting
Securities
(2)
 
         
5% Stockholders:        
Satellite Overseas (Holdings) Limited(3)   26,263,144    23.2%
           
Corey Wiegard   6,254,843    5.5%
           
OZG Agriculture KY, LP   6,250,000    5.5%
           
Directors and Named Executive Officers:          
Gary C. Evans(4)   38,014,242    33.6%
           
Melissa Pagen   -    -%
           
Jack Sibley(5)   6,500,000    5.7%
           
Watt Stephens(5)   6,500,000    5.7%
           
Gary Elliston   4,090,909    3.6%
           
John Harris   284,090    0.3%
           
Joe McClaugherty   2,027,210    1.8%
           
All officers and directors as a group   51,166,451    45.2%

 

(1) Beneficial Ownership is determined in accordance with the rules of the Securities and Exchange Commission and generally includes voting or investment power with respect to securities. Each of the beneficial owners listed above has direct ownership of and sole voting power and investment power to the shares of the common stock. For each Beneficial Owner listed, any options or convertible securities exercisable or convertible within 60 days have been also included for purposes of calculating their beneficial ownership of outstanding common stock.

 

(2) Ownership percentage based on 113,204,002 fully diluted shares of common stock outstanding as calculated on an as-converted basis.

 

(3) Satellite Overseas (Holdings) Limited (“SOHL”) is the record holder of these shares of Common Stock. SOHL is a wholly-owned subsidiary of Cadila Pharmaceuticals Ltd. (“Cadila”). Cadila is owned by the IRM Trust. Rajiv I. Modi, Ph. D. and Mrs. Shilaben I. Modi are the trustees of the IRM Trust. As trustees of the IRM Trust, Dr. Modi and Mrs. Modi have shared voting and dispositive power with respect to these shares and, therefore, under rules issued by the Commission may be deemed to be beneficial owners of the shares.
   
(4) Includes 1,061,970 shares of common stock owned by Investment Hunter, LLC, a Texas LLC controlled by Gary C. Evans.
   
(5) Because of the relationship of Messrs. Sibley and Stephens to OZG Agriculture KY, LP, Messrs. Sibley and Stephens may be deemed indirect beneficial owners of the 6,250,000 shares of common stock owned by OZG Agriculture KY, LP.

 

40

 

 

Item 13. Certain Relationships and Related Persons Transactions

 

Board Role in Risk Oversight

 

Our Board of Directors is responsible for the oversight of the Company’s risk management efforts. Members of management are responsible for particular areas of risk for the company and provide presentations, information and updates on risk management efforts as requested by our Board. 

 

Family Relationships

 

There are no family relationships among our executive officers and directors.

 

Related Transactions

 

2021 Issuances of Common Stock Units – In the first quarter of 2021, the Company issued 800,000 common stock units for total proceeds of $400,000. Each common stock unit consists of one share of common stock and a warrant for the purchase of two shares of common stock for $0.50 each. Each warrant is exercisable any time before its expiration on the second anniversary of its issuance. Mr. Evans purchased 100,000 commons stock units in this issuance.

 

Subordinated Promissory Note to Gary C. Evans – Gary C. Evans made advances of $490,000 to the Company during 2020 under a subordinated promissory note initially due September 30, 2021. This note was amended to a new maturity date of June 30, 2022. If the Company raises new equity capital of $3 million or more, then the full amount outstanding under the note is due within five days. The note bears interest at 10% per annum. The outstanding amount of this this subordinated promissory note was $523,551 and accrued interest totaled $7,602 at December 31, 2021.

 

Convertible Promissory Note to Gary C. Evans – In 2021, Gary C. Evans made advances totaling $410,000 to the Company under a convertible promissory note. The convertible note matured on January 1, 2022 but was subsequently amended to extend the maturity date to June 30, 2022. If the Company raises new equity capital of $3 million or more, then the full amount outstanding under the note is due within five days. The note bears interest at 10%. The principal and interest due on the convertible note may be converted, at the option of the holder, into restricted shares of the Company’s common stock at a conversion price equal to $0.50 per share. Accrued interest on this convertible promissory note totaled $19,118 at December 31, 2021.

 

Advances under Promissory Note – In the first quarter of 2022, Investment Hunter, LLC, a Texas LLC controlled by Gary C. Evans, made advances totaling $439,000 to the Company under a promissory note due June 30, 2022. If the Company raises new equity capital of $3 million or more, then the full amount outstanding under the note is due within five days. The note bears interest at 10% per annum.

 

December 2020 Issuance of Series B Preferred Stock Units – On December 30, 2020, the Company sold to certain accredited investors, including Gary C. Evans (50 shares), CEO and chairman, and Gary Elliston (25 shares), one of our incoming directors, an aggregate of 135 preferred stock units comprised of (i) one share of Series B Redeemable Convertible Preferred Stock, no par value, and (ii) one warrant exercisable for 50,000 shares of common stock of the Company. On March 9, 2021, Mr. Elliston exercised cash warrants received by him in the Series B Preferred Stock Unit issuance for 1,250,000 shares of common stock.

 

Gary C. Evans Convertible Note with EHR. In October and December of 2019, Mr. Evans advanced EHR $370,770 under a convertible note bearing interest at 10% per annum. This note, including accrued interest, was converted into 1,061,970 shares of common stock on December 31, 2019.

 

41

 

 

EHR Series C Preferred Stock – In the third quarter of 2019, EHR raised $850,000 of additional funding through the issuance of 34,000 shares of EHR Series C Preferred Stock. The EHR Series C Preferred Stock converted into 2,414,773 shares of EHR’s common stock upon completion of the Transaction. These common shares were initially accounted for as non-controlling interests in EHR. In an exchange transaction effective November 27, 2019, the Company acquired these non-controlling interests representing approximately 26% of the ownership of EHR through the issuance of 2,414,773 shares of Company common stock and 14,488,638 warrants for the purchase of Company common stock. The warrants have an exercise price of $0.352 per share and expire on November 27, 2021. The warrants may be redeemed beginning October 1, 2020 for $0.0001 per warrant at the Company’s option with 30-days advanced notice should the volume weighted average price exceed $1.00 for any five out of seven consecutive trading days with a minimum average daily trading volume for such seven-day period of at least 25,000 shares of common stock. One-half of the warrants have a cashless exercise feature.

 

In connection with the exchange transaction, on November 27, 2019, John Harris obtained beneficial ownership of 71,022 shares of common stock, 213,068 cash warrants, and 213,068 cashless warrants. On February 26, 2021, the cash warrants were exercised for the purchase of 213,068 shares of common stock. Also, at the time of the exchange, Gary Elliston received 710,227 shares of common stock, 2,130,682 cash warrants, and 2,130,682 cashless warrants. On March 9, 2021, Mr. Elliston exercised all of his cash warrants and received 2,130,682 shares of common stock. Lastly, at the time of the exchange, Joe McClaugherty received 71,022 shares of common stock, 213,068 cash warrants, and 213,068 cashless warrants. On November 23, 2021, Mr. McClaugherty exercised all of his cash warrants and received 213,068 shares of common stock.

 

Warrant Exercises – In the fourth quarter of 2021, the Company received $375,000 for the exercise of 1,065,340 outstanding warrants. Mr. Evans exercised warrants that he had acquired from an unrelated stockholder. Mr. Evans received 852,272 shares of the Company’s common stock for total proceeds of $300,000.

 

Option Grants – In the fourth quarter of 2021, the Company awarded options for 13,850,000 shares of the Company’s common stock as incentive compensation. One-third of the awarded options vested immediately with the remaining options vesting in two equal tranches over the next two years. Vested options may be exercised at any time until their expiration after 10 years. Unvested shares are forfeited upon termination of employment. Mr. Evans received options for 8,000,000 shares of the Company’s common stock in this issuance. Messrs. McClaugherty, Elliston and Harris each received options for 500,000 of the Company’s common stock in this issuance.

 

Other Related Party Transactions

 

Please see Note 5 to our audited consolidated financial statements contained in Item 8 of Part II of this Annual Report on Form 10-K for a description of certain other transactions with related parties, which descriptions are incorporated by reference herein.

 

Director Independence

 

See Item 10. “Directors, Executive Officers and Corporate Governance” for information regarding our directors and independence requirements applicable for the Board of Directors and its committees.

 

Item 14. Principal Accountant Fees and Services

 

Our independent public accounting firm is Marcum LLP, Houston, Texas, PCAOB Auditor ID 688.

 

The following table sets forth the fees paid by us for the audit and other services provided by our auditor, Marcum, LLC during the years ended December 31, 2022 and 2021:

 

   2022   2021 
Audit fees (1)  $239,763   $283,050 
Audit related fees   -    - 
Tax fees   -    - 
All other fees   -    - 
           
Total fees  $239,763   $283,050 

 

(1)Audit Fees: This category represents the aggregate fees billed for professional services rendered by the principal independent accountant for the audit of our annual financial statements and review of financial statements included in our Form 10-K and services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for the fiscal years.

 

42

 

 

Audit Committee Pre-Approval Policies and Procedures

 

The audit committee charter of our board of directors requires the audit committee to pre-approve all audit services and permitted non-audit services (other than de minimis non-audit services as defined by the Sarbanes-Oxley Act of 2002) to be provided by our independent registered public accounting firm. The Audit Committee may form and delegate authority to subcommittees consisting of one or more members when appropriate, including the authority to grant preapprovals of audit and permitted non-audit services, provided that decisions of such subcommittee to grant preapprovals shall be presented to the full Audit Committee at its next scheduled meeting for ratification.

 

Item 15. Exhibits and Financial Statement Schedules

 

(a) The following documents are filed as part of this Report:

 

  (1) Report of Independent Registered Public Accounting Firm (PCAOB ID Number 688) F-2
       
    Consolidated Balance Sheets as of December 31, 2022 and 2021 F-4
       
    Consolidated Statements of Operations for the Years Ended December 31, 2022 and 2021 F-5
       
    Consolidated Statements of Changes in Stockholders’ Equity (Deficit) for the Years Ended December 31, 2022 and 2021 F-6
       
    Consolidated Statements of Cash Flows for the Years Ended December 31, 2022 and 2021 F-7
       
    Notes to Consolidated Financial Statements F-8
       
  (2) Supplemental Oil and Gas Information (Unaudited) F-22

 

43

 

 

(b) Exhibits:

 

Exhibit Number   Description
     
3.1   Certificate of Incorporation (filed as Exhibit 3.1 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed on April 12, 2022 (file number 333-176154))  
     
3.2   Bylaws (filed as Exhibit 3.2 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed on April 12, 2022 (file number 333-176154))
     
3.3   Certificate of Designation of Rights, Preferences and Limitations of the Series A Convertible Voting Preferred Stock (filed as Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on December 4, 2019 (file number 000-176154))
     
3.4   Certificate of Designation of Rights, Preferences and Limitations of the Series B Redeemable Convertible Preferred Stock (filed as Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on January 6, 2021 (file number 000-55019))
     
3.5**   Certificate of Designation of Rights, Preferences and Limitations of the Series C Redeemable Convertible Preferred Stock
     
4.1   2020 Form of Generation Hemp Warrant (filed as Exhibit 4.1 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 filed on December 15, 2020 (file number 333-176154))
     
4.2   Form of Warrant (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on January 6, 2021 (file number 000-55019))
     
4.4   Description of Securities (filed as Exhibit 4.4 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed on April 12, 2022 (file number 333-176154))
     
4.5**   Form of Warrant (2023)
     
10.1   Deed of Trust, dated September 15, 2014, between  JDONE LLC and Thomas S. Yang. (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on September 19, 2014 (file number 333-176154))
     
10.2   Promissory Note, dated September 15, 2014, made by JDONE LLC in favor Thomas S. Yang. (filed as Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on September 19, 2014 (file number 333-176154))
     
10.3   Amendment No. 1 to Promissory Note and Deed of Trust, dated October 1, 2019, between JDONE LLC, Thomas S. Yang, and Gary C. Evans (filed as Exhibit 10.3 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 filed on December 15, 2020 (file number 333-176154))
     
10.4   Amendment and Extension Agreement to Promissory Note and Deed of Trust, dated October 1, 2019, between JDONE LLC, Thomas S. Yang, and Gary C. Evan (filed as Exhibit 10.4 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed on April 12, 2022 (file number 333-176154))
     
10.5   Amendment and Extension Agreement, dated April 20, 2022, to Promissory Note and Deed of Trust between JDONE LLC, Thomas S. Yang, and Gary C. Evans (filed as Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2022 filed on May 23, 2022 (file number 333-176154))
     
10.6   Amendment and Extension Agreement, dated July 18, 2022, to Promissory Note and Deed of Trust between JDONE LLC, Thomas S. Yang, and Gary C. Evans (filed as Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2022 filed on August 19, 2022 (file number 333-176154))
     
10.7   Secured Promissory Note Amendment and Extension Agreement, dated October 10, 2022, between JDONE LLC, Thomas S. Yang, and Gary C. Evans (filed as Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2022 filed on November 14, 2022 (file number 333-176154))
     
10.8   Biomass Tolling Agreement, dated July 11, 2021, but effective as of June 30, 2021 (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on July 12, 2021 (file number 000-55019))

 

44

 

 

10.9   Toll Processing Agreement, dated June 8, 2021, between GenH Halcyon Acquisition and Bragg Canna, LLC (filed as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2021 filed on August 13, 2021 (file number 000-55019))
     
10.10   Biomass Services Agreement, dated August 11, 2021, between GenH Halcyon Acquisition and Kushco Holdings, Inc (filed as Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2021 filed on August 13, 2021 (file number 000-55019))
     
10.11   Merchandise License Agreement dated February 17, 2022 between Gas Monkey Holdings, LLC and Generation Hemp, Inc (filed as Exhibit 10.8 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed on April 12, 2022 (file number 333-176154))
     
10.12   2020 Form of Common Stock and Warrant Subscription Agreement of Generation Hemp, Inc. (filed as Exhibit 10.10 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 filed on December 15, 2020 (file number 333-176154))
     
10.13   Subordinated Promissory Note, dated September 30, 2020, made by Generation Hemp, Inc. in favor of Gary C. Evans (filed as Exhibit 10.11 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 filed on December 15, 2020 (file number 333-176154))
     
10.14   Amended and Restated Subordinated Promissory Note, dated November 11, 2021, with Gary C. Evans as holder (filed as Exhibit 10.8 to the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2021 filed on November 15, 2021 (file number 000-55019))
     
10.15   Amended and Restated Subordinated Promissory Note, dated January 1, 2022, with Gary C. Evans as holder (filed as Exhibit 10.14 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed on April 12, 2022 (file number 333-176154))
     
10.16   Amended and Restated Subordinated Promissory Note, by Generation Hemp, Inc. with Gary C. Evans as holder, dated July 1, 2022 (filed as Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2022 filed on August 19, 2022 (file number 333-176154))
     
10.18   Amended and Restated Subordinated Promissory Note, by Generation Hemp, Inc. with Gary C. Evans as holder, dated July 1, 2022 (filed as Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2022 filed on August 19, 2022 (file number 333-176154))
     
10.19   First Amendment to Purchase Agreement, dated March 7, 2020, by and among, Generation Hemp, Inc., GENH Halcyon Acquisition, LLC, Oz Capital, LLC, OZC Agriculture KY LP, Halcyon Thruput, LLC, and the owners set forth therein (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on January 15, 2021 (file number 000-55019))
     
10.20   Asset Purchase Agreement, dated March 7, 2020, by and among, Generation Hemp, Inc., GENH Halcyon Acquisition, LLC, Oz Capital, LLC, OZC Agriculture KY LP, Halcyon Thruput, LLC, and the owners set forth therein (filed as Exhibit 10.12 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 filed on December 15, 2020 (file number 333-176154))
     
10.21   Subscription Agreement (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on January 6, 2021 (file number 000-55019))
     
10.22   Guaranty Agreement by Generation Hemp, Inc. in favor of Coventry Asset Management (filed as Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on January 15, 2021 (file number 000-55019))

 

45

 

 

10.23   Letter Agreement, dated November 11, 2021, with Coventry Asset Management, LTD (filed as Exhibit 10.7 to the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2021 filed on November 15, 2021 (file number 000-55019))
     
10.24   Letter Agreement, dated March 7, 2022, with Coventry Asset Management, LTD (filed as Exhibit 10.23 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed on April 12, 2022 (file number 333-176154))
     
10.25  

Letter Agreement, dated May 11, 2022, with Coventry Asset Management, LTD (filed as Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2022 filed on May 23, 2022 (file number 333-176154))

     
10.26   Letter Agreement, dated July 31, 2022, with Coventry Asset Management, LTD (filed as Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2022 filed on August 19, 2022 (file number 333-176154))
     
10.27   Unsecured Promissory Note, dated August 11, 2021, with Gary C. Evans as holder (filed as Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2021 filed on August 13, 2021 (file number 000-55019))
     
10.28   Amended and Restated Promissory Note, by Generation Hemp, Inc., dated August 30, 2021, with Gary C. Evans as holder (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on August 30, 2021 (file number 000-55019))
     
10.29   Amended and Restated Promissory Note, by Generation Hemp, Inc., dated September 9, 2021, with Gary C. Evans as holder (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on September 10, 2021 (file number 000-55019))
     
10.30   Amended and Restated Promissory Note, by Generation Hemp, Inc., dated September 28, 2021, with Gary C. Evans as holder (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on September 29, 2021 (file number 000-55019))
     
10.31   Amended and Restated Promissory Note, by Generation Hemp, Inc., dated November 11, 2021, with Gary C. Evans as holder (filed as Exhibit 10.9 to the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2021 filed on November 15, 2021 (file number 000-55019))
     
10.32   Amended and Restated Promissory Note, by Generation Hemp, Inc., dated January 1, 2022, with Gary C. Evans as holder (filed as Exhibit 10.29 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed on April 12, 2022 (file number 333-176154))
     
10.33   Amended and Restated Promissory Note, by Generation Hemp, Inc., dated May 19, 2022, with Gary C. Evans as holder (filed as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2022 filed on May 23, 2022 (file number 333-176154))
     
10.34   Amended and Restated Promissory Note by Generation Hemp, Inc. with Gary C. Evans as holder, dated July 1, 2022 (filed as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2022 filed on August 19, 2022 (file number 333-176154))
     
10.35   Amended and Restated Convertible Promissory Note by Generation Hemp, Inc. with Gary C. Evans as holder, dated September 30, 2022 (filed as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2022 filed on November 14, 2022 (file number 333-176154))
     
10.36   Unsecured Promissory Note, dated March 18, 2022, with Investment Hunter, LLC as holder (filed as Exhibit 10.32 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed on April 12, 2022 (file number 333-176154))
     
10.37   Amended and Restated Unsecured Promissory Note, dated May 19, 2022, with Investment Hunter, LLC as holder (filed as Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2022 filed on May 23, 2022 (file number 333-176154))

 

46

 

 

10.38   Revised and Extended Unsecured Promissory Note with Investment Hunter, LLC as holder, dated July 1, 2022 (filed as Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2022 filed on August 19, 2022 (file number 333-176154))
     
10.39   Revised and Extended Unsecured Promissory Note, dated September 30, 2022, with Investment Hunter, LLC as holder, dated September 30, 2022 (filed as Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2022 filed on November 14, 2022 (file number 333-176154))
     
10.40#   Term Employment Agreement with Jack Sibley (filed as Exhibit 10.4 to the Company’s Current Report on Form 8-K filed on January 15, 2021 (file number 000-55019))
     
10.41#   Term Employment Agreement with Watt Stephens (filed as Exhibit 10.5 to the Company’s Current Report on Form 8-K filed on January 15, 2021 (file number 000-55019))
     
 10.42   Note Contribution Agreement, dated March 9, 2021, among Energy Hunter Resources, Inc., Satellite Overseas (Holdings) Limited, and Generation Hemp, Inc. (filed as Exhibit 10.21 to the Company’s Annual Report on Form 10-K filed on March 31, 2021 (file number 000-55019))
     
10.43   2021 Form of Common Stock and Warrant Subscription Agreement of Generation Hemp, Inc. (filed as Exhibit 10.22 to the Company’s Annual Report on Form 10-K filed on March 31, 2021 (file number 000-55019))
     
10.44#   Form of Incentive Stock Option Agreement under 2021 Omnibus Incentive Plan (filed as Exhibit 10.37 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed on April 12, 2022 (file number 333-176154))
     
10.45#   Form of Non-Qualified Stock Option Agreement under 2021 Omnibus Incentive Plan (filed as Exhibit 10.38 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed on April 12, 2022 (file number 333-176154))
     
10.46#   Form of Restricted Stock Award Agreement under 2021 Omnibus Incentive Plan (filed as Exhibit 10.39 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed on April 12, 2022 (file number 333-176154))
     
10.47#   Form of Restricted Stock Units Award Agreement under 2021 Omnibus Incentive Plan (filed as Exhibit 10.40 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed on April 12, 2022 (file number 333-176154))
     
10.48#   Form of Stock Appreciation Right Grant Agreement under 2021 Omnibus Incentive Plan (filed as Exhibit 10.41 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed on April 12, 2022 (file number 333-176154))
     
10.49**   Form of Subscription Agreement for Series C Redeemable Convertible Preferred Stock
     
10.50**   Letter Agreement, dated April 27, 2023, with Coventry Asset Management, LTD
     
10.51**   Secured Promissory Note, dated April 19, 2023, made by Razorback I, LLC, in favor of Michael A. McManus and Gary C. Evans
     
10.52**   Guaranty Agreement by Evergreen Sustainable Enterprises, Inc. in favor of in favor of Michael A. McManus and Gary C. Evans
     
21**   List of Subsidiaries of the Company
     
31.1**   Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 302
     
32.1**   Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of The Sarbanes-Oxley Act of 2004
     
101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

**Exhibit filed herewith

 

#Constitutes a management compensatory plan or arrangement.

 

47

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

EVERGREEN SUSTAINABLE ENTERPRISES, INC.

(FORMERLY GENERATION HEMP, INC.)
(
Registrant)

     
DATE: May 18, 2023 By: /s/ Gary C. Evans
    Gary C. Evans
    Chairman and Chief Executive Officer

 

 

48

 

false FY false 0001527102 0001527102 2022-01-01 2022-12-31 0001527102 2022-06-30 0001527102 2023-05-18 0001527102 2022-12-31 0001527102 2021-12-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2022-12-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2021-12-31 0001527102 2021-01-01 2021-12-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2020-12-31 0001527102 us-gaap:PreferredStockMember 2020-12-31 0001527102 us-gaap:CommonStockMember 2020-12-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001527102 us-gaap:RetainedEarningsMember 2020-12-31 0001527102 us-gaap:NoncontrollingInterestMember 2020-12-31 0001527102 2020-12-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2021-01-01 2021-12-31 0001527102 us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001527102 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001527102 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001527102 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2021-12-31 0001527102 us-gaap:PreferredStockMember 2021-12-31 0001527102 us-gaap:CommonStockMember 2021-12-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001527102 us-gaap:RetainedEarningsMember 2021-12-31 0001527102 us-gaap:NoncontrollingInterestMember 2021-12-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2022-01-01 2022-12-31 0001527102 us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001527102 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001527102 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001527102 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2022-12-31 0001527102 us-gaap:PreferredStockMember 2022-12-31 0001527102 us-gaap:CommonStockMember 2022-12-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001527102 us-gaap:RetainedEarningsMember 2022-12-31 0001527102 us-gaap:NoncontrollingInterestMember 2022-12-31 0001527102 genh:EnergyHunterResourcesIncMember 2019-11-02 2019-11-27 0001527102 2021-01-01 2021-01-11 0001527102 us-gaap:LandMember 2022-12-31 0001527102 us-gaap:LandMember 2021-12-31 0001527102 srt:WarehouseMember 2022-01-01 2022-12-31 0001527102 srt:WarehouseMember 2022-12-31 0001527102 srt:WarehouseMember 2021-12-31 0001527102 us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001527102 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001527102 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001527102 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2022-01-01 2022-12-31 0001527102 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2022-01-01 2022-12-31 0001527102 us-gaap:MachineryAndEquipmentMember 2022-12-31 0001527102 us-gaap:MachineryAndEquipmentMember 2021-12-31 0001527102 us-gaap:VehiclesMember 2022-01-01 2022-12-31 0001527102 us-gaap:VehiclesMember 2022-12-31 0001527102 us-gaap:VehiclesMember 2021-12-31 0001527102 us-gaap:ComputerEquipmentMember 2022-01-01 2022-12-31 0001527102 us-gaap:ComputerEquipmentMember 2022-12-31 0001527102 us-gaap:ComputerEquipmentMember 2021-12-31 0001527102 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0001527102 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0001527102 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001527102 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001527102 2022-01-01 2022-09-30 0001527102 us-gaap:CustomerRelationshipsMember 2022-12-31 0001527102 us-gaap:CustomerRelationshipsMember 2021-12-31 0001527102 genh:NoncompetitionAgreementsMember 2022-12-31 0001527102 genh:NoncompetitionAgreementsMember 2021-12-31 0001527102 genh:SubordinatedPromissoryNoteToCEOMember 2020-01-01 2020-12-31 0001527102 genh:SubordinatedPromissoryNoteToCEOMember 2022-12-31 0001527102 genh:SubordinatedPromissoryNoteToCEOMember 2022-01-01 2022-12-31 0001527102 genh:PromissoryNoteToInvestmentHunterLLCMember 2022-12-31 0001527102 genh:ConvertiblePromissoryNoteToCEOMember 2021-01-01 2021-12-31 0001527102 genh:ConvertiblePromissoryNoteToCEOMember 2022-12-31 0001527102 2022-07-31 0001527102 genh:SecuredPromissoryNoteAndWarrantsToCoventryAssetManagementLTDMember 2020-12-30 0001527102 genh:SecuredPromissoryNoteAndWarrantsToCoventryAssetManagementLTDMember 2020-12-01 2020-12-30 0001527102 genh:PromissoryNoteMember genh:SecuredPromissoryNoteAndWarrantsToCoventryAssetManagementLTDMember 2022-01-01 2022-12-31 0001527102 genh:SecuredPromissoryNoteAndWarrantsToCoventryAssetManagementLTDMember 2022-01-01 2022-12-31 0001527102 2023-05-25 2023-06-01 0001527102 2023-08-01 2023-08-31 0001527102 genh:SubordinatedPromissoryNoteAndWarrantsToInvestorMember 2020-12-30 0001527102 genh:SubordinatedPromissoryNoteAndWarrantsToInvestorMember 2020-12-01 2020-12-30 0001527102 genh:SubordinatedPromissoryNoteAndWarrantsToInvestorMember 2022-01-01 2022-12-31 0001527102 us-gaap:SubsequentEventMember 2023-03-01 0001527102 genh:PromissoryNoteToInvestmentHunterLLCMember 2022-01-01 2022-12-31 0001527102 genh:SubordinatedPromissoryNoteToCEOMember 2021-12-31 0001527102 genh:ConvertiblePromissoryNoteToCEOMember 2021-12-31 0001527102 genh:SecuredPromissoryNoteToCoventryAssetManagementLtdMember 2022-12-31 0001527102 genh:SecuredPromissoryNoteToCoventryAssetManagementLtdMember 2021-12-31 0001527102 genh:SubordinatedPromissoryNoteMember 2022-12-31 0001527102 genh:SubordinatedPromissoryNoteMember 2021-12-31 0001527102 genh:PromissoryNoteToInvestmentHunterLLCMember 2022-12-31 0001527102 genh:PromissoryNoteToInvestmentHunterLLCMember 2021-12-31 0001527102 2020-04-29 0001527102 genh:OzCapitalLLCMember 2022-01-01 2022-12-31 0001527102 genh:OzCapitalLLCMember 2021-01-01 2021-12-31 0001527102 srt:MinimumMember 2022-01-01 2022-12-31 0001527102 srt:MaximumMember 2022-01-01 2022-12-31 0001527102 genh:HalcyonThruputLLCsMember 2022-01-01 2022-12-31 0001527102 genh:GrandTraverseHoldingsLLCMember 2022-12-31 0001527102 2020-12-01 2020-12-23 0001527102 us-gaap:SeriesAPreferredStockMember 2021-09-08 0001527102 us-gaap:SeriesBPreferredStockMember 2020-12-01 2020-12-30 0001527102 us-gaap:SeriesBPreferredStockMember 2022-12-31 0001527102 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-12-31 0001527102 2021-04-30 0001527102 us-gaap:WarrantMember 2022-12-31 0001527102 genh:DecemberTwoThousandTwentyMember genh:SubordinatedNoteToInvestorMember 2022-12-31 0001527102 genh:DecemberTwoThousandTwentyMember genh:SubordinatedNoteToInvestorMember 2022-01-01 2022-12-31 0001527102 genh:MarchTwoThousandTwentyOneMember genh:CommonStockUnitsMember 2022-12-31 0001527102 genh:MarchTwoThousandTwentyOneMember genh:CommonStockUnitsMember 2022-01-01 2022-12-31 0001527102 genh:DecemberTwoThousandTwentyOneMember genh:CommonStockUnitsMember 2022-12-31 0001527102 genh:DecemberTwoThousandTwentyOneMember genh:CommonStockUnitsMember 2022-01-01 2022-12-31 0001527102 genh:TwoThousandTwentyOnePlanMember 2021-01-01 2021-12-31 0001527102 us-gaap:RestrictedStockMember 2021-01-01 2021-03-31 0001527102 2021-10-01 2021-12-31 0001527102 2022-07-01 2022-09-30 0001527102 srt:MinimumMember 2022-07-01 2022-09-30 0001527102 srt:MaximumMember 2022-07-01 2022-09-30 0001527102 srt:MinimumMember 2022-09-30 0001527102 srt:MaximumMember 2022-09-30 0001527102 us-gaap:SegmentDiscontinuedOperationsMember 2022-12-31 0001527102 us-gaap:SegmentDiscontinuedOperationsMember 2021-12-31 0001527102 us-gaap:SegmentDiscontinuedOperationsMember 2022-01-01 2022-12-31 0001527102 us-gaap:SegmentDiscontinuedOperationsMember 2021-01-01 2021-12-31 0001527102 us-gaap:SubsequentEventMember 2023-01-01 2023-01-31 0001527102 genh:ToroEnergaSociedadAnonimaMember us-gaap:SubsequentEventMember 2023-01-09 0001527102 us-gaap:SubsequentEventMember 2023-01-09 0001527102 us-gaap:SubsequentEventMember 2023-01-09 2023-01-09 0001527102 genh:ToroEnergaSociedadAnonimaMember 2022-12-31 0001527102 genh:ToroEnergaSociedadAnonimaMember 2022-01-01 2022-12-31 0001527102 us-gaap:SubsequentEventMember 2023-01-10 2023-01-10 0001527102 us-gaap:SubsequentEventMember 2023-01-15 0001527102 us-gaap:SubsequentEventMember 2023-03-01 2023-03-01 0001527102 genh:SeriesCRedeemableConvertiblePreferredStockMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2023-01-01 2023-03-31 0001527102 genh:SeriesCRedeemableConvertiblePreferredStockMember us-gaap:SubsequentEventMember 2023-03-31 0001527102 genh:SeriesCRedeemableConvertiblePreferredStockMember us-gaap:SubsequentEventMember 2023-01-01 2023-03-31 0001527102 us-gaap:SubsequentEventMember 2023-01-01 2023-03-31 0001527102 us-gaap:WarrantMember us-gaap:SubsequentEventMember 2023-03-31 0001527102 us-gaap:WarrantMember us-gaap:SubsequentEventMember 2023-01-01 2023-03-31 0001527102 srt:ScenarioForecastMember 2023-04-15 0001527102 srt:ScenarioForecastMember 2023-07-15 0001527102 srt:ScenarioForecastMember 2023-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:USD utr:sqft
EX-3.5 2 f10k2022ex3-5_evergreen.htm CERTIFICATE OF DESIGNATION OF RIGHTS, PREFERENCES AND LIMITATIONS OF THE SERIES C REDEEMABLE CONVERTIBLE PREFERRED STOCK

Exhibit 3.5

 

CERTIFICATE OF DESIGNATIONS

OF THE

8.50% SERIES C REDEEMABLE CONVERTIBLE PREFERRED STOCK

OF

GENERATION HEMP, INC

 

 

 

Generation Hemp, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware, in accordance with Section 151 of the Delaware General Corporation Law, DOES HEREBY CERTIFY:

 

FIRST: The name of the corporation is Generation Hemp, Inc. (the “Corporation”).

 

SECOND: The Certificate of Incorporation of the Corporation was filed with the Secretary of State of the State of Delaware on August 20, 2021 (the “Certificate of Incorporation”).

 

THIRD: This Certificate of Designations for the Corporation’s 8.50% Series C Redeemable Convertible Preferred Stock (the “Series C Preferred Stock”) was duly adopted by the affirmative vote of the Corporation’s Board of Directors (the “Board of Directors”) on February, 9, 2023, and which provides for the designations, powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations or restrictions thereof, of the Series C Preferred Stock:.

 

RESOLVED, that the Corporation is hereby authorized to issue up to 100 shares of the Series C Preferred Stock, $0.00001 par value per share, which shall have the following designations, powers, preferences and other special rights:

 

1. Designation, Amount and Par Value. The series of Preferred Stock shall be designated as the Corporation’s Series C Redeemable Convertible Preferred Stock, and the number of shares so designated shall be 100. Each share of Series C Preferred Stock shall have par value $0.00001 per share and a stated value equal to $50,000.00 (as adjusted for any stock split, stock dividend, stock combination or other similar transactions with respect to the Series C Preferred Stock, the “Stated Value”).

 

2. Definitions. In addition to the terms defined elsewhere in this Certificate of Designation, the following terms have the meanings indicated:

 

Bankruptcy Event” means any of the following events: (a) the Corporation or any Significant Subsidiary (as such term is defined in Rule 1.02(w) of Regulation S-X) thereof commences a case or other proceeding under any bankruptcy, reorganization, arrangement, adjustment of debt, relief of debtors, dissolution, insolvency or liquidation or similar law of any jurisdiction relating to the Corporation or any Significant Subsidiary thereof; (b) there is commenced against the Corporation or any Significant Subsidiary thereof any such case or proceeding that is not dismissed within 60 days after commencement; (c) the Corporation or any Significant Subsidiary thereof is adjudicated insolvent or bankrupt or any order of relief or other order approving any such case or proceeding is entered; (d) the Corporation or any Significant Subsidiary thereof suffers any appointment of any custodian or the like for it or any substantial part of its property that is not discharged or stayed within 60 days; (e) the Corporation or any Significant Subsidiary thereof makes a general assignment for the benefit of creditors; (f) the Corporation or any Significant Subsidiary thereof calls a meeting of its creditors with a view to arranging a composition, adjustment or restructuring of its debts; or (g) the Corporation or any Significant Subsidiary thereof, by any act or failure to act, expressly indicates its consent to, approval of or acquiescence in any of the foregoing or takes any corporate or other action for the purpose of effecting any of the foregoing.

 

 

 

 

Business Day” means any day other than Saturday, Sunday and any day on which banks are required or authorized by law to be closed in the State of Texas.

 

Change of Control Event” means the occurrence after the Original Issue Date (as defined below), excluding a Liquidation Event, of any of (i) an acquisition after the date hereof by an individual or legal entity or “group” (as described in Rule 13d-5(b)(1) promulgated under the Exchange Act) of effective control (whether through legal or beneficial ownership of capital stock of the Corporation, by contract or otherwise) of in excess of 35% of the voting securities of the Corporation, or (ii) the Corporation merges into or consolidates with any other Person, or any Person merges into or consolidates with the Corporation and, after giving effect to such transaction, the stockholders of the Corporation immediately prior to such transaction own less than 65% of the aggregate voting power of the Corporation or the successor entity of such transaction, or (iii) the Corporation sells or transfers its assets, as an entirety or substantially as an entirety, to another Person and the stockholders of the Corporation immediately prior to such transaction own less than 65% of the aggregate voting power of the acquiring entity immediately after the transaction, or (iv) a replacement at one time or within a one-year period of more than one-half of the members of the Corporation’s board of directors which is not approved by a majority of those individuals who are members of the board of directors on the date hereof (or by those individuals who are serving as members of the board of directors on any date whose nomination to the board of directors was approved by a majority of the members of the board of directors who are members on the date hereof), or (v) the execution by the Corporation of an agreement to which the Corporation is a party or by which it is bound, providing for any of the events set forth above in (i) through (iv).

 

Commission” means the Securities and Exchange Commission.

 

Common Stock” means the common stock of the Corporation, no par value per share.

 

Dividend Rate” means 8.50% per annum of the sum of (i) the Stated Value per share of Series C Preferred Stock plus (ii) all accrued but unpaid dividends on such share of Series C Preferred Stock that remain unpaid following the Dividend Payment Date when due.

 

Eligible Market” means any of (i) the New York Stock Exchange, (ii) the NYSE American, (iii) The NASDAQ Global Market, The NASDAQ Capital Market or The NASDAQ Global Select Market (each in clause (iii), a “NASDAQ Stock Market) or (iv) OTC Markets Pink or OTCQB.

 

Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

2

 

 

Holder” means any holder of Series C Preferred Stock.

 

Junior Securities” means (i) the Common Stock and all other outstanding equity or equity equivalent securities of the Corporation, and (ii) all equity or equity equivalent securities issued by the Corporation after the Original Issue Date that do not rank senior to or pari passu with the Series C Preferred Stock.

 

Original Issue Date” means the date of the first issuance of any shares of the Series C Preferred Stock, regardless of the number of transfers of any particular shares of Series C Preferred Stock and regardless of the number of certificates that may be issued to evidence such Series C Preferred Stock.

 

Person” means any individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture or other non-corporate business enterprise, limited liability company, joint stock company, trust, organization, business, labor union or government (or an agency or subdivision thereof) or any court or other federal, state, local or other governmental authority or other entity of any kind.

 

Series C Preferred Stock” means the Corporation’s Series C Redeemable Convertible Preferred Stock authorized pursuant to the Series C Preferred Stock Designation.

 

Series C Preferred Stock Designation” means the Certificate of Designation for the Corporation’s Series C Redeemable Convertible Preferred Stock, as adopted by the by the affirmative vote of the Board of Directors on February 9, 2023.

 

Trading Day” shall mean, if a security is listed or admitted to trading, or quoted, on an Eligible Market, their successors or another national securities exchange or national securities market, a full day on which the NASDAQ Stock Market or such other national securities exchange or national securities market on which the security is traded is open for business and on which trades may be made thereon.

 

Triggering Event” means any one or more of the following events (whatever the reason, and whether it shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or order of any court, or any order, rule or regulation of any administrative or governmental body: (i) a Change of Control Event; (ii) the Corporation shall fail to deliver certificates representing Conversion Shares issuable upon a conversion hereunder that comply with the provisions hereof prior to the 5th Trading Day after such shares are required to be delivered hereunder, or the Corporation shall provide written notice to any Holder, including by way of public announcement, at any time, of its intention not to comply with requests for conversion of any shares of Series C Preferred Stock in accordance with the terms hereof; (iii) the Corporation shall fail to have available a sufficient number of authorized and unreserved shares of Common Stock to issue to such Holder upon a conversion hereunder; (iv) the Corporation shall fail to observe or perform any other covenant, agreement contained in, or otherwise commit any breach of this Certificate of Designation, and such failure or breach shall not, if subject to the possibility of a cure by the Corporation, have been remedied within 30 calendar days after the date on which written notice of such failure or breach shall have been given; or (v) there shall have occurred a Bankruptcy Event.

 

3

 

 

3. Voting Rights. Holders of the Series C Preferred Stock shall no voting rights; provided, however, that so long as shares of Series C Preferred Stock are outstanding, the Corporation shall not, without the prior approval of the Holders of at least a majority of the then issued and outstanding shares of Series C Preferred Stock, voting as a separate class: (a) authorize or increase the authorized number of shares of Series C Preferred Stock or any shares of capital stock of the Corporation having any right, preference or priority ranking senior to the Series C Preferred Stock, (b) authorize, adopt or approve any amendment to the Certificate of Incorporation or Bylaws of the Corporation or this Certificate of Designation that would increase or decrease the par value or the Stated Value of the shares of the Series C Preferred Stock, alter or change the powers, preferences or rights of the shares of Series C Preferred Stock or alter or change the powers, preferences or rights of any other capital stock of the Corporation if after such alteration or change such capital stock would be senior to or pari passu with Series C Preferred Stock, (c) amend, alter or repeal the Certificate of Incorporation or the Bylaws of the Corporation or this Certificate of Designation so as to affect adversely the shares of Series C Preferred Stock, or (d) authorize or issue any security convertible into, exchangeable for or evidencing the right to purchase or otherwise receive any shares of any class or classes of capital stock of the Corporation having any right, preference or priority ranking senior to the Series C Preferred Stock.

 

4. Dividends.

 

(a) Subject to the limitations set forth in Section 8(d), Holders shall be entitled to receive, out of funds legally available therefor, and the Corporation shall pay, cumulative dividends on the Series C Preferred Stock at the Dividend Rate per share. Dividends on the Series C Preferred Stock shall accrue daily commencing as of the Original Issue Date at the Dividend Rate then in effect, and shall be deemed to accrue from the Original Issue Date whether or not earned or declared and whether or not there are profits, surplus or other funds of the Corporation legally available for the payment of dividends. Dividends on the Series C Preferred Stock shall (i) be calculated on the basis of a 360-day year, and (ii) commencing on the Original Issue Date, be payable quarterly in arrears on each March 31, June 30, September 30, and December 31, except if such date is not a Business Day, such dividend shall be payable on the next succeeding Business Day (each, a “Dividend Payment Date”).

 

(b) The Corporation may pay required dividends (i) in shares of Series C Preferred Stock or (ii) subject to the receipt of any consent required under the Corporation’s senior secured credit facility as from time to time in effect, in cash; provided, however, the Corporation shall not pay any cash dividends on its Common Stock, or any other Junior Securities, within a 180-day period before or after a Dividend Payment Date upon which the Corporation has paid in kind, rather than cash, dividends on the Series C Preferred Stock. In the event that the Corporation elects to pay dividends in shares of Series C Preferred Stock, the number of shares of Series C Preferred Stock to be issued to each Holder in respect of such dividend shall be determined by dividing the total dividend then payable to such Holder by the Stated Value, and rounding up to the nearest whole share, and the Corporation shall, on or before the fifth Business Day following the applicable Dividend Payment Date, issue and deliver to such Holder a certificate, registered in the name of the Holder or its designee, for the number of shares of Series C Preferred Stock to which the Holder shall be entitled. Notwithstanding any other provision of this Certificate of Designation, the Corporation shall not be entitled to pay dividends by issuing Series C Preferred Stock unless the Corporation has obtained stockholder approval, if required, for the issuance in accordance with the applicable rules and regulations of the Eligible Market on which the Common Stock is listed, if applicable.

 

4

 

 

(c) Notwithstanding any other provision of this Certificate of Designation, the Corporation shall not pay any dividends on, or make any distributions with respect to, in cash or in kind or otherwise, its Common Stock or any other Junior Securities when accrued and unpaid dividends are owed to the Holders.

 

5. Registration of Series C Preferred Stock. The Corporation shall register shares of the Series C Preferred Stock, upon records to be maintained by the Corporation for that purpose (the “Series C Preferred Stock Register”), in the name of the record Holders thereof from time to time. The Corporation may deem and treat the registered Holder of shares of Series C Preferred Stock as the absolute owner thereof for the purpose of any conversion or redemption thereof or any distribution to such Holder, and for all other purposes, absent actual written notice to the contrary from the registered Holder.

 

6. Registration of Transfers. The Corporation shall register the transfer of any shares of Series C Preferred Stock in the Series C Preferred Stock Register, upon surrender of certificates evidencing such shares to the Corporation at its address specified herein. Upon any such registration or transfer, a new certificate evidencing the shares of Series C Preferred Stock so transferred shall be issued to the transferee and a new certificate evidencing the remaining portion of the shares not so transferred, if any, shall be issued to the transferring Holder.

 

7. Liquidation.

 

(a) In the event of any liquidation, dissolution or winding up of the Corporation, either voluntary or involuntary (a “Liquidation Event”), which shall be deemed to include (i) the acquisition of the Corporation by another Person or affiliated group of Persons by means of any transaction or series of related transactions (including, without limitation, any reorganization, merger, consolidation, issuance of new securities or transfer of issued and outstanding securities) where less than a majority of the voting power of the acquiring or surviving Person or group immediately following such acquisition is held by Persons who were stockholders of the Corporation immediately prior to such acquisition, (ii) a sale or other disposition of all or substantially all of the assets of the Corporation and (iii) a sale or other disposition of assets that results in funds being available for distribution to stockholders that are in excess of those necessary or appropriate for the Corporation to conduct its business operations (including repayment of its outstanding liabilities) and execute its business plan and that are sufficient to pay the Series C Stock Liquidation Preference in full (as defined below), as determined by the Board of Directors, the Holders of Series C Preferred Stock shall be entitled to receive, prior and in preference to any distribution of any of the assets or surplus funds of the Corporation to the holders of Junior Securities by reason of their ownership thereof, an amount per share in cash equal to the greater of (x) the Stated Value for each share of Series C Preferred Stock then held by them, plus all accrued and unpaid dividends on such Series C Preferred Stock as of the date of such event, or (y) the amount payable per share of Common Stock which such Holder of Series C Preferred Stock would have received if such Holder had converted to Common Stock immediately prior to the Liquidation Event all of the shares of Series C Preferred Stock then held by such Holder together with all accrued but unpaid dividends on such Series C Preferred Stock as of the date of such event (the “Series C Stock Liquidation Preference”). If, upon the occurrence of a Liquidation Event, the funds thus distributed among the Holders of the Series C Preferred Stock shall be insufficient to permit the payment to such Holders of the full Series C Stock Liquidation Preference, then the entire assets and funds of the Corporation legally available for distribution (including after giving effect to the terms of Section 20(c)(iii)) shall be distributed ratably among the Holders of the Series C Preferred Stock in proportion to the aggregate Series C Stock Liquidation Preference that would otherwise be payable to each of such Holders.

 

5

 

 

(b) In the event of a Liquidation Event, following completion of the distributions required by the first sentence of paragraph (a) of this Section 7, if assets or surplus funds remain in the Corporation, the holders of the Junior Securities shall share in all remaining assets of the Corporation, in accordance with the General Corporation Law of Colorado and the Certificate of Incorporation.

 

(c) The Corporation shall give each Holder written notice of any Liquidation Event no less than 30 days prior to the occurrence thereof.

 

(d) For the avoidance of doubt, in no circumstances shall (i) any event occurring on, or in connection with, the Original Issue Date or (ii) the sale of all or substantially all of the assets of Energy Hunter Resources, Inc. be construed as a Liquidation Event for purposes of the Series C Preferred Stock and this Certificate of Designations.

 

8. Conversion.

 

(a) Optional Conversion. Any Holder at any time after the Original Issue Date (the “Conversion Period”), all or any portion of the Series C Preferred Stock held by such Holder may be converted into 100,000 shares of duly authorized, validly issued, fully-paid and non-assessable share of Common Stock (each an “Underlying Share”) per share of Series C Preferred Stock to be converted by such Holder, as adjusted for any stock dividends, splits, combinations or similar events. The number of Underlying Shares into which each share of Series C Preferred Stock is convertible, as adjusted from time to time in accordance with this Section 8, is referred to herein as the “Conversion Number.” A Holder may convert Series C Preferred Stock into Common Stock pursuant to this paragraph at any time, and from time to time by delivering to the Corporation during the Conversion Period (i) a written notice of the election to convert executed by the Holder (the “Notice of Conversion”), specifying the number of shares of Series C Preferred Stock to be converted, the name in which the shares of the Common Stock deliverable upon conversion shall be registered, and the address of the named person, and (ii) the original certificate(s), if any, evidencing the Series C Preferred Stock being converted. The “Conversion Date,” or the date on which an optional conversion shall be deemed effective, shall be defined as the first Trading Day on which the Corporation has received each of (i) if applicable, the original certificates representing the shares of the Series C Preferred Stock being converted, duly endorsed, and (ii) the accompanying Conversion Notice.

 

6

 

 

(b) Automatic Conversion.

 

(i) At any time after the occurrence of a Qualifying Event, the Corporation shall have the right to cause each share of Series C Preferred Stock (and all accrued in-kind dividends with respect thereto) to be converted into shares of Common Stock as provided in Section 8(a). In order to effectuate such conversion, the Corporation shall be required to provide written notice to each Holder of Series A Preferred Stock being converted at least five (5) business days prior to such conversion. For purposes of this Certificate of Designations, a “Qualifying Event” shall have occurred if (A) the rolling five (5)-trading day volume-weighted average trading price of shares of the Corporation’s Common Stock exceeds $0.75 and (B) there shall be an effective registration statement under the Securities Act of 1933, as amended (the “Act”) covering all of the shares of the Corporation’s Common Stock which would be issuable upon conversion of all of the outstanding shares of Series C Preferred Stock (including shares of Series C Preferred Stock deemed issued as payment-in-kind of accrued dividends).

 

(ii) The Corporation agrees that it shall in good faith, promptly, take any and all such corporate action as may, in the opinion of its counsel, be necessary to effect the filing of a registration statement registering the resale of such shares (to the extent necessary) and to expeditiously effect the conversion of all outstanding shares of the Series C Preferred Stock to shares of Common Stock, including, without limitation, use its reasonable best efforts to obtain the requisite stockholder approval of any necessary amendment to the Certificate of Incorporation to achieve the foregoing.

 

(iii) The Corporation shall use commercially reasonable efforts to issue or cause its transfer agent to issue the Common Stock issuable upon the Automatic Conversion as soon as practicable after the Automatic Conversion. The Corporation shall bear the cost associated with the issuance of the Common Stock issuable upon the Automatic Conversion. The Common Stock issuable upon the Automatic Conversion shall be issued with a restrictive legend indicating that it was issued in a transaction which is exempt from registration under the Securities Act of 1933, as amended (“Securities Act”), and that it cannot be transferred unless it is so registered, or an exemption from registration is available, in the opinion of counsel to the Corporation. The Common Stock issuable upon the Automatic Conversion shall be issued in the same name as the person who is the holder of the Series C Preferred Stock unless, in the opinion of counsel to the Corporation, a change of name and such transfer can be made in compliance with applicable securities laws. The person in whose name the certificates of Common Stock are so recorded and other securities issuable upon the Automatic Conversion shall be treated as a common stockholder of the Corporation at the close of business on the date of the Automatic Conversion. The certificates, if any, representing the Series C Preferred Stock shall be cancelled, on the date of the Automatic Conversion.

 

(c) Adjustments to Conversion Number. Stock Splits and Combinations. If the outstanding shares of Common Stock are split into a greater number of shares, the Conversion Number will be proportionately increased. If the outstanding shares of Common Stock are combined into a smaller number of shares, the Conversion Number then in effect immediately before such combination will be proportionately decreased. These adjustments will be effective at the close of business on the date the split or combination becomes effective.

 

(ii) Dividends and Other Distributions in Shares of Common Stock. If the Corporation declares or makes a dividend or other distribution payable in shares of Common Stock to holders of Common Stock, then the Conversion Number will be increased, effective at the close of business on the date of issuance of the shares of Common Stock paid as a dividend or distribution (the “Measurement Date”), to a number determined by multiplying such Conversion Number by a fraction:

 

(A) the numerator of which will be sum of (x) the number of shares of Common Stock outstanding immediately prior to the Measurement Date plus (y) the number of shares of Common Stock issued in payment of such dividend or distribution, and

 

7

 

 

(B) the denominator of which will be the number of shares of Common Stock outstanding, on a fully diluted basis, immediately prior to the Measurement Date.

 

(iii) Rules of Calculation; Treasury Stock. The number of shares of Common Stock outstanding will be calculated on the basis of the number of issued and outstanding shares of Common Stock on the applicable date, not including shares held in the treasury of the Corporation. The Corporation shall not pay any dividend on or make any distribution to shares of Common Stock held in treasury.

 

(iv) Waiver. Notwithstanding the foregoing, the Conversion Number will not be increased if the Corporation receives, prior to the Measurement Date, written notice from the Holders representing at least a majority of the then outstanding shares of Series C Preferred Stock, voting together as a separate class, that no adjustment is to be made as the result of a dividend or other distribution on shares of Common Stock. This waiver will be limited in scope and will not be valid for any dividend or other distribution on shares of Common Stock not specifically provided for in such notice.

 

9. Mechanics of Conversion.

 

(a) Delivery of Certificate(s) Upon Conversion. Upon conversion of any share of Series C Preferred Stock, the Corporation shall promptly (but in no event later than three Trading Days after the Conversion Date or Automatic Conversion Date, as applicable (the “Share Delivery Date”) issue or cause to be issued and cause to be delivered to or upon the written order of the Holder and in such name or names as the Holder may designate a certificate or certificates for the Underlying Shares issuable upon such conversion. The Corporation shall, upon request of the Holder, deliver any certificate or certificates required to be delivered by the Corporation under this Section electronically through the Depositary Trust Company or another established clearing corporation performing similar functions. The Holder, or any Person so designated by the Holder to receive Underlying Shares, shall be deemed to have become the holder of record of such Underlying Shares as of the Conversion Date. Upon surrender of a certificate representing the shares of Series C Preferred Stock to be converted following one or more partial conversions, the Corporation shall promptly deliver to the Holder a new certificate representing the remaining shares of Series C Preferred Stock. If the shares of Series C Preferred Stock are not certificated, the holder must deliver evidence of ownership satisfactory to us and the transfer agent. If in the case of any Notice of Conversion such certificate or certificates are not delivered to or as directed by the applicable Holder by the third Trading Day after the Conversion Date, the Holder shall be entitled to elect by written notice to the Corporation at any time on or before its receipt of such certificate or certificates thereafter, to rescind such conversion, in which event the Corporation shall immediately return the certificates representing the shares of Series C Preferred Stock tendered for conversion.

 

8

 

 

(b) Transfer Tax Matters. Unless the shares of Common Stock deliverable upon conversion are to be issued in the same name as the name in which the shares of Series C Preferred Stock to be converted are registered, the Holder must also deliver to the transfer agent an instrument of transfer, in form satisfactory to the Corporation, duly executed by the Holder or the Holder’s duly authorized attorney, together with, subject to Section 12, an amount sufficient to pay any transfer or similar tax in connection with the issuance and delivery of such shares of Common Stock in such name (or evidence reasonably satisfactory to us demonstrating that such taxes have been paid).

 

(c) Obligation Absolute. The Corporation’s obligations to issue and deliver the shares of Common Stock upon conversion of Series C Preferred Stock in accordance with the terms hereof (the “Conversion Shares”) are absolute and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other Person of any obligation to the Corporation or any violation or alleged violation of law by the Holder or any other person, and irrespective of any other circumstance which might otherwise limit such obligation of the Corporation to the Holder in connection with the issuance of such Conversion Shares. In the event a Holder shall elect to convert any or all of the Holder’s shares of Series C Preferred Stock, the Corporation may not refuse conversion based on any claim that such Holder or anyone associated or affiliated with the Holder of has been engaged in any violation of law, agreement or for any other reason, unless, an injunction from a court, on notice, restraining and or enjoining conversion of all or part of this Series C Preferred Stock shall have been sought and obtained and the Corporation posts a surety bond for the benefit of the Holder in the amount of 150% of the value of the Holder’s shares of Series C Preferred Stock, which is subject to the injunction, which bond shall remain in effect until the completion of arbitration/litigation of the dispute and the proceeds of which shall be payable to such Holder to the extent it obtains judgment. In the absence of an injunction precluding the same, the Corporation shall issue Conversion Shares or, if applicable, cash, upon a properly noticed conversion. If the Corporation fails to deliver to the Holder such certificate or certificates pursuant to Section 9(a) within two Trading Days of the Share Delivery Date applicable to such conversion, the Corporation shall pay to such Holder, in cash, as liquidated damages and not as a penalty, for each $5,000 of Stated Value of Preferred Stock being converted, $50 per Trading Day (increasing to $100 per Trading Day after three Trading Days and increasing to $200 per Trading Day six Trading Days after such damages begin to accrue) for each Trading Day after the Share Delivery Date until such certificates are delivered. Nothing herein shall limit a Holder’s right to pursue actual damages for the Corporation’s failure to deliver certificates representing shares of Common Stock upon conversion within the period specified herein and such Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief.

 

10. Redemption Rights.

 

(a) Optional Redemption. The Series C Preferred Stock may be redeemed by the Corporation for the Stated Value, plus accrued and unpaid dividends, at any time. The date on which the Series C Preferred Stock is redeemed pursuant to the provisions of this paragraph shall be referred to as the “Redemption Date.”

 

9

 

 

12. Reservation of Common Stock. The Corporation shall at all times reserve and keep available for issuance upon the conversion of shares of Series C Preferred Stock, such number of its authorized but unissued shares of Common Stock as will from time to time be sufficient to permit the conversion of all outstanding shares of Series C Preferred Stock (including any shares of Series C Preferred Stock paid by the Corporation as in kind dividends on the Series C Preferred Stock), and shall take all action to increase the authorized number of shares of Common Stock if at any time there shall be insufficient authorized but unissued shares of Common Stock to permit such reservation or to permit the conversion of all outstanding shares of Series C Preferred Stock; provided, that the Holders approve any such action that requires a vote of the Holders in accordance with Section 3. The Corporation covenants that all shares of Common Stock that shall be so issuable shall, upon issue, be duly and validly authorized, issued and fully paid, nonassessable.

 

13. Charges, Taxes and Expenses. The issuance of certificates for shares of Series C Preferred Stock and for Underlying Shares issued upon conversion of (or otherwise in respect of) the Series C Preferred Stock shall be made without charge to the Holders for any issue or transfer tax, withholding tax, transfer agent fee or other incidental tax or expense in respect of the issuance of such certificates, all of which taxes and expenses shall be paid by the Corporation; provided, however, that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved in the registration of any certificates for Common Stock or Series C Preferred Stock in a name other than that of the Holder. The Holder shall be responsible for all other tax liability that may arise as a result of holding or transferring the Series C Preferred Stock or receiving Underlying Shares in respect of the Series C Preferred Stock.

 

14. Replacement Certificates. If any certificate evidencing Series C Preferred Stock or Underlying Shares is mutilated, lost, stolen or destroyed, the Corporation shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and substitution for such certificate, a new certificate, but only upon receipt of evidence reasonably satisfactory to the Corporation of such loss, theft or destruction and customary and reasonable indemnity, if requested. Applicants for a new certificate under such circumstances shall also comply with such other reasonable regulations and procedures and pay such other reasonable third-party costs as the Corporation may prescribe.

 

15. Fundamental Transactions. If, at any time while any shares of Series C Preferred Stock are outstanding, (i) the Corporation effects any merger of the Corporation into or consolidation of the Corporation with another Person, (ii) the Corporation effects any sale of all or substantially all of its assets in one or a series of related transactions, or (iii) the Corporation effects any reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property (other than as a result of a subdivision or combination of shares of Common Stock covered by Section 14(a)) (in any such case, a “Fundamental Transaction”), then, to the extent such Fundamental Transaction does not constitute a Liquidation Event, upon any subsequent conversion of Series C Preferred Stock, each Holder shall have the right to receive, for each Underlying Share that would have been issuable upon such conversion absent such Fundamental Transaction, the same kind and amount of securities, cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction, the record holder of such Underlying Shares immediately prior to such record date (the “Alternate Consideration”). The foregoing provisions shall be in addition to any other rights that Holders of Series C Preferred Stock shall have hereunder in the event of a Change of Control Event, and shall apply regardless of whether or not there would have been a sufficient number of shares of Common Stock authorized and available for issuance upon conversion of the shares of Series C Preferred Stock outstanding as of the date of such transaction, and shall similarly apply to successive mergers, consolidations, sales, reclassifications or share exchanges.

 

10

 

 

16. No Fractional Shares. No fractional shares of Common Stock shall be issued upon conversion of the Series C Preferred Stock, whether voluntary or mandatory. Instead, the Corporation shall pay the cash value to each Holder that would otherwise be entitled to a fractional share.

 

17. Notice of Corporate Events. If the Corporation (i) declares a dividend or any other distribution of cash, securities or other property in respect of its Common Stock, including, without limitation, any granting of rights or warrants to subscribe for or purchase any capital stock of the Corporation or any subsidiary, or (ii) authorizes or approves, enters into any agreement contemplating or solicits stockholder approval for any Liquidation Event, Fundamental Transaction, Change of Control or other Triggering Event, then the Corporation shall deliver to each Holder a notice which shall specify (1) the record date for the purpose of such dividend or distribution and a description of such dividend or distribution, (2) the date on which any such Liquidation Event, Fundamental Transaction, Change of Control or other Triggering Event is expected to become effective, and (3) the date, if any, that is to be fixed as to when the holders of record of Common Stock (or other securities) shall be entitled to exchange their shares of Common Stock (or other securities) for securities or other property deliverable upon any such Liquidation Event or Fundamental Transaction.

 

18. Negative Covenants. So long as any shares of Series C Preferred Stock are outstanding, the Corporation will not, and will not permit any of its Subsidiaries to, directly or indirectly, without the prior written consent of the Holders of a majority of the Series C Preferred Stock then outstanding: (i) amend its Certificate of Incorporation, bylaws or other charter documents so as to materially and adversely affect any rights of any Holder; (ii) repay, repurchase or offer to repay, repurchase or otherwise acquire more than a de minimis number of shares of its Common Stock or Common Stock Equivalents; (iii) enter into any agreement with respect to the foregoing; or (iv) pay cash dividends or distributions on any equity securities of the Corporation other than pursuant to the terms of the Corporation’s outstanding Series C Redeemable Convertible Preferred Stock. For purposes of this Section 17, the following terms shall have the meanings set forth below:

 

Common Stock Equivalents” means any securities of the Corporation or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

 

11

 

 

19. Notices. Any and all notices or other communications or deliveries hereunder (including without limitation any Conversion Notice) shall be in writing and shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number specified in this Section prior to 5:00 p.m. (Houston time) on a Business Day, (ii) the next Business Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number specified in this Section on a day that is not a Business Day or later than 5:00 p.m. (Denver time) on any Business Day, (iii) the Business Day following the date of transmittal, if sent by nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. The addresses for such communications shall be: (i) if to the Corporation, to Duane Morris LLP, One Riverfront Plaza, 1037 Raymond Blvd., Suite 1800, Newark, NJ 07102 Attn: Dean M. Colucci, or (ii) if to a Holder, to the address or facsimile number appearing on the Corporation’s Preferred Stock Register or such other address or facsimile number as such Holder may provide to the Corporation in accordance with this Section.

 

20. Miscellaneous.

 

(a) The headings herein are for convenience only, do not constitute a part of this Certificate of Designation and shall not be deemed to limit or affect any of the provisions hereof.

 

(b) No provision of this Certificate of Designation may be amended, except in a written instrument signed by the Corporation and Holders of at least a majority of the shares of Series C Preferred Stock then outstanding.

 

(c) The Series C Preferred Stock (i) is senior to all other equity interests in the Corporation outstanding as of the Original Issue Date in right of payment, whether with respect to dividends or upon liquidation or dissolution, or otherwise, other than the outstanding Series C Preferred Stock, and (ii) unless otherwise approved in accordance with this Certificate of Designation, will be senior to all other equity or equity equivalent securities issued by the Corporation after the Original Issue Date, other than Series C Preferred Stock issued after the Original Issue Date in accordance with this Series C Preferred Stock Certificate of Designation.

 

(d) Any of the rights of the Holders of Series C Preferred Stock set forth herein may be waived by the affirmative vote of Holders of a majority of the shares of Series C Preferred Stock then outstanding. No waiver of any default with respect to any provision, condition or requirement of this Certificate of Designation shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of either party to exercise any right hereunder in any manner impair the exercise of any such right.

 

[Signature Page Follows.]

 

12

 

 

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Designation for the Series C Preferred Stock to be executed by its duly authorized officer on February 23, 2023.

 

 

GENERATION HEMP, INC

   
  By: /s/ Gary C. Evans
    Name: Gary C. Evans 
    Title: Chief Executive Officer

 

13

EX-4.5 3 f10k2022ex4-5_evergreen.htm FORM OF WARRANT (2023)

Exhibit 4.5

 

Exhibit B

Form of Warrant

 

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE PURCHASER TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.

 

GENERATION HEMP, INC.

 

WARRANT TO PURCHASE COMMON STOCK

(Cash Exercise)

 

Warrant No.: ___

Number of Shares of Common Stock:

Issuance Date: _______

 

Generation Hemp, Inc., a Colorado corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [ ● ], the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon surrender of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”), at any time or times on or after the Issuance Date, but not after 11:59 p.m., New York time, on the Expiration Date (as defined below), one (1) fully paid non-assessable share of Common Stock (as defined below) (the “Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Warrant shall have the meanings set forth in Section 16. This Warrant is the Warrant to purchase Common Stock (this “Warrant”) issued pursuant to Section 1(a) of that certain Preferred Stock and Warrant Subscription Agreement (the “Subscription Agreement”), dated as of this date (the “Closing Date”), by and between the Company and the Purchasers (as defined therein).

 

1. EXERCISE OF WARRANT.

 

(a) Mechanics of Exercise. Subject to the terms and conditions hereof, this Warrant may be exercised by the Holder on any day on or after the Issuance Date, in whole or in part, by (i) delivery of a written notice, in the form attached hereto as Exhibit A (the “Exercise Notice”), of the Holder’s election to exercise this Warrant and (ii) (A) payment to the Company of an amount equal to the applicable Exercise Price multiplied by the number of Warrant Shares as to which this Warrant is being exercised (the “Aggregate Exercise Price”) in cash or by wire transfer of immediately available funds or (B) provided the conditions for cashless exercise set forth in Section 1(d) are satisfied, by notifying the Company that this Warrant is being exercised pursuant to a Cashless Exercise (as defined in Section 1(d)). The Holder shall not be required to deliver the original Warrant in order to effect an exercise hereunder. Execution and delivery of the Exercise Notice with respect to less than all of the Warrant Shares shall have the same effect as cancellation of the original Warrant and issuance of a new Warrant evidencing the right to purchase the remaining number of Warrant Shares. On or before the first (1st ) Business Day following the date on which the Company has received each of the Exercise Notice and the Aggregate Exercise Price (or notice of a Cashless Exercise) (collectively, the “Exercise Delivery Documents”), the Company shall transmit by facsimile or electronic mail an acknowledgment of receipt of the Exercise Delivery Documents to the Holder and Stock Transfer Corporation (the Company’s “Transfer Agent”). On or before the third (3rd) Business Day following the date on which the Company has received all of the Exercise Delivery Documents (the “Share Delivery Date”), the Company shall cause the Shares to be issued in the name of and delivered to the Holder (i) written confirmation that the Shares have been issued in the name of the Holder, and (ii) a new warrant of like tenor to purchase all of the Shares that may be purchased pursuant to the portion, if any, of this Warrant not exercised by the Holder. No fractional shares of Common Stock are to be issued upon the exercise of this Warrant, but rather the number of shares of Common Stock to be issued shall be rounded down to the nearest whole number.

 

 

 

 

(b) Exercise Price. For purposes of this Warrant, “Exercise Price” means $0.50 per share of Common Stock subject to adjustment as provided herein.

 

(c) Legend. The Holder acknowledges that each certificate evidencing the Warrant Shares acquired upon the exercise of this Warrant will have restrictions upon resale imposed by state and federal securities laws. Each such certificate shall be stamped or imprinted with a legend substantially in the following form:

 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER APPLICABLE FEDERAL AND STATE SECURITIES LAWS OR PURSUANT TO AN APPLICABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE PURCHASER TO SUCH EFFECT, WHICH OPINION SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.

 

(d) Beneficial Ownership. The Company shall not effect the exercise of this Warrant, and the Holder shall not have the right to exercise this Warrant, to the extent that after giving effect to such exercise, such Person (together with such Person’s affiliates) would beneficially own in excess of 9.99% (the “Maximum Percentage”) of the shares of Common Stock outstanding immediately after giving effect to such exercise (including in connection with any Fundamental Transaction (as defined below)). For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such Person and its affiliates shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of Common Stock which would be issuable upon (i) exercise of the remaining, unexercised portion of this Warrant beneficially owned by such Person and its affiliates and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such Person and its affiliates (including, without limitation, any convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended. For purposes of this Warrant, in determining the number of outstanding shares of Common Stock, the Holder may rely on the number of outstanding shares of Common Stock as reflected in (1) the Company’s most recent Form 10-K, Form 10-Q, Current Report on Form 8-K or other public filing with the Securities and Exchange Commission, as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. To the extent that the limitation contained in this Section 1(f) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by such Holder) and of which a portion of this Warrant is exercisable shall be in the sole discretion of a Holder, and the submission of an Exercise Notice shall be deemed to be each Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by such Holder) and of which portion of this Warrant is exercisable, in each case subject to such aggregate percentage limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. For any reason at any time, upon the written or oral request of the Holder, the Company shall within two (2) Business Days confirm to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder and its affiliates since the date as of which such number of outstanding shares of Common Stock was reported. By written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage not in excess of 9.99% specified in such notice; provided that (i) any such increase will not be effective until the sixty-first (61st) day after such notice is delivered to the Company, and (ii) any such increase or decrease will apply only to the Holder. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 1(g) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended beneficial ownership limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation.

 

2

 

 

2. ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES. The Exercise Price and the number of Warrant Shares shall be adjusted from time to time as follows:

 

(a) Adjustment upon Subdivision or Combination of Common Stock. If the Company at any time on or after the Closing Date subdivides (by any stock split, stock dividend, recapitalization, reorganization, scheme, arrangement or otherwise) one or more classes of its outstanding shares of Common Stock into a greater number of shares, the Exercise Price in effect immediately prior to such subdivision will be proportionately reduced and the number of Warrant Shares will be proportionately increased. If the Company at any time on or after the Closing Date combines (by any stock split, stock dividend, recapitalization, reorganization, scheme, arrangement or otherwise) one or more classes of its outstanding shares of Common Stock into a smaller number of shares, the Exercise Price in effect immediately prior to such combination will be proportionately increased and the number of Warrant Shares will be proportionately decreased. Any adjustment under this Section 2(a) shall become effective at the close of business on the date the subdivision or combination becomes effective.

 

(b) Other Events. If any event occurs of the type contemplated by the provisions of this Section 2 but not expressly provided for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with equity features), then the Company’s Board of Directors will make an appropriate adjustment in the Exercise Price and the number of Warrant Shares so as to protect the rights of the Holder; provided that no such adjustment pursuant to this Section 2(b) will increase the Exercise Price or decrease the number of Warrant Shares as otherwise determined pursuant to this Section 2 .

 

3. RIGHTS UPON DISTRIBUTION OF ASSETS. If the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to all holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such case:

 

(a) any Exercise Price in effect immediately prior to the close of business on the record date fixed for the determination of holders of shares of Common Stock entitled to receive the Distribution shall be reduced, effective as of the close of business on such record date, to a price determined by multiplying such Exercise Price by a fraction of which (i) the numerator shall be the Closing Bid Price of the shares of Common Stock on the Trading Day immediately preceding such record date minus the value of the Distribution (as determined in good faith by the Company’s Board of Directors) applicable to one share of Common Stock, and (ii) the denominator shall be the Closing Bid Price of the shares of Common Stock on the Trading Day immediately preceding such record date; and

 

(b) the number of Warrant Shares shall be increased to a number of shares equal to the number of shares of Common Stock obtainable immediately prior to the close of business on the record date fixed for the determination of holders of shares of Common Stock entitled to receive the Distribution multiplied by the reciprocal of the fraction set forth in the immediately preceding paragraph (a); provided that in the event that the Distribution is of shares of Common Stock (or common stock) (“Other Shares of Common Stock”) of a company whose shares of common stock are traded on a national securities exchange or a national automated quotation system, then the Holder may elect to receive a warrant to purchase Other Shares of Common Stock in lieu of an increase in the number of Warrant Shares, the terms of which shall be identical to those of this Warrant, except that such warrant shall be exercisable into the number of shares of Other Shares of Common Stock that would have been payable to the Holder pursuant to the Distribution had the Holder exercised this Warrant immediately prior to such record date and with an aggregate exercise price equal to the product of the amount by which the exercise price of this Warrant was decreased with respect to the Distribution pursuant to the terms of the immediately preceding paragraph (a) and the number of Warrant Shares calculated in accordance with the first part of this paragraph (b).

 

3

 

 

4. PURCHASE RIGHTS; FUNDAMENTAL TRANSACTIONS.

 

(a) Purchase Rights. In addition to any adjustments pursuant to Section 2 above, if at any time the Company grants, issues or sells any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights.

 

(b) Fundamental Transactions. The Company shall not enter into or be party to a Fundamental Transaction unless the Successor Entity assumes this Warrant in accordance with the provisions of this Section (4)(b), including agreements to deliver to each holder of Warrants in exchange for such Warrants a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant, including, without limitation, an adjusted exercise price equal to the value for the shares of Common Stock reflected by the terms of such Fundamental Transaction, and exercisable for a corresponding number of shares of capital stock equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and satisfactory to the Holder. Upon the occurrence of any Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein. Upon consummation of the Fundamental Transaction, the Successor Entity shall deliver to the Holder confirmation that there shall be issued upon exercise of this Warrant at any time after the consummation of the Fundamental Transaction, in lieu of the shares of the Common Stock (or other securities, cash, assets or other property) purchasable upon the exercise of the Warrant prior to such Fundamental Transaction, such shares of stock, securities, cash, assets or any other property whatsoever (including warrants or other purchase or subscription rights) which the Holder would have been entitled to receive upon the happening of such Fundamental Transaction had this Warrant been converted immediately prior to such Fundamental Transaction, as adjusted in accordance with the provisions of this Warrant. In addition to and not in substitution for any other rights hereunder, prior to the consummation of any Fundamental Transaction pursuant to which holders of shares of Common Stock are entitled to receive securities or other assets with respect to or in exchange for shares of Common Stock (a “Corporate Event”), the Company shall make appropriate provision to insure that the Holder will thereafter have the right to receive upon an exercise of this Warrant at any time after the consummation of the Fundamental Transaction but prior to the Expiration Date, in lieu of the shares of the Common Stock (or other securities, cash, assets or other property) purchasable upon the exercise of the Warrant prior to such Fundamental Transaction, such shares of stock, securities, cash, assets or any other property whatsoever (including warrants or other purchase or subscription rights) which the Holder would have been entitled to receive upon the happening of such Fundamental Transaction had the Warrant been exercised immediately prior to such Fundamental Transaction. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The provisions of this Section 4 shall apply similarly and equally to successive Fundamental Transactions and Corporate Events and shall be applied without regard to any limitations on the exercise of this Warrant.

 

5. NONCIRCUMVENTION. The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation, Bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good faith carry out all the provisions of this Warrant and take all action as may be required to protect the rights of the Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase the par value of any shares of Common Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii) shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of this Warrant, and (iii) shall, so long as this Warrant is outstanding, take all action necessary to reserve and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose of effecting the exercise of this Warrant, 100% of the number of shares of Common Stock issuable upon exercise of this Warrant then outstanding (without regard to any limitations on exercise).

 

4

 

 

6. WARRANT HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically provided herein, the Holder, solely in such Person’s capacity as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in such Person’s capacity as the Holder of this Warrant, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which such Person is then entitled to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.

 

7. REISSUANCE OF WARRANTS.

 

(a) Transfer of Warrant. If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company together with a written assignment of this Warrant in the form attached hereto as Exhibit B duly executed by the Holder or its agent or attorney, whereupon the Company will forthwith, subject to compliance with any applicable securities laws, issue and deliver upon the order of the Holder a new Warrant (in accordance with Section 7(d)), registered as the Holder may request, representing the right to purchase the number of Warrant Shares being transferred by the Holder and, if less than the total number of Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in accordance with Section 7(d)) to the Holder representing the right to purchase the number of Warrant Shares not being transferred.

 

(b) Lost, Stolen or Mutilated Warrant. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant, and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company in customary form and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company shall execute and deliver to the Holder a new Warrant (in accordance with Section 7(d)) representing the right to purchase the Warrant Shares then underlying this Warrant.

 

(c) Exchangeable for Multiple Warrants. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the Company, for a new Warrant or Warrants (in accordance with Section 7(d)) representing in the aggregate the right to purchase the number of Warrant Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion of such Warrant Shares as is designated by the Holder at the time of such surrender; provided, however, that no Warrants for fractional shares of Common Stock shall be given.

 

(d) Issuance of New Warrants. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant (i) shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to purchase the Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section 7(a) or Section 7(c), the Warrant Shares designated by the Holder which, when added to the number of shares of Common Stock underlying the other new Warrants issued in connection with such issuance, does not exceed the number of Warrant Shares then underlying this Warrant), (iii) shall have an issuance date, as indicated on the face of such new Warrant, which is the same as the Issuance Date, and (iv) shall have the same rights and conditions as this Warrant.

 

5

 

 

8. OPTIONAL REDEMPTION. Beginning on the first anniversary of the Issuance Date at any time within 10 days following the occurrence of a Trading Threshold (as defined in Section 16(q)), the Company shall be entitled to redeem the Warrants, or any of them, at a per Warrant Share redemption price of $0.001 (the “Redemption Price”), upon 30 days’ written notice to the Holder. Hereinafter such 30-day period, as it may be extended pursuant to this Section 8, is referred to as the “Redemption Period.” Upon the expiration of the Redemption Period (the “Redemption Date”), all Warrants noticed for redemption that have not theretofore been exercised by the Holder shall, upon payment of the aggregate Redemption Price therefor, cease to represent the right to purchase any shares of Common Stock and shall be deemed cancelled and void and of no further force or effect without any further act or deed on the part of the Company. The Holder undertakes to return the certificate representing any redeemed Warrants to the Company upon their redemption and to indemnify the Company with respect to any losses, claims, damages or liabilities arising from the Holder’s failure to return such certificate. In the event the certificate so returned represents a number of Warrants in excess of the number being redeemed, the Company shall as promptly as practicable issue to the Holder a new certificate for the number of unredeemed Warrants.

 

9. NOTICES. The Company shall provide the Holder with prompt written notice of all actions taken pursuant to this Warrant, including in reasonable detail a description of such action and the reason therefor. Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given in writing, will be mailed (a) if within the domestic United States by first-class registered or certified mail, or nationally recognized overnight express courier, postage prepaid, or by facsimile or (b) if delivered from outside the United States, by International Federal Express or facsimile, and (c) will be deemed given (i) if delivered by first-class registered or certified mail domestic, three business days after so mailed, (ii) if delivered by nationally recognized overnight carrier, one business day after so mailed, (iii) if delivered by International Federal Express, two business days after so mailed and (iv) if delivered by facsimile, upon electronic confirmation of receipt, and will be delivered and addressed as follows:

 

  (a) if to the Company, to:

 

Generation Hemp, Inc.

P.O. Box 540308

Dallas, Texas 75354

Attention: Gary C. Evans

Email: gevans@genhempinc.com

 

with copies to:

 

Duane Morris LLP

1540 Broadway

New York, NY 10036-4086

Attention: Dean M. Colucci

Email: dmcolucci@duanemorris.com

 

  (b) if to the Holder, to:

 

[INSERT NAME AND ADDRESS]

Attn:

Facsimile:

 

with copies to:

 

[ ]

Attn:

Email:

 

or to Holder’s address on any Exercise Notice delivered to the Company in the form attached as Exhibit A hereto, or at such other address or addresses as may have been furnished to the Company in writing.

 

6

 

 

10. AMENDMENT AND WAIVER. Except as otherwise provided herein, the provisions of this Warrant may be amended only with the written consent of the Company and the Holder, and the Company may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only with the written consent of the Holder.

 

11. GOVERNING LAW. All questions concerning the construction, validity, enforcement and interpretation of this Common Stock Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Warrant(whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of this Warrant), and hereby irrevocably waives, and agrees not to assert in any action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If either party shall commence an action or proceeding to enforce any provisions of this Warrant, the prevailing party in such action or proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.

 

12. CONSTRUCTION; HEADINGS. This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against any person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form part of, or affect the interpretation of, this Warrant.

 

13. DISPUTE RESOLUTION. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares, the Company shall submit the disputed determinations or arithmetic calculations via facsimile or electronic mail within two (2) Business Days of receipt of the Exercise Notice giving rise to such dispute, as the case may be, to the Holder. If the Holder and the Company are unable to agree upon such determination or calculation of the Exercise Price or the Warrant Shares within three Business Days of such disputed determination or arithmetic calculation being submitted to the Holder, then the Company shall, within two (2) Business Days submit via facsimile or electronic mail (a) the disputed determination of the Exercise Price to an independent, reputable investment bank selected by the Company and approved by the Holder or (b) the disputed arithmetic calculation of the Warrant Shares to the Company’s independent, outside accountant. The Company shall cause at its expense the investment bank or the accountant, as the case may be, to perform the determinations or calculations and notify the Company and the Holder of the results no later than ten Business Days from the time it receives the disputed determinations or calculations. Such investment bank’s or accountant’s determination or calculation, as the case may be, shall be binding upon all parties absent demonstrable error.

 

14. REMEDIES, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF. The remedies provided in this Warrant shall be cumulative and in addition to all other remedies available under this Warrant, at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder to pursue actual damages for any failure by the Company to comply with the terms of this Warrant.

 

7

 

 

15. TRANSFER. Subject to compliance with any applicable securities laws, this Warrant may be offered for sale, sold, transferred or assigned without the consent of the Company.

 

16. CERTAIN DEFINITIONS. For purposes of this Warrant, the following terms shall have the following meanings:

 

(a) “Bloomberg” means Bloomberg Financial Markets.

 

(b) “Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain closed.

 

(c) “Change of Control” means any Fundamental Transaction other than (A) any reorganization, recapitalization or reclassification of the Common Stock, in which holders of the Company’s voting power immediately prior to such reorganization, recapitalization or reclassification continue after such reorganization, recapitalization or reclassification to hold publicly traded securities and, directly or indirectly, the voting power of the surviving entity or entities necessary to elect a majority of the members of the board of directors (or their equivalent if other than a corporation) of such entity or entities, or (B) pursuant to a migratory merger effected solely for the purpose of changing the jurisdiction of incorporation of the Company.

 

(d) “Closing Bid Price” and “Closing Sale Price” means, for any security as of any date, the last closing bid price and last closing trade price, respectively, for such security on the Principal Market, as reported by Bloomberg, or, if the Principal Market begins to operate on an extended hours basis and does not designate the closing bid price or the closing trade price, as the case may be, then the last bid price or the last trade price, respectively, of such security prior to 4:00:00 p.m., New York time, as reported by Bloomberg, or, if the Principal Market is not the principal securities exchange or trading market for such security, the last closing bid price or last trade price, respectively, of such security on the principal securities exchange or trading market where such security is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the last closing bid price or last trade price, respectively, of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg, or, if no closing bid price or last trade price, respectively, is reported for such security by Bloomberg, the average of the bid prices, or the ask prices, respectively, of any market makers for such security as reported in the “pink sheets” by Pink Sheets LLC (formerly the National Quotation Bureau, Inc.). If the Closing Bid Price or the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Bid Price or the Closing Sale Price, as the case may be, of such security on such date shall be the fair market value as determined by the Board of Directors of the Company in the exercise of its good faith judgment. All such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during the applicable calculation period.

 

(e) “Common Stock” means (i) the Company’s shares of Common Stock, par value $0.001 per share, and (ii) any share capital into which such Common Stock shall have been changed or any share capital resulting from a reclassification of such Common Stock.

 

(f) “Eligible Market” means the Principal Market, The New York Stock Exchange, Inc., The American Stock Exchange, The NASDAQ Global Select Market, The NASDAQ Global Market or OTC Bulletin Board.

 

8

 

 

(g) “Expiration Date” means the date three (3) years following the Issuance Date or, if such date falls on a day other than a Business Day or on which trading does not take place on the Principal Market (a “Holiday”), the next date that is not a Holiday.

 

(h) “Fundamental Transaction” means that the Company shall, directly or indirectly, in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company is the surviving corporation) another Person, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all of the properties or assets of the Company to another Person, or (iii) allow another Person to make a purchase, tender or exchange offer that is accepted by the holders of more than the 67% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the Person or Persons making or party to, or associated or affiliated with the Persons making or party to, such purchase, tender or exchange offer), or (iv) consummate a stock purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than the 67% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock purchase agreement or other business combination), (v) reorganize, recapitalize or reclassify its Common Stock, or (vi) any “person” or “group” (as these terms are used for purposes of Sections 13(d) and 14(d) of the Exchange Act) is or shall become the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of 67% of the aggregate ordinary voting power represented by issued and outstanding Common Stock.

 

(i) “Parent Entity” of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock or equivalent equity security is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the Person or Parent Entity with the largest public market capitalization as of the date of consummation of the Fundamental Transaction.

 

(j) “Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity and a government or any department or agency thereof.

 

(k) “Principal Market” means OTC Markets.

 

(l) “Successor Entity” means the Person (or, if so elected by the Holder, the Parent Entity) formed by, resulting from or surviving any Fundamental Transaction or the Person (or, if so elected by the Holder, the Parent Entity) with which such Fundamental Transaction shall have been entered into.

 

9

 

 

(m) “Trading Day” means any day on which shares of Common Stock are traded on the Principal Market, or, if the Principal Market is not the principal trading market for the Common Stock, then on the principal securities exchange or securities market or electronic quotations system on which the shares of Common Stock are then traded; provided that “Trading Day” shall not include any day on which the Common Stock is scheduled to trade on such exchange, market or system for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange, market or system (or if such exchange, market or system does not designate in advance the closing time of trading on such exchange, market or system, then during the hour ending at 4:00 p.m., New York time).

 

(n) A “Trading Threshold” shall be deemed to occur on any date that the reported Weighted Average Price for any ten (10) consecutive Trading Days immediately prior to such date, exceeds 175% of the Exercise Price with a minimum average daily trading volume for such ten (10) day period of at least 25,000 shares of Common Stock as reported by the Principal Market for such period (with such price and volume criteria being appropriately adjusted for any share dividend, share split or other similar transaction that may occur on or after the Issuance Date).

 

(o) “Weighted Average Price” means, for any security as of any date, the dollar volume-weighted average price for such security on the Principal Market (or, if the Principal Market is not the principal trading market for the Common Stock, then on the principal securities exchange or securities market or electronic quotations system on which the shares of Common Stock are then traded) during the period beginning at 9:30:01 a.m., New York City time, and ending at 4:00:00 p.m., New York City time, as reported by Bloomberg through its “Volume at Price” function or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York City time, and ending at 4:00:00 p.m., New York City time, as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported in the “pink sheets” by OTC Markets LLC (or any successor thereto). If the Weighted Average Price cannot be calculated for such security on such date on any of the foregoing bases, the Weighted Average Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then such dispute shall be resolved pursuant to Section 13 with the term “Weighted Average Price” being substituted for the term “Exercise Price.” All such determinations shall be appropriately adjusted for any share dividend, share split or other similar transaction during such period.

 

[Signature Page Follows]

 

10

 

 

IN WITNESS WHEREOF, the Company has caused this Warrant to Purchase Common Stock to be duly executed as of the Issuance Date.

 

  GENERATION HEMP, INC.
   
 

By:

               
  Name:  Gary C. Evans
  Title: Chief Executive Officer

 

11

 

 

EXHIBIT A

 

EXERCISE NOTICE

 

TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS

WARRANT TO PURCHASE COMMON STOCK

 

GENERATION HEMP, INC.

 

The undersigned holder hereby exercises the right to purchase _________________ of the shares of Common Stock (“Warrant Shares”) of Generation Hemp, Inc, a Colorado corporation (the “Company”), evidenced by the attached Warrant to Purchase Common Stock (the “Warrant”). Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.

 

1. Payment of Exercise Price. In the event that the holder has elected a Cash Exercise with respect to some or all of the Warrant Shares to be issued pursuant hereto, the holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the Company in accordance with the terms of the Warrant.

 

2. Delivery of Warrant Shares. The Company shall deliver __________ Warrant Shares in the name of the undersigned holder or in the name of ______________________ in accordance with the terms of the Warrant or by physical delivery of a certificate to:

 

_______________________________

 

_______________________________

 

_______________________________

 

Date: _______________ __, ______

 

   
Name of Registered Holder

 

By:    
  Name:
  Title:

 

12

 

 

ACKNOWLEDGMENT

 

The Company hereby acknowledges this Exercise Notice and hereby directs [●] to issue the above indicated number of shares of Common Stock in accordance with the Transfer Agent Instructions dated [ ], 2020 from the Company and acknowledged and agreed to [●].

 

  GENERATION HEMP, INC
   
  By:  
    Name:
    Title:

 

13

 

 

EXHIBIT B

 

ASSIGNMENT FORM

 

(To assign the foregoing warrant, execute

this form and supply required information.

Do not use this form to exercise the warrant.)

 

FOR VALUE RECEIVED, all of or [_______] shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

_______________________________________________ whose address is

 

_______________________________________________________________.

 

_______________________________________________________________

 

Dated: ______________, _______

 

  Holder’s Signature:     
  Holder’s Address:    

 

Signature Guaranteed:    

 

NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever, and must be guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.

 

 

14

 

EX-10.49 4 f10k2022ex10-49_evergreen.htm FORM OF SUBSCRIPTION AGREEMENT FOR SERIES C REDEEMABLE CONVERTIBLE PREFERRED STOCK

Exhibit 10.49

 

GENERATION HEMP, INC.

COMMON STOCK AND WARRANT

SUBSCRIPTION AGREEMENT

 

Units Consisting of

One Share of 8.50% Series C Redeemable Convertible Preferred Stock and

5,000 Common Stock Purchase Warrants

 

$50,000 per Unit

 

Date: Full Subscription Commitment: $

 

1. Subscription:

 

(a) The undersigned (individually and/or collectively, the “Purchaser”) hereby applies to purchase Units composed of (i) one share of Series C Redeemable Convertible Preferred Stock (the “Series C Preferred Stock” or the “Shares”) of Generation Hemp, Inc., a Delaware corporation (the “Company”), and (ii) five thousand common stock purchase warrants (the “Warrants”) each Warrant exercisable for one share of common stock of the Company (the “Common Stock”), in accordance with the terms and conditions of this Subscription Agreement (this “Subscription”) and the form of Warrant, which is attached as Exhibit B hereto, at a purchase price (the “Offering Price”) of $50,000 per Unit (collectively the “Units”). This Subscription is one of several Subscriptions to be entered into by and between the Company and Purchasers, pursuant to which the Company will raise up to $5,000,000 (the “Offering”). The Purchaser acknowledges and understands that the Offering of the Units is being made without registration of the Units, the Series C Preferred stock, the Warrant or the Common Stock for which each Warrant is exercisable, under the Securities Act of 1933, as amended (the “Securities Act”), or any securities “blue sky” or other similar laws of any state.

 

(b) Before this Subscription is considered, the Purchaser must confirm its agreement with each of the following:

 

(i) Execution of this Subscription;

 

(ii) Certificate of Designation for the Company’s 8.50% Series C Redeemable Convertible Preferred Stock attached hereto as Exhibit A;

 

(iii) The Form of Warrant attached hereto as Exhibit B;

 

(iv) Conpletion of the Certificate of Accredited Investor Status, attached hereto as Exhibit C; and

 

(v) Purchaser’s aggregate payment in the amount of $           in exchange for Units purchased, or wire transfer sent to the Company in accordance with wire transfer instructions contained in Schedule 1 hereto.

 

(c) This Subscription is irrevocable by the Purchaser.

 

(d) This Subscription is not transferable or assignable by the Purchaser.

 

  Subscription Agreement
 2Generation Hemp, Inc.

 

 

(e) This Subscription may be rejected in whole or in part by the Company in its sole discretion prior to the applicable Closing (as defined in Section 1(g) hereof), regardless of whether Purchaser’s funds have theretofore been deposited by the Company. Purchaser’s execution and delivery of this Subscription will not constitute an agreement between the undersigned and the Company until this Agreement has been accepted and executed by the Company. In the event this Subscription is rejected by the Company, all funds and documents tendered by the Purchaser shall be returned and the parties’ obligations hereunder, shall terminate.

 

(f) Each Purchaser shall be issued at Closing three-year Warrants in substantially the form attached hereto as Exhibit A. Each Warrant to acquire one share of Common Stock is exercisable only for a cash Purchase Price of $0.50 per share (the shares of Common Stock issuable upon exercise of or otherwise pursuant to the Warrant collectively are referred to herein as the “Warrant Shares”). The Shares, the Warrant, and the Warrant Shares collectively are referred to herein as the “Securities”.

 

(g) The sale of Units will take place in one or more closings (the “Closing” or “Closing Date”), the first of which is scheduled to close on or about March 1, 2023, subject to the satisfaction of all parties hereto of their obligations herein. The minimum investment amount shall be $50,000 by each Purchaser in the Offering, although the Company may waive this minimum in its sole discretion and accept lesser investment amounts from Purchasers. The maximum Offering size shall be 100 Units. There shall be no minimum Offering size. Purchaser acknowledges and agrees that their subscription is irrevocable and binding on the part of the Purchaser and that once the funds have been tendered, the Company may conduct a Closing without any consent or notice to the Purchaser. Once a Closing has occurred, the subscribed funds will become assets of the Company and will be available for use by the Company as described herein.

 

(h) The Company plans to use the proceeds from the Offering for acquisitions, capital expenditures, and general working capital purposes.

 

(i) Purchaser hereby agrees not to, and will cause its affiliates not to, enter into any “put equivalent position” as such term is defined in Rule 16a-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or Short Sale (as defined below) position (a) with respect to the Securities; or (b) with respect to the Company’s Common Stock, prior to the exercise in full of the Warrants by the Purchaser, or expiration of the Warrants held by the Purchaser.

 

(j) Registration Procedures and Expenses.

 

(i) The Company shall prepare and file with the SEC, as promptly as reasonably practicable following Closing, but in no event later than 210 days following Closing (the “Filing Date”), a registration statement on Form S-1 (or Form S-3, if available), covering the resale of theWarrant Shares (the “Registrable Securities” and the “Registration Statement”) and shall use its commercially reasonable efforts to have the Registration Statement declared effective within 270 days after the Closing.

 

(ii) The Company shall use its commercially reasonable best efforts to:

 

(a) prepare and file with SEC such amendments and supplements to the Registration Statement and the prospectus forming part thereof (the “Prospectus”) used in connection therewith as may be necessary or advisable to keep the Registration Statement current and effective for the Registrable Securities held by a Purchaser for a period ending on the earliest of (i) the second anniversary of the Closing Date, (ii) the date on which all Registrable Securities may be sold pursuant to Rule 144 under the Securities Act or any successor rule (“Rule 144”) during any three-month period without the requirement for the Company to be in compliance with the current public information required under Rule 144(c)(1) or (iii) such time as all Registrable Securities have been sold pursuant to a registration statement or Rule 144. The Company shall notify each Purchaser promptly upon the Registration Statement and each post-effective amendment thereto, being declared effective by the SEC and advise each Purchaser that the form of Prospectus contained in the Registration Statement or post-effective amendment thereto, as the case may be, at the time of effectiveness meets the requirements of Section 10(a) of the Securities Act or that it intends to file a Prospectus pursuant to Rule 424(b) under the Securities Act that meets the requirements of Section 10(a) of the Securities Act;

 

  Subscription Agreement
 2Generation Hemp, Inc.

 

 

(b) furnish to the Purchaser with respect to the Registrable Securities registered under the Registration Statement such number of copies of the Registration Statement and the Prospectus (including supplemental prospectuses) filed with the SEC in conformance with the requirements of the Securities Act and other such documents as the Purchaser may reasonably request, in order to facilitate the public sale or other disposition of all or any of the Registrable Securities by the Purchaser;

 

(c) pay the expenses incurred by the Company in complying with this Section, including, all registration and filing fees, FINRA fees, exchange listing fees, printing expenses, fees and disbursements of counsel for the Company, blue sky fees and expenses and the expense of any special audits incident to or required by any such registration (but excluding attorneys’ fees of any Purchaser and any and all underwriting discounts and selling commissions applicable to the sale of Registrable Securities by the Purchasers);

 

(d) advise the Purchasers, promptly after it shall receive notice or obtain knowledge of the issuance of any stop order by the SEC delaying or suspending the effectiveness of the Registration Statement or of the initiation of any proceeding for that purpose; and it will promptly use its commercially reasonable best efforts to prevent the issuance of any stop order or to obtain its withdrawal at the earliest possible moment if such stop order should be issued; and

 

(e) with a view to making available to the Purchaser the benefits of Rule 144 and any other rule or regulation of the SEC that may at any time permit the Purchaser to sell Registrable Securities to the public without registration, the Company covenants and agrees to use its commercially reasonable efforts to: (i) make and keep public information available, as those terms are understood and defined in Rule 144, until the earlier of (A) such date as all of the Registrable Securities qualify to be resold immediately pursuant to Rule 144 or any other rule of similar effect during any three-month period without the requirement for the Company to be in compliance with the current public information required under Rule 144(c)(1) or (B) such date as all of the Registrable Securities shall have been resold pursuant to Rule 144 (and may be further resold without restriction); (ii) file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and under the Exchange Act; and (iii) furnish to the Purchaser upon request, as long as the Purchaser owns any Registrable Securities, (A) a written statement by the Company as to whether it has complied with the reporting requirements of the Securities Act and the Exchange Act, (B) a copy of the Company’s most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q, and (C) such other information as may be reasonably requested in order to avail the Purchaser of any rule or regulation of the SEC that permits the selling of any such Registrable Securities without registration.

 

(iii) The Purchaser agrees and confirms that a requirement to the Company including such Purchaser’s Registrable Securities in the Registration Statement is that the Purchaser will work in good faith with the Company to supply the Company with any and all information the Company may reasonably request from the Purchaser from time to time in connection with the preparation of the Registration Statement, including, customary and reasonable representations and confirmations regarding the Warrant Shares held by the Purchasers, information relating to the beneficial ownership of other securities of the Company held by such Purchaser and its affiliates, information regarding the persons with voting and dispositive control over the Purchaser and such other information as the Company or its legal counsel may reasonably request (which requirement may be waived by the Company).

 

  Subscription Agreement
 3Generation Hemp, Inc.

 

 

(iv) The Purchasers acknowledge and understand that the Filing Date shall be extended in the event the Company is currently in the process of undertaking and/or is currently contemplating an offering by the Company of securities for its own account if the managing underwriter or placement agent shall have advised the Company in writing that such Registration Statement or the inclusion of such Registrable Securities in such registration statement will have a material adverse effect upon the ability of the Company to sell securities for its own account, and provided further that the Purchasers are not treated less favorably than others seeking to have their securities included in such registration statement. Notwithstanding the obligations set forth above, if any SEC guidance sets forth a limitation on the number of securities permitted to be registered on the Registration Statement (including any other securities included by the Company in such Registration Statement; provided further that the Company shall not be prohibited from including other securities on such Registration Statement), the number of Registrable Securities to be included on such Registration Statement for the benefit of the Purchasers will be reduced pro rata between the Purchasers (or other parties) whose securities are included in such Registration Statement and the Company; provided further that the Company shall take action to file additional registration statements at the written request of the holders of a majority in interest of the Shares sold in the Offering after the effectiveness of the Registration Statement, subject to SEC rules and guidance and the requirements set forth above, provided, however, that the Company shall not be required to file more than one additional Registration Statement in any rolling six (6) month period. Notwithstanding the above, the Purchasers agree that the Company shall not be required to register securities totaling more than 1/3rd of its then public float on the Registration Statement. Further notwithstanding the above, the Company may at any time take action to register the Warrant Shares under the Securities Act and the Purchasers agree to take reasonable actions and provide the Company reasonable information to facilitate any such registration.

 

(k) Expenses. The Company will be responsible for all of its own expenses (e.g., legal, accounting, printing) in connection with the Offering as well as, whether the Offering is consummated or not. Each Purchaser shall be responsible for all of its own expenses (e.g., legal, tax, or other advisers).

 

2. Representations by Purchaser. In consideration of the Company’s potential acceptance of the Subscription, Purchaser makes the following representations and warranties to the Company and to its principals, jointly and severally, which warranties and representations shall survive any acceptance of the Subscription by the Company:

 

(a) Prior to the time of purchase of any Securities, Purchaser has had an opportunity to review the Company’s reports, schedules, forms, statements and other documents filed by it with the United States Securities and Exchange Commission (the “SEC Reports”) (which filings can be accessed by going to http://www.sec.gov/edgar/searchedgar/companysearch.html, typing “Generation Hemp” in the “Company name” field, and clicking the “Search” button), including (A) the Form 10-K for the year ended December 31, 2021; (B) the Forms 10-Q for the quarters ended March 31, 2022, June 30, 2022, and September 30, 2022; and (C) the Form 8-K filed with the SEC on January 18, 2023 and any other Form 8-K filed after January 18, 2023 and prior to the date of this Subscription.

 

(b) Purchaser has been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Units and the merits and risks of investing in the Units; (ii) access to information about the Company and its respective financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment. Purchaser acknowledges that no officer, director, broker-dealer, placement agent, finder or other person affiliated with the Company has given Purchaser any information or made any representations, oral or written, other than as provided in the SEC Reports and herein, on which Purchaser has relied upon in deciding to invest in the Securities, including without limitation, any information with respect to future acquisitions, mergers or operations of the Company or the economic returns which may accrue as a result of the purchase of the Securities.

 

  Subscription Agreement
 4Generation Hemp, Inc.

 

 

(c) Purchaser recognizes that the total amount of funds tendered to purchase the Units is placed at the risk of the business and may be completely lost. The Purchaser confirms and represents that it is able (i) to bear the economic risk of its investment, (ii) to hold the securities for an indefinite period of time, and (iii) to afford a complete loss of its investment.

 

(d) Purchaser acknowledges that Purchaser has not seen, received, been presented with, or been solicited by any leaflet, public promotional meeting, newspaper or magazine article or advertisement, radio or television advertisement, or any other form of advertising or general solicitation with respect to the Securities.

 

(e) The Securities are being purchased for Purchaser’s own account for long-term investment and not with a view to immediately resale the Securities. No other person or entity will have any direct or indirect beneficial interest in, or right to, the Securities. No person has made to the Purchaser any written or oral representations: (x) that any person will resell or repurchase any of the Securities; (y) that any person will refund the purchase price of any of the Securities, or (z) as to the future price or value of any of the Securities. The Purchaser does not presently have any contract, agreement, undertaking, arrangement or understanding, directly or indirectly, with any person to sell, transfer, pledge, assign or otherwise effect any distribution of any of the Securities, and Purchaser is not a registered broker-dealer under Section 15 of the Exchange Act or an entity engaged in a business that would require it to be so registered as a broker-dealer.

 

(f) Purchaser acknowledges that the Securities have not been registered under the Securities Act, or qualified under any state securities laws, or any other applicable blue sky laws, in reliance, in part, on Purchaser’s representations, warranties and agreements made herein.

 

(g) Other than the rights specifically set forth in this Subscription and disclosed in the SEC Reports, Purchaser represents, warrants and agrees that the Company and the officers of the Company (the “Company’s Officers”) are under no obligation to register or qualify the Securities under the Securities Act or under any state securities law, or to assist the undersigned in complying with any exemption from registration and qualification.

 

(h) Purchaser represents that Purchaser meets the criteria for participation because: (i) Purchaser has a pre-existing personal or business relationship with the Company or one or more of its partners, officers, directors or controlling persons; or (ii) by reason of Purchaser’s business or financial experience, or by reason of the business or financial experience of its financial advisors who are unaffiliated with, and are not compensated, directly or indirectly, by the Company or any affiliate or selling agent of the Company, Purchaser is capable of evaluating the risk and merits of an investment in the Securities and of protecting its own interests.

 

(i) Purchaser represents that Purchaser is an “accredited investor” within the meaning of Rule 501 of Regulation D under the Securities Act and Purchaser has executed the Certificate of Accredited Investor Status, attached hereto as Exhibit C.

 

(j) Purchaser understands that the Units are illiquid and must be held indefinitely unless such Units are registered under the Securities Act or an exemption from registration is available. Purchaser acknowledges that Purchaser is familiar with Rule 144 of the rules and regulations of the SEC, as amended, promulgated pursuant to the Securities Act (“Rule 144”), and that such Purchaser has been advised that Rule 144 permits resales only under certain circumstances. Such Purchaser understands that to the extent that Rule 144 is not available, such Purchaser will be unable to sell any Securities without either registration under the Securities Act or the existence of another exemption from such registration requirement. Purchaser may not sell or dispose of the Units or utilize the Securities as collateral for a loan. Purchaser must not purchase the Securities unless Purchaser has liquid assets sufficient to assure Purchaser that such purchase will cause it no undue financial difficulties, and that Purchaser can still provide for current and possible personal contingencies, and that the commitment herein for the Units, combined with other investments of Purchaser, is reasonable in relation to its net worth.

 

  Subscription Agreement
 5Generation Hemp, Inc.

 

 

(k) Other than with respect to the transactions contemplated herein, since the time that such Purchaser was first contacted by the Company or any other person regarding the transactions contemplated hereby, neither the Purchaser nor, to the knowledge of such Purchaser, any affiliate of such Purchaser which (i) had knowledge of the transactions contemplated hereby, (ii) has or shares discretion relating to such Purchaser’s investments or trading or information concerning such Purchaser’s investments, including in respect of the Units and (iii) is subject to such Purchaser’s review or input concerning such affiliate’s investments or trading (collectively, “Trading Affiliates”) has directly or indirectly, nor has any person acting on behalf of or pursuant to any understanding with such Purchaser or Trading Affiliate, effected or agreed to effect any transactions in the securities of the Company (including, without limitation, any short sales involving the Company’s securities). Notwithstanding the foregoing, in the case of a Purchaser and/or Trading Affiliate that is, individually or collectively, a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser’s or Trading Affiliate’s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser’s or Trading Affiliate’s assets, the representation set forth above shall apply only with respect to the portion of assets managed by the portfolio manager(s) that have knowledge about the financing transaction contemplated by this Subscription. Other than to other persons party to this Subscription, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with the transactions contemplated hereby (including the existence and terms of such transactions).

 

(l) No person will have, as a result of the transactions contemplated by this Subscription, any valid right, interest or claim against or upon the Company or any Purchaser for any commission, fee or other compensation pursuant to any agreement, arrangement or understanding entered into by or on behalf of such Purchaser.

 

(m) Purchaser has independently evaluated the merits of its decision to purchase Units, and hereby confirms that it has not relied on the advice of any other Purchaser’s business and/or legal counsel in making such decision. Purchaser understands that nothing in this Subscription or any other materials presented by or on behalf of the Company to the Purchaser in connection with the purchase of the Units constitutes legal, tax or investment advice. Such Purchaser has consulted such legal, tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with its purchase of the Units.

 

(n) Purchaser understands that the right to transfer the Securities will be restricted unless the transfer is not in violation of the Securities Act or any other applicable state or foreign securities laws (including investment suitability standards), that the Company will not consent to a transfer of the Securities unless the transferee represents that such transferee meets the financial suitability standards required of an initial Purchaser, and that the Company has the right, in its absolute discretion, to refuse to consent to such transfer.

 

(o) Purchaser has been advised to consult with its own attorney or attorneys regarding all legal matters concerning an investment in the Company and the tax consequences of purchasing the Securities, and have done so, to the extent Purchaser considers necessary.

 

(p) Purchaser acknowledges that the tax consequences of investing in the Company will depend on particular circumstances, and neither the Company, the Company’s officers, any other investors, nor the partners, shareholders, members, directors, agents, officers, directors, employees, affiliates or consultants of any of them, will be responsible or liable for the tax consequences to Purchaser of an investment in the Company. Purchaser will look solely to and rely upon its own advisers with respect to the tax consequences of this investment.

 

  Subscription Agreement
 6Generation Hemp, Inc.

 

 

(q) The Purchaser: (i) if a natural person, represents that the Purchaser has reached the age of 21 and has full authority, legal capacity and competence to enter into, execute and deliver this Agreement and all other related agreements or certificates and to take all actions required pursuant hereto and thereto and to carry out the provisions hereof and thereof, or (ii) if a corporation, partnership, or limited liability company or partnership, or association, joint stock company, trust, unincorporated organization or other entity, represents that such entity was not formed for the specific purpose of acquiring the Securities and such entity is duly organized, validly existing and in good standing under the laws of the state of its organization. Purchaser is a bona fide resident and domiciliary of the state set forth on the signature page of this Subscription and has no present intention to become a resident of any other state or jurisdiction.

 

(r) The Purchaser agrees to sell all Registrable Securities registered under the Registration Statement and sold in connection therewith, in compliance with the plan of distribution set forth in such Registration Statement and any and all applicable prospectus delivery requirements.

 

(s) All information which Purchaser has provided to the Company concerning Purchaser, its financial position and its knowledge of financial and business matters, and any information found in the Certificate of Accredited Investor Status, is truthful, accurate, correct, and complete as of the date set forth herein.

 

(t) Each Purchaser shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys’ fees) and expenses (collectively, “Losses”), as incurred, to the extent arising out of or based solely upon: (x) such Purchaser’s failure to comply with any applicable prospectus delivery requirements of the Securities Act through no fault of the Company or (y) any untrue or alleged untrue statement of a material fact contained in any registration statement, any prospectus, or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained in any information so furnished in writing by such Purchaser to the Company expressly for inclusion in such registration statement or such prospectus or (ii) to the extent, but only to the extent, that such information relates to such Purchaser’s proposed method of distribution of registrable securities and was reviewed and expressly approved in writing by such Purchaser expressly for use in a registration statement, such prospectus or in any amendment or supplement thereto or (iii) in the case such Purchaser uses an outdated, defective or otherwise unavailable prospectus after the Company has notified such Purchaser in writing that the prospectus is outdated, defective or otherwise unavailable for use by such Purchaser. In no event shall the liability of any selling Purchaser under this Section be greater in amount than the dollar amount of the net proceeds received by such Purchaser upon the sale of the registrable securities giving rise to such indemnification obligation.

 

(u) Each certificate or instrument representing securities issuable pursuant to this Agreement will be endorsed with the following legend (or a substantially similar legend):

 

THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES, THE TRANSFER IS MADE IN COMPLIANCE WITH RULE 144 PROMULGATED UNDER SUCH ACT OR THE COMPANY RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF THESE SECURITIES WHICH IS REASONABLY SATISFACTORY TO THE COMPANY, STATING THAT SUCH SALE, TRANSFER, ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF SUCH ACT.

 

(v) Purchaser understands that the Units are being offered and sold to it in reliance on specific exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying in part upon the truth and accuracy of, and such Purchaser’s compliance with, the representations, warranties, agreements, acknowledgements and understandings of such Purchaser set forth herein in order to determine the availability of such exemptions and the eligibility of such Purchaser to acquire the Units.

 

  Subscription Agreement
 7Generation Hemp, Inc.

 

 

(w) Purchaser understands that no United States federal or state agency or any other government or governmental agency has passed on or made any recommendation or endorsement of the Units or the fairness or suitability of the investment in the Units nor have such authorities passed upon or endorsed the merits of the offering of the Units.

 

(x) Purchaser is aware that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of Common Stock and other activities with respect to the Common Stock by the Purchaser.

 

(y) Purchaser confirms and acknowledges that this is a “best efforts” offering, and that the initial Closing will not occur until the Minimum Offering Amount has been raised.

 

3. Representations and Warranties by the Company. The Company represents and warrants that:

 

(a) Due Formation. The Company is a corporation duly organized, validly existing and in good standing under the laws of the jurisdiction of its formation and has the requisite corporate power to own its properties and to carry on its business as now being conducted. The Company is duly qualified as a foreign entity to do business and is in good standing in each jurisdiction where the nature of the business conducted or property owned by it makes such qualification necessary, other than those jurisdictions in which the failure to so qualify would not have a material adverse effect on the business, operations or financial condition of the Company.

 

(b) Authority; Enforceability. This Subscription and the Warrants delivered together with this Subscription or in connection herewith have been duly authorized, executed, and delivered by the Company and are valid and binding agreements, enforceable in accordance with their terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium, and similar laws of general applicability relating to or affecting creditors’ rights generally and to general principles of equity; and the Company has full corporate power and authority necessary to enter into this Subscription and the Warrants, and to perform its obligations hereunder and under all other agreements entered into by the Company relating hereto.

 

(c) No General Solicitation. Neither the Company, nor any of its affiliates, nor to its knowledge, any person acting on its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act) in connection with the offer or sale of the Securities.

 

(d) Governmental Consents. No consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority on the part of the Company is required in connection with the consummation of the transactions contemplated by this Subscription, except for filings pursuant to applicable state securities laws, and Regulation D of the Securities Act.

 

(e) Litigation. There is no action, suit, proceeding or investigation pending or, to the Company’s knowledge, currently threatened against the Company or any of its majority-owned or any controlled subsidiaries that questions the validity of this Subscription or the right of the Company to enter into it, or to consummate the transactions contemplated hereby or thereby. Neither the Company nor any of its majority-owned or any controlled subsidiaries is a party or subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality. There is no action, suit, proceeding or investigation by the Company or any of its majority-owned or any controlled subsidiaries currently pending or which the Company or any of its majority-owned or any controlled subsidiaries intends to initiate. The foregoing includes, without limitation, actions, suits, proceedings or investigations pending or threatened in writing (or any basis therefor known to the Company) involving the prior employment of any of the Company’s employees, their use in connection with the Company’s business, or any information or techniques allegedly proprietary to any of their former employers, or their obligations under any agreements with prior employers.

 

  Subscription Agreement
 8Generation Hemp, Inc.

 

 

(f) Permits. The Company and each of its majority-owned or any controlled subsidiaries has all franchises, permits, licenses and any similar authority necessary for the conduct of its business, the lack of which could materially and adversely affect the business, properties, prospects, or financial condition of the Company. The Company is not in default in any material respect under any of such franchises, permits, licenses or other similar authority.

 

(g) No Conflicts. The execution, delivery and performance by the Company of the Subscription and the consummation by the Company of the transactions contemplated hereby (including, without limitation, the issuance of the Securities) do not and will not (i) conflict with or violate any provisions of the Company’s certificate of incorporation or bylaws or otherwise result in a violation of the organizational documents of the Company, (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any lien upon any of the properties or assets of the Company or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any contract or (iii) result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company is subject (including federal and state securities laws and regulations and the rules and regulations, assuming the correctness of the representations and warranties made by the Purchasers herein, of any self-regulatory organization to which the Company or its securities are subject, including OTC Markets LLC, or by which any property or asset of the Company is bound or affected).

 

(h) Issuance of the Securities. The Securities have been duly authorized and, when issued and paid for in accordance with the terms of the Subscription, will be duly and validly issued, fully paid and nonassessable and free and clear of all liens suffered or permitted by the Company, other than restrictions on transfer provided for in the Subscription or imposed by applicable securities laws, and shall not be subject to preemptive or similar rights. Assuming the accuracy of the representations and warranties of the Purchasers in this Subscription, the Securities will be issued in compliance with all applicable federal and state securities laws.

 

(i) Capitalization. The number of shares and type of all authorized, issued and outstanding capital stock, options and other securities of the Company (whether or not presently convertible into or exercisable or exchangeable for shares of capital stock of the Company) has been set forth in the SEC Reports and may change thereafter to reflect stock issuances, convertible debt conversions, stock option exercises and grants and warrant exercises which will not, individually or in the aggregate, have a material effect on the issued and outstanding capital stock, options and other securities of the Company. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and non-assessable, have been issued in compliance in all material respects with all applicable federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase any capital stock of the Company. Except as set forth in the SEC Reports: (i) no shares of the Company’s capital stock are subject to preemptive rights or any other similar rights or any liens suffered or permitted by the Company; (ii) except for the Subscription or as a result of the performance by the Company of the Subscription, there are no outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable for, any shares of capital stock of the Company, or contracts, commitments, understandings or arrangements by which the Company is or may become bound to issue additional shares of capital stock of the Company or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable for, any shares of capital stock of the Company; (iii) there are no outstanding debt securities, notes, credit agreements, credit facilities or other agreements, documents or instruments evidencing indebtedness of the Company or by which the Company is or may become bound in any material amounts; (iv) there are no financing statements securing obligations in any material amounts, either singly or in the aggregate, filed in connection with the Company; (v) there are no agreements or arrangements under which the Company is obligated to register the sale of any of their securities under the Securities Act; (vi) there are no outstanding securities or instruments of the Company or which contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company is or may become bound to redeem a security of the Company; (vii) there are no securities or instruments containing anti-dilution or similar provisions that will be triggered by the issuance of the Securities; (viii) the Company does not have any stock appreciation rights or “phantom stock” plans or agreements or any similar plan or agreement; and (ix) the Company has no liabilities or obligations required to be disclosed in the SEC Reports (including, for purposes hereof, any liabilities that are required to be disclosed in a Form 10) but not so disclosed in the SEC Reports.

 

  Subscription Agreement
 9Generation Hemp, Inc.

 

 

(j) SEC Reports. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by it under the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for twelve (12) months preceding and including the date hereof. As of the date hereof, the Company has no knowledge of any event occurring on or prior to the Closing Date (other than the transactions contemplated by the Subscription) that requires the filing of a Current Report on Form 8-K after the Closing.

 

(k) Financial Statements. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the SEC with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with GAAP applied on a consistent basis during the periods involved, except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company taken as a whole as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, year-end audit adjustments.

 

(l) Tax Matters. The Company (i) has prepared and filed all foreign, federal and state income and all other tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations, except those being contested in good faith, with respect to which adequate reserves have been set aside on the books of the Company and (iii) has set aside on its books provisions reasonably adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply.

 

(m) Material Changes. Since the date of the latest financial statements included within the SEC Reports, except as specifically disclosed in the SEC Reports, (i) there have been no events, occurrences or developments that have had or would reasonably be expected to have a material adverse effect on the Company, (ii) the Company has not incurred any material liabilities (contingent or otherwise) other than (A) trade payables, accrued expenses and other liabilities incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company’s financial statements pursuant to GAAP or to be disclosed in filings made with the Commission, (iii) the Company has not materially altered its method of accounting or the manner in which it keeps its accounting books and records, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock (other than in connection with repurchases of unvested stock issued to employees of the Company), (v) the Company has not issued any equity securities to any officer, director or affiliate, except stock options and restricted stock issued to newly hired and promoted officers in the ordinary course pursuant to Company stock option or stock purchase plans or executive and director corporate arrangements disclosed in the SEC Reports and (vi) there has not been any material change or amendment to, or any waiver of any material right under, any contract under which the Company or any of its assets is bound or subject. Except for the issuance of the Securities contemplated by this Agreement, no event, liability or development has occurred or exists with respect to the Company or its business, properties, operations or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made that has not been publicly disclosed in the SEC Reports.

 

  Subscription Agreement
 10Generation Hemp, Inc.

 

 

(n) Environmental Matters. The Company (i) is not in violation of any statute, rule, regulation, decision or order of any governmental agency or body or any court, domestic or foreign, relating to the use, disposal or release of hazardous or toxic substances or relating to the protection or restoration of the environment or human exposure to hazardous or toxic substances (collectively, “Environmental Laws”) which would have a material adverse effect on the business, operations or financial condition of the Company, (ii) does not own or operate any real property contaminated with any substance that is in violation of any Environmental Laws, (iii) is not liable for any off-site disposal or contamination pursuant to any Environmental Laws, and (iv) is not subject to any claim relating to any Environmental Laws; and there is no pending or, to the Company’s knowledge, threatened investigation that might lead to such a claim.

 

(o) Litigation. There is no action which adversely affects or challenges the legality, validity or enforceability of any of the Subscription or the Securities. Except as disclosed in the SEC Reports, there are no pending actions, suits or proceedings against or affecting the Company or any of its properties; and to the Company’s knowledge, no such actions, suits or proceedings are threatened or contemplated against the Company.

 

(p) Employment Matters. No material labor dispute exists or, to the Company’s knowledge, is imminent with respect to any of the employees of the Company. None of the Company’s employees is a member of a union that relates to such employee’s relationship with the Company, and the Company is not a party to a collective bargaining agreement, and the Company believes that its relationship with its employees is good.

 

(q) Compliance. Except as disclosed in the SEC Reports, the Company (i) is not in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company), nor has the Company received written notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other significant contract (whether or not such default or violation has been waived), (ii) is not in violation of any order of any court, arbitrator or governmental body having jurisdiction over the Company or its properties or assets.

 

(r) Title to Assets. The Company has good and marketable title to all tangible personal property owned by it which is material to the business of the Company. The Company does not own any real property in fee simple, except for interests in oil or gas properties that may be deemed real property under state law. Except as disclosed in the SEC Reports, the Company holds defensible title to the leasehold and other real property interests held by it (the “Real Property”), in each case, free and clear of all liens other than the Encumbrances. “Encumbrances” means: (a) statutory liens of landlords, banks (and rights of set off), carriers, warehousemen, mechanics, repairmen, workmen, materialmen, vendors and other similar liens arising in the ordinary course of business for amounts not yet overdue or for amounts that are overdue and that are being contested in good faith by appropriate proceedings; (b) liens for taxes, assessments, or other governmental charges or levies and other liens imposed by law, in each case incurred in the ordinary course of business consistent with past practice for amounts not yet overdue or being contested in good faith by appropriate proceedings; (c) the terms and conditions of all liens created by oil and gas leases, easements, rights of way, restrictions, encroachments, and all other burdens recorded in the real property records of the county in which the real property is located; (d) liens to operators and non-operators under model form operating agreements arising in the ordinary course of the business; (e) liens arising from precautionary UCC filings; (f) lease burdens existing as of the date of this agreement constituting monetary obligations payable to third parties, including, without limitation, any royalty, overriding royalty, net profits interest, production payment, carried interest or reversionary working interest; (g) liens arising under unitization and pooling agreements and orders, farmout agreements, gas balancing agreements and other customary agreements in the energy industry; and (h) the lien under Deed of Trust filed in Texas in connection with the SOHL Note, as defined below. Any real property and facilities held under lease by the Company are held by it under valid, subsisting and enforceable leases with such exceptions as are not material and do not interfere with the use made of such property and buildings by the Company.

 

  Subscription Agreement
 11Generation Hemp, Inc.

 

 

(s) Intellectual Property. To the Company’s knowledge, the Company owns, possesses, licenses or has other rights to use all foreign and domestic patents, patent applications, trade and service marks, trade and service mark registrations, trade names, copyrights, licenses, inventions, trade secrets, technology and other proprietary rights and processes (collectively, the “Intellectual Property”) necessary for the conduct of its businesses as now conducted. To the Company’s knowledge (i) the Company’s use of any such Intellectual Property in the conduct of its business as presently conducted does not infringe upon the rights of any third parties; (ii) there is no infringement by third parties of any such Intellectual Property; (iii) there is no pending or threatened action challenging the Company’s rights in or to any such Intellectual Property; (iv) there is no pending or threatened action challenging the validity or scope of any such Intellectual Property; and (v) there is no pending or threatened action that the Company infringes or otherwise violates any patent, trademark, copyright, trade secret or other proprietary rights of others.

 

(t) Insurance. The Company is insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as the Company believes to be prudent in the businesses and locations in which the Company is engaged. The Company has not received any notice of cancellation of any such insurance, nor does the Company have any knowledge that it will be unable to renew its existing insurance coverage for the Company as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.

 

(u) Transactions With Officers, Directors and Employees. Other than as set forth in the SEC Reports, none of the officers or directors of the Company and, to the Company’s knowledge, none of the employees of the Company, is presently a party to any transaction with the Company or to a presently contemplated transaction (other than for services as employees, officers and directors) that would be required to be disclosed pursuant to Item 404 of Regulation S-K promulgated under the Securities Act, except as contemplated by the Subscription or set forth in the SEC Reports.

 

(v) Certain Fees. No person or entity will have, as a result of the transactions contemplated by this Agreement, any valid right, interest or claim against or upon the Company or a Purchaser for any commission, fee or other compensation pursuant to any agreement, arrangement or understanding entered into by or on behalf of the Company. The Company shall indemnify, pay, and hold each Purchaser harmless against, any liability, loss or expense (including, without limitation, attorneys’ fees and out-of-pocket expenses) arising in connection with any such right, interest or claim.

 

(w) Private Placement. Assuming the accuracy of the Purchasers’ representations and warranties set forth this Subscription (without giving effect to any materiality qualifiers therein) and the accuracy of the information disclosed by each Purchaser’s Certificate of Accredited Investor Status, no registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers under the Subscription.

 

(x) Registration Rights. Other than each of the Purchasers, no person has any right to cause the Company to effect the registration under the Securities Act of any securities of the Company.

 

(y) No Directed Selling Efforts or General Solicitation. Neither the Company nor, to its knowledge, any person acting on its behalf has conducted any “general solicitation” or “general advertising” (as those terms are used in Regulation D) in connection with the offer or sale of any of the Securities.

 

  Subscription Agreement
 12Generation Hemp, Inc.

 

 

(z) No Integrated Offering. Assuming the accuracy of the Purchasers’ representations and warranties set forth in the Subscription (without giving effect to any materiality qualifiers therein), except as disclosed in the SEC Reports, neither the Company nor any Person acting on its behalf has, directly or indirectly, at any time within the past six (6) months, made any offers or sales of any Company security or solicited any offers to buy any security under circumstances that would (i) eliminate the availability of the exemption from registration under Regulation D under the Securities Act in connection with the offer and sale by the Company of the Securities as contemplated hereby or (ii) cause the offering of the Securities pursuant to the Subscription to be integrated with prior offerings by the Company for purposes of any applicable law, regulation or shareholder approval provisions, including, without limitation, under the rules and regulations of the NYSE MKT.

 

(aa) Investment Company. The Company is not required to be registered as, and is not an affiliate of, and immediately following the Closing will not be required to register as, an “investment company” within the meaning of the Investment Company Act of 1940, as amended.

 

(bb) Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports and is not so disclosed.

 

(cc) Acknowledgment Regarding the Purchasers’ Purchase of Securities. The Company acknowledges and agrees that each of the Purchasers is acting solely in the capacity of an arm’s length Purchaser with respect to the Subscription and the transactions contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to the Subscription and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection with the Subscription and the transactions contemplated thereby is merely incidental to the Purchasers’ purchase of the Securities.

 

(dd) Foreign Corrupt Practices. Neither the Company, nor to the Company’s knowledge, any agent or other person acting on behalf of the Company, has: (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company (or made by any person acting on its behalf of which the Company is aware) which is in violation of law or (iv) violated in any material respect any provision of the Foreign Corrupt Practices Act of 1977, as amended.

 

(ee) No Additional Agreements. The Company does not have any agreement or understanding with any Purchaser with respect to the transactions contemplated by the Subscription other than as specified in the Subscription.

 

  Subscription Agreement
 13Generation Hemp, Inc.

 

 

4. Other Agreements.

 

(a) Transfer Restrictions.

 

(i) Compliance with Laws. Notwithstanding any other provision of the Subscription, each Purchaser acknowledges and covenants that the Securities may be disposed of only pursuant to an effective registration statement under, and in compliance with the requirements of, the Securities Act, or pursuant to an available exemption from, or in a transaction not subject to, the registration requirements of the Securities Act, and in compliance with any applicable state and federal securities laws. In connection with any transfer of the Securities other than (i) pursuant to an effective registration statement, (ii) to the Company, (iii) to an affiliate of a Purchaser, (iv) pursuant to Rule 144 (provided that the Purchaser provides the Company with reasonable assurances (in the form of seller and broker representation letters if required) that the securities may be sold pursuant to such rule) or Rule 144A, (v) pursuant to Rule 144 without the requirement that the Company be in compliance with the current public information requirements of Rule 144 and without other restriction following the applicable holding period or (vi) in connection with a bona fide pledge, the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Subscription and shall have the rights of a Purchaser under this Subscription.

 

(ii) Removal of Legends. Subject to the Company’s right to request an opinion of counsel as set forth in Section 4(a)(i), the legend set forth in Section 2(u) above shall be removable and the Company shall issue or cause to be issued a certificate without such legend or any other legend to the holder of the applicable Shares upon which it is stamped or issue or cause to be issued to such holder by electronic delivery at the applicable balance account at The Depository Trust Company (“DTC”) as provided in this Section 4(a)(ii), if (i) such Securities are registered for resale under the Securities Act (provided that, if the Purchaser is selling pursuant to the effective registration statement registering the Securities for resale, the Purchaser agrees to only sell such Securities during such time that such registration statement is effective and not withdrawn or suspended, and only as permitted by such registration statement), (ii) such Securities are sold or transferred in compliance with Rule 144, including without limitation in compliance with the current public information requirements of Rule 144 if applicable to the Company at the time of such sale or transfer, and the holder and its broker have delivered customary documents reasonably requested by the Company Counsel in connection with such sale or transfer, or (iii) such Securities are eligible for sale under Rule 144 without the requirement that the Company be in compliance with the current public information requirements of Rule 144 and without other restriction and Company Counsel has provided written confirmation of such eligibility to the Company’s transfer agent, (the “Transfer Agent”). Any fees (with respect to the Transfer Agent, Company Counsel or otherwise) associated with the removal of such legend shall be borne by the Company. Following the effective date of the applicable registration statement, or at such other time as a legend is no longer required for certain Securities, the Company will no later than three (3) Trading Days following the delivery by a Purchaser to the Company or the Transfer Agent (with concurrent notice and delivery of copies to the Company) of a legended certificate representing such Shares (endorsed or with stock powers attached, signatures guaranteed, and otherwise in form necessary to affect the reissuance and/or transfer, and together with such other customary documents as the Transfer Agent and/or Company Counsel shall reasonably request), deliver or cause to be delivered to the transferee of such Purchaser or such Purchaser, as applicable, a certificate representing such Securities that is free from all restrictive and other legends. The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4(a). Certificates for Shares subject to legend removal hereunder shall be transmitted by the Transfer Agent to the Purchasers, as applicable, by crediting the account of the transferee’s Purchaser’s prime broker with DTC.

 

(iii) Irrevocable Transfer Agent Instructions. The Company shall issue irrevocable instructions to its Transfer Agent, and any subsequent Transfer Agent, in the form of Exhibit D attached hereto (the “Irrevocable Transfer Agent Instructions”). The Company represents and warrants that no instruction other than the Irrevocable Transfer Agent Instructions or instructions consistent therewith or otherwise contemplated hereby or thereby or by the Subscription or such other documents as the Transfer Agent may request in connection with any such instructions will be given by the Company to its Transfer Agent in connection with this Subscription, and that the Securities shall otherwise be freely transferable on the books and records of the Company as and to the extent provided in and subject to the terms of this Subscription and applicable law.

 

  Subscription Agreement
 14Generation Hemp, Inc.

 

 

(iv) Acknowledgement. Each Purchaser hereunder acknowledges its primary responsibilities under the Securities Act and accordingly will not sell or otherwise transfer the Shares or any interest therein without complying with the requirements of the Securities Act. While the applicable Registration Statement remains effective, each Purchaser hereunder may sell the Shares in accordance with the plan of distribution contained in the applicable Registration Statement and, if it does so, it will comply therewith and with the related prospectus delivery requirements unless an exemption therefrom is available. Each Purchaser, severally and not jointly with the other Purchasers, agrees that if it is notified by the Company in writing at any time that the Registration Statement registering the resale of the Shares is not effective or that the prospectus included in such Registration Statement no longer complies with the requirements of Section 10 of the Securities Act, the Purchaser will refrain from selling such Shares until such time as the Purchaser is notified by the Company that such Registration Statement is effective or such prospectus is compliant with Section 10 of the Securities Act, unless such Purchaser is able to, and does, sell such Shares pursuant to an available exemption from the registration requirements of Section 5 of the Securities Act. Each Purchaser acknowledges that the delivery of the Irrevocable Transfer Agent Instructions and any removal of any legends from certificates representing the Shares as set forth in this Section 4(a) is predicated on the Company’s reliance upon the Purchaser’s acknowledgement in this Section 4(a).

 

(b) Acknowledgment of Dilution. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding shares of Common Stock. The Company specifically acknowledges that its obligation to issue the Warrant Shares upon exercise of the Warrants, in accordance with its terms, is binding upon the Company and enforceable regardless of the dilution such issuance may have on the ownership interest of other stockholders of the Company or parties entitled to receive equity of the Company.

 

(c) Furnishing of Information. In order to enable the Purchasers to sell the Securities under Rule 144 of the Securities Act, for a period of one year from the Closing Date, the Company shall use its commercially reasonable efforts to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act. During such one year period, if the Company is not required to file reports pursuant to such laws, it will prepare and furnish to the Purchasers and make publicly available in accordance with Rule 144(c) such information as is required for the Purchasers to sell the Shares under Rule 144.

 

(d) Form D and Blue Sky. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D and to provide a copy thereof to each Purchaser who requests a copy in writing promptly after such filing. The Company shall take such action as the Company shall reasonably determine is necessary in order to qualify the Securities for sale to the Purchasers at the Closing pursuant to this Subscription under applicable securities or “Blue Sky” laws of the states of the United States (or to obtain an exemption from such qualification), which, subject to the accuracy of the Company’s and the Purchaser’s representations and warranties set forth herein, shall consist of the submission of all filings and reports relating to the offer and sale of the Securities pursuant to Rule 506 of Regulation D required under applicable securities or “Blue Sky” laws of the states of the United States following the Closing Date, and shall provide evidence of any such action so taken to the Purchasers who request in writing such evidence.

 

  Subscription Agreement
 15Generation Hemp, Inc.

 

 

(e) Securities Laws Disclosure; Publicity. Within the time required by the Exchange Act, the Company will file a Current Report on Form 8-K with the SEC describing the terms of the Subscription (and including as exhibits to such Current Report on Form 8-K the Subscription). Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any press release or filing with the SEC (other than the Registration Statement) or any regulatory agency or OTC Markets, LLC, without the prior written consent of such Purchaser, except (i) as required by federal securities law in connection with (A) any registration statement contemplated by the Subscription and (B) the filing of final Subscription (including signature pages thereto) with the SEC or (ii) to the extent such disclosure is required by law, request of the Staff of the SEC or OTC Markets, LLC regulations, in which case the Company shall provide the Purchasers with prior written notice of such disclosure permitted under this subclause (ii). From and after the issuance of the Form 8-K, no Purchaser shall be in possession of any material, non-public information received from the Company or any of its respective officers, directors, employees or agents, that is not disclosed in the Form 8-K unless a Purchaser shall have executed a written agreement regarding the confidentiality and use of such information. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company as described in this Section 4(f) such Purchaser will maintain the confidentiality of all disclosures made to it in connection with such transactions (including the existence and terms of such transactions).

 

(f) Non-Public Information. Except with respect to the material terms and conditions of the transactions contemplated by the Subscription, the Company shall not and shall cause each of its officers, directors, employees and agents, not to, provide any Purchaser with any information the Company believes is material, non-public information regarding the Company without the express written consent of such Purchaser, unless prior thereto such Purchaser shall have executed a written agreement regarding the confidentiality and use of such information.

 

(g) Indemnification.

 

(i) Indemnification of the Purchasers. Subject to this Section 4(h), the Company will indemnify and hold each Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other persons with a functionally equivalent role of a person holding such titles notwithstanding a lack of such title or any other title), each person who controls such Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling Person (each, a “Purchaser Party”) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation that any such Purchaser Party may suffer or incur, as a result of or relating to third party claims against such Purchaser relating to any breach of any of the representations, warranties, covenants or agreements made by the Company in this Subscription, provided that such a claim for indemnification relating to any breach of any of the representations or warranties made by the Company in this Agreement is made within one (1) year from the Closing. The Company will not be liable to any Purchaser Party under this Agreement to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party’s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Subscription or such Purchaser Party’s bad faith, fraud or willful misconduct.

 

  Subscription Agreement
 16Generation Hemp, Inc.

 

 

(ii) Conduct of Indemnification Proceedings. Promptly after receipt by any Person (the “Indemnified Person”) of notice of any demand, claim or circumstances which would or might give rise to a claim or the commencement of any action, proceeding or investigation in respect of which indemnity may be sought pursuant to Section 4(h)(i), such Indemnified Person shall promptly notify the Company in writing and the Company shall have the right to assume the defense thereof, including the employment of counsel reasonably satisfactory to such Indemnified Person and the assumption of the payment of all fees and expenses; provided, however, that the failure of any Indemnified Person so to notify the Company shall not relieve the Company of its obligations hereunder except to the extent that the Company is actually and materially prejudiced by such failure to notify. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless: (i) the Company and the Indemnified Person shall have mutually agreed to the retention of such counsel; (ii) the Company shall have failed promptly to assume the defense of such proceeding and to employ counsel reasonably satisfactory to such Indemnified Person in such proceeding; or (iii) in the reasonable judgment of counsel to such Indemnified Person and counsel to the Company, representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company shall not be liable for any settlement of any proceeding effected without its written consent, which consent shall not be unreasonably withheld, delayed or conditioned. Without the prior written consent of the Indemnified Person, which consent shall not be unreasonably withheld, delayed or conditioned, the Company shall not effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person is a party, unless such settlement includes an unconditional release of such Indemnified Person from all liability arising out of such Proceeding.

 

(h) Dispositions and Confidentiality After The Date Hereof. Each Purchaser shall not, and shall cause its Trading Affiliates not to, prior to the effectiveness of the Registration Statement: (a) sell, offer to sell, solicit offers to buy, dispose of, loan, pledge or grant any right with respect to (collectively, a “Disposition”) the Securities; or (b) engage in any hedging or other transaction which is designed or could reasonably be expected to lead to or result in a Disposition of the Securities by such Purchaser or an affiliate of the Purchaser, except, in each case, for Dispositions pursuant to an available exemption from, or in a transaction not subject to, the registration requirements of the Securities Act, and in compliance with any applicable state and federal securities laws. In addition, the Purchaser agrees that for so long as it owns any Common Stock, it will not enter into any Short Sale (as such term is defined in Rule 200 of Regulation SHO) of Shares executed at a time when the Purchaser has no equivalent offsetting long position in the Common Stock. For purposes of determining whether the Purchaser has an equivalent offsetting long position in the Common Stock, shares that the Purchaser is entitled to receive within sixty (60) days (whether pursuant to contract or upon conversion or exercise of convertible securities) will be included as if held long by the Purchaser. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser’s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser’s assets, the representation set forth above shall apply only with respect to the portion of assets managed by the portfolio manager that have knowledge about the financing transaction contemplated by this Agreement. Each Purchaser understands and acknowledges, severally and not jointly with any other Purchaser, that the SEC currently takes the position that covering a short position established prior to effectiveness of a resale registration statement with shares included in such registration statement would be a violation of Section 5 of the Securities Act, as set forth in Division of Corporation Financing Compliance and Disclosure Interpretation 239.10 regarding short selling.

 

5. Adjustment in Share Numbers and Prices. In the event of any stock split, subdivision, dividend or distribution payable in shares of Common Stock (or other securities or rights convertible into, or entitling the holder thereof to receive directly or indirectly shares of Common Stock), combination or other similar recapitalization or event occurring after the date hereof and prior to the Closing Date, each reference in the Subscription to a number of shares or price per share shall be deemed to be amended to appropriately account for such event.

 

6. Subscription Binding on Heirs, etc. This Subscription, upon acceptance by the Company, shall be binding upon the heirs, executors, administrators, successors and assigns of the Purchaser. If the undersigned is more than one person, the obligations of the undersigned shall be joint and several and the representations and warranties shall be deemed to be made by and be binding on each such person and his or her heirs, executors, administrators, successors, and assigns.

 

7. Execution Authorized. If this Subscription is executed on behalf of a corporation, partnership, trust or other entity, the undersigned has been duly authorized and empowered to legally represent such entity and to execute this Subscription and all other instruments in connection with the Shares and the signature of the person is binding upon such entity.

 

  Subscription Agreement
 17Generation Hemp, Inc.

 

 

8. Adoption of Terms and Provisions. The Purchaser hereby adopts, accepts and agrees to be bound by all the terms and provisions hereof.

 

9. Governing Law. This Subscription shall be construed in accordance with the laws of the State of New York.

 

10. Dispute Resolution. In the event of any dispute arising out of or relating to this Subscription, then such dispute shall be submitted to binding arbitration with the New York, New York branch of the American Arbitration Association (“AAA”) to be governed by AAA’s Commercial Rules of Arbitration (the “AAA Rules”) and heard before one arbitrator. The parties shall attempt to mutually select the arbitrator. In the event they are unable to mutually agree, the arbitrator shall be selected by the procedures prescribed by the AAA Rules. Notwithstanding anything in the AAA Rules to the contrary, discovery shall be limited exclusively to the mutual production of documents, and written submissions to the arbitrator shall be limited to one brief from each party and one responsive brief from each party.

 

11. Construction. When used in this Subscription and the Warrants, unless a contrary intention appears: (i) a term has the meaning assigned to it; (ii) “or” is not exclusive; (iii) “including” means including without limitation; (iv) words in the singular include the plural and words in the plural include the singular, and words importing the masculine gender include the feminine and neuter genders; (v) any agreement, instrument or statute defined or referred to herein or in any instrument or certificate delivered in connection herewith means such agreement, instrument or statute as from time to time amended, modified or supplemented and includes (in the case of agreements or instruments) references to all attachments thereto and instruments incorporated therein; (vi) the words “hereof”, “herein” and “hereunder” and words of similar import when used in this Subscription shall refer to this Subscription as a whole and not to any particular provision hereof; (vii) references contained herein to Article, Section, Schedule and Exhibit, as applicable, are references to Articles, Sections, Schedules and Exhibits in this Subscription unless otherwise specified; (viii) references to “writing” include printing, typing, lithography and other means of reproducing words in a visible form, including, but not limited to email; (ix) references to “dollars”, “Dollars” or “$” in this Subscription shall mean United States dollars; (x) reference to a particular statute, regulation or Law means such statute, regulation or Law as amended or otherwise modified from time to time; (xi) any definition of or reference to any agreement, instrument or other document herein shall be construed as referring to such agreement, instrument or other document as from time to time amended, supplemented or otherwise modified (subject to any restrictions on such amendments, supplements or modifications set forth herein); (xii) unless otherwise stated in this Subscription, in the computation of a period of time from a specified date to a later specified date, the word “from” means “from and including” and the words “to” and “until” each mean “to but excluding”; (xiii) references to “days” shall mean calendar days; and (xiv) the paragraph headings contained in this Subscription are for convenience only, and shall in no manner be construed as part of this Subscription.

 

12. Review of Document; Arm’s Length Transaction. Each party herein expressly represents and warrants to all other parties hereto that (a) before executing this Subscription, said party has fully informed itself of the terms, contents, conditions and effects of this Subscription; (b) said party has relied solely and completely upon its own judgment in executing this Subscription; (c) said party has had the opportunity to seek and has obtained the advice of its own legal, tax and business advisors before executing this Subscription; (d) said party has acted voluntarily and of its own free will in executing this Subscription; and (e) this Subscription is the result of arm’s length negotiations conducted by and among the parties and their respective counsel.

 

13. Counterparts. This Subscription and any signed agreement or instrument entered into in connection with this Subscription, and any amendments hereto or thereto, may be executed in one or more counterparts, all of which shall constitute one and the same instrument. Any such counterpart, to the extent delivered by means of a facsimile machine or by .pdf, .tif, .gif, .peg or similar attachment to electronic mail (any such delivery, an “Electronic Delivery”) shall be treated in all manner and respects as an original executed counterpart and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. At the request of any party, each other party shall re execute the original form of this Subscription and deliver such form to all other parties. No party shall raise the use of Electronic Delivery to deliver a signature or the fact that any signature or agreement or instrument was transmitted or communicated through the use of Electronic Delivery as a defense to the formation of a contract, and each such party forever waives any such defense, except to the extent such defense relates to lack of authenticity.

 

  Subscription Agreement
 18Generation Hemp, Inc.

 

 

14. Investor Information: (This must be consistent with the form of ownership selected below and the information provided in the Certificate of Accredited Investor Status (Exhibit B, included herewith.)

 

Name (please print): _______________________________________________________________________

 

If entity named above, By:___________________________________________________________________

 Its:___________________________________________________________________

 

Social Security or Taxpayer I.D. Number:________________________________________________________

 

Business Address (including zip code):_________________________________________________________

_______________________________________________________________________________________

 

Business Phone: __________________________________________________________________________

 

Residence Address (including zip code):_________________________________________________________

 

________________________________________________________________________________________

 

Email Address:_____________________________________________________________________________

 

Residence Phone:___________________________________________________________________________

 

All communications to be sent to:

 

__________ Business or ______ Residence Address ________ Email

 

Please indicate below the form in which you will hold title to your interest in the Units. PLEASE CONSIDER CAREFULLY. ONCE YOUR SUBSCRIPTION IS ACCEPTED, A CHANGE IN THE FORM OF TITLE CONSTITUTES A TRANSFER OF THE INTEREST IN THE SHARES AND/OR WARRANTS AND MAY THEREFORE BE RESTRICTED BY THE TERMS OF THIS SUBSCRIPTION OR APPLICABLE LAW, AND MAY RESULT IN ADDITIONAL COSTS TO YOU. Purchasers should seek the advice of their attorneys in deciding in which of the forms they should take ownership of the interest in the Units, because different forms of ownership can have varying gift tax, estate tax, income tax, and other consequences, depending on the state of the investor’s domicile and his or her particular personal circumstances.

 

______ INDIVIDUAL OWNERSHIP (one signature required)

 

______ JOINT TENANTS WITH RIGHT OF SURVIVORSHIP AND NOT AS TENANTS IN COMMON (both or all parties must sign)

 

______ COMMUNITY PROPERTY (one signature required if interest held in one name, i.e., managing spouse; two signatures required if interest held in both names)

 

______ TENANTS IN COMMON (both or all parties must sign)

 

______ GENERAL PARTNERSHIP (fill out all documents in the name of the PARTNERSHIP, by a PARTNER authorized to sign)

 

______ LIMITED PARTNERSHIP (fill out all documents in the name of the LIMITED PARTNERSHIP, by a GENERAL PARTNER authorized to sign)

 

______ LIMITED LIABILITY COMPANY (fill out all documents in the name of the LIMITED LIABILITY COMPANY, by a member authorized to sign)

 

______ CORPORATION (fill out all documents in the name of the CORPORATION, by the President or other officer authorized to sign)

 

______ TRUST (fill out all documents in the name of the TRUST, by the Trustee, and include a copy of the instrument creating the trust and any other documents necessary to show the investment by the Trustee is authorized. The date of the trust must appear on the Notarial where indicated.)

 

  Subscription Agreement
 19Generation Hemp, Inc.

 

 

Subject to acceptance by the Company, the undersigned has completed this Subscription Agreement to evidence his/her/its subscription for the purchase of Securities of the Company, this _______ day of _____, 2023.

 

  PURCHASER
   
  (Signature
   
  By:  
   
  If Entity, Entity Name:   
   
  Its:  

 

The Company has accepted this subscription this ____ day of _____, 2023

 

  “COMPANY”
   
  GENERATION HEMP, INC.,
  a Delaware corporation
   
  By:                              
    Gary C. Evans
    Chairman and CEO
   
  Address for notice:
   
  Generation Hemp, Inc.
  8533 Midway Road
  Dallas, Texas 75209
  Attn: gevans@genhempinc.com

 

  Subscription Agreement
 20Generation Hemp, Inc.

 

 

Schedule 1

 

WIRE INSTRUCTIONS

 

Beneficiary: Generation Hemp, Inc.

Beneficiary Address: 8533 Midway Road, Dallas TX 75209-1711

 

Truist Bank

200 W. 2nd Street

Winston Salem NC 27101

 

State and Routing Number: TX 111017694

Account #: 1440002048713

 

For International Wire:

Swift Code: BRBTUS33

 

Bank Contact:

Adam Wilkinson

325-374-7664

 

  Subscription Agreement
 21Generation Hemp, Inc.

 

 

Exhibit A

 

CERTIFICATE OF DESIGNATION

OF RIGHTS, PREFERENCES AND LIMITATIONS OF THE

SERIES C REDEEMABLE CONVERTIBLE PREFERRED STOCK

OF

GENERATION HEMP, INC

 

  Subscription Agreement
 22Generation Hemp, Inc.

 

 

Exhibit B

 

Form of Warrant

 

  Subscription Agreement
 23Generation Hemp, Inc.

 

 

Exhibit C

 

CERTIFICATE OF ACCREDITED INVESTOR STATUS

 

Except as may be indicated by the undersigned below, the undersigned is an “accredited investor,” as that term is defined in Regulation D under the Securities Act of 1933, as amended (the “Securities Act”). The undersigned has initialed the box below indicating the basis on which he is representing his status as an “accredited investor”:

 

______ a bank as defined in Section 3(a)(2) of the Securities Act, or any savings and loan association or other institution as defined in Section 3(a)(5)(A) of the Securities Act whether acting in its individual or fiduciary capacity; a broker or dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934, as amended (the “Securities Exchange Act”); an insurance company as defined in Section 2(13) of the Securities Act; an investment company registered under the Investment Company Act of 1940 or a business development company as defined in Section 2(a)(48) of that Act; a small business investment company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small Business Investment Act of 1958; a plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit of its employees, and such plan has total assets in excess of $5,000,000; an employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, if the investment decision is made by a plan fiduciary, as defined in Section 3(21) of such Act, which is either a bank, savings and loan association, insurance company, or registered investment adviser, or if the employee benefit plan has total assets in excess of $5,000,000 or, if a self-directed plan, with investment decisions made solely by persons that are “accredited investors”;

 

____ a private business development company as defined in Section 202(a)(22) of the Investment Advisers Act of 1940;

 

____ an organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, Massachusetts or similar business trust, or partnership, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;

 

____ a natural person whose individual net worth, or joint net worth with the undersigned’s spouse, at the time of this purchase exceeds $1,000,000. For purposes of this item, “net worth” means the excess of total assets at fair market value (including personal and real property, but excluding the estimated fair market value of a person’s primary home) over total liabilities. Total liabilities excludes any mortgage on the primary home in an amount of up to the home’s estimated fair market value as long as the mortgage was incurred more than 60 days before the Securities are purchased, but includes (i) any mortgage amount in excess of the home’s fair market value and (ii) any mortgage amount that was borrowed during the 60-day period before the closing date for the sale of Securities for the purpose of investing in the Securities;

 

____ a natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with the undersigned’s spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current year;

 

____ a trust with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the securities offered, whose purchase is directed by a person who has such knowledge and experience in financial and business matters that he is capable of evaluating the merits and risks of the prospective investment;

 

____ an entity in which all of the equity holders are “accredited investors” by virtue of their meeting one or more of the above standards; or

 

____ an individual who is a director or executive officer of Generation Hemp, Inc.

 

 

 

 

IN WITNESS WHEREOF, the undersigned has executed this Certificate of Accredited Investor Status effective as of __________________, 2023.

 

  Name:   
     
  By:  
    Signature
   
  Printed Name of Signatory (if entity):
   
  Title:  
    (required for any stockholder that is a corporation, partnership, trust or other entity)

 

 

 

 

Exhibit D

 

FORM OF IRREVOCABLE TRANSFER AGENT INSTRUCTIONS

 

As of _____________, 2023

 

__________________________

 

Attn: _____________

 

Ladies and Gentlemen:

 

Reference is made to those certain Subscription Agreements, dated as of _____________, 2023 (collectively, the “Agreement”), by and among Generation Hemp, Inc., a Delaware corporation (the “Company”), and the purchasers named on the signature pages thereto (collectively, and including permitted transferees, the “Holders”), pursuant to which the Company is issuing to the Holders units (the “Units”) comprised of (i) one share of Series C Redeemable Convertible Preferred Stock (the “Series C Preferred Stock” or the “Shares”) and (ii) 5,000 warrants (the “Warrant”) to purchase one share of common stock of the Company (the “Common Stock”) at an exercise price of $0.50 per share (the “Warrant Shares”).

 

This letter shall serve as our irrevocable authorization and direction to you (provided that you are the transfer agent of the Company at such time and the conditions set forth in this letter are satisfied), subject to any stop transfer instructions that we may issue to you from time to time, if any, to (i) issue, promptly following the date hereof, certificates representing the Shares (or the Warrant Shares upon exercise of the Warrants) bearing the legend set forth herein below, in the names of the Holders and the number of Shares (or Warrant Shares, if applicable) as set forth in the attachments delivered herewith, and to deliver such certificates within six (6) business days after the date hereof to the address for each such Holder as set forth on such attachments delivered herewith, and (ii) issue certificates representing shares of Common Stock upon conversion of the Shares (or Warrant Shares, if applicable), which certificates shall or shall not bear the legend set forth herein below as described below.

 

You acknowledge and agree that so long as you have received (a) written confirmation from the Company’s legal counsel that a registration statement covering resales of the Shares (or Warrant Shares, if applicable) has been declared effective by the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”), a copy of such registration statement and any other documents reasonably requested by you from the applicable Holder (and provided that you have not received written instruction from the Company or its legal counsel that such registration statement has been suspended or is no longer effective), (b) written confirmation from the Company’s legal counsel that the Shares (or Warrant Shares, if applicable) are eligible for sale in conformity with Rule 144 under the Securities Act (“Rule 144”) and customary documentation from a Holder and its broker with respect to a sale pursuant to Rule 144, or (c) written confirmation from the Company’s legal counsel that the Shares (or Warrant Shares, if applicable) are eligible for sale without the requirement that the Company be in compliance with the current public information requirements of Rule 144 and without other restriction in conformity with Rule 144, then, unless otherwise required by law, within three (3) business days of your receipt of certificate of Common Stock and documentation required pursuant to clause (a) or (b) above, as applicable, or a request from a Holder for the issuance of an unlegended certificate in the event that you have received the written confirmation set forth in clause (c) above, you shall issue the certificates representing the Shares (or Warrant Shares, if applicable) registered in the names of the purchaser of such Shares or the Holder, as the case may be, and such certificates shall not bear any legend restricting transfer of the Shares (or Warrant Shares, if applicable) thereby and should not be subject to any stop-transfer restriction.

 

 

 

 

All certificates representing the Shares (or Warrant Shares, if applicable) issued pursuant to the instruction set forth in clause (i) of the second paragraph of this letter shall bear the following legend (and, solely to the extent instructed to you by the Company or its legal counsel, a customary “affiliates” legend), and, in the event that you have not received the documentation required pursuant to clause (a), (b) or (c) of the immediately preceding paragraph, then the certificates representing any shares of Common Stock issued pursuant to the instruction set forth in clause (ii) of the second paragraph of this letter shall bear the following legend:

 

THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES, THE TRANSFER IS MADE IN COMPLIANCE WITH RULE 144 PROMULGATED UNDER SUCH ACT OR THE COMPANY RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF THESE SECURITIES WHICH IS REASONABLY SATISFACTORY TO THE COMPANY, STATING THAT SUCH SALE, TRANSFER, ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF SUCH ACT.

 

Please be advised that the Holders are relying upon this letter as an inducement to enter into the Agreement and, accordingly, each Holder is a third party beneficiary to these instructions.

 

Please execute this letter in the space indicated to acknowledge your agreement to act in accordance with these instructions.

 

  Very truly yours,
   
  GENERATION HEMP, INC.
   
  By:  
  Name:  Gary C. Evans
  Title: Chairman and CEO

 

Acknowledged and Agreed:  
   
By:               
Name:    
Title:    
Date:    

 

 

 

 

EX-10.50 5 f10k2022ex10-50_evergreen.htm LETTER AGREEMENT, DATED APRIL 27, 2023, WITH COVENTRY ASSET MANAGEMENT, LTD

Exhibit 10.50

 

Generation Hemp, Inc.

8533 Midway Road

Dallas, Texas 75209

 

April 27, 2023

 

Coventry Asset Management, Ltd.

2048 Coventry Ct.

Keller, Texas 76262

 

Re:In reference to that certain Secured Promissory Note Issued by Halcyon Thruput, LLC, dated December 30, 2020 (the “Note”).

 

Coventry Assert Management, Ltd.:

 

To Coventry Asset Management, Ltd. (“Coventry”), this letter agreement (the “Agreement”) is being issued by Generation Hemp, Inc. (the “Company”) to amend certain terms and conditions of the Note referenced above. All terms used herein shall have the meanings ascribed to such terms in the Note.

 

All principal payments shall be suspended until the Maturity Date of the Note, except as outlined below. The Maturity Date of the Note shall be amended to reflect that it is December 31, 2023; provided however that if the Company successfully completes a private or public equity offering equal to or in excess of $5,000,000 (the “Offering”) prior to such date, then the Company will pay all outstanding principal and interest payments due under the Note within five business days of the closing of such offering.

 

The Company agrees to make a principal payment in the amount of $250,000.00 (Two Hundred Fifty Thousand Dollars) of the original principal balance of this Note on or by June 1, 2023. Additionally, the Company agrees to make another principal payment in the amount of $250,000.00 (Two Hundred Fifty Thousand Dollars) of the original principal balance of this Note on or before August 31, 2023.

 

The interest rate on the remaining principal balance of this Note shall continue at 14% per annum.

 

In consideration of such modifications to the Note, the Company agrees to issue to Coventry 50,000 (Fifty Thousand) shares of the Company’s common stock. These shares will be unregistered restricted securities and shall be subject to the restrictions placed on such shares through both Blue-Sky Laws of the applicable states and the rules and regulations of the United States Securities and Exchange Commission and applicable laws and regulatory authorities.

 

Except as modified by this Agreement, all other terms of the Note shall remain in full force and effect.

 

Coventry Asset Management, Ltd. Note Extension
page 1

 

 

Agreed to and Accepted by Generation Hemp, Inc.

 

/s/ Gary C. Evans   4/27/2023
Gary C. Evans, Chairman and   DATE
Chief Executive Officer    

 

Agreed and Accepted by Coventry Asset Management, Ltd.

 

/s/ Gen Fukunaga   5/5/2023
Gen Fukunaga, Managing Partner   DATE

 

 

Coventry Asset Management, Ltd. Note Extension
page 2

 

EX-10.51 6 f10k2022ex10-51_evergreen.htm SECURED PROMISSORY NOTE, DATED APRIL 19, 2023, MADE BY RAZORBACK I, LLC, IN FAVOR OF MICHAEL A. MCMANUS AND GARY C. EVANS

Exhibit 10.51

 

SECURED PROMISSORY NOTE

 

RAZORBACK I, LLC

 

DUE APRIL 15, 2024

 

Original Issue Date: April 19, 2023 $300,000.00

 

FOR VALUE RECEIVED, RAZORBACK I, LLC, a Texas Limited Liability Company (the “Borrower”) with a mailing address of P.O. Box 540308, Dallas, Texas 75354, promises to pay to the order of MICHAEL A. McMANUS, a natural person (the “Holder”) with a mailing address of 265 Coconut Place, Vero Beach, Florida 32963, the principal sum of One Hundred Fifty Thousand and 00/100 Dollars ($150,000.00) (one-half of the “Principal Amount”), and promises to pay to the order of GARY C. EVANS, a natural person (the “Holder”) with a mailing address of P.O. Box 540308, Dallas, Texas 75354, the principal sum of One Hundred Fifty Thousand and 00/100 Dollars ($150,000.00) (one-half of the “Principal Amount”) in lawful currency of the United States, subject to the terms and conditions set forth in this Secured Promissory Note (the “Note”). Mr. McManus and Mr. Evans are jointly referred to as Holders (“Holders”).

 

This Note together with the Pledge Agreement (as defined below) and all other promissory notes, pledge agreements, guaranties, deeds of trust, security agreements, affidavits, and other instruments, documents and agreements executed and delivered by Borrower pursuant to or in connection with this Agreement and any future amendments hereto or thereto shall constitute the “Loan Documents”. The proceeds received from this note will be utilized to acquire a 2.21± acre parcel of land located at 111 Cherry Street, Monticello, Arkansas.

 

Article I.

 

Section 1.01  Payments and Conversion.

 

(a) The entire Principal Amount and all accrued and unpaid interest thereon (collectively, the “Obligations”) shall be due and payable in full without setoff, deduction or counterclaim on April 15, 2024 (the “Maturity Date”). Accrued interest through the end of each fiscal quarter shall be due and payable on July 15, 2023, October 15, 2023, January 15, 2024, and April 15, 2024.

 

(b) Notwithstanding to the contrary, all outstanding principal and all accrued and unpaid interest hereunder shall be due and payable in full at the Maturity Date. In addition, the Holders shall each have the option to convert the then outstanding balance of principal and interest under this Note into restricted shares of the Borrower’s Common Stock at a conversion price equal to $0.30 per share of Common Stock.

 

(c) From the Original Issue Date until the indefeasible payment and performance in full of all Obligations, interest shall accrue on the principal balance at a rate equal to the lesser of (a) twelve percent (12.00%) per annum, calculated on a basis of 365-day year, and (b) the Highest Lawful Rate (the “Interest Rate”). For purposes of this Note, “Highest Lawful Rate” means the maximum non-usurious rate of interest permitted by applicable federal or Texas law from time to time. All matured and past due amounts under this Note shall bear interest at the Highest Lawful Rate. All payments shall be applied first to accrued but unpaid interest and then to principal.

  

Section 1.02  Absolute Obligation/Ranking.

 

(a) This Note is a direct debt obligation of the Borrower. Except as expressly provided herein, no provision of this Note shall alter or impair the obligation of the Borrower, which is absolute and unconditional, to pay the principal of, and interest on, this Note at the time, place, and rate, and in the coin or currency, herein prescribed.

 

(b) Unless waived by the holders of a majority of the aggregate outstanding principal amount of the Note, and all other Notes now or hereafter issued, this Note shall rank senior to all existing indebtedness of the Borrower, and will rank senior to all future indebtedness of the Borrower except for trade payables and accrued liabilities incurred in the ordinary course of business consistent with past practices.

 

 

 

 

Section 1.03  Pre-Payment.  This Note may be prepaid, in whole or in part, at any time prior to the Maturity Date without penalty as to principal, upon thirty (30) days written notice to Holders and interest shall immediately cease on all amounts so prepaid; All prepayments to principal shall be applied to principal in the inverse order of its stated maturity

 

Section 1.04 Collateral; Other Rights.

 

(a) The obligations of the Borrower to the Holders under this Note shall be contractually secured by the Borrower as more fully set forth in the Pledge Agreement associated with this Note.

 

(b) In addition to the rights and remedies given by this Note, the Holders shall have all those rights and remedies allowed by applicable laws. The rights and remedies of the Holders are cumulative and recourse to one or more right or remedy shall not constitute a waiver of the others.

 

(c) In addition to the rights and remedies given by this Note, and all those rights and remedies allowed by applicable laws, pursuant to that certain Pledge Agreement (“Pledge Agreement”), the Holders shall have the right to a pledge of the 100% ownership interest in Razorback I, LLC, as listed on Exhibit A attached hereto.

 

(d) In addition to the rights and remedies given by this Note, by all those rights and remedies allowed by applicable laws, the Holders shall have a first lien on the Collateral.

 

Article II.

 

Section 2.01  Events of Default.  Each of the following events shall constitute a default under this Note (each an “Event of Default”):

 

(a) failure by the Borrower to pay any amount when due hereunder on any other Loan Document;

 

(b) the Borrower or any subsidiary of the Borrower shall: (i) make a general assignment for the benefit of its creditors; (ii) apply for or consent to the appointment of a receiver, trustee, assignee, custodian, sequestrator, liquidator or similar official for itself or any of its assets and properties; (iii) commence a voluntary case for relief as a debtor under the United States Bankruptcy Code; (iv) file with or otherwise submit to any governmental authority any petition, answer or other document seeking: (A) reorganization, (B) an arrangement with creditors or (C) to take advantage of any other present or future applicable law respecting bankruptcy, reorganization, insolvency, readjustment of debts, relief of debtors, dissolution or liquidation; (v) file or otherwise submit any answer or other document admitting or failing to contest the material allegations of a petition or other document filed or otherwise submitted against it in any proceeding under any such applicable law, or (vi) be adjudicated a bankrupt or insolvent by a court of competent jurisdiction;

 

(c) any case, proceeding or other action shall be commenced against the Borrower or any subsidiary of the Borrower for the purpose of effecting, or an order, judgment or decree shall be entered by any court of competent jurisdiction approving (in whole or in part) anything specified in Section 2.01(b) hereof, or any receiver, trustee, assignee, custodian, sequestrator, liquidator or other official shall be appointed with respect to the Borrower, or shall be appointed to take or shall otherwise acquire possession or control of all or a substantial part of the assets and properties of the Borrower, and any of the foregoing shall continue unstayed and in effect for any period of sixty (60) days;

  

(d) any material breach by the Borrower of any of its representations or warranties contained in this Note; or

 

(e) any default other than a payment default, whether in whole or in part, shall occur in the due observance or performance of any obligations or other covenants, terms or provisions to be performed by the Borrower under this Note, which is not cured within fifteen (15) days after receipt of written notice thereof.

 

The cure period referenced in (d) and (e) above shall not apply to Events of Default which are not capable of being cured and to breaches of negative covenants.

 

(f) any event of default by the Borrower shall have occurred and be continuing beyond all grace and/or cure periods or assert the invalidity thereof prior to payment in full of all amounts payable under this Note.

 

2

 

 

Section 2.02 If any Event of Default occurs, the full principal amount of this Note, together with interest and any other amounts due and owing in respect thereof, to the date of the Event of Default shall become, at the Holders’ elections, immediately due and payable and the Holders hereof shall have the right to foreclose or otherwise enforce all liens or security interests securing payment hereof, or any part hereof, and offset against this Note any sum or sums owed by Holders to Borrower. In all events, interest shall accrue through the date of payment. The Holders need not provide, and the Borrower hereby waives, any presentment, demand, protest or other notice of any kind, and the Holders may immediately and without expiration of any grace period enforce any and all of its rights and remedies hereunder and all other remedies available to it under applicable law. Such declaration may be rescinded and annulled by the Holders at any time prior to payment hereunder and the Holders shall have all rights as a Note holder until such time, if any, as the full payment under this Section shall have been received by it. No such rescission or annulment shall affect any subsequent Event of Default or impair any right consequent thereon.

 

Article III.

 

Section 3.01 Negative Covenants. So long as this Note shall remain in effect and until all outstanding principal and interest and all fees and all other expenses or amounts payable under this Note have been paid in full, unless the holders of a majority of the aggregate unpaid principal amount of the Note shall otherwise consent in writing (such consent not to be unreasonably withheld), the Borrower shall not:

 

(a) Senior or Pari Passu Indebtedness.  Incur, create, assume, guaranty or permit to exist any indebtedness that ranks senior in priority to, or pari-passu with, the obligations under this Note and (other than trade payables and accrued liabilities incurred in the ordinary course of business consistent with past practices).

 

(b) Liens.  Create, incur, assume or permit to exist any lien on any Collateral (as such term is defined in this Note, now owned or hereafter acquired and owned by it or on any income or revenues or rights in respect thereof, except:

 

(i) liens on Collateral of the Borrower existing on the date hereof, provided that such liens shall secure only those obligations which they secure on the date hereof;

 

(ii) any lien created under this Note;

 

(iii) any lien existing on any Collateral prior to the acquisition thereof by the Borrower, provided that

 

1) such lien is not created in contemplation of or in connection with such acquisition and

  

(iv) liens for taxes, assessments and governmental charges; and

 

(v) any lien created by operation of law, such as materialmen’s liens, mechanics’ liens and other similar liens, arising in the ordinary course of business with respect to a liability that is not yet due or delinquent or that are being contested in good faith by appropriate proceedings,

 

(vi) liens arising out of judgments or awards (other than any judgment that constitutes an Event of Default hereunder) in respect of which the Borrower shall in good faith be prosecuting an appeal or proceedings for review and in respect of which it shall have secured a subsisting stay of execution pending such appeal or proceedings for review, provided the Borrower shall have set aside on its books adequate reserves with respect to such judgment or award.

 

(c) Dividends and Distributions. Declare or pay, directly or indirectly, any dividend or make any other distribution (by reduction of capital or otherwise), whether in cash, property, securities or a combination thereof, with respect to any shares of its capital stock or directly or indirectly redeem, purchase, retire or otherwise acquire for value any shares of any class of its capital stock or set aside any amount for any such purpose.

 

(d) Limitation on Certain Payments and Prepayments.

 

(i) Pay in cash any amount in respect of any indebtedness or preferred stock that may at the obligor’s option be paid in kind or in other securities; or

 

(ii) Optionally prepay, repurchase or redeem or otherwise defease or segregate funds with respect to any indebtedness of the Borrower, other than indebtedness under this Note. For avoidance of doubt, nothing in the Section shall be deemed to prevent or limit the Borrower from paying accounts payable and accrued liabilities.

 

(a) Amendments. Amend, modify or limit any terms of this Note or assert the invalidity of this Note.

 

3

 

 

Article IV.

 

Section 4.01  Section 4.01 Spreading. Notwithstanding anything to the contrary contained herein, no provisions of this Note shall require the payment or permit the collection of interest in excess of the Highest Lawful Rate. If any excess of interest in such respect is herein provided for, or shall be adjudicated to be so provided, in this Note or otherwise in connection with this loan transaction, the provisions of this paragraph shall govern and prevail, and neither Borrower nor the sureties, guarantors, successors or assigns of Borrower shall be obligated to pay the excess amount of such interest, or any other excess sum paid for the use, forbearance or detention of sums loaned pursuant hereto. If for any reason interest in excess of the Highest Lawful Rate shall be deemed charged, required or permitted by any court of competent jurisdiction, any such excess shall be applied as a payment and reduction of the principal of indebtedness evidenced by this Note; and, if the principal amount hereof has been paid in full, any remaining excess shall forthwith be paid to Borrower

 

Section 4.02 Notice. All notice and other communications hereunder which are required or permitted under this Note will be in writing and shall be deemed effectively given to a party by (a) the date of transmission if sent by facsimile or e-mail with confirmation of transmission by the transmitting equipment if such notice or communication is delivered prior to 5:00 P.M., Dallas, Texas time, on a business day, or the next business day after the date of transmission, if such notice or communication is delivered on a day that is not a business day or later than 5:00 P.M., Dallas, Texas time, on any business day; (b) seven days after deposit with the United States Post Office, by certified mail, return receipt requested, first-class mail, postage prepaid; (c) on the date delivered, if delivered by hand or by messenger or overnight courier, addressee signature required (costs prepaid), to the addresses below or at such other address and/or to such other persons as shall have been furnished by the parties:

 

  If to the Borrower:

Razorback I, LLC

PO Box 540308

Dallas, Texas 75354

Attention:  Gary C. Evans, Manager

     
 

If to the Holders:

To the Holders’ addresses set forth in the Recitals to this Promissory Agreement

  

Section 4.03  Governing Law; Jurisdiction. This Note is being delivered in, is intended to be performed in, shall be construed and enforceable in accordance with, and shall be governed by the laws of the State of Texas, without regard to the conflicts of laws principles thereof. THE PARTIES AGREE THAT THE EXCLUSIVE FORUM AND VENUE FOR ANY ACTION BROUGHT PURSUANT TO THE TERMS OF THIS NOTE, OR IN ANY WAY RELATING TO THIS NOTE, SHALL BE BROUGHT IN DALLAS COUNTY, TEXAS. This Note constitutes a major transaction under Texas Civil Practice and Remedies Code Section 15.020. Each party hereto hereby irrevocably submits to the jurisdiction of the State and Federal Courts in Dallas County, Texas for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of this Note), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, or such Texas Courts are improper or inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Note and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing herein shall affect the right of the Holders to commence legal proceedings or otherwise proceed against the Borrower in any other jurisdiction.

 

Section 4.04  Severability.  The invalidity of any of the provisions of this Note shall not invalidate or otherwise affect any of the other provisions of this Note, which shall remain in full force and effect.

 

Section 4.05  Entire Agreement and Amendments.  This Note represents the entire agreement between the parties hereto with respect to the subject matter hereof and there are no representations, warranties or commitments, except as set forth herein. This Note may be amended only by an instrument in writing executed by the Borrower and persons holding at least a majority of the principal amount of the Note.

 

Section 4.06  Cancellation.  After all principal, accrued interest and other amounts at any time owed on this Note has been paid in full, this Note shall automatically be deemed canceled, shall be surrendered to the Borrower for cancellation and shall not be reissued.

 

4

 

 

Section 4.07  Lost, Stolen, Destroyed or Mutilated Notes. In case the Note shall be mutilated, lost, stolen or destroyed, the Borrower shall issue a new Note of like date, tenor and denomination and deliver the same in exchange and substitution for and upon surrender and cancellation of any mutilated Note, or in lieu of any Note lost, stolen or destroyed, upon receipt of evidence satisfactory to the Borrower of the loss, theft or destruction of such Note or a sworn affidavit with respect thereto.

 

Section 4.08  Construction; Headings.  The headings of this Note are for convenience of reference and shall not form part of, or affect the interpretation of, this Note.

 

Section 4.09  Payment of Collection, Enforcement and Other Costs.  If (a) this Note is placed in the hands of an attorney for collection or enforcement or is collected or enforced through any legal proceeding or the Holders otherwise takes action to collect amounts due under this Note or to enforce the provisions of this Note or (b) there occurs any bankruptcy, reorganization, receivership of the Borrower or other proceedings affecting Borrower creditors’ rights and involving a claim under this Note, then the Borrower shall pay the costs incurred by the Holders for such collection, enforcement or action or in connection with such bankruptcy, reorganization, receivership or other proceeding, including, but not limited to, attorneys’ fees and disbursements.

 

Section 4.10  Waiver of Notice. To the extent permitted by law, Borrower and each surety, guarantor, endorser and other party ever liable for payment of any sums of money payable on this Note jointly and severally waive presentment and demand for payment, protest, notice of protest and non-payment or dishonor, notice of acceleration, notice of intent to accelerate, notice of intent to demand, diligence in collecting and grace, and consent to all extensions without notice for any period or periods of time and partial payments, before or after maturity, without prejudice to the Holders. The Holders shall similarly have the right to deal in any way, at any time, with one or more of the foregoing parties without notice to any other party, and to grant any such party any extensions of time for payment of any of said indebtedness, or to release part or all of the Collateral securing this Note, or to grant any other indulgences or forbearances whatsoever, without notice to any other party and without in any way affecting the personal liability of any party hereunder.

  

Section 4.11 The Borrower hereby covenants and agrees that the Borrower will not, by amendment of its certificate of incorporation, bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Note, and will at all times in good faith carry out all of the provisions of this Note and take all action as may be required to protect the rights of the Holders of this Note.

 

Section 4.12 Balloon Feature. This Note is payable in full when due. At maturity, Borrower must repay the entire principal balance of this Note and unpaid interest then due. Holders are under no obligation to refinance this Note at that time. Borrower will, therefore, be required to make payment out of other assets that Borrower may own or Borrower will have to find a lender, which may be Holders, willing to lend Borrower the money. If Borrower refinances this loan at maturity, Borrower will have to pay some or all of the closing costs normally associated with a new loan even if Borrower obtains refinancing from Holders.

 

[SIGNATURE PAGE TO FOLLOW]

 

5

 

 

IN WITNESS WHEREOF, the Borrower have executed this Note as of the date first written above.

 

  BORROWER:
   
  RAZORBACK I, LLC
     
  By: /s/ Gary C. Evans
    Gary C. Evans, Chairman of the Board, President, and
Chief Executive Officer

  

ACKNOWLEDGED AND AGREED:  
     
MICHAEL A. McMANUS  
     
By /s/ Michael A. McManus  
  Michael A. McManus  
     
ACKNOWLEDGED AND AGREED:  
     
GARY C. EVANS  
     
By: /s/ Gary C. Evans  
  Gary C. Evans  

 

 

 

 

EXHIBIT A

 

Collateral: The collateral for this note consists solely of the 100% ownership of Razorback I, LLC. This entity will be the owner of the real estate acquired representing a 2.21± acre parcel of land located at 111 Cherry Street, Monticello, Arkansas.

 

 

 

 

 

EX-10.52 7 f10k2022ex10-52_evergreen.htm GUARANTY AGREEMENT BY EVERGREEN SUSTAINABLE ENTERPRISES, INC. IN FAVOR OF IN FAVOR OF MICHAEL A. MCMANUS AND GARY C. EVANS

Exhibit 10.52

 

GUARANTY AGREEMENTEVERGREEN
SUSTAINABLE ENTERPRISES, INC.

 

This Guaranty Agreement dated as of April 19, 2023 (this “Guaranty”) is executed by Evergreen Sustainable Enterprises, Inc., a Delaware corporation (the “Guarantor”), in favor of Michael A. McManus, an individual, and Gary C. Evans, an individual, jointly referred to as Lenders (“Lenders”).

 

INTRODUCTION

 

A. This Guaranty is given in connection with that certain Secured Promissory Note of even date herewith (as it may be amended, supplemented, restated or otherwise modified from time to time, the “Note”), between Razorback I, LLC, a Texas limited liability company, as Borrower (“Razorback” or “Borrower”) and the Lenders.

 

B. The Borrower is a wholly-owned subsidiary of the Guarantor and, therefore, the Guarantor will derive substantial direct and indirect benefit from the transactions contemplated by the Note and the other Loan Documents (as defined in the Note).

 

C. The Guarantor is executing and delivering this Guaranty (i) to induce the Lenders to provide the loan under the Note, and (ii) intending it to be a legal, valid, binding, enforceable and continuing obligation of the Guarantor, whether or not the Guarantor derives any benefit from the Note or from any other Loan Document.

 

NOW THEREFORE, for good and valuable consideration the receipt of which is hereby acknowledged, the Guarantor agrees, for the benefit of the Lenders, as follows:

 

Section 1. Definitions. All capitalized terms not otherwise defined in this Guaranty shall have the meanings assigned to such terms in the Note.

 

Section 2. Guaranty.

 

(a) The Guarantor hereby absolutely, unconditionally and irrevocably guarantees the punctual payment and performance, when due, whether at stated maturity, by acceleration or otherwise, of all Obligations, whether absolute or contingent and whether for principal, interest (including, without limitation, interest that but for the existence of a bankruptcy, reorganization or similar proceeding would accrue), fees, amounts required to be provided as collateral, indemnities, expenses or otherwise, and the full, complete and punctual performance, observance, fulfillment and satisfaction of each and every agreement, covenant, warranty and obligation of Borrower under the Loan Documents in accordance with their respective terms (collectively, the “Guaranteed Obligations”). Without limiting the generality of the foregoing, the Guarantor’s liability shall extend to all amounts that constitute part of the Guaranteed Obligations and would be owed by the Borrower to the Lenders under the Loan Documents but for the fact that they are unenforceable or not allowable due to insolvency or the existence of a bankruptcy, reorganization or similar proceeding involving the Borrower. This Guaranty is an absolute guaranty of payment and performance and not merely of collection.

 

1

 

 

(b) It is the intention of the Guarantor and the Lenders that the amount of the Guaranteed Obligations guaranteed by the Guarantor shall be in, but not in excess of, the maximum amount permitted by fraudulent conveyance, fraudulent transfer or similar laws, statutes, ordinances, decrees, requirements, orders, judgments, rules, or regulations applicable to the Guarantor. Accordingly, notwithstanding anything to the contrary contained in this Guaranty or in any other agreement or instrument executed in connection with the payment of any of the Guaranteed Obligations, the amount of the Guaranteed Obligations guaranteed by the Guarantor under this Guaranty shall be limited to an aggregate amount equal to the largest amount that would not render the Guarantor’s obligations hereunder subject to avoidance under Section 548 of the United States Bankruptcy Code or any comparable provision of any other applicable law.

 

Section 3. Guaranty Absolute. The Guarantor guarantees that the Guaranteed Obligations will be paid strictly in accordance with the terms of the Loan Documents and the other documents governing such Guaranteed Obligations, regardless of any law, regulation or order now or hereafter in effect in any jurisdiction affecting any of such terms or the rights of the Lenders with respect thereto but subject to Section 2(b) above. The obligations of the Guarantor under this Guaranty are independent of the Guaranteed Obligations or any other obligations of any other person under the Loan Documents, and a separate action or actions may be brought and prosecuted against the Guarantor to enforce this Guaranty, irrespective of whether any action is brought against the Borrower or any other person or whether the Borrower or any other person is joined in any such action or actions. The liability of the Guarantor under this Guaranty shall be irrevocable, absolute and unconditional irrespective of, and the Guarantor hereby irrevocably waives any defenses it may now or hereafter have in any way relating to, any or all of the following:

 

(a) any lack of validity or enforceability of any Loan Document or any agreement or instrument relating to any part of the Guaranteed Obligations being irrecoverable;

 

(b) any acceleration, forbearance, renewal, extension, change in the time, manner or place of payment of, or in any other term of, all or any of the Guaranteed Obligations or any other obligations of any person under the Loan Documents or any other amendment or waiver of or any consent to departure from any Loan Document, including, without limitation, any increase in the Guaranteed Obligations resulting from the extension of additional credit to the Borrower or otherwise;

 

(c) any acceptance, taking, exchange, release or non-perfection of any collateral, or any taking, release or amendment or waiver of or consent to departure from any other guaranty, for all or any of the Guaranteed Obligations;

 

(d) any manner of application of collateral, or proceeds thereof, to all or any of the Guaranteed Obligations, or any manner of sale or other disposition of any collateral for all or any of the Guaranteed Obligations or any other obligations of any other person under the Loan Documents or any other assets of any other guarantor, the Borrower or any Subsidiary of the Borrower;

 

(e) any change, restructuring or termination of the corporate structure or existence of any other guarantor, the Borrower or any Subsidiary of the Borrower;

 

2

 

 

(f) any failure of the Lenders to disclose to the Borrower or the Guarantor any information relating to the business, condition (financial or otherwise), operations, properties or prospects of any person now or in the future known to the Lenders (and the Guarantor hereby irrevocably waives any duty on the part of the Lenders to disclose such information);

 

(g) any signature of any officer of the Borrower being mechanically reproduced in facsimile or otherwise; or

 

(h) any other circumstance or any existence of or reliance on any representation by the Lenders that might otherwise constitute a defense available to, or a discharge of, the Borrower or any other guarantor, surety or other person, including but not limited to any defense of waiver, release, fraud, invalidity, anti-deficiency statutes or laws, illegality, unenforceability, force majeure, act of God, casualty, impossibility, impracticability, statute of limitations, res judicata or any other defense or excuse whatsoever.

 

Section 4. Continuation and Reinstatement, Etc. The Guarantor agrees that, to the extent that payments of any of the Guaranteed Obligations are made, or the Lenders receive any proceeds of collateral, and such payments or proceeds or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, or otherwise required to be repaid, then to the extent of such repayment the Guaranteed Obligations shall be reinstated and continued in full force and effect as of the date such initial payment or collection of proceeds occurred. THE GUARANTOR SHALL DEFEND AND INDEMNIFY THE LENDERS AND ITS RELATED PARTIES FROM AND AGAINST ANY CLAIM, DAMAGE, LOSS, LIABILITY, COST OR EXPENSE UNDER THIS SECTION 4 (INCLUDING REASONABLE ATTORNEYS’ FEES AND EXPENSES) IN THE DEFENSE OF ANY SUCH ACTION OR SUIT INCLUDING SUCH CLAIM, DAMAGE, LOSS, LIABILITY, COST, OR EXPENSE ARISING AS A RESULT OF THE INDEMNIFIED PARTY’S OWN NEGLIGENCE BUT EXCLUDING SUCH CLAIM, DAMAGE, LOSS, LIABILITY, COST, OR EXPENSE THAT IS FOUND IN A FINAL, NON-APPEALABLE JUDGMENT BY A COURT OF COMPETENT JURISDICTION TO HAVE RESULTED FROM SUCH INDEMNIFIED PARTY’S GROSS NEGLIGENCE OR WILLFUL MISCONDUCT.

 

Section 5. Waivers and Acknowledgments.

 

(a) The Guarantor hereby waives promptness, diligence, presentment, protest, notice of acceptance, notice of demand, notice of default, notice of assignment, and any other notice with respect to any of the Guaranteed Obligations and this Guaranty and any requirement that the Lenders protect, secure, perfect or insure any Lien or any property or exhaust any right or take any action against the Borrower or any other person or any collateral.

 

(b) The Guarantor hereby irrevocably waives any right to revoke this Guaranty, and acknowledges that this Guaranty is continuing in nature and applies to all Guaranteed Obligations, whether existing now or in the future.

 

(c) The Guarantor acknowledges that it will receive substantial direct and indirect benefits from the financing arrangements involving the Borrower contemplated by the Loan Documents and that the waivers set forth in this Guaranty are knowingly made in contemplation of such benefits.

 

3

 

 

Section 6. Specific Waiver of Fraudulent Conveyance Claims. The Guarantor hereby waives the right to assert any claim or cause of action to avoid any transfer to the Lenders contemplated by and made pursuant to the Note or any other Loan Document that may exist by virtue of any federal or state statute providing for such avoidance.

 

Section 7. Subrogation. Until one year and one day after the date that all Guaranteed Obligations (other than contingent Guaranteed Obligations with respect to indemnity and reimbursement of expenses as to which no claim has been made as of the time of determination) have been paid in full in cash (the “Termination Date”), the Guarantor shall not exercise any rights that it may now have or hereafter acquire against the Borrower or any other person to the extent that such rights arise from the existence, payment, performance or enforcement of the Guarantor’s obligations under this Guaranty or any other Loan Document, including, without limitation, any right of subrogation, reimbursement, exoneration, contribution or indemnification and any right to participate in any claim or remedy of the Lenders against the Borrower or any other person, whether or not such claim, remedy or right arises in equity or under contract, statute or common law, including, without limitation, the right to take or receive from the Borrower or any other person, directly or indirectly, in cash or other property or by set-off or in any other manner, payment or security on account of such claim, remedy or right. If any amount shall be paid to the Guarantor in violation of the preceding sentence, such amount shall be held in trust for the benefit of the Lenders and shall forthwith be paid to the Lenders to be credited and applied to the Guaranteed Obligations and any and all other amounts payable by the Guarantor under this Guaranty, whether matured or unmatured, in accordance with the terms of the Loan Documents.

 

Section 8. Representations and Warranties. The Guarantor hereby represents and warrants as follows:

 

(a) The Guarantor is duly formed and is in good standing in the state of Colorado

 

(b) There are no conditions precedent to the effectiveness of this Guaranty. The Guarantor benefits from executing this Guaranty.

 

(c) The Guarantor has, independently and without reliance upon the Lenders and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Guaranty, and the Guarantor has established adequate means of obtaining from the Borrower and each other relevant person on a continuing basis information pertaining to, and is now and on a continuing basis will be completely familiar with, the business, condition (financial and otherwise), operations, properties and prospects of the Borrower and each other relevant person.

 

(d) The obligations of the Guarantor under this Guaranty are the valid, binding and legally enforceable obligations of the Guarantor, and the execution and delivery of this Guaranty by the Guarantor has been duly and validly authorized in all respects by the Guarantor, and the person who is executing and delivering this Guaranty on behalf of the Guarantor has full power, authority and legal right to so do, and to observe and perform all of the terms and conditions of this Guaranty on the Guarantor’s part to be observed or performed.

 

4

 

 

(e) The execution and delivery of this Guaranty and the loan and the fulfillment of the terms and conditions hereof and thereof do not and will not conflict with or result in a breach of any of the terms or conditions of any restriction, agreement or instrument to which any of the Borrower or Guarantor is a party or to which any of their respective properties is subject, and do not and will not constitute a default or cause for acceleration under any of the foregoing, or result in the creation or imposition of any lien, charge or encumbrance of any nature upon any of the property or assets of Guarantor, and does not require the consent or approval of any governmental body, agency, authority, or any other person not already obtained.

 

(f) All financial statements and financial information regarding Guarantor which has been or is hereafter provided to Lenders is, to Guarantor’s current actual knowledge as of the date of such statements, complete and accurate in all material respects and does not omit material information, and as of the date of this Guaranty, unless otherwise disclosed to Lenders in writing, there are no suits, actions or proceedings of any kind pending or, to Guarantor’s current actual knowledge as of the date of this Guaranty, threatened against Guarantor which would, if adversely determined, materially and adversely affect Guarantors’ ability to fulfill their obligations under this Guarantor.

 

(g) And Guarantor further acknowledges and agrees that: (a) all terms and conditions of the Loan Documents are in full force and effect; and (b) upon the occurrence and during to continuance of an Event of Default, Lenders reserve their right to demand full, complete, and immediate performance of all of Borrower’s and Guarantor’s obligations under the Loan Documents.

 

Section 9. Default. Guarantor shall be in default under this Guaranty if any representation made herein is untrue in any material respect, or if Guarantor fails to fulfill any obligation or covenant under this Guaranty or under any agreement or document evidencing or securing the Note. Lenders have no duty or obligation to provide Guarantor with any grace period or notice and cure right. Time is of the essence. In addition, Guarantor shall be in default under this Guaranty if Guarantor becomes the subject of any voluntary or involuntary bankruptcy, insolvency, arrangement, reorganization, or other debtor-relief proceeding under any federal or state law, whether now existing or hereafter enacted, or if any property of Guarantor is attached, levied or seized by any creditor or becomes subject to any receivership. Whenever any such event of default shall exist and continue, Lenders may, at Lenders’ option, take and pursue any and all remedies against Guarantor and may declare and deem the Loan to be fully accelerated and in default and immediately due and payable, regardless of whether such obligations are in fact accelerated or in default or are otherwise immediately due and payable.

 

Section 10. Non-Petition Covenant. Prior to the date that is one year and one day after the Termination Date, the Guarantor shall not directly, or indirectly, commence, join any other person in commencing, or authorize a trustee or other person acting on its behalf or on behalf of others to commence, any bankruptcy, reorganization, arrangement, insolvency, liquidation, or receivership proceeding under the laws of the United States or any state of the United States against the Guarantor or the Borrower.

 

Section 11. Amendments, Etc. No amendment or waiver of any provision of this Guaranty and no consent to any departure by the Guarantor therefrom shall in any event be effective unless the same shall be in writing and signed by the Guarantor and the Lenders, and then such waiver or consent shall be effective only in the specific instance and for the specific purpose for which given.

 

5

 

 

Section 12. Notices, Etc. All notices and other communications provided for hereunder shall be sent in the manner provided for in the Note and at the applicable address specified in or pursuant to the Note. All such notices and communications shall be effective when delivered, except that notices and communications to the Lenders shall not be effective until received by the Lenders.

 

Section 13. Fees and Costs. Guarantor shall pay on demand all reasonable attorney’s fees and all other costs and expenses incurred by Lenders in connection with the enforcement or collection of this Guaranty

 

Section 14. No Waiver: Remedies. No failure on the part of the Lenders to exercise, and no delay in exercising, any right hereunder shall operate as a waiver thereof; nor shall any single or partial exercise of any right hereunder preclude any other or further exercise thereof or the exercise of any other right. The remedies herein provided are cumulative and not exclusive of any remedies provided by law.

 

Section 15. Continuing Guaranty: Assignments under the Note. This Guaranty is a continuing guaranty and shall (a) remain in full force and effect until the payment in full of all Guaranteed Obligations and all other amounts payable under the Loan Documents, (b) be binding upon the Guarantor and its successors and assigns, and (c) inure to the benefit of and be enforceable by the Lenders and their successors, transferees and assigns. The Guarantor may not assign its rights or delegate its duties hereunder without the prior written consent of the Lenders. Without limiting the generality of the foregoing clause (c), the Lenders may assign or otherwise transfer all or any portion of its rights and obligations under the Note (including, without limitation, the Promissory Note held by it) to any other person, and such other person shall thereupon become vested with all the benefits in respect thereof granted to the Lenders herein or otherwise, subject, however, in all respects to the provisions of the Note. The Guarantor acknowledges that upon any person becoming the Lenders in accordance with the Note, such person shall be entitled to the benefits hereof.

 

Section 16. Governing Law. This Guaranty has been prepared, is being executed and delivered, and is intended to be performed in the State of Texas, and the substantive laws of the State of Texas and the applicable federal laws of the United States shall govern the validity, construction, enforcement, and interpretation of this Guaranty; provided, however, Chapter 346 the Texas Finance Code does not apply does not apply to this Guaranty.

 

Section 17. Submission to Jurisdiction. The Guarantor hereby irrevocably submits to the jurisdiction of any Texas state or federal court sitting in Dallas County, Texas, in any action or proceeding arising out of or relating to this Guaranty, and the Guarantor hereby irrevocably agrees that all claims in respect of such action or proceeding may be heard and determined in such court. The Guarantor hereby unconditionally and irrevocably waives, to the fullest extent it may effectively do so, any right it may have to the defense of an inconvenient forum to the maintenance of such action or proceeding. The Guarantor hereby agrees that service of copies of the summons and complaint and any other process which may be served in any such action or proceeding may be made by mailing or delivering a copy of such process to the Guarantor at its address set forth in the Note. The Guarantor agrees that a final non-appealable judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. Nothing in this Section shall affect the rights of the Lenders to serve legal process in any other manner permitted by the law or affect the right of the Lenders to bring any action or proceeding against the Guarantor or any of its property in the courts of any other jurisdiction.

 

6

 

 

Section 18. Survival. All representations and warranties of the Guarantor hereunder shall survive the execution and delivery of this Guaranty and the making of the loan.

 

Section 19. Indemnification; Waiver of Damages. The Guarantor hereby agrees to indemnify and hold harmless the Lenders and their Related Parties (each an “Indemnified Party” and collectively, the “Indemnified Parties”) from and against (and will reimburse each Indemnified Party as the same are incurred for) any and all claims, damages, losses, liabilities and expenses (including, without limitation, the reasonable fees, disbursements and other charges of counsel) that may be incurred by or asserted or awarded against any Indemnified Party, in each case arising out of or in connection with or by reason of (including, without limitation, in connection with any investigation, litigation or proceeding or preparation of a defense in connection therewith) this Guaranty, any other Loan Document, or the transactions contemplated hereunder or thereunder, or any use made or proposed to be made with the proceeds thereof (IN ALL CASES, WHETHER OR NOT CAUSED OR ARISING, IN WHOLE OR IN PART, OUT OF THE COMPARATIVE, CONTRIBUTORY OR SOLE NEGLIGENCE OF THE INDEMNIFIED PARTY), except to the extent such claim, damage, loss, liability or expense is found in a final, nonappealable judgment by a court of competent jurisdiction to have resulted from such Indemnified Party’s gross negligence or willful misconduct. In the case of an investigation, litigation or proceeding to which the indemnity in this paragraph applies, such indemnity shall be effective whether or not such investigation, litigation or proceeding is brought by Borrower or Guarantor, any equity holder or creditor of Borrower of Guarantor or an Indemnified Party, whether or not an Indemnified Party is otherwise a party thereto. The Guarantor also agrees that no Indemnified Party shall have any liability (whether direct or indirect, in contract or tort or otherwise) to the Guarantor or any Subsidiary or Affiliate of the Guarantor or any of its equity holders or creditors arising out of, related to or in connection with any aspect of this Guaranty, the other Loan Documents or the transactions contemplated hereby or thereby, except to the extent of direct, as opposed to special, indirect, consequential or punitive, damages determined in a final, nonappealable judgment by a court of competent jurisdiction to have resulted from such Indemnified Party’s gross negligence or willful misconduct. Notwithstanding any other provision of this Guaranty, no Indemnified Party shall be liable for any damages arising from the use by others of information or other materials obtained through electronic telecommunications or other information transmission systems, other than for direct or actual damages resulting from the gross negligence or willful misconduct of such Indemnified Party as determined by a final and nonappealable judgment of a court of competent jurisdiction. No Indemnified Party seeking indemnification under this paragraph with respect to any claim will, without the Guarantor’s prior written consent (which shall not be unreasonably withheld), settle, compromise or consent to entry of any judgment with respect so such claim; provided that the foregoing requirement shall apply only to such claims that the Borrower or Guarantor has confirmed and agreed in writing to the Lenders are fully covered under the indemnity obligations of Borrower or Guarantor arising under this Guaranty and the Note.

 

Section 20. WAIVER OF JURY TRIAL. THE GUARANTOR AND THE LENDERS HEREBY ACKNOWLEDGE THAT THEY HAVE BEEN REPRESENTED BY AND HAVE CONSULTED WITH COUNSEL OF THEIR CHOICE, AND HEREBY KNOWINGLY, VOLUNTARILY, INTENTIONALLY, AND IRREVOCABLY WAIVE ANY AND ALL RIGHT TO TRIAL BY JURY IN RESPECT OF ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS GUARANTY, ANY OTHER LOAN DOCUMENT, OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.

 

NOTICE OF FINAL AGREEMENTS. THIS GUARANTY AND THE OTHER LOAN DOCUMENTS REPRESENT THE FINAL AGREEMENT AMONG THE PARTIES WITH RESPECT TO THE SUBJECT MATTER HEREOF AND MAY NOT BE CONTRADICTED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS, OR SUBSEQUENT ORAL AGREEMENTS OF THE PARTIES.

 

THERE ARE NO UNWRITTEN ORAL AGREEMENTS AMONG THE PARTIES.

 

[Signature Page Follows]

 

7

 

 

The Guarantor has caused this Guaranty to be duly executed as of the date first above written.

 

  GUARANTOR:
   
  EVERGREEN SUSTAINABLE ENTERPRISES, INC.
   
  By: /s/ Gary C. Evans
  Name:  Gary C. Evans
  Title: Chairman of the Board, President, and
Chief Executive Officer

 

Signature Page to Guaranty Agreement

(Evergreen Sustainable Enterprises, Inc.)

 

 

 

 

 

EX-21 8 f10k2022ex21_evergreen.htm LIST OF SUBSIDIARIES OF THE COMPANY

Exhibit 21

 

List of Subsidiaries

 

Entity   Jurisdiction
     
Energy Hunter Resources, Inc.   Delaware
     
JDONE LLC   Colorado
     

GENH Halcyon Acquisition, LLC

 

Texas

     
CryptoRica, LLC   Delaware

 

 

EX-31.1 9 f10k2022ex31-1_evergreen.htm CERTIFICATION

Exhibit 31.1

 

CERTIFICATION PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

 

I, Gary C. Evans, certify that:

 

1)I have reviewed this annual report of Evergreen Sustainable Enterprises, Inc. (formerly Generation Hemp, Inc.) on Form 10-K;

 

2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

 

4)I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have;

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure the material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation.

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5)I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal controls over financial reporting.

 

DATE: May 18, 2023 By: /s/ Gary C. Evans
   

Gary C. Evans

Chairman

Chief Executive Officer (Principal Executive Office and Principal Accounting and Financial Officer)

 

EX-32.1 10 f10k2022ex32-1_evergreen.htm CERTIFICATION

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT 0F 2002

 

In connection with the Annual Report of Evergreen Sustainable Enterprises, Inc. (formerly Generation Hemp, Inc.) (the Company”) on Form 10-K for the period ended herein as filed with the Securities and Exchange Commission (the “Report”), I. Gary C. Evans, Chairman and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)The information contained in the Report fully presents, in all material respects, the financial condition and results of operations or the Company.

 

DATE: May 18, 2023 By: /s/ Gary C. Evans
   

Gary C. Evans

Chairman

Chief Executive Officer (Principal Executive Office and Principal Accounting and Financial Officer)

 

 

 

EX-101.SCH 11 genh-20221231.xsd XBRL SCHEMA FILE 001 - Statement - Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Statements of Changes in Stockholders’ Equity (Deficit) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Consolidated Statements of Cash Flows (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Business link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Property and Equipment link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Intangible and Other Assets link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Notes Payable – Related Parties link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Other Indebtedness link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Leases link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Equity link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Stock-Based Compensation link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Discontinued Operations link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Supplemental Cash Flow Information link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Earnings (Loss) Per Share link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Property and Equipment (Tables) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Intangible and Other Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Notes Payable – Related Parties (Tables) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Income Taxes (Tables) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Equity (Tables) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Discontinued Operations (Tables) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Supplemental Cash Flow Information (Tables) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Earnings (Loss) Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Business (Details) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Property and Equipment (Details) - Schedule of property and equipment link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Intangible and Other Assets (Details) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Intangible and Other Assets (Details) - Schedule of finite-lived intangible assets link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Notes Payable – Related Parties (Details) link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Notes Payable – Related Parties (Details) - Schedule of notes payable – related parties link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - Other Indebtedness (Details) link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - Leases (Details) link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - Income Taxes (Details) link:presentationLink link:definitionLink link:calculationLink 043 - Disclosure - Income Taxes (Details) - Schedule of reconciliation of the expected statutory federal tax link:presentationLink link:definitionLink link:calculationLink 044 - Disclosure - Income Taxes (Details) - Schedule of deferred tax assets and liabilities link:presentationLink link:definitionLink link:calculationLink 045 - Disclosure - Equity (Details) link:presentationLink link:definitionLink link:calculationLink 046 - Disclosure - Equity (Details) - Schedule of warrants outstanding link:presentationLink link:definitionLink link:calculationLink 047 - Disclosure - Equity (Details) - Schedule of outstanding stock warrants activity link:presentationLink link:definitionLink link:calculationLink 048 - Disclosure - Stock-Based Compensation (Details) link:presentationLink link:definitionLink link:calculationLink 049 - Disclosure - Stock-Based Compensation (Details) - Schedule of summarizes options outstanding link:presentationLink link:definitionLink link:calculationLink 050 - Disclosure - Discontinued Operations (Details) - Schedule of discontinued operations to assets and liabilities held for sale link:presentationLink link:definitionLink link:calculationLink 051 - Disclosure - Discontinued Operations (Details) - Schedule of discontinued operations shown in the consolidated statements of operations link:presentationLink link:definitionLink link:calculationLink 052 - Disclosure - Supplemental Cash Flow Information (Details) - Schedule of supplemental cash flow information link:presentationLink link:definitionLink link:calculationLink 053 - Disclosure - Earnings (Loss) Per Share (Details) - Schedule of earnings (loss) per basic and diluted share link:presentationLink link:definitionLink link:calculationLink 054 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 12 genh-20221231_cal.xml XBRL CALCULATION FILE EX-101.DEF 13 genh-20221231_def.xml XBRL DEFINITION FILE EX-101.LAB 14 genh-20221231_lab.xml XBRL LABEL FILE EX-101.PRE 15 genh-20221231_pre.xml XBRL PRESENTATION FILE XML 16 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document And Entity Information - USD ($)
12 Months Ended
Dec. 31, 2022
May 18, 2023
Jun. 30, 2022
Document Information Line Items      
Entity Registrant Name Evergreen Sustainable Enterprises, Inc.    
Trading Symbol EGSE    
Document Type 10-K    
Current Fiscal Year End Date --12-31    
Entity Common Stock, Shares Outstanding   113,254,002  
Entity Public Float     $ 18,658,253
Amendment Flag false    
Entity Central Index Key 0001527102    
Entity Current Reporting Status No    
Entity Voluntary Filers No    
Entity Filer Category Non-accelerated Filer    
Entity Well-known Seasoned Issuer No    
Document Period End Date Dec. 31, 2022    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
ICFR Auditor Attestation Flag false    
Document Annual Report true    
Entity File Number 000-55019    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 26-3119496    
Entity Address, Address Line One 8533 Midway Road    
Entity Address, City or Town Dallas    
Entity Address, State or Province TX    
Entity Address, Postal Zip Code 75209    
City Area Code (469)    
Local Phone Number 209-6154    
Title of 12(b) Security Common Stock, par value $0.00001 per share    
Entity Interactive Data Current Yes    
Auditor Firm ID 688    
Auditor Name Marcum llp    
Auditor Location Houston, Texas    
Document Transition Report false    
XML 17 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current Assets:    
Cash $ 275,506 $ 20,656
Accounts receivable 470,719
Inventories 148,427 212,518
Prepaid expenses 22,143 4,723
Total current assets 916,795 237,897
Property and equipment, net 2,161,952 2,580,662
Operating lease right-of-use asset 161,827 263,065
Intangible assets, net 1,271,398 1,857,908
Goodwill 799,888 799,888
Other assets 2,060 407,000
Total Assets 5,313,920 6,146,420
Current Liabilities:    
Accounts payable 686,297 883,485
Accrued liabilities 767,396 410,990
Payables to related parties 591,574 204,007
Operating lease liability - related party 111,839 101,238
Notes payable – related parties 3,322,620 2,183,551
Other indebtedness - current 250,002 501,668
Current liabilities of discontinued operations held for sale 166,186 153,482
Total current liabilities 5,895,914 4,438,421
Operating lease liability - related party, net of current portion 49,988 161,827
Long-term liabilities of discontinued operations held for sale 207,197 162,948
Total liabilities 6,153,099 4,763,196
Commitments and contingencies
Series B redeemable preferred stock, no par value, $10,000 stated value, 300 shares authorized, 118 shares issued and outstanding at December 31, 2022 and 2021 591,558 591,558
Equity (Deficit):    
Preferred stock, $0.00001 par value; 200,000,000 shares authorized, none outstanding
Common stock, $0.00001 par value; 200,000,000 shares authorized, 113,204,002 and 113,094,002 shares issued and outstanding at December 31, 2022 and 2021, respectively 1,132 1,131
Additional paid-in capital 34,029,851 29,150,258
Accumulated deficit (35,230,018) (28,118,245)
Evergreen Sustainable Enterprises equity (deficit) (1,199,035) 1,033,144
Noncontrolling interest (231,702) (241,478)
Total equity (deficit) (1,430,737) 791,666
Total Liabilities and Equity (Deficit) $ 5,313,920 $ 6,146,420
XML 18 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets (Parentheticals) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Preferred stock, par value (in Dollars per share) $ 0.00001 $ 0.00001
Preferred stock, shares authorized 200,000,000 200,000,000
Preferred stock, shares outstanding
Common stock, par value (in Dollars per share) $ 0.00001 $ 0.00001
Common stock, shares authorized 200,000,000 200,000,000
Common stock, shares issued 113,204,002 113,094,002
Common stock, shares outstanding 113,204,002 113,094,002
Series B Redeemable Preferred Stock    
Preferred stock, par value (in Dollars per share)
Preferred stock, stated Value (in Dollars) $ 10,000 $ 10,000
Preferred stock, shares authorized 300 300
Preferred stock, shares issued 118 118
Preferred stock, shares outstanding 118 118
XML 19 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenue:    
Post-harvest and midstream services $ 2,505,590 $ 592,024
Rental 90,000 82,500
Total revenue 2,595,590 674,524
Costs and Expenses:    
Cost of revenue (exclusive of items shown separately below) 1,016,930 652,521
Depreciation and amortization 1,005,220 1,340,425
Impairment expense 407,000
General and administrative 7,128,421 7,803,196
Total costs and expenses 9,557,571 9,796,142
Operating loss (6,961,981) (9,121,618)
Other expense (income):    
Other income (500,905) (25,424)
Change in fair value of marketable security (11,770)
Interest expense 501,146 708,338
Total other expense (income) 241 671,144
Loss from continuing operations (6,962,222) (9,792,762)
Income (loss) from discontinued operations (59,773) (32,213)
Net loss (7,021,995) (9,824,975)
Less: net income (loss) attributable to noncontrolling interests 9,776 (2,247)
Net loss attributable to Evergreen Sustainable Enterprises $ (7,031,771) $ (9,822,728)
Loss from continuing operations    
Basic (in Dollars per share) $ (0.06) $ (0.17)
Diluted (in Dollars per share) (0.06) (0.17)
Loss from discontinued operations    
Basic (in Dollars per share)
Diluted (in Dollars per share)
Earnings (loss) per share    
Basic (in Dollars per share) (0.06) (0.17)
Diluted (in Dollars per share) $ (0.06) $ (0.17)
XML 20 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
Series B Redeemable Preferred Stock
Series A Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interest
Total
Balance at Dec. 31, 2020 $ 729,058 $ 4,975,503 $ 6,083,480 $ 4,436,018 $ (18,220,705) $ (239,231) $ (2,964,935)
Balance (in Shares) at Dec. 31, 2020 135 6,328,948 17,380,317        
Acquisition of Certain Assets of Halcyon Thruput, LLC $ 2,500,000 2,500,000
Acquisition of Certain Assets of Halcyon Thruput, LLC (in Shares) 6,250,000        
Issuances of common stock units $ 136,717 838,283 975,000
Issuances of common stock units (in Shares) 1,758,333        
Warrant exercises $ 4,771,679 (1,429,679) 3,342,000
Warrant exercises (in Shares) 9,494,316        
Issuance of common shares for Convertible Promissory Note $ 217,769 217,769
Issuance of common shares for Convertible Promissory Note (in Shares) 618,660        
Issuance of common shares for Senior Secured Promissory Note $ 1,942,500 1,942,500
Issuance of common shares for Senior Secured Promissory Note (in Shares) 1,000,000        
Common shares issued to vendor for services $ 117,500 117,500
Common shares issued to vendor for services (in Shares) 125,000        
Issuance of common shares for extension of secured note $ 18,000 18,000
Issuance of common shares for extension of secured note (in Shares) 20,000        
Change in common stock par value due to change in corporate domicile     $ (15,868,273) 15,868,273
Conversion of Series A preferred stock $ (4,975,503) $ 759 4,974,744
Conversion of Series A preferred stock (in Shares) (6,328,948) 75,947,376        
Series B preferred stock redemptions $ (137,500)
Series B preferred stock redemptions (in Shares) (17)        
Series B preferred stock dividend     (74,812) (74,812)
Stock-based compensation $ 81,000 4,462,619 4,543,619
Stock-based compensation (in Shares) 500,000        
Net loss         (9,822,728) (2,247) (9,824,975)
Balance at Dec. 31, 2021 $ 591,558 $ 1,131 29,150,258 (28,118,245) (241,478) 791,666
Balance (in Shares) at Dec. 31, 2021 118 113,094,002        
Issuance of common shares for extension of secured note $ 1 52,580 52,581
Issuance of common shares for extension of secured note (in Shares) 110,000        
Modification of warrants for extension of promissory note to investor     68,756 68,756
Series B preferred stock dividend     (80,002) (80,002)
Stock-based compensation     4,758,257 4,758,257
Net loss         (7,031,771) 9,776 (7,021,995)
Balance at Dec. 31, 2022 $ 591,558 $ 1,132 $ 34,029,851 $ (35,230,018) $ (231,702) $ (1,430,737)
Balance (in Shares) at Dec. 31, 2022 118 113,204,002        
XML 21 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash Flows From Operating Activities    
Net loss $ (7,021,995) $ (9,824,975)
Loss from discontinued operations (59,773) (32,213)
Net loss from continuing operations (6,962,222) (9,792,762)
Adjustments to reconcile net loss from continuing operations to net cash from operating activities:    
Depreciation and amortization 1,005,220 1,340,425
Impairment expense 407,000
Amortization of debt discount 52,581 380,282
Stock-based compensation 4,758,257 4,543,619
Common shares issued to vendor for services 117,500
Modification of warrants for extension of promissory note to investor 68,756
Other income - PPP Loan forgiveness (25,424)
Loss on disposal of property and equipment 6,938
Change in fair value of marketable securities (11,770)
Changes in operating assets and liabilities:    
Accounts receivable (470,719) 75,470
Inventories 64,091 (212,518)
Prepaid expenses and other assets (19,480) (4,723)
Accounts payable and accrued liabilities 466,783 85,939
Net cash from operating activities – continuing operations (629,733) (3,497,024)
Net cash from operating activities – discontinued operations (2,820)
Net cash from operating activities (632,553) (3,497,024)
Cash Flows From Investing Activities    
Capital expenditures (77,715)
Acquisition of certain assets of Halcyon Thruput, LLC, net of acquired cash of $224,530 (1,525,470)
Proceeds from sale of investment in common stock 34,847
Net cash from investing activities – continuing operations (1,568,338)
Cash Flows From Financing Activities    
Issuance of common stock units 925,000
Redemptions of Series B preferred stock (137,500)
Series B preferred stock dividends paid (16,500)
Proceeds from warrant exercises 3,342,000
Repayment of Halcyon bank note (995,614)
Proceeds from notes payable - related parties 1,294,069
Repayments of notes payable - related parties (105,000)
Proceeds from subordinated notes 410,000
Repayment of subordinated notes (50,000) (1,100,000)
Payment of mortgage payable (251,666) (117,793)
Net cash from financing activities – continuing operations 887,403 2,309,593
Net change in cash 254,850 (2,755,769)
Cash, beginning of period 20,656 2,776,425
Cash, end of period $ 275,506 $ 20,656
XML 22 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows (Parentheticals) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Statement of Cash Flows [Abstract]    
Net of acquired cash $ 224,530 $ 224,530
XML 23 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Business
12 Months Ended
Dec. 31, 2022
Business [Abstract]  
Business

1. Business

 

Evergreen Sustainable Enterprises, Inc. (formerly Generation Hemp, Inc.) (the “Company”) was incorporated on August 21, 2021 in the State of Delaware. The Company was originally incorporated as Home Treasure Finders, Inc. (“HTF”) on July 28, 2008 in the State of Colorado. On November 27, 2019, HTF purchased approximately 94% of the common stock of Energy Hunter Resources, Inc. (“EHR”) in a series of transactions accounted for as a reverse merger. Upon closing, HTF changed its name to Generation Hemp, Inc. In March 2023, the Company changed its name to Evergreen Sustainable Enterprises, Inc.

 

On January 11, 2021, we completed the acquisition of certain assets of Halcyon Thruput, LLC (“Halcyon”). With this acquisition, we commenced providing post-harvest and midstream services to hemp growers by drying, processing, cleaning and stripping harvested hemp directly from the field and wetbaled at our 48,000 square foot leased facility located in Hopkinsville, Kentucky. The Company also offers safe storage services for processed hemp, which enables farmers to maximize strategic market timing. We market two retail products, Gas Monkey Spill-Jack, an all-natural, plant-based, sustainable, and biodegradable loose absorbent, and Rowdy Rooster, an animal bedding consumer goods product, each made from the hemp hurd byproduct that is produced from our hemp processing operations.

 

We also generate revenue from rental of our “Cannabis Zoned” (Hemp) warehouse property located in Denver, Colorado currently leased to an unaffiliated hemp seed company.

 

As of December 31, 2022, EHR held an approximate 8% working interest in an oil & gas property located in Cochran County, Texas within the Slaughter-Levelland Field of the San Andres formation in the Northwest Shelf of West Texas. EHR’s oil & gas activities are currently held for sale and are presented in these consolidated financial statements as discontinued operations for each of the periods presented.

 

Our management team has been and continues to actively review acquisition candidates involved in the hemp industry that operate within a number of vertical businesses, predominantly within the midstream sector that are attractive to us and are within the hemp supply chain. Additionally, the Company has been studying the Bitcoin mining space and in January 2023 announced a new strategic initiative in this area and commenced bitcoin operations. Refer to Note 15 for more discussion.

 

Liquidity and Going Concern – The Company is dependent upon obtaining additional funding to continue ongoing operations and to pursue its strategy and execute its acquisition plans.

 

In the year ended December 31, 2022, the Company used $633 thousand of cash for its operating activities. At December 31, 2022, the Company’s current liabilities, including financing obligations due within one year, totaled $5.9 million as compared with its current assets of $917 thousand.

 

The Company will continue to pursue additional capital raising opportunities in order to fund future acquisitions and meet its obligations as they become due. We may not be successful in obtaining additional financing needed. In the event financing cannot be obtained, the Company may not be able to satisfy these plans and obligations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

XML 24 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

 

Basis of Presentation – The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and U.S. Securities and Exchange Commission regulations. The consolidated financial statements comprise the financial statements of the Company, its wholly-owned subsidiaries, and subsidiaries that it controls due to ownership of a majority voting interest. Subsidiaries are fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continue to be consolidated until the date when such control ceases. The financial statements of the subsidiaries are prepared for the same reporting period as the Company. All significant intercompany balances and transactions are eliminated upon consolidation.

 

Business Combinations – The Company accounts for business combinations under the acquisition method of accounting. Under this method, acquired assets, including separately identifiable intangible assets, and any assumed liabilities are recorded at their acquisition date estimated fair value. Determining the fair value of assets acquired and liabilities assumed involves the use of significant estimates and assumptions. The excess of purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents the goodwill amount resulting from the acquisition.

 

Use of Estimates – The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the (i) impairment of long-lived assets and goodwill, (ii) valuation allowances for deferred income tax assets and (iii) estimates of accrued liabilities. Actual results could differ from those estimates.

 

Revenue Recognition – Post-harvest and midstream services revenue is typically determined based on volumes processed at agreed-upon contractual prices and is recognized at the point in time when performance obligations under the terms of a contract with our customers are satisfied. This occurs when control of the product is transferred to our customers upon completion of our processing.

 

Rental revenue is recognized based on the contractual cash rental payments for the period.

 

Cash – The Company maintains its deposits of cash in financial institutions, which may at times exceed amounts covered by insurance provided by the U.S. Federal Deposit Insurance Corporation (“FDIC”). The Company has not experienced any losses related to amounts in excess of FDIC limits.

 

Inventories – Inventories consist of processed hemp product and are stated at the lower of cost or net realizable value. Cost, which includes the cost of raw materials, labor and overhead, is determined using the first-in, first-out method. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable cost of completion, disposal and transportation.

 

Property and Equipment – Property and equipment is stated at cost and depreciated using the straight-line method over the estimated useful lives of assets. Upon disposition, the cost and accumulated depreciation are removed and any gain or loss on the disposal is reflected in the statements of operations. The cost of maintenance and repairs is charged to income as incurred; significant renewals and improvements are capitalized.

 

Leases – The Company’s lease arrangements are operating leases which are capitalized on the balance sheet as right-of-use (“ROU”) assets and obligations. Right of use (“ROU”) assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. These are recognized at the lease commencement date based on the present value of payments over the lease term. If leases do not provide for an implicit rate, we use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term as the lease payments. Lease expense is recognized on a straight-line basis over the lease term.

 

Intangible Assets – Finite-lived intangible assets are amortized and are tested for impairment when an event occurs or circumstances change that indicate it is more likely than not that an impairment exists. Intangible assets consist of customer relationships and non-compete agreements acquired in the acquisition of certain assets of Halcyon.

 

Impairment of Long-Lived Assets – We review long-lived assets for potential impairment when events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. In this assessment, future pre-tax cash flows (undiscounted) resulting from the use of the asset and its eventual disposal are estimated. If the undiscounted future cash flows are less than the carrying amount of the asset, an impairment loss is recognized for the difference between its carrying value and estimated fair value.

 

Noncontrolling Interest – Noncontrolling interests represent the portion of net assets in consolidated entities that are not owned by the Company. As of December 31, 2022 and 2021, minority investors owned approximately 6% of EHR.

 

Stock-based Compensation – We account for stock-based compensation using the fair value method. Compensation cost for equity incentive awards is based on the fair value of the equity instrument generally on the date of grant and is recognized over the requisite service period. Forfeitures are recognized as they occur.

 

Income Taxes – Income taxes are accounted for using a balance sheet approach. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. In assessing the realizability of deferred tax assets, management considers whether it is more-likely-than-not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax asset (including the impact of available carryback and carryforward periods), projected future taxable income, and tax-planning strategies in making this assessment. A valuation allowance for deferred tax assets is recorded when it is more likely than not that the benefit from the deferred tax asset will not be realized.

 

The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which a change in judgment occurs. The Company had no material uncertain tax positions as of December 31, 2022 or 2021. Income tax returns we file may be routinely examined by tax authorities. The statute of limitations is currently open for tax returns filed after 2018.

 

The Company is subject to the Texas margin tax; however, tax expense was zero for the years ended December 31, 2022 and 2021.

 

Discontinued Operations – In connection with the Transaction, management determined to fully divest of EHR’s oil and gas activities. As such, these activities are presented as discontinued operations for each of the periods presented.

 

The Company follows the successful efforts method of accounting for its oil and gas properties. Costs to acquire mineral interests in oil and gas properties and to drill and equip new development wells and related asset retirement costs are capitalized. In 2019, the Company’s oil and gas properties became fully impaired and the carrying amount of the properties was expensed to the market decline and the Company’s determination to exit the oil and gas business. The oil & gas properties have limited production and operations for which the Company recognizes its share as a non-operating working interest owner. Oil & gas revenue is recognized for discontinued operations based on delivered quantities in the amount of the consideration to which the Company is entitled.

 

The Company records a liability for the plugging, abandonment and remediation of its properties at the end of their productive lives. The Company computes the liability for asset retirement obligations by calculating the present value of estimated future cash flows related to each property. This requires the Company to use significant assumptions, including current estimates of plugging and abandonment costs, annual inflation of these costs, the productive lives of wells and its risk-adjusted interest rate. Changes in any of these assumptions can result in significant revisions to the estimated asset retirement obligations.

 

Asset retirement obligations are recorded as a liability at their estimated present value at the asset’s inception, with an offsetting increase to producing properties in the accompanying balance sheet which is amortized to expense on a unit-of-production basis. Periodic accretion of the discount on asset retirement obligations is recorded as expense.

 

Fair Value Measurements – Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The three levels related to fair value measurements are as follows:

 

Level 1 —    Observable inputs such as quoted prices in active markets for identical assets or liabilities.
   
Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data.
   
Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

 

The estimated fair values of cash, accounts receivable, accounts payable and indebtedness approximate their carrying amounts due to the relatively short maturity of these instruments.

 

Earnings (loss) per Share – Basic earnings (loss) per share amounts are calculated by dividing income available to common shareholders, after deducting preferred stock dividends, by the weighted average number of shares of common stock outstanding. Diluted earnings per share amounts are calculated by dividing net income by the weighted average number of shares of common stock and common stock equivalents outstanding. Common stock equivalents represent shares issuable upon the assumed conversion of preferred stock, outstanding convertible notes and the assumed exercise of common stock options and warrants outstanding.

 

Major Customer and Concentration of Credit Risk – We estimate an allowance for doubtful accounts based on an analysis of specific customers, taking into consideration the age of past due accounts and an assessment of the customer’s ability to pay. An allowance for doubtful accounts was not needed as of December 31, 2022 or 2021.

 

During 2022, one customer accounted for approximately 96% of our post-harvest and midstream services revenue. Amounts due from this customer represented all of our accounts receivable at December 31, 2022. During 2021, one customer accounted for approximately 91% of our post-harvest and midstream services revenue. No amounts were due from this customer at December 31, 2021.

 

Our rental revenue is derived from a single lessee on a commercial warehouse owned by the Company. There were no amounts due from this customer at December 31, 2022 or 2021.

 

Recent Accounting Pronouncements – In December 2019, the FASB issued ASU 2019-12, Income Taxes, which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. We adopted this standard in the first quarter of 2021. Adoption of this ASU did not have a significant impact on our consolidated financial statements.

 

In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40). The new standard reduces the number of accounting models for convertible debt instruments and convertible preferred stock and amends the guidance for the derivatives scope exception for contracts in an entity’s own equity. The standard also amends and makes targeted improvements to the related earnings per share guidance. The ASU is effective for fiscal years beginning after December 15, 2021. The standard allows for either modified or full retrospective transition methods. The Company adopted this standard on January 1, 2022. The adoption of this ASU did not have a significant impact on our consolidated financial statements.

  

There are no other new accounting pronouncements that are expected to have a material impact on the consolidated financial statements.

XML 25 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Property and Equipment
12 Months Ended
Dec. 31, 2022
Property and Equipment [Abstract]  
Property and Equipment

3. Property and Equipment

 

Property and equipment consisted of the following:

 

   Useful  December 31, 
   Life (yrs)  2022   2021 
Land     $96,000   $96,000 
Warehouse  30   916,500    916,500 
Leasehold Improvements  3   473,601    473,601 
Machinery and equipment  5-7   1,506,447    1,506,447 
Vehicles  4   149,440    149,440 
Computer equipment and software  3   46,825    46,825 
Office furniture and equipment  3-5   17,294    17,294 
              
Subtotal      3,206,107    3,206,107 
Less accumulated depreciation and amortization      (1,044,155)   (625,445)
Total property and equipment, net     $2,161,952   $2,580,662 
XML 26 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Intangible and Other Assets
12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible and Other Assets

4. Intangible and Other Assets

 

The following table summarizes information related to finite-lived intangible assets:

 

   December 31, 2022   December 31, 2021 
   Gross           Gross         
   Carrying   Accumulated       Carrying   Accumulated     
   Amount   Amortization   Net   Amount   Amortization   Net 
Customer relationships  $2,612,649   $(1,362,311)  $1,250,338   $2,612,649   $(796,858)  $1,815,791 
Non-competition agreements   63,176    (42,116)   21,060    63,176    (21,059)   42,117 
Total  $2,675,825   $(1,404,427)  $1,271,398   $2,675,825   $(817,917)  $1,857,908 

 

Future amortization expense for intangible assets in each of the next five years are expected to be $419 thousand for 2023, $278 thousand for 2024, $194 thousand for 2025, $130 thousand for 2026 and $86 thousand for 2027.

 

Other assets included $407,000 at December 31, 2021 for the Company’s option to purchase the facility located in Hopkinsville, Kentucky leased from Halcyon. Under this agreement, the Company had the option to purchase the facility on or before August 25, 2022, as amended, for a purchase price of $993 thousand. This agreement was not renewed upon its expiration. Impairment expense totaling $407 thousand was recognized in the third quarter of 2022 as a result.

XML 27 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Notes Payable – Related Parties
12 Months Ended
Dec. 31, 2022
Notes Payable – Related Parties [Abstract]  
Notes Payable – Related Parties

5. Notes Payable – Related Parties

 

Notes payable – related parties consisted of the following:

 

   December 31, 
   2022   2021 
Subordinated Promissory Note to CEO  $523,551   $523,551 
Convertible Promissory Note to CEO   1,107,069    410,000 
Secured Promissory Note to Coventry Asset Management, LTD.   1,000,000    1,000,000 
Subordinated Promissory Note to Investor   200,000    250,000 
Promissory Note to Investment Hunter, LLC   492,000    
-
 
Total notes payable – related parties  $3,322,620   $2,183,551 

 

Subordinated Promissory Note to CEO – Our CEO made advances to the Company during 2020 under a subordinated promissory note in the amount of $524 thousand initially due September 30, 2021. This note was amended to a new maturity date of January 1, 2023. The note bore interest at 10% per annum. Accrued interest on this subordinated promissory note totaled $60 thousand at December 31, 2022. In January 2023, the amounts due under this note were restructured and rolled into a new Secured Promissory Note from our CEO (see Note 15).

 

Convertible Promissory Note to CEO – In 2021, our CEO made advances totaling $410 thousand to the Company under a convertible promissory note. Additional advances made in 2022 totaled $697 thousand. The convertible note initially matured on January 1, 2022 but was subsequently amended to extend the maturity date to January 1, 2023. The note bore interest at 10%. The principal and interest due on the convertible note were convertible, at the option of the holder, into restricted shares of the Company’s common stock at an initial conversion price of $0.50 per share but that was lowered in July 2022 to $0.30 per share. Accrued interest on this convertible promissory note totaled $107 thousand at December 31, 2022. In January 2023, the amounts due under this note were restructured and rolled into a new Secured Promissory Note from our CEO (see Note 15).

 

Secured Promissory Note and Warrants to Coventry Asset Management, LTD. – On December 30, 2020, the Company received proceeds from issuance of a secured promissory note in principal amount of $1 million to Coventry Asset Management, LTD, a Company stockholder. The promissory note is secured by the property acquired in the acquisition of certain assets of Halcyon. The unpaid balance of the secured promissory note bears interest at a rate of 14% per annum. The promissory note has been extended seven times including the issuance of 20,000 restricted common shares as extension fees each for the first five extensions and the issuance of 50,000 restricted common shares for the last two extensions. The maturity date of the promissory note is December 31, 2023, as amended. If before December 31, 2023, the Company raises new equity capital of $5 million or more, then the full amount outstanding under the promissory note is due within five days. As amended, principal payments of $250 thousand each are due June 1, 2023 and August 31, 2023. Accrued interest on this secured note totaled $200 thousand at December 31, 2022.

 

Subordinated Promissory Note and Warrants to Investor – On December 30, 2020, the Company issued a subordinated promissory note in principal amount of $500 thousand to an accredited investor who is also a Company stockholder. The Company previously made principal payment totaling $300 thousand. The unpaid balance of the Subordinated Note bears interest at a rate of 10% per annum. The subordinated note principal together with accrued and unpaid interest was due, as previously amended, on March 31, 2022 but was extended to June 30, 2022. On March 1, 2023, the Company paid $240 thousand in full repayment of this note and accrued interest thereon.

 

The holder of the subordinated note received a warrant to purchase 500 thousand shares of common stock exercisable for cash at an exercise price of $0.352 per share. As consideration for the April 2022 extension, the term of this warrant was extended by one year to December 30, 2023. The Company recognized $69 thousand of interest expense in 2022 for the modification related to this extension of the warrant term.

 

Promissory Note to Investment Hunter, LLC – In 2022, Investment Hunter, LLC, a Texas LLC controlled by our CEO, made advances totaling $492 thousand to the Company under a promissory note due January 1, 2023, as amended. If the Company raises new equity capital of $3 million or more, then the full amount outstanding under the note is due within five days. The note bears interest at 10% per annum. Accrued interest on this subordinated promissory note totaled $43 thousand at December 31, 2022.

XML 28 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Other Indebtedness
12 Months Ended
Dec. 31, 2022
Other Indebtedness [Abstract]  
Other Indebtedness

6. Other Indebtedness

 

Mortgage Payable and Operating Lease –The Company is obligated under a mortgage payable dated September 15, 2014 secured by its warehouse property located in Denver, Colorado. The note has been amended a number of times to a maturity date of October 1, 2023. In the latest extension, the Company made a principal payment of $25 thousand plus accrued interest in January 2023 and agreed to make seven additional monthly principal payments of $25 thousand plus accrued interest each beginning on March 1, 2023. A final payment of $50 thousand plus accrued interest is due at maturity. The interest rate on the mortgage payable is 12%. If before the final maturity of the mortgage payable, the Company raises new equity capital of $5 million or more, then the full amount outstanding is due within ten days.

 

The Company leases the Denver warehouse property to a tenant under an operating lease which was renewed with a new tenant and extended to August 1, 2023 for a monthly rent of $7.5 thousand. The lease requires a true-up with the tenant for property taxes and insurance paid by the Company and requires the tenant to maintain the interior and exterior of the warehouse (except for the roof). The lease provides for a rent abatement in the first and last month of the contracted extension. Minimum future rents for 2023 are $52 thousand.

 

Paycheck Protection Program Loan – Congress created the Paycheck Protection Program (“PPP”) under the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) to provide forgivable loans to eligible small businesses facing economic hardship to retain U.S. employees on their payroll during the Coronavirus Disease 2019 (“COVID-19”) pandemic. PPP loan recipients may be eligible to have their loans forgiven if the funds were used for eligible expenses. On April 29, 2020, we received disbursement of an approved PPP loan in the amount of $25 thousand. The Company received notice that the PPP Loan principal and interest thereon was fully forgiven on April 20, 2021.

XML 29 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Leases
12 Months Ended
Dec. 31, 2022
Leases [Abstract]  
Leases

7. Leases

 

Office Space – The Company leases office space in Fort Worth, Texas for managerial offices. This lease requires monthly payments of $2 thousand and is month-to-month. Lease expense for this facility totaled $24 thousand for 2022 and $22 thousand for 2021.

 

Hemp Processing Operating Facility – The Company leases its operating facility in Kentucky from Oz Capital, LLC, a related party, under a lease expiring May 31, 2024. The lease provides for monthly payments of $10 thousand. Oz Capital, LLC is responsible for all taxes and maintenance under the lease. Lease expense for this facility totaled $123 thousand for 2022 and $119 thousand for 2021. A right-of-use asset and lease liability is recorded for this lease. As the lease does not provide an implicit rate, the Company used its estimated incremental borrowing rate of 10% in determining the present value of the lease payments.

 

Future Bitcoin Mining Premises – In 2022, the Company entered a five-year commercial lease for land and premises in Arkansas. We expect to use these premises as a future Bitcoin mining location because of its favorable power rates and land availability. The lease commences once the Company begins receiving power for its operations conducted at the location. The monthly rent will vary from a minimum of $1 thousand per megawatt of power usage monthly up to $4 thousand per megawatt monthly depending on the average power usage over a trailing 90-day period and the price of bitcoin. We anticipate commencing operations at the leased premises in 2023.

XML 30 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies
12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

8. Commitments and Contingencies

 

Litigation – From time to time, we are subject to various litigation and other claims in the normal course of business. Below is a discussion of specific matters. We cannot estimate the ultimate outcome of these matters.

 

Evergreen Sustainable Enterprises, Inc. (formerly Generation Hemp, Inc.) v. Colorado Mill Equipment, LLC

 

The defendant sold to the Company a faulty piece of equipment for $16 thousand and will not refund to the Company the purchase price after repeated attempts to return their equipment. An original lawsuit filed by the Company against Colorado Mill Equipment in January 2022 in Dallas County was subsequently dismissed due to jurisdiction. A second lawsuit was subsequently filed in El Paso County, Colorado and is currently pending.

 

Halcyon Thruput, LLC, Plaintiff v. United National Insurance Company, Defendant, United States District Court for the Northern District of Texas, Dallas Division, Case No. 3:21-CV-3136-K

 

Halcyon Thruput, LLC (Halcyon) obtained an all-risks commercial insurance policy, including an Equipment Breakdown Endorsement (Policy) from United National Insurance Company (UNIC) to provide substantial coverages for Halcyon Thruput LLC’s (Halcyon) $1.2 million hemp processing dryer (Dryer) at its facility in Hopkinsville, Kentucky. During the Policy period, the Dryer caught fire due to the Dryer being defectively designed.

 

While UNIC has paid a number of Halcyon’s claims, Halcyon’s claim for the cost of the replacement Dryer of $1.5 million was denied as described below.

  

Buyer, a wholly owned subsidiary of the Company, pursuant to an Asset Purchase Agreement as twice amended, then acquired all the assets of Halcyon, except for the right to the proceeds of UNIC’s insurance policy since the Policy prohibited assignment. Halcyon and Buyer agreed that Buyer’s principal, Gary C. Evans, had the right to control the litigation, engage counsel for Halcyon and make all decisions relating to any proceeds received in the litigation by settlement or otherwise.

 

Halcyon’s suit against UNIC, which was removed to federal court, seeks over $1 million plus statutory interest on that sum from August 10, 2020 for violating the Texas Insurance Code’s requirement that claims be promptly paid, additional statutory penalties, and attorneys’ fees. Certain documents have been executed between the Company, Halcyon and legal counsel, which provide for a sharing of costs and expenses and awards, if any, against UNIC. Mediation of the case was held in April 2022 where no agreement was reached by the parties. Depositions of the Company’s expert witnesses were completed in July 2022 and of UNIC’s representatives in September 2022.

 

In August 2022, the Company received a second payment from UNIC of $357 thousand as a partial settlement of this claim, which amount was reported as other income in the consolidated financial statements.

 

JDONE, LLC v. Grand Traverse Holdings, LLC and John Gallegos, Denver District Court Case No. 2019CV33723

 

JDONE, LLC (“JDONE”), a wholly owned subsidiary of the Company and landlord of a commercial warehouse building in Denver, brought suit against Grand Traverse Holdings, LLC for default of its commercial lease of the warehouse from JDONE. This case settled in October 2022 and the Company received $122 thousand from the defendant, which amount was reported as other income in the consolidated financial statements.

 

KBSIII Tower at Lake Carolyn, LLC and Prime US-Tower at Lake Carolyn, LLC (collectively – “KBSIII”) v. Energy Hunter Resources, Inc.

 

Plaintiff/Counterdefendant KBSIII was seeking lost rent on office space for periods after EHR vacated office premises located in Las Colinas, Texas. EHR filed a counter suit alleging specific damages due to uninhabitable premises of the office space due to the intolerable conduct of other tenants located on the same floor. On December 23, 2020, the trial court entered a summary judgment against EHR for $231 thousand. The judgment provides for post-judgment interest at a rate of 5% per annum until paid and further provides for additional amounts owed should EHR pursue unsuccessful appeals to higher courts. At December 31, 2022, the Company had accrued $253 thousand for this judgment, which is exclusively an EHR obligation.

 

Ogborn-Mihm, LLP v. Evergreen Sustainable Enterprises, Inc. (formerly Generation Hemp, Inc.), JDONE, LLC and Gary C. Evans

 

The Company was recently made aware of litigation filed against it in the District Court of Denver from a law firm which was previously engaged by the Company. While none of the parties have been officially served, the alleged amount being sought from the Company is less than $50,000. 

XML 31 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes
12 Months Ended
Dec. 31, 2022
Income Taxes [Abstract]  
Income Taxes

9. Income Taxes

 

No amounts were recorded for income tax expense during the years ended December 31, 2022 or 2021. A reconciliation of the expected statutory federal tax and the total income tax expense from continuing operations was as follows:

 

   Year Ended December 31, 
   2022   2021 
Federal statutory rate  $(1,462,067)  $(2,056,480)
State income taxes, net   (141,438)   (198,940)
Change in valuation allowance   1,630,110    3,655,210 
Change in state tax rates   
-
    (178,644)
True-up of prior year deferred items   
-
    (929,450)
Other, net   (26,605)   (291,696)
Total income tax expense  $
-
   $
-
 

 

The tax effect of temporary differences that gave rise to significant components of deferred tax assets and liabilities consisted of the following:

 

   December 31, 
   2022   2021 
Assets:        
Net operating loss carryforwards  $5,471,098   $4,960,487 
Stock-based compensation   2,142,362    1,046,464 
Property and equipment   (24,310)   33,803 
Intangible assets   216,726    135,012 
Subtotal   7,805,876    6,175,766 
Valuation allowance   (7,805,876)   (6,175,766)
Net deferred tax asset  $
-
   $
-
 

 

The Company has federal net operating loss (“NOL”) carryforwards of approximately $23.8 million at December 31, 2022, of which approximately $6.5 million begin to expire in 2034 and the remainder have no expiration. The Company estimates that a majority of its NOL carryforwards are subject to annual limitations under Internal Revenue Code Section 382 as a result of ownership changes at various times including in the Transaction. These NOL carryforwards may never be utilized by the Company.

 

The Company is delinquent in filing its 2021 Federal and state tax returns.

XML 32 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Equity
12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Equity

10. Equity

 

Series A Preferred Stock Our Series A Preferred Stock was originally issued in connection with HTF’s acquisition of EHR in 2019. On September 8, 2021, holders of the Company’s Series A Preferred Stock elected to convert such shares into shares of the Company’s common stock. As a result, 6,328,948 shares of Series A Preferred Stock were converted into 75,947,376 shares of common stock, with each share of Series A Preferred Stock converting into 12 shares of restricted common stock pursuant to the applicable Certificate of Designations.

 

Series B Preferred Stock Units – On December 30, 2020, the Company sold to certain accredited investors, including Gary C. Evans, our Chief Executive Officer, an aggregate of 135 preferred stock units comprised of (i) one share of Series B Redeemable Convertible Preferred Stock, no par value, and (ii) one warrant exercisable for 50 thousand shares of common stock of the Company until December 30, 2022 at an exercise price of $0.352 per share.

 

The sale of the preferred stock units for $10 thousand each resulted in aggregate gross proceeds of approximately $1.35 million, before deducting estimated offering expenses payable by the Company. Substantially all of the proceeds raised in the offering were used to fund the acquisition of assets of Halcyon, expenses related thereto and for general corporate purposes.

 

Each share of Series B Preferred Stock is initially convertible into 25,000 shares of common stock, subject to adjustment. Holders of Series B Preferred Stock are entitled to receive dividends of 6.00% per annum based on the stated value equal to $10 thousand per share. Except as otherwise required by law, the Series B Preferred Stock does not have voting rights. However, as long as any shares of Series B Preferred Stock are outstanding, the Company will not, without the affirmative vote of the holders of a majority of the then outstanding shares of the Series B Preferred Stock, (a) alter or change adversely the powers, preferences or rights given to the Series B Preferred Stock, (b) alter or amend the related certificate of designation, (c) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of Series B Preferred Stock, (d) repay, repurchase or offer to repay, repurchase or otherwise acquire more than a de minimis number of shares of its common stock, (e) enter into any agreement with respect to any of the foregoing, or (f) pay cash dividends or distributions on any equity securities of the Company other than pursuant to the terms of the outstanding Series B Preferred Stock. The Series B Preferred Stock does not have a preference upon any liquidation, dissolution or winding-up of the Company.

 

Any or all of the Series B Preferred Stock may be converted, at their holder’s option, into 25,000 shares of common stock, as adjusted for any stock dividends, splits, combinations or similar events.

 

At any time after the occurrence of a “Qualifying Event,” the Company, upon 5-day written notice, shall have the right to cause each share of Series B Preferred Stock (and all accrued in-kind dividends with respect thereto) to be converted into common stock. For purposes of this automatic conversion of the Series B Preferred Stock, a “Qualifying Event” shall have occurred if (A) (1) the rolling five-trading day volume-weighted average trading price of shares of the common stock exceeds $1.00, and (2) there shall be an effective registration statement under the Securities Act of 1933, as amended covering all of the shares of common stock which would be issuable upon conversion of all of the outstanding shares of Series B Preferred Stock or (B) the Company closes a firm commitment underwriting of the common stock on a Form S-1 Registration Statement with aggregate gross proceeds of at least $5 million at a price per share equal to or greater than $1.00. In each instance, a conversion may not be made unless the Company has filed an amendment to its Articles of Incorporation effecting an increase in its authorized common stock so that the Company has a sufficient number of authorized and unissued shares of common stock so as to permit the conversion of all outstanding shares.

 

The Series B Preferred Stock may be redeemed by the Company for its stated value, plus accrued and unpaid dividends, at any time. Initially, redemption payments of 12.5% each of the total amount of Series B Preferred Stock then outstanding plus accrued dividends were due from the Company to each Holder of Series B Preferred Stock at the end of each calendar quarter of 2021. The first required redemption payments totaling $137 thousand were made in April 2021. In May, June and October of 2021, the three holders of the Series B Preferred Stock, including the Company’s chief executive officer, entered into transactions in which they accepted the mandatory redemption payment required pursuant to the Series B Preferred Stock certificate of designation in a number of Series B Units to effectively waive the redemption requirement. All other terms of the Series B Units remain unchanged and the holders’ ownership interest in the Series B Preferred Units remains the same as it was before such transactions.

 

Common Stock – At December 31, 2022, the Company had 113,204,002 common shares outstanding. Following is a discussion of common stock issuances during the periods presented:

 

  Acquisition of Certain Assets of Halcyon – In January 2021, the Company issued 6,250,000 shares of common stock valued at $2.5 million ($0.40 per share; restricted from trading for a period of up to one year) in the acquisition.
     
  2021 First Quarter Issuances of Common Stock Units – In the first quarter of 2021, the Company issued 800,000 common stock units for total proceeds of $400,000. Each common stock unit consisted of one share of common stock and a warrant for the purchase of two shares of common stock for $0.50 each. Each warrant is exercisable any time before its expiration on the second anniversary of its issuance. The Company allocated the total proceeds based on the relative fair values of the common stock and warrants. The fair value of the warrants was determined using an options valuation model with key assumptions including a risk-free interest rate of 0.11% and historical volatility of 272%. A total of $263 thousand was allocated to the warrants and reported in additional paid-in capital.  
     
  Warrant Exercises – In the first quarter of 2021, the Company received approximately $3 million for the exercise of 8,428,976 outstanding warrants. In the fourth quarter of 2021, the Company received $375 thousand for the exercise of 1,065,340 outstanding warrants.
     
  Issuances for Exchange or Conversion of Debt – The Company issued a total of 1,618,660 common shares for the exchange or conversion of outstanding indebtedness totaling $2.2 million in the first quarter of 2021.
     
  Issuance to Vendor for Services – In the third quarter of 2021, the Company issued 125,000 common shares valued at $117.5 thousand to a vendor for services performed.
     
  Issuance for Extension of Secured Note – The Company issued 20,000 common shares valued at $18 thousand as consideration to extend the maturity of a senior note in the third quarter of 2021.
     
  Issuance for Conversion of Series A Preferred Stock – As noted above, in the third quarter of 2021, the Company issued 75,947,376 common shares for the conversion of all outstanding shares of its Series A Preferred Stock.
     
  2021 Fourth Quarter Issuances of Common Stock Units – In the fourth quarter of 2021, the Company issued 958,333 common stock units to accredited investors for total proceeds of $575 thousand. Each common stock unit consists of one share of common stock and a warrant for the purchase of one share of common stock for $0.60 each. Each warrant is exercisable any time before its expiration on the second anniversary of its issuance. The Company allocated the total proceeds based on the relative fair values of the common stock and warrants. The fair value of the warrants was determined using an options valuation model with key assumptions including risk-free interest rates ranging from 0.48% to 0.70% and historical volatility ranging from 237% to 258%. A total of $277 thousand was allocated to the warrants and reported in additional paid-in capital..
     
  Issuance for Extensions of Secured Note – The Company issued 110,000 common shares valued at $52.6 thousand as consideration for extensions of the maturity of a senior note in 2022. Refer to Note 5.

 

Common Stock Warrants Outstanding – Following is a summary of warrants outstanding as of December 31, 2022:

 

   # of
Warrants
   Price
(each)
   Expiration Date  Method of Exercise
Issued in December 2020 with subordinated note to investor (1)   500,000   $0.352   December 30, 2023  Cash
Issued in Q1 2021 with common stock units (1)   1,600,000   $0.500   January-February, 2023  Cash
Issued in Q4 2021 with common stock units (1)   958,333   $0.600   October-December, 2023  Cash
Total warrants outstanding at December 31, 2022   3,058,333            

 

(1) May be redeemed for $0.0001 per warrant at the Company’s option with 30 days advanced notice should the weighted average market price of common stock exceed $1.00 for any five out of seven consecutive trading days with a minimum average daily trading volume for such seven-day period of at least 25,000 shares of common stock.

 

Following is a summary of outstanding stock warrants activity for the periods presented:

 

   # of
Warrants
   Weighted
Average
Price
 
Warrants as of January 1, 2021   22,988,632   $0.353 
Issued   2,558,333   $0.537 
Cancelled   (7,244,316)  $0.352 
Exercised   (9,494,316)  $0.352 
Warrants as of December 31, 2021   8,808,333   $0.407 
Canceled   (5,750,000)  $0.354 
Warrants as of December 31, 2022   3,058,333   $0.507 
XML 33 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation

11. Stock-Based Compensation

 

We award restricted stock or stock options as incentive compensation to employees and compensation to our Board of Directors for services. Generally, these awards include vesting periods of up to three years from the date of grant.

 

The 2021 Omnibus Incentive Plan (“2021 Plan”) was adopted by our Board on July 1, 2021. The 2021 Plan provides for the initial reservation of 15 million shares of common stock for issuance, and provides that the maximum number of shares that may be issued pursuant to the exercise of ISOs is 15 million. On the one-year anniversary date of the 2021 Plan, the number of shares of common stock reserved for issuance automatically increased to 20% of the fully diluted common shares outstanding, including shares issuable upon the conversion of preferred shares, as calculated on an as-converted basis.

 

In the first quarter of 2021, the Company issued 500,000 restricted shares valued at $155 thousand as incentive compensation to two executives who joined the Company. Compensation expense related to these awards totaled $155 thousand for 2021. These awards became fully vested in January 2022.

 

In the fourth quarter of 2021, the Company awarded options for 13,850,000 shares of the Company’s common stock as incentive compensation to management and the Board of Directors. One-third of the awarded options vested immediately with the remaining options vesting in two equal annual tranches over the next two years. Vested options may be exercised at any time until their expiration after 10 years at an exercise price of $0.76 per share. Unvested options are forfeited upon termination of service. The fair value of the awards at the date of grant of $10.5 million was determined using the Black-Scholes option pricing model. Key assumptions included a risk-free interest rate ranging from 1.18% to 1.28%, historical volatility ranging from 331% to 643% and an expected life of the stock options ranging from five to six years.

 

In the third quarter of 2022, the Company awarded options for 1,915,000 shares of the Company’s common stock as incentive compensation to its CEO and board of directors. The awarded options vest over the next three years. Vested options may be exercised at any time until their expiration ranging from eight to 10 years at their exercise prices ranging from $0.30 to $0.33 per share. Unvested options are forfeited upon termination of service. The fair value of the awards at the date of grant of $576 thousand was determined using the Black-Scholes option pricing model. Key assumptions included a risk-free interest rate ranging from 2.87% to 3.03%, historical volatility ranging from 251% to 408% and an expected life of the stock options ranging from four to seven years.

 

We recognized $4.7 million of compensation expense in 2022 and $1.4 million in 2021 for option awards. As of December 31, 2022, there was $2.0 million of total unrecognized compensation cost related to options to be recognized over a remaining weighted average period of 17 months.

 

The following table summarizes options outstanding, as well as activity for the periods presented:

 

   Shares   Weighted
Average
Grant Date
Fair Value
  

Weighted
Average
Exercise

Price

   Aggregate
Intrinsic
Value
 
Outstanding at January 1, 2021   
   -
   $
   -
   $
   -
    
     -
 
Granted   13,850,000   $0.76   $0.76    
-
 
Outstanding at December 31, 2021   13,850,000   $0.76   $0.76    
-
 
Granted   1,915,000   $0.30   $0.31    
-
 
Outstanding at December 31, 2022   15,765,000   $0.70   $0.71    
-
 

 

The remaining weighted average contractual life of exercisable options at December 31, 2022 was nine years.

XML 34 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Discontinued Operations
12 Months Ended
Dec. 31, 2022
Discontinued Operations [Abstract]  
Discontinued Operations

12. Discontinued Operations

 

In 2019, management determined to fully divest of EHR’s oil and gas activities. As such, these activities are presented as discontinued operations for each of the periods presented. The following is a summary of the carrying amounts of major classes of assets and liabilities of the discontinued operations to assets and liabilities held for sale:

 

   December 31, 
   2022   2021 
Assets:        
Oil and natural gas properties held for sale, at cost  $1,874,849   $1,874,849 
Accumulated DD&A   (1,874,849)   (1,874,849)
Total assets of discontinued operations held for sale  $
-
   $
-
 
           
Liabilities:          
Accrued liabilities  $61,701   $48,997 
Asset retirement obligations   52,368    52,368 
Revenue payable   52,117    52,117 
Current liabilities of discontinued operations held for sale   166,186    153,482 
Asset retirement obligations -          
Long-term liabilities of discontinued operations held for sale   207,197    162,948 
Total liabilities of discontinued operations held for sale  $373,383   $316,430 

 

The following is a summary of the major classes of line items constituting loss on discontinued operations shown in the consolidated statements of operations:

 

   For the year ended
December 31,
 
   2022   2021 
Revenue -        
Oil and gas sales  $147,828   $116,710 
           
Costs and Expenses:          
Lease operating expense   163,352    134,590 
Accretion of asset retirement obligations   44,249    14,333 
Total costs and expenses   207,601    148,923 
Loss from discontinued operations  $(59,773)  $(32,213)
XML 35 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Supplemental Cash Flow Information
12 Months Ended
Dec. 31, 2022
Supplemental Cash Flow Information [Abstract]  
Supplemental Cash Flow Information

13. Supplemental Cash Flow Information

 

   For the year ended
December 31,
 
   2022   2021 
Cash paid for interest  $68,321   $138,736 
Cash paid for taxes   
-
    
-
 
           
Noncash investing and financing activities:          
Acquisition of certain assets of Halcyon Thruput, LLC          
- issuance of common shares   
-
    2,500,000 
- issuance of subordinated note   
-
    850,000 
- assumption of Halcyon bank note   
-
    995,614 
Series B preferred stock dividend payable   80,002    58,312 
Issuance of common stock units previously subscribed   
-
    50,000 
Issuances of common shares for exchange or conversion of debt   
-
    2,160,269 
Conversion of Series A preferred stock into common stock   -    4,975,503 
XML 36 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings (Loss) Per Share
12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Earnings (Loss) per Share

14. Earnings (Loss) per Share

 

The following is the computation of earnings (loss) per basic and diluted share:

 

   For the year ended
December 31,
 
   2022   2021 
Amounts attributable to Generation Hemp:        
Numerator        
Loss from continuing operations attributable to common stockholders  $(6,975,740)  $(9,792,532)
Income (loss) from discontinued operations   (56,031)   (30,196)
Less: preferred stock dividends   (80,002)   (74,812)
Net loss attributable to common stockholders  $(7,111,773)  $(9,897,540)
Denominator          
Weighted average shares used to compute basic EPS   113,163,591    57,159,659 
Dilutive effect of convertible note   1,164,773    1,164,773 
Dilutive effect of preferred stock   2,950,000    55,075,900 
Dilutive effect of common stock options   229,762    709,981 
Dilutive effect of common stock warrants   1,320,951    11,022,542 
Weighted average shares used to compute diluted EPS   118,829,077    125,132,855 
Earnings (loss) per share:          
Loss from continuing operations          
Basic  $(0.06)  $(0.17)
Diluted  $(0.06)  $(0.17)
Loss from discontinued operations          
Basic  $
-
   $
-
 
Diluted  $
-
   $
-
 
Earnings (loss) per share          
Basic  $(0.06)  $(0.17)
Diluted  $(0.06)  $(0.17)

 

The computation of diluted earnings per common share excludes the assumed conversion of the Series B Preferred Stock and outstanding convertible notes and exercise of common stock options and warrants in periods when we report a loss. The dilutive effect of the assumed exercise of outstanding options and warrants was calculated using the treasury stock method.

XML 37 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events
12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract] [Standard Label]  
Subsequent Events

15. Subsequent Events

 

Issuance of common stock options – In January 2023, the Company issued options for the purchase of 100,000 shares of common stock each to our three directors as board fees for the year. The exercise price of the options is $0.30 and they have a ten year term. One-third of the options vested immediately. The remaining options vest in equal tranches over the next two years.

 

Commencement of Bitcoin Operations and Acquisition of Toro Energía Sociedad Anonima – In January 2023, the Company announced a new strategic direction into sustainable energy projects, starting with bitcoin mining. The Company’s name was changed to Evergreen Sustainable Enterprises, Inc. (“EGSE”) in March 2023. The Company’s existing operations will continue to be maintained as a fully operating wholly-owned subsidiary.

 

On January 9, 2023, the Company purchased 80% of Toro Energía Sociedad Anonima (“Toro”), a Costa Rican corporation with ownership of a hydroelectric dam in Costa Rica. The source of approximately one megawatt of power produced from the hydroelectric dam (six generators) will be used to power new Bitcoin mining machines at an extremely low cost. The transaction included seller-financed debt of $985 thousand. The seller-financed debt has a term of 10 years and a 9.5% per annum variable interest rate (based on the prime rate) with straight line amortization. The seller-financed debt is secured by pledge of the Toro Dam.

 

The purchase price for 80% of Toro’s equity was $1.4 million. These amounts were paid in cash from proceeds of a Secured Promissory Note (“Secured Note”) with the Gary C. Evans, CEO of the Company (‘Evans”). Under the terms of the Secured Note, (a) the Company and Evans restructured (i) the Subordinated Promissory Note dated November 20, 2020 and (ii) Convertible Promissory Note dated July 20, 2021, such that all accrued and unpaid interest on each note were rolled into a new Secured Note, (b) Evans lent the Company $500 thousand on January 9, 2023 and $969 thousand on January 10, 2023. The Secured Note has a maturity date of July 15, 2023 and bears interest at the rate of 10.00% per annum. The Secured Note has a conversion feature which permits Evans to convert at the Maturity Date then outstanding principal and interest at a conversion price of $0.275 (the closing price of the Company’s stock on January 9, 2023).

 

The Toro Dam is located approximately 25 miles from San Jose between two volcano craters. The site generates all its energy from green resources with a proven 98% run time over the years and has a full-time staff in place under a new Operating & Maintenance Agreement.

 

Hydroelectric power is a clean and renewable energy source that is used to generate electricity by harnessing the energy of falling water and can provide a reliable and a very cost-effective source of energy for bitcoin mining operations. Hydroelectric power can help reduce the carbon footprint of cryptocurrency mining, as many cryptocurrencies are produced using fossil fuels, which continues to contribute to greenhouse gas emissions and climate change. By using hydroelectric power, bitcoin mining can be made more environmentally friendly and sustainable and can help improve the stability and reliability of cryptocurrency networks. Hydroelectric power is a relatively stable and reliable source of energy, compared to other sources such as coal or fossil fuels, which can be prone to price fluctuations and supply disruptions. The Company has committed to acquire 240 new Bitmain S19J Pro+ ASIC miners that will be deployed at the Toro Dam in the first half of 2023.

 

Subordinated Promissory Note and Warrants to Investor – As discussed in Note 5, on March 1, 2023, the Company paid $240 thousand in full repayment of this note and accrued interest thereon.

 

Hemp Processing Operating Facility – The Company’s lease of its operating facility in Kentucky from Oz Capital, LLC, a related party, was amended in January 2023. As amended, the lease payment was increased to $20.5 thousand monthly beginning in March 2023. The lease expiration date of May 31, 2024 was not changed.

 

Issuance of Series C Preferred Units – In the first quarter of 2023, the Company issued six Series C Preferred Units in a private placement for total proceeds of $300 thousand. Each unit consists of one share of 8.50% Series C Redeemable Convertible Preferred Stock and 5,000 warrants to acquire one share of common stock. Cumulative dividends at 8.5% of the stated value of the Series C Redeemable Convertible Preferred Stock are payable each calendar quarter end in cash or additional shares of Series C Redeemable Convertible Preferred Stock, at the Company’s option.

 

Each share of Series C Redeemable Convertible Preferred Stock is convertible, at the holder’s option, into 100 thousand shares of our common stock at any time. It is subject to automatic conversion if (a) the rolling five (5)-trading day volume-weighted average trading price of shares of our common stock exceeds $0.75 and (b) there shall be an effective registration statement under the Securities Act of 1933. The conversion ratio may be adjusted for certain dilutive issuances or in the event a dividend is paid on our common stock. The Series C Redeemable Convertible Preferred Stock is redeemable at any time at the Company’s option.

 

The warrants are exercisable for a cash exercise price of $0.50 per share and expire in three years. The warrants may be redeemed at the Company’s option if after one year from issuance, the trading price of the Company’s common stock exceeds $0.875 over a ten consecutive day trading period having a minimum trading volume of 25 thousand shares daily.

 

Promissory Note to Investment Hunter, LLC – In the first quarter of 2023, Investment Hunter, LLC, a Texas LLC controlled by our CEO, made advances totaling $300 thousand to the Company.

 

Secured Promissory Note to a Director and our CEO – On April 19, 2023, Razorback I, LLC, a wholly-owned subsidiary of the Company, borrowed $300 thousand under a secured promissory note from one of our directors and our CEO. Proceeds from the note are expected to be utilized in the acquisition of land in Arkansas to expand bitcoin mining operations.

 

The promissory note matures on April 15, 2024. Interest accrues at 12% per annum and is due quarterly beginning on July 15, 2023. The holders have the option to convert the outstanding principal and interest into restricted shares at a conversion price of $0.30 per share of common stock.

 

The secured promissory note is collateralized by a pledge of 100% of the ownership interest of Razorback I, LLC and has been guaranteed by the Company as well.

XML 38 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Accounting Policies, by Policy (Policies)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation – The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and U.S. Securities and Exchange Commission regulations. The consolidated financial statements comprise the financial statements of the Company, its wholly-owned subsidiaries, and subsidiaries that it controls due to ownership of a majority voting interest. Subsidiaries are fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continue to be consolidated until the date when such control ceases. The financial statements of the subsidiaries are prepared for the same reporting period as the Company. All significant intercompany balances and transactions are eliminated upon consolidation.

 

Business Combinations

Business Combinations – The Company accounts for business combinations under the acquisition method of accounting. Under this method, acquired assets, including separately identifiable intangible assets, and any assumed liabilities are recorded at their acquisition date estimated fair value. Determining the fair value of assets acquired and liabilities assumed involves the use of significant estimates and assumptions. The excess of purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents the goodwill amount resulting from the acquisition.

 

Use of Estimates

Use of Estimates – The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the (i) impairment of long-lived assets and goodwill, (ii) valuation allowances for deferred income tax assets and (iii) estimates of accrued liabilities. Actual results could differ from those estimates.

 

Revenue Recognition

Revenue Recognition – Post-harvest and midstream services revenue is typically determined based on volumes processed at agreed-upon contractual prices and is recognized at the point in time when performance obligations under the terms of a contract with our customers are satisfied. This occurs when control of the product is transferred to our customers upon completion of our processing.

 

Rental revenue is recognized based on the contractual cash rental payments for the period.

 

Cash

Cash – The Company maintains its deposits of cash in financial institutions, which may at times exceed amounts covered by insurance provided by the U.S. Federal Deposit Insurance Corporation (“FDIC”). The Company has not experienced any losses related to amounts in excess of FDIC limits.

 

Inventories

Inventories – Inventories consist of processed hemp product and are stated at the lower of cost or net realizable value. Cost, which includes the cost of raw materials, labor and overhead, is determined using the first-in, first-out method. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable cost of completion, disposal and transportation.

 

Property and Equipment

Property and Equipment – Property and equipment is stated at cost and depreciated using the straight-line method over the estimated useful lives of assets. Upon disposition, the cost and accumulated depreciation are removed and any gain or loss on the disposal is reflected in the statements of operations. The cost of maintenance and repairs is charged to income as incurred; significant renewals and improvements are capitalized.

 

Leases

Leases – The Company’s lease arrangements are operating leases which are capitalized on the balance sheet as right-of-use (“ROU”) assets and obligations. Right of use (“ROU”) assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. These are recognized at the lease commencement date based on the present value of payments over the lease term. If leases do not provide for an implicit rate, we use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term as the lease payments. Lease expense is recognized on a straight-line basis over the lease term.

 

Intangible Assets

Intangible Assets – Finite-lived intangible assets are amortized and are tested for impairment when an event occurs or circumstances change that indicate it is more likely than not that an impairment exists. Intangible assets consist of customer relationships and non-compete agreements acquired in the acquisition of certain assets of Halcyon.

 

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets – We review long-lived assets for potential impairment when events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. In this assessment, future pre-tax cash flows (undiscounted) resulting from the use of the asset and its eventual disposal are estimated. If the undiscounted future cash flows are less than the carrying amount of the asset, an impairment loss is recognized for the difference between its carrying value and estimated fair value.

 

Noncontrolling Interests Policy Text Block

Noncontrolling Interest – Noncontrolling interests represent the portion of net assets in consolidated entities that are not owned by the Company. As of December 31, 2022 and 2021, minority investors owned approximately 6% of EHR.

 

Stock-based Compensation

Stock-based Compensation – We account for stock-based compensation using the fair value method. Compensation cost for equity incentive awards is based on the fair value of the equity instrument generally on the date of grant and is recognized over the requisite service period. Forfeitures are recognized as they occur.

 

Income Taxes

Income Taxes – Income taxes are accounted for using a balance sheet approach. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. In assessing the realizability of deferred tax assets, management considers whether it is more-likely-than-not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax asset (including the impact of available carryback and carryforward periods), projected future taxable income, and tax-planning strategies in making this assessment. A valuation allowance for deferred tax assets is recorded when it is more likely than not that the benefit from the deferred tax asset will not be realized.

 

The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which a change in judgment occurs. The Company had no material uncertain tax positions as of December 31, 2022 or 2021. Income tax returns we file may be routinely examined by tax authorities. The statute of limitations is currently open for tax returns filed after 2018.

 

The Company is subject to the Texas margin tax; however, tax expense was zero for the years ended December 31, 2022 and 2021.

 

Discontinued Operations – In connection with the Transaction, management determined to fully divest of EHR’s oil and gas activities. As such, these activities are presented as discontinued operations for each of the periods presented.

 

The Company follows the successful efforts method of accounting for its oil and gas properties. Costs to acquire mineral interests in oil and gas properties and to drill and equip new development wells and related asset retirement costs are capitalized. In 2019, the Company’s oil and gas properties became fully impaired and the carrying amount of the properties was expensed to the market decline and the Company’s determination to exit the oil and gas business. The oil & gas properties have limited production and operations for which the Company recognizes its share as a non-operating working interest owner. Oil & gas revenue is recognized for discontinued operations based on delivered quantities in the amount of the consideration to which the Company is entitled.

 

The Company records a liability for the plugging, abandonment and remediation of its properties at the end of their productive lives. The Company computes the liability for asset retirement obligations by calculating the present value of estimated future cash flows related to each property. This requires the Company to use significant assumptions, including current estimates of plugging and abandonment costs, annual inflation of these costs, the productive lives of wells and its risk-adjusted interest rate. Changes in any of these assumptions can result in significant revisions to the estimated asset retirement obligations.

 

Asset retirement obligations are recorded as a liability at their estimated present value at the asset’s inception, with an offsetting increase to producing properties in the accompanying balance sheet which is amortized to expense on a unit-of-production basis. Periodic accretion of the discount on asset retirement obligations is recorded as expense.

 

Fair Value Measurement

Fair Value Measurements – Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The three levels related to fair value measurements are as follows:

 

Level 1 —    Observable inputs such as quoted prices in active markets for identical assets or liabilities.
   
Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data.
   
Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

 

The estimated fair values of cash, accounts receivable, accounts payable and indebtedness approximate their carrying amounts due to the relatively short maturity of these instruments.

 

Earnings (loss) per Share

Earnings (loss) per Share – Basic earnings (loss) per share amounts are calculated by dividing income available to common shareholders, after deducting preferred stock dividends, by the weighted average number of shares of common stock outstanding. Diluted earnings per share amounts are calculated by dividing net income by the weighted average number of shares of common stock and common stock equivalents outstanding. Common stock equivalents represent shares issuable upon the assumed conversion of preferred stock, outstanding convertible notes and the assumed exercise of common stock options and warrants outstanding.

 

Major Customer and Concentration of Credit Risk

Major Customer and Concentration of Credit Risk – We estimate an allowance for doubtful accounts based on an analysis of specific customers, taking into consideration the age of past due accounts and an assessment of the customer’s ability to pay. An allowance for doubtful accounts was not needed as of December 31, 2022 or 2021.

 

During 2022, one customer accounted for approximately 96% of our post-harvest and midstream services revenue. Amounts due from this customer represented all of our accounts receivable at December 31, 2022. During 2021, one customer accounted for approximately 91% of our post-harvest and midstream services revenue. No amounts were due from this customer at December 31, 2021.

 

Our rental revenue is derived from a single lessee on a commercial warehouse owned by the Company. There were no amounts due from this customer at December 31, 2022 or 2021.

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements – In December 2019, the FASB issued ASU 2019-12, Income Taxes, which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. We adopted this standard in the first quarter of 2021. Adoption of this ASU did not have a significant impact on our consolidated financial statements.

 

In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40). The new standard reduces the number of accounting models for convertible debt instruments and convertible preferred stock and amends the guidance for the derivatives scope exception for contracts in an entity’s own equity. The standard also amends and makes targeted improvements to the related earnings per share guidance. The ASU is effective for fiscal years beginning after December 15, 2021. The standard allows for either modified or full retrospective transition methods. The Company adopted this standard on January 1, 2022. The adoption of this ASU did not have a significant impact on our consolidated financial statements.

  

There are no other new accounting pronouncements that are expected to have a material impact on the consolidated financial statements.

XML 39 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Property and Equipment (Tables)
12 Months Ended
Dec. 31, 2022
Property and Equipment [Abstract]  
Schedule of property and equipment
   Useful  December 31, 
   Life (yrs)  2022   2021 
Land     $96,000   $96,000 
Warehouse  30   916,500    916,500 
Leasehold Improvements  3   473,601    473,601 
Machinery and equipment  5-7   1,506,447    1,506,447 
Vehicles  4   149,440    149,440 
Computer equipment and software  3   46,825    46,825 
Office furniture and equipment  3-5   17,294    17,294 
              
Subtotal      3,206,107    3,206,107 
Less accumulated depreciation and amortization      (1,044,155)   (625,445)
Total property and equipment, net     $2,161,952   $2,580,662 
XML 40 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Intangible and Other Assets (Tables)
12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of finite-lived intangible assets
   December 31, 2022   December 31, 2021 
   Gross           Gross         
   Carrying   Accumulated       Carrying   Accumulated     
   Amount   Amortization   Net   Amount   Amortization   Net 
Customer relationships  $2,612,649   $(1,362,311)  $1,250,338   $2,612,649   $(796,858)  $1,815,791 
Non-competition agreements   63,176    (42,116)   21,060    63,176    (21,059)   42,117 
Total  $2,675,825   $(1,404,427)  $1,271,398   $2,675,825   $(817,917)  $1,857,908 

 

XML 41 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Notes Payable – Related Parties (Tables)
12 Months Ended
Dec. 31, 2022
Notes Payable – Related Parties [Abstract]  
Schedule of notes payable – related parties
   December 31, 
   2022   2021 
Subordinated Promissory Note to CEO  $523,551   $523,551 
Convertible Promissory Note to CEO   1,107,069    410,000 
Secured Promissory Note to Coventry Asset Management, LTD.   1,000,000    1,000,000 
Subordinated Promissory Note to Investor   200,000    250,000 
Promissory Note to Investment Hunter, LLC   492,000    
-
 
Total notes payable – related parties  $3,322,620   $2,183,551 

 

XML 42 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Taxes [Abstract]  
Schedule of reconciliation of the expected statutory federal tax
   Year Ended December 31, 
   2022   2021 
Federal statutory rate  $(1,462,067)  $(2,056,480)
State income taxes, net   (141,438)   (198,940)
Change in valuation allowance   1,630,110    3,655,210 
Change in state tax rates   
-
    (178,644)
True-up of prior year deferred items   
-
    (929,450)
Other, net   (26,605)   (291,696)
Total income tax expense  $
-
   $
-
 

 

Schedule of deferred tax assets and liabilities
   December 31, 
   2022   2021 
Assets:        
Net operating loss carryforwards  $5,471,098   $4,960,487 
Stock-based compensation   2,142,362    1,046,464 
Property and equipment   (24,310)   33,803 
Intangible assets   216,726    135,012 
Subtotal   7,805,876    6,175,766 
Valuation allowance   (7,805,876)   (6,175,766)
Net deferred tax asset  $
-
   $
-
 

 

XML 43 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Equity (Tables)
12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Schedule of warrants outstanding
   # of
Warrants
   Price
(each)
   Expiration Date  Method of Exercise
Issued in December 2020 with subordinated note to investor (1)   500,000   $0.352   December 30, 2023  Cash
Issued in Q1 2021 with common stock units (1)   1,600,000   $0.500   January-February, 2023  Cash
Issued in Q4 2021 with common stock units (1)   958,333   $0.600   October-December, 2023  Cash
Total warrants outstanding at December 31, 2022   3,058,333            

 

(1) May be redeemed for $0.0001 per warrant at the Company’s option with 30 days advanced notice should the weighted average market price of common stock exceed $1.00 for any five out of seven consecutive trading days with a minimum average daily trading volume for such seven-day period of at least 25,000 shares of common stock.

 

Schedule of outstanding stock warrants activity
   # of
Warrants
   Weighted
Average
Price
 
Warrants as of January 1, 2021   22,988,632   $0.353 
Issued   2,558,333   $0.537 
Cancelled   (7,244,316)  $0.352 
Exercised   (9,494,316)  $0.352 
Warrants as of December 31, 2021   8,808,333   $0.407 
Canceled   (5,750,000)  $0.354 
Warrants as of December 31, 2022   3,058,333   $0.507 
XML 44 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of summarizes options outstanding
   Shares   Weighted
Average
Grant Date
Fair Value
  

Weighted
Average
Exercise

Price

   Aggregate
Intrinsic
Value
 
Outstanding at January 1, 2021   
   -
   $
   -
   $
   -
    
     -
 
Granted   13,850,000   $0.76   $0.76    
-
 
Outstanding at December 31, 2021   13,850,000   $0.76   $0.76    
-
 
Granted   1,915,000   $0.30   $0.31    
-
 
Outstanding at December 31, 2022   15,765,000   $0.70   $0.71    
-
 

 

XML 45 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Discontinued Operations (Tables)
12 Months Ended
Dec. 31, 2022
Discontinued Operations [Abstract]  
Schedule of discontinued operations to assets and liabilities held for sale
   December 31, 
   2022   2021 
Assets:        
Oil and natural gas properties held for sale, at cost  $1,874,849   $1,874,849 
Accumulated DD&A   (1,874,849)   (1,874,849)
Total assets of discontinued operations held for sale  $
-
   $
-
 
           
Liabilities:          
Accrued liabilities  $61,701   $48,997 
Asset retirement obligations   52,368    52,368 
Revenue payable   52,117    52,117 
Current liabilities of discontinued operations held for sale   166,186    153,482 
Asset retirement obligations -          
Long-term liabilities of discontinued operations held for sale   207,197    162,948 
Total liabilities of discontinued operations held for sale  $373,383   $316,430 

 

Schedule of discontinued operations shown in the consolidated statements of operations
   For the year ended
December 31,
 
   2022   2021 
Revenue -        
Oil and gas sales  $147,828   $116,710 
           
Costs and Expenses:          
Lease operating expense   163,352    134,590 
Accretion of asset retirement obligations   44,249    14,333 
Total costs and expenses   207,601    148,923 
Loss from discontinued operations  $(59,773)  $(32,213)
XML 46 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Supplemental Cash Flow Information (Tables)
12 Months Ended
Dec. 31, 2022
Supplemental Cash Flow Information [Abstract]  
Schedule of supplemental cash flow information
   For the year ended
December 31,
 
   2022   2021 
Cash paid for interest  $68,321   $138,736 
Cash paid for taxes   
-
    
-
 
           
Noncash investing and financing activities:          
Acquisition of certain assets of Halcyon Thruput, LLC          
- issuance of common shares   
-
    2,500,000 
- issuance of subordinated note   
-
    850,000 
- assumption of Halcyon bank note   
-
    995,614 
Series B preferred stock dividend payable   80,002    58,312 
Issuance of common stock units previously subscribed   
-
    50,000 
Issuances of common shares for exchange or conversion of debt   
-
    2,160,269 
Conversion of Series A preferred stock into common stock   -    4,975,503 
XML 47 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings (Loss) Per Share (Tables)
12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Schedule of earnings (loss) per basic and diluted share
   For the year ended
December 31,
 
   2022   2021 
Amounts attributable to Generation Hemp:        
Numerator        
Loss from continuing operations attributable to common stockholders  $(6,975,740)  $(9,792,532)
Income (loss) from discontinued operations   (56,031)   (30,196)
Less: preferred stock dividends   (80,002)   (74,812)
Net loss attributable to common stockholders  $(7,111,773)  $(9,897,540)
Denominator          
Weighted average shares used to compute basic EPS   113,163,591    57,159,659 
Dilutive effect of convertible note   1,164,773    1,164,773 
Dilutive effect of preferred stock   2,950,000    55,075,900 
Dilutive effect of common stock options   229,762    709,981 
Dilutive effect of common stock warrants   1,320,951    11,022,542 
Weighted average shares used to compute diluted EPS   118,829,077    125,132,855 
Earnings (loss) per share:          
Loss from continuing operations          
Basic  $(0.06)  $(0.17)
Diluted  $(0.06)  $(0.17)
Loss from discontinued operations          
Basic  $
-
   $
-
 
Diluted  $
-
   $
-
 
Earnings (loss) per share          
Basic  $(0.06)  $(0.17)
Diluted  $(0.06)  $(0.17)

 

XML 48 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Business (Details)
$ in Thousands
1 Months Ended 12 Months Ended
Jan. 11, 2021
$ / ft²
Nov. 27, 2019
Dec. 31, 2022
USD ($)
Business (Details) [Line Items]      
Square foot facility (in Dollars per Square Foot) | $ / ft² 48,000    
Description of business, description     As of December 31, 2022, EHR held an approximate 8% working interest in an oil & gas property located in Cochran County, Texas within the Slaughter-Levelland Field of the San Andres formation in the Northwest Shelf of West Texas. EHR’s oil & gas activities are currently held for sale and are presented in these consolidated financial statements as discontinued operations for each of the periods presented. 
Cash for its operating activities     $ 633
Financing obligations terms     1 year
Current assets     $ 5,900
Financing obligations     $ 917
Energy Hunter Resources, Inc. [Member]      
Business (Details) [Line Items]      
Percentage of common stock   94.00%  
XML 49 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Details)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Accounting Policies [Abstract]    
Noncontrolling interest 6.00% 6.00%
Income tax, percentage 50.00%  
Midstream service revenue 96.00%  
Service revenue percentage   91.00%
XML 50 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Property and Equipment (Details) - Schedule of property and equipment - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Subtotal $ 3,206,107 $ 3,206,107
Less accumulated depreciation and amortization (1,044,155) (625,445)
Total property and equipment, net 2,161,952 2,580,662
Land [Member]    
Property, Plant and Equipment [Line Items]    
Subtotal $ 96,000 96,000
Warehouse [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, useful Life (years) 30 years  
Subtotal $ 916,500 916,500
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, useful Life (years) 3 years  
Subtotal $ 473,601 473,601
Machinery and equipment [Member]    
Property, Plant and Equipment [Line Items]    
Subtotal $ 1,506,447 1,506,447
Machinery and equipment [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, useful Life (years) 5 years  
Machinery and equipment [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, useful Life (years) 7 years  
Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, useful Life (years) 4 years  
Subtotal $ 149,440 149,440
Computer equipment and software [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, useful Life (years) 3 years  
Subtotal $ 46,825 46,825
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Subtotal $ 17,294 $ 17,294
Furniture and Fixtures [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, useful Life (years) 3 years  
Furniture and Fixtures [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, useful Life (years) 5 years  
XML 51 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Intangible and Other Assets (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]      
Future amortization expense for intangible assets 2023   $ 419,000  
Future amortization expense for intangible assets 2024   278,000  
Future amortization expense for intangible assets 2025   194,000  
Future amortization expense for intangible assets 2026   130,000  
Future amortization expense for intangible assets 2027   86,000  
Other assets   $ 2,060 $ 407,000
Option to purchase, description   the Company’s option to purchase the facility located in Hopkinsville, Kentucky leased from Halcyon. Under this agreement, the Company had the option to purchase the facility on or before August 25, 2022, as amended, for a purchase price of $993 thousand.  
Impairment expense $ 407,000    
XML 52 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Intangible and Other Assets (Details) - Schedule of finite-lived intangible assets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 2,675,825 $ 2,675,825
Accumulated Amortization (1,404,427) (817,917)
Net 1,271,398 1,857,908
Customer relationships [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 2,612,649 2,612,649
Accumulated Amortization (1,362,311) (796,858)
Net 1,250,338 1,815,791
Non-competition agreements [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 63,176 63,176
Accumulated Amortization (42,116) (21,059)
Net $ 21,060 $ 42,117
XML 53 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Notes Payable – Related Parties (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Jun. 01, 2023
Aug. 31, 2023
Dec. 30, 2020
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Mar. 01, 2023
Jul. 31, 2022
Notes Payable – Related Parties (Details) [Line Items]                
Accrued interest       $ 60        
Convertible note matured, description       The convertible note initially matured on January 1, 2022 but was subsequently amended to extend the maturity date to January 1, 2023.        
Conversion price per share (in Dollars per share)               $ 0.3
Restricted common shares (in Shares)       50,000        
Principal payments $ 250 $ 250            
Warrant to purchase shares of common stock (in Shares)       500,000        
Exercise price per share (in Dollars per share)       $ 0.352        
Warrant term       1 year        
Extension date       Dec. 30, 2023        
Interest expense       $ 69        
Subordinated Promissory Note to CEO [Member]                
Notes Payable – Related Parties (Details) [Line Items]                
Subordinated promissory note amount           $ 524    
Subordinated promissory note due date       Sep. 30, 2021        
Debt Instrument, Maturity Date       Jan. 01, 2023        
Bears interest rate       10.00%        
Accrued interest       $ 43        
New equity capital       $ 3,000        
Convertible Promissory Note to CEO [Member]                
Notes Payable – Related Parties (Details) [Line Items]                
Bears interest rate       10.00%        
Advances totaling         $ 410      
Additional advances       $ 697        
Conversion price per share (in Dollars per share)       $ 0.5        
Accrued interest       $ 107        
Subsequent Event [Member]                
Notes Payable – Related Parties (Details) [Line Items]                
Accrued interest             $ 240  
Promissory Note to Investment Hunter, LLC [Member]                
Notes Payable – Related Parties (Details) [Line Items]                
Bears interest rate       10.00%        
Advances totaling       $ 492        
Due date       Jan. 01, 2023        
Secured Promissory Note and Warrants to Coventry Asset Management, LTD. [Member]                
Notes Payable – Related Parties (Details) [Line Items]                
Bears interest rate     14.00%          
Principal amount     $ 1,000          
Restricted common shares (in Shares)     20,000          
New equity capital       $ 5,000        
Accrued interest       $ 200        
Secured Promissory Note and Warrants to Coventry Asset Management, LTD. [Member] | Promissory Note [Member]                
Notes Payable – Related Parties (Details) [Line Items]                
Maturity date       Dec. 31, 2023        
Subordinated Promissory Note and Warrants to Investor [Member]                
Notes Payable – Related Parties (Details) [Line Items]                
Convertible note matured, description       subordinated note principal together with accrued and unpaid interest was due, as previously amended, on March 31, 2022 but was extended to June 30, 2022.        
Principal amount     $ 500          
Principal payments     $ 300          
Interest rate, percentage     10.00%          
XML 54 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Notes Payable – Related Parties (Details) - Schedule of notes payable – related parties - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Notes Payable – Related Parties (Details) - Schedule of notes payable – related parties [Line Items]    
Total notes payable – related parties $ 3,322,620 $ 2,183,551
Subordinated Promissory Note to CEO [Member]    
Notes Payable – Related Parties (Details) - Schedule of notes payable – related parties [Line Items]    
Total 523,551 523,551
Convertible Promissory Note to CEO [Member]    
Notes Payable – Related Parties (Details) - Schedule of notes payable – related parties [Line Items]    
Total 1,107,069 410,000
Secured Promissory Note to Coventry Asset Management, LTD. [Member]    
Notes Payable – Related Parties (Details) - Schedule of notes payable – related parties [Line Items]    
Total 1,000,000 1,000,000
Subordinated Promissory Note to Investor [Member]    
Notes Payable – Related Parties (Details) - Schedule of notes payable – related parties [Line Items]    
Total 200,000 250,000
Promissory Note to Investment Hunter, LLC [Member]    
Notes Payable – Related Parties (Details) - Schedule of notes payable – related parties [Line Items]    
Total $ 492,000
XML 55 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Other Indebtedness (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Apr. 29, 2020
Other Indebtedness [Abstract]    
Mortgage payable, description The note has been amended a number of times to a maturity date of October 1, 2023. In the latest extension, the Company made a principal payment of $25 thousand plus accrued interest in January 2023 and agreed to make seven additional monthly principal payments of $25 thousand plus accrued interest each beginning on March 1, 2023.  
Accrued interest $ 50,000  
Interest rate 12.00%  
Interest expenses $ 5,000,000  
Lease and rental expense 7,500  
Minimum future rents $ 52,000  
Loan amount   $ 25,000
XML 56 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Leases (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Leases (Details) [Line Items]    
Lease payment $ 2  
Lease expense $ 24 $ 22
Borrowing rate percentage 10.00%  
Minimum [Member]    
Leases (Details) [Line Items]    
Monthly rent $ 1  
Maximum [Member]    
Leases (Details) [Line Items]    
Monthly rent 4  
Oz Capital, LLC [Member]    
Leases (Details) [Line Items]    
Lease payment 10  
Lease expense $ 123 $ 119
XML 57 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies (Details) - USD ($)
1 Months Ended 12 Months Ended
Dec. 23, 2020
Dec. 31, 2022
Commitments and Contingencies (Details) [Line Items]    
Purchase price of equipment   $ 16,000
Insurance claim for replacement   $ 1,500,000
Description of suit against UNIC   Halcyon’s suit against UNIC, which was removed to federal court, seeks over $1 million plus statutory interest on that sum from August 10, 2020 for violating the Texas Insurance Code’s requirement that claims be promptly paid, additional statutory penalties, and attorneys’ fees. Certain documents have been executed between the Company, Halcyon and legal counsel, which provide for a sharing of costs and expenses and awards, if any, against UNIC.
Partial settlement claim   $ 357,000
Amount of summary judgment $ 231,000 50,000
Litigation settlement interest percentage 5.00%  
Amount accrued for judgment   253,000
Halcyon Thruput LLC’s [Member]    
Commitments and Contingencies (Details) [Line Items]    
Substantial coverages   1,200,000
Grand Traverse Holdings, LLC [Member]    
Commitments and Contingencies (Details) [Line Items]    
Amount received from defendant   $ 122,000
XML 58 R43.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Details)
$ in Millions
Dec. 31, 2022
USD ($)
Income Taxes [Abstract]  
Federal net operating loss not expiration $ 23.8
Federal net operating loss expiration $ 6.5
XML 59 R44.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Details) - Schedule of reconciliation of the expected statutory federal tax - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Schedule Of Reconciliation Of The Expected Statutory Federal Tax [Abstract]    
Federal statutory rate $ (1,462,067) $ (2,056,480)
State income taxes, net (141,438) (198,940)
Change in valuation allowance 1,630,110 3,655,210
Change in state tax rates (178,644)
True-up of prior year deferred items (929,450)
Other, net (26,605) (291,696)
Total income tax expense
XML 60 R45.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Details) - Schedule of deferred tax assets and liabilities - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Assets:    
Net operating loss carryforwards $ 5,471,098 $ 4,960,487
Stock-based compensation 2,142,362 1,046,464
Property and equipment (24,310) 33,803
Intangible assets 216,726 135,012
Subtotal 7,805,876 6,175,766
Valuation allowance (7,805,876) (6,175,766)
Net deferred tax asset
XML 61 R46.htm IDEA: XBRL DOCUMENT v3.23.1
Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Dec. 30, 2020
Dec. 31, 2022
Dec. 31, 2021
Sep. 08, 2021
Apr. 30, 2021
Equity (Details) [Line Items]          
Converted into shares of common stock   25,000      
Sale of preferred stock units (in Dollars)   $ 10      
Aggregate gross proceeds (in Dollars)   $ 1,350      
Price per share (in Dollars per share)   $ 1      
Redemption payments percentage   12.50%      
Redemption payments total (in Dollars)         $ 137
Common stock, shares outstanding   113,204,002 113,094,002    
Weighted average market price of common stock exceed (in Dollars per share)   $ 1      
Shares of Common stock   25,000      
Common Stock [Member]          
Equity (Details) [Line Items]          
Equity, description   ●Acquisition of Certain Assets of Halcyon – In January 2021, the Company issued 6,250,000 shares of common stock valued at $2.5 million ($0.40 per share; restricted from trading for a period of up to one year) in the acquisition.     ●2021 First Quarter Issuances of Common Stock Units – In the first quarter of 2021, the Company issued 800,000 common stock units for total proceeds of $400,000. Each common stock unit consisted of one share of common stock and a warrant for the purchase of two shares of common stock for $0.50 each. Each warrant is exercisable any time before its expiration on the second anniversary of its issuance. The Company allocated the total proceeds based on the relative fair values of the common stock and warrants. The fair value of the warrants was determined using an options valuation model with key assumptions including a risk-free interest rate of 0.11% and historical volatility of 272%. A total of $263 thousand was allocated to the warrants and reported in additional paid-in capital.      ●Warrant Exercises – In the first quarter of 2021, the Company received approximately $3 million for the exercise of 8,428,976 outstanding warrants. In the fourth quarter of 2021, the Company received $375 thousand for the exercise of 1,065,340 outstanding warrants.    ●Issuances for Exchange or Conversion of Debt – The Company issued a total of 1,618,660 common shares for the exchange or conversion of outstanding indebtedness totaling $2.2 million in the first quarter of 2021.     ●Issuance to Vendor for Services – In the third quarter of 2021, the Company issued 125,000 common shares valued at $117.5 thousand to a vendor for services performed.    ●Issuance for Extension of Secured Note – The Company issued 20,000 common shares valued at $18 thousand as consideration to extend the maturity of a senior note in the third quarter of 2021.    ●Issuance for Conversion of Series A Preferred Stock – As noted above, in the third quarter of 2021, the Company issued 75,947,376 common shares for the conversion of all outstanding shares of its Series A Preferred Stock.    ●2021 Fourth Quarter Issuances of Common Stock Units – In the fourth quarter of 2021, the Company issued 958,333 common stock units to accredited investors for total proceeds of $575 thousand. Each common stock unit consists of one share of common stock and a warrant for the purchase of one share of common stock for $0.60 each. Each warrant is exercisable any time before its expiration on the second anniversary of its issuance. The Company allocated the total proceeds based on the relative fair values of the common stock and warrants. The fair value of the warrants was determined using an options valuation model with key assumptions including risk-free interest rates ranging from 0.48% to 0.70% and historical volatility ranging from 237% to 258%. A total of $277 thousand was allocated to the warrants and reported in additional paid-in capital..    ●Issuance for Extensions of Secured Note – The Company issued 110,000 common shares valued at $52.6 thousand as consideration for extensions of the maturity of a senior note in 2022. Refer to Note 5.      
Aggregate gross proceeds (in Dollars)   $ 5,000      
Price per share (in Dollars per share)   $ 1      
Warrant [Member]          
Equity (Details) [Line Items]          
Warrant per share (in Dollars per share)   $ 0.0001      
Series A Preferred Stock [Member]          
Equity (Details) [Line Items]          
Shares of preferred stock       6,328,948  
Converted into shares of common stock       75,947,376  
Converting into shares of restricted common stock       12  
Series B Preferred Stock [Member]          
Equity (Details) [Line Items]          
Converted into shares of common stock   25,000      
Equity, description On December 30, 2020, the Company sold to certain accredited investors, including Gary C. Evans, our Chief Executive Officer, an aggregate of 135 preferred stock units comprised of (i) one share of Series B Redeemable Convertible Preferred Stock, no par value, and (ii) one warrant exercisable for 50 thousand shares of common stock of the Company until December 30, 2022 at an exercise price of $0.352 per share.        
Dividends percentage   6.00%      
Stated value per share (in Dollars)   $ 10      
XML 62 R47.htm IDEA: XBRL DOCUMENT v3.23.1
Equity (Details) - Schedule of warrants outstanding
12 Months Ended
Dec. 31, 2022
$ / shares
shares
Equity (Details) - Schedule of warrants outstanding [Line Items]  
Number of Warrants 3,058,333
Issued in December 2020 [Member] | Subordinated note to investor [Member]  
Equity (Details) - Schedule of warrants outstanding [Line Items]  
Number of Warrants 500,000 [1]
Price (each) | $ / shares $ 0.352 [1]
Expiration Date December 30, 2023 [1]
Method of Exercise Cash [1]
Issued in Q1 2021 [Member] | Common stock units [Member]  
Equity (Details) - Schedule of warrants outstanding [Line Items]  
Number of Warrants 1,600,000 [1]
Price (each) | $ / shares $ 0.5 [1]
Expiration Date January-February, 2023 [1]
Method of Exercise Cash [1]
Issued in Q4 2021 [Member] | Common stock units [Member]  
Equity (Details) - Schedule of warrants outstanding [Line Items]  
Number of Warrants 958,333 [1]
Price (each) | $ / shares $ 0.6 [1]
Expiration Date October-December, 2023 [1]
Method of Exercise Cash [1]
[1] May be redeemed for $0.0001 per warrant at the Company’s option with 30 days advanced notice should the weighted average market price of common stock exceed $1.00 for any five out of seven consecutive trading days with a minimum average daily trading volume for such seven-day period of at least 25,000 shares of common stock.
XML 63 R48.htm IDEA: XBRL DOCUMENT v3.23.1
Equity (Details) - Schedule of outstanding stock warrants activity - $ / shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Schedule Of Outstanding Stock Warrants Activity Abstract    
Number of Warrants, Warrants beginning 8,808,333 22,988,632
Weighted Average Exercise Price, Warrants beginning $ 0.407 $ 0.353
Number of Warrants, Warrants ending 3,058,333 8,808,333
Weighted Average Exercise Price, Warrants ending $ 0.507 $ 0.407
Number of Warrants, Warrants Issued   2,558,333
Weighted Average Exercise Price, Issued   $ 0.537
Number of Warrants, Warrants Cancelled (5,750,000) (7,244,316)
Weighted Average Exercise Price, Cancelled $ 0.354 $ 0.352
Number of Warrants, Warrants Exercised   (9,494,316)
Weighted Average Exercise Price, Exercised   $ 0.352
XML 64 R49.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Mar. 31, 2021
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Stock-Based Compensation (Details) [Line Items]            
Diluted common shares outstanding percentage         20.00%  
Compensation expense related to awards         $ 155  
Common stock incentive compensation 1,915,000 13,850,000        
Weighted average contractual life   10 years     9 years  
Exercise price per share   0.76       0.76
Grant value   $ 10,500,000   $ 576,000 $ 1,400,000  
Awarded options vest over year 3 years          
Compensation expense         4,700,000  
Total unrecognized compensation cost         $ 2,000,000  
Minimum [Member]            
Stock-Based Compensation (Details) [Line Items]            
Weighted average contractual life 8 years          
Exercise price per share 0.3     0.3    
Risk free interest rate 2.87%       1.18%  
Volatility ranging 251.00%       331.00%  
Stock options range 4 years       5 years  
Maximum [Member]            
Stock-Based Compensation (Details) [Line Items]            
Weighted average contractual life 10 years          
Exercise price per share 0.33     0.33    
Risk free interest rate 3.03%          
Risk free interest rate         1.28%  
Volatility ranging 408.00%       643.00%  
Stock options range 7 years       6 years  
2021 Plan [Member]            
Stock-Based Compensation (Details) [Line Items]            
common stock for issuance           15,000,000
Number of shares           15,000,000
Restricted Stock [Member]            
Stock-Based Compensation (Details) [Line Items]            
Restricted shares, issued     500,000      
Restricted shares, value     $ 155,000      
XML 65 R50.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation (Details) - Schedule of summarizes options outstanding - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Schedule Of Summarizes Options Outstanding Abstract    
Shares Beginning (in Shares) 13,850,000
Weighted Average Grant Date Fair Value Beginning $ 0.76
Weighted Average Exercise Price Beginning $ 0.76
Aggregate Intrinsic Value Beginning (in Dollars)
Shares Ending (in Shares) 15,765,000 13,850,000
Weighted Average Grant Date Fair Value Ending $ 0.7 $ 0.76
Weighted Average Exercise Price Ending $ 0.71 $ 0.76
Aggregate Intrinsic Value Ending (in Dollars)
Shares Granted (in Shares) 1,915,000 13,850,000
Weighted Average Grant Date Fair Value Granted $ 0.3 $ 0.76
Weighted Average Exercise Price Granted $ 0.31 $ 0.76
Aggregate Intrinsic Value Granted (in Dollars)
XML 66 R51.htm IDEA: XBRL DOCUMENT v3.23.1
Discontinued Operations (Details) - Schedule of discontinued operations to assets and liabilities held for sale - Discontinued Operations [Member] - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Assets:    
Oil and natural gas properties held for sale, at cost $ 1,874,849 $ 1,874,849
Accumulated DD&A (1,874,849) (1,874,849)
Total assets of discontinued operations held for sale
Liabilities:    
Accrued liabilities 61,701 48,997
Asset retirement obligations 52,368 52,368
Revenue payable 52,117 52,117
Current liabilities of discontinued operations held for sale 166,186 153,482
Long-term liabilities of discontinued operations held for sale 207,197 162,948
Total liabilities of discontinued operations held for sale $ 373,383 $ 316,430
XML 67 R52.htm IDEA: XBRL DOCUMENT v3.23.1
Discontinued Operations (Details) - Schedule of discontinued operations shown in the consolidated statements of operations - Discontinued Operations [Member] - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenue -    
Oil and gas sales $ 147,828 $ 116,710
Costs and Expenses:    
Lease operating expense 163,352 134,590
Accretion of asset retirement obligations 44,249 14,333
Total costs and expenses 207,601 148,923
Loss from discontinued operations $ (59,773) $ (32,213)
XML 68 R53.htm IDEA: XBRL DOCUMENT v3.23.1
Supplemental Cash Flow Information (Details) - Schedule of supplemental cash flow information - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Schedule Of Supplemental Cash Flow Information [Abstract]    
Cash paid for interest $ 68,321 $ 138,736
Cash paid for taxes
Acquisition of certain assets of Halcyon Thruput, LLC    
issuance of common shares 2,500,000
issuance of subordinated note 850,000
assumption of Halcyon bank note 995,614
Series B preferred stock dividend payable 80,002 58,312
Issuance of common stock units previously subscribed 50,000
Issuances of common shares for exchange or conversion of debt 2,160,269
Conversion of Series A preferred stock into common stock   $ 4,975,503
XML 69 R54.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings (Loss) Per Share (Details) - Schedule of earnings (loss) per basic and diluted share - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Numerator    
Loss from continuing operations attributable to common stockholders $ (6,975,740) $ (9,792,532)
Income (loss) from discontinued operations (56,031) (30,196)
Less: preferred stock dividends (80,002) (74,812)
Net loss attributable to common stockholders $ (7,111,773) $ (9,897,540)
Denominator    
Weighted average shares used to compute basic EPS 113,163,591 57,159,659
Dilutive effect of convertible note 1,164,773 1,164,773
Dilutive effect of preferred stock 2,950,000 55,075,900
Dilutive effect of common stock options 229,762 709,981
Dilutive effect of common stock warrants 1,320,951 11,022,542
Weighted average shares used to compute diluted EPS 118,829,077 125,132,855
Loss from continuing operations    
Basic $ (0.06) $ (0.17)
Diluted (0.06) (0.17)
Loss from discontinued operations    
Basic
Diluted
Earnings (loss) per share    
Basic (0.06) (0.17)
Diluted $ (0.06) $ (0.17)
XML 70 R55.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 01, 2023
Jan. 10, 2023
Jan. 09, 2023
Jan. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Jul. 15, 2023
Apr. 15, 2023
Jan. 15, 2023
Jul. 31, 2022
Subsequent Events [Abstract]                    
Operating & maintenance agreement description           The Toro Dam is located approximately 25 miles from San Jose between two volcano craters. The site generates all its energy from green resources with a proven 98% run time over the years and has a full-time staff in place under a new Operating & Maintenance Agreement.         
Lease payment           $ 2,000        
Shares value           25        
Advances total           $ 300,000        
Conversion price, per share (in Dollars per share)                   $ 0.3
Toro Energía Sociedad Anonima [Member]                    
Subsequent Events [Abstract]                    
Ownership percentage           80.00%        
Subsequent Event [Member]                    
Subsequent Events [Abstract]                    
Purchase of common stock (in Shares)       100,000            
exercise price (in Dollars per share)       $ 0.3            
Seller-financed debt     $ 985,000              
Seller financed debt term     10 years              
Interest rate per annum     9.50%           10.00%  
Accrued and unpaid interest   $ 969,000 $ 500,000              
Conversion price     0.275%              
Repayment accrued interest $ 240,000                  
Lease payment $ 20,500                  
Common stock, shares         $ 100,000          
Common stock exceeds, per share (in Dollars per share)         $ 0.75          
Subsequent Event [Member] | Warrant [Member]                    
Subsequent Events [Abstract]                    
Common stock exceeds, per share (in Dollars per share)         0.875          
Exercise price, per share (in Dollars per share)         $ 0.5          
Warrant expire         3 years          
Subsequent Event [Member] | Toro Energía Sociedad Anonima [Member]                    
Subsequent Events [Abstract]                    
Ownership percentage     80.00%              
Subsequent Event [Member] | Series C Redeemable Convertible Preferred Stock [Member]                    
Subsequent Events [Abstract]                    
Redeemable Convertible Preferred Stock (in Dollars per share)         $ 8.5          
Warrants shares (in Shares)         5,000          
Cumulative dividends, percentage         8.50%          
Subsequent Event [Member] | Series C Redeemable Convertible Preferred Stock [Member] | Private Placement [Member]                    
Subsequent Events [Abstract]                    
Total proceeds         $ 300,000          
Forecast [Member]                    
Subsequent Events [Abstract]                    
borrowing               $ 300    
Interest accrued, rate             12.00%      
Conversion price, per share (in Dollars per share)             $ 0.3      
Qwnership, percentage         100.00%          
Toro Energía Sociedad Anonima [Member]                    
Subsequent Events [Abstract]                    
Equity total Amount           $ 1,400,000        
XML 71 f10k2022_evergreen_htm.xml IDEA: XBRL DOCUMENT 0001527102 2022-01-01 2022-12-31 0001527102 2022-06-30 0001527102 2023-05-18 0001527102 2022-12-31 0001527102 2021-12-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2022-12-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2021-12-31 0001527102 2021-01-01 2021-12-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2020-12-31 0001527102 us-gaap:PreferredStockMember 2020-12-31 0001527102 us-gaap:CommonStockMember 2020-12-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001527102 us-gaap:RetainedEarningsMember 2020-12-31 0001527102 us-gaap:NoncontrollingInterestMember 2020-12-31 0001527102 2020-12-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2021-01-01 2021-12-31 0001527102 us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001527102 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001527102 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001527102 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2021-12-31 0001527102 us-gaap:PreferredStockMember 2021-12-31 0001527102 us-gaap:CommonStockMember 2021-12-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001527102 us-gaap:RetainedEarningsMember 2021-12-31 0001527102 us-gaap:NoncontrollingInterestMember 2021-12-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2022-01-01 2022-12-31 0001527102 us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001527102 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001527102 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001527102 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2022-12-31 0001527102 us-gaap:PreferredStockMember 2022-12-31 0001527102 us-gaap:CommonStockMember 2022-12-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001527102 us-gaap:RetainedEarningsMember 2022-12-31 0001527102 us-gaap:NoncontrollingInterestMember 2022-12-31 0001527102 genh:EnergyHunterResourcesIncMember 2019-11-02 2019-11-27 0001527102 2021-01-01 2021-01-11 0001527102 us-gaap:LandMember 2022-12-31 0001527102 us-gaap:LandMember 2021-12-31 0001527102 srt:WarehouseMember 2022-01-01 2022-12-31 0001527102 srt:WarehouseMember 2022-12-31 0001527102 srt:WarehouseMember 2021-12-31 0001527102 us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001527102 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001527102 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001527102 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2022-01-01 2022-12-31 0001527102 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2022-01-01 2022-12-31 0001527102 us-gaap:MachineryAndEquipmentMember 2022-12-31 0001527102 us-gaap:MachineryAndEquipmentMember 2021-12-31 0001527102 us-gaap:VehiclesMember 2022-01-01 2022-12-31 0001527102 us-gaap:VehiclesMember 2022-12-31 0001527102 us-gaap:VehiclesMember 2021-12-31 0001527102 us-gaap:ComputerEquipmentMember 2022-01-01 2022-12-31 0001527102 us-gaap:ComputerEquipmentMember 2022-12-31 0001527102 us-gaap:ComputerEquipmentMember 2021-12-31 0001527102 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0001527102 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0001527102 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001527102 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001527102 2022-01-01 2022-09-30 0001527102 us-gaap:CustomerRelationshipsMember 2022-12-31 0001527102 us-gaap:CustomerRelationshipsMember 2021-12-31 0001527102 genh:NoncompetitionAgreementsMember 2022-12-31 0001527102 genh:NoncompetitionAgreementsMember 2021-12-31 0001527102 genh:SubordinatedPromissoryNoteToCEOMember 2020-01-01 2020-12-31 0001527102 genh:SubordinatedPromissoryNoteToCEOMember 2022-12-31 0001527102 genh:SubordinatedPromissoryNoteToCEOMember 2022-01-01 2022-12-31 0001527102 genh:PromissoryNoteToInvestmentHunterLLCMember 2022-12-31 0001527102 genh:ConvertiblePromissoryNoteToCEOMember 2021-01-01 2021-12-31 0001527102 genh:ConvertiblePromissoryNoteToCEOMember 2022-12-31 0001527102 2022-07-31 0001527102 genh:SecuredPromissoryNoteAndWarrantsToCoventryAssetManagementLTDMember 2020-12-30 0001527102 genh:SecuredPromissoryNoteAndWarrantsToCoventryAssetManagementLTDMember 2020-12-01 2020-12-30 0001527102 genh:PromissoryNoteMember genh:SecuredPromissoryNoteAndWarrantsToCoventryAssetManagementLTDMember 2022-01-01 2022-12-31 0001527102 genh:SecuredPromissoryNoteAndWarrantsToCoventryAssetManagementLTDMember 2022-01-01 2022-12-31 0001527102 2023-05-25 2023-06-01 0001527102 2023-08-01 2023-08-31 0001527102 genh:SubordinatedPromissoryNoteAndWarrantsToInvestorMember 2020-12-30 0001527102 genh:SubordinatedPromissoryNoteAndWarrantsToInvestorMember 2020-12-01 2020-12-30 0001527102 genh:SubordinatedPromissoryNoteAndWarrantsToInvestorMember 2022-01-01 2022-12-31 0001527102 us-gaap:SubsequentEventMember 2023-03-01 0001527102 genh:PromissoryNoteToInvestmentHunterLLCMember 2022-01-01 2022-12-31 0001527102 genh:SubordinatedPromissoryNoteToCEOMember 2021-12-31 0001527102 genh:ConvertiblePromissoryNoteToCEOMember 2021-12-31 0001527102 genh:SecuredPromissoryNoteToCoventryAssetManagementLtdMember 2022-12-31 0001527102 genh:SecuredPromissoryNoteToCoventryAssetManagementLtdMember 2021-12-31 0001527102 genh:SubordinatedPromissoryNoteMember 2022-12-31 0001527102 genh:SubordinatedPromissoryNoteMember 2021-12-31 0001527102 genh:PromissoryNoteToInvestmentHunterLLCMember 2022-12-31 0001527102 genh:PromissoryNoteToInvestmentHunterLLCMember 2021-12-31 0001527102 2020-04-29 0001527102 genh:OzCapitalLLCMember 2022-01-01 2022-12-31 0001527102 genh:OzCapitalLLCMember 2021-01-01 2021-12-31 0001527102 srt:MinimumMember 2022-01-01 2022-12-31 0001527102 srt:MaximumMember 2022-01-01 2022-12-31 0001527102 genh:HalcyonThruputLLCsMember 2022-01-01 2022-12-31 0001527102 genh:GrandTraverseHoldingsLLCMember 2022-12-31 0001527102 2020-12-01 2020-12-23 0001527102 us-gaap:SeriesAPreferredStockMember 2021-09-08 0001527102 us-gaap:SeriesBPreferredStockMember 2020-12-01 2020-12-30 0001527102 us-gaap:SeriesBPreferredStockMember 2022-12-31 0001527102 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-12-31 0001527102 2021-04-30 0001527102 us-gaap:WarrantMember 2022-12-31 0001527102 genh:DecemberTwoThousandTwentyMember genh:SubordinatedNoteToInvestorMember 2022-12-31 0001527102 genh:DecemberTwoThousandTwentyMember genh:SubordinatedNoteToInvestorMember 2022-01-01 2022-12-31 0001527102 genh:MarchTwoThousandTwentyOneMember genh:CommonStockUnitsMember 2022-12-31 0001527102 genh:MarchTwoThousandTwentyOneMember genh:CommonStockUnitsMember 2022-01-01 2022-12-31 0001527102 genh:DecemberTwoThousandTwentyOneMember genh:CommonStockUnitsMember 2022-12-31 0001527102 genh:DecemberTwoThousandTwentyOneMember genh:CommonStockUnitsMember 2022-01-01 2022-12-31 0001527102 genh:TwoThousandTwentyOnePlanMember 2021-01-01 2021-12-31 0001527102 us-gaap:RestrictedStockMember 2021-01-01 2021-03-31 0001527102 2021-10-01 2021-12-31 0001527102 2022-07-01 2022-09-30 0001527102 srt:MinimumMember 2022-07-01 2022-09-30 0001527102 srt:MaximumMember 2022-07-01 2022-09-30 0001527102 srt:MinimumMember 2022-09-30 0001527102 srt:MaximumMember 2022-09-30 0001527102 us-gaap:SegmentDiscontinuedOperationsMember 2022-12-31 0001527102 us-gaap:SegmentDiscontinuedOperationsMember 2021-12-31 0001527102 us-gaap:SegmentDiscontinuedOperationsMember 2022-01-01 2022-12-31 0001527102 us-gaap:SegmentDiscontinuedOperationsMember 2021-01-01 2021-12-31 0001527102 us-gaap:SubsequentEventMember 2023-01-01 2023-01-31 0001527102 genh:ToroEnergaSociedadAnonimaMember us-gaap:SubsequentEventMember 2023-01-09 0001527102 us-gaap:SubsequentEventMember 2023-01-09 0001527102 us-gaap:SubsequentEventMember 2023-01-09 2023-01-09 0001527102 genh:ToroEnergaSociedadAnonimaMember 2022-12-31 0001527102 genh:ToroEnergaSociedadAnonimaMember 2022-01-01 2022-12-31 0001527102 us-gaap:SubsequentEventMember 2023-01-10 2023-01-10 0001527102 us-gaap:SubsequentEventMember 2023-01-15 0001527102 us-gaap:SubsequentEventMember 2023-03-01 2023-03-01 0001527102 genh:SeriesCRedeemableConvertiblePreferredStockMember us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2023-01-01 2023-03-31 0001527102 genh:SeriesCRedeemableConvertiblePreferredStockMember us-gaap:SubsequentEventMember 2023-03-31 0001527102 genh:SeriesCRedeemableConvertiblePreferredStockMember us-gaap:SubsequentEventMember 2023-01-01 2023-03-31 0001527102 us-gaap:SubsequentEventMember 2023-01-01 2023-03-31 0001527102 us-gaap:WarrantMember us-gaap:SubsequentEventMember 2023-03-31 0001527102 us-gaap:WarrantMember us-gaap:SubsequentEventMember 2023-01-01 2023-03-31 0001527102 srt:ScenarioForecastMember 2023-04-15 0001527102 srt:ScenarioForecastMember 2023-07-15 0001527102 srt:ScenarioForecastMember 2023-03-31 iso4217:USD shares iso4217:USD shares pure iso4217:USD utr:sqft 10-K true 2022-12-31 --12-31 2022 000-55019 Evergreen Sustainable Enterprises, Inc. DE 26-3119496 8533 Midway Road Dallas TX 75209 (469) 209-6154 Common Stock, par value $0.00001 per share EGSE No No No Yes Non-accelerated Filer true false false false 18658253 113254002 688 Marcum llp Houston, Texas 275506 20656 470719 148427 212518 22143 4723 916795 237897 2161952 2580662 161827 263065 1271398 1857908 799888 799888 2060 407000 5313920 6146420 686297 883485 767396 410990 591574 204007 111839 101238 3322620 2183551 250002 501668 166186 153482 5895914 4438421 49988 161827 207197 162948 6153099 4763196 10000 10000 300 300 118 118 118 118 591558 591558 0.00001 0.00001 200000000 200000000 0.00001 0.00001 200000000 200000000 113204002 113204002 113094002 113094002 1132 1131 34029851 29150258 -35230018 -28118245 -1199035 1033144 -231702 -241478 -1430737 791666 5313920 6146420 2505590 592024 90000 82500 2595590 674524 1016930 652521 1005220 1340425 407000 7128421 7803196 9557571 9796142 -6961981 -9121618 -500905 -25424 11770 501146 708338 241 671144 -6962222 -9792762 -59773 -32213 -7021995 -9824975 9776 -2247 -7031771 -9822728 -0.06 -0.17 -0.06 -0.17 -0.06 -0.17 -0.06 -0.17 135 729058 6328948 4975503 17380317 6083480 4436018 -18220705 -239231 -2964935 6250000 2500000 2500000 1758333 136717 838283 975000 9494316 4771679 -1429679 3342000 618660 217769 217769 1000000 1942500 1942500 125000 117500 117500 20000 18000 18000 -15868273 15868273 -6328948 -4975503 75947376 759 4974744 -17 -137500 74812 74812 500000 81000 4462619 4543619 -9822728 -2247 -9824975 118 591558 113094002 1131 29150258 -28118245 -241478 791666 110000 1 52580 52581 68756 68756 80002 80002 4758257 4758257 -7031771 9776 -7021995 118 591558 113204002 1132 34029851 -35230018 -231702 -1430737 -7021995 -9824975 -59773 -32213 -6962222 -9792762 1005220 1340425 407000 52581 380282 4758257 4543619 117500 68756 -25424 -6938 11770 470719 -75470 -64091 212518 19480 4723 466783 85939 -629733 -3497024 -2820 -632553 -3497024 77715 224530 224530 -1525470 34847 -1568338 925000 137500 16500 3342000 995614 1294069 105000 410000 50000 1100000 251666 117793 887403 2309593 254850 -2755769 20656 2776425 275506 20656 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>1. Business</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">Evergreen Sustainable Enterprises, Inc. (formerly Generation Hemp, Inc.) (the “Company”) was incorporated on August 21, 2021 in the State of Delaware. The Company was originally incorporated as Home Treasure Finders, Inc. (“HTF”) on July 28, 2008 in the State of Colorado. On November 27, 2019, HTF purchased approximately 94% of the common stock of Energy Hunter Resources, Inc. (“EHR”) in a series of transactions accounted for as a reverse merger. Upon closing, HTF changed its name to Generation Hemp, Inc. In March 2023, the Company changed its name to Evergreen Sustainable Enterprises, Inc.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">On January 11, 2021, we completed the acquisition of certain assets of Halcyon Thruput, LLC (“Halcyon”). With this acquisition, we commenced providing post-harvest and midstream services to hemp growers by drying, processing, cleaning and stripping harvested hemp directly from the field and wetbaled at our 48,000 square foot leased facility located in Hopkinsville, Kentucky. The Company also offers safe storage services for processed hemp, which enables farmers to maximize strategic market timing. We market two retail products, <i>Gas Monkey Spill-Jack</i>, an all-natural, plant-based, sustainable, and biodegradable loose absorbent, and <i>Rowdy Rooster</i>, an animal bedding consumer goods product, each made from the hemp hurd byproduct that is produced from our hemp processing operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">We also generate revenue from rental of our “Cannabis Zoned” (Hemp) warehouse property located in Denver, Colorado currently leased to an unaffiliated hemp seed company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">As of December 31, 2022, EHR held an approximate 8% working interest in an oil &amp; gas property located in Cochran County, Texas within the Slaughter-Levelland Field of the San Andres formation in the Northwest Shelf of West Texas. EHR’s oil &amp; gas activities are currently held for sale and are presented in these consolidated financial statements as discontinued operations for each of the periods presented.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">Our management team has been and continues to actively review acquisition candidates involved in the hemp industry that operate within a number of vertical businesses, predominantly within the midstream sector that are attractive to us and are within the hemp supply chain. Additionally, the Company has been studying the Bitcoin mining space and in January 2023 announced a new strategic initiative in this area and commenced bitcoin operations. Refer to Note 15 for more discussion.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><i>Liquidity and Going Concern – </i>The Company is dependent upon obtaining additional funding to continue ongoing operations and to pursue its strategy and execute its acquisition plans.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">In the year ended December 31, 2022, the Company used $633 thousand of cash for its operating activities. At December 31, 2022, the Company’s current liabilities, including financing obligations due within one year, totaled $5.9 million as compared with its current assets of $917 thousand.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">The Company will continue to pursue additional capital raising opportunities in order to fund future acquisitions and meet its obligations as they become due. We may not be successful in obtaining additional financing needed. In the event financing cannot be obtained, the Company may not be able to satisfy these plans and obligations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p> 0.94 48000 As of December 31, 2022, EHR held an approximate 8% working interest in an oil & gas property located in Cochran County, Texas within the Slaughter-Levelland Field of the San Andres formation in the Northwest Shelf of West Texas. EHR’s oil & gas activities are currently held for sale and are presented in these consolidated financial statements as discontinued operations for each of the periods presented.  633000 P1Y 5900000 917000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>2. Summary of Significant Accounting Policies</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Basis of Presentation <b>– </b></i>The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and U.S. Securities and Exchange Commission regulations. The consolidated financial statements comprise the financial statements of the Company, its wholly-owned subsidiaries, and subsidiaries that it controls due to ownership of a majority voting interest. Subsidiaries are fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continue to be consolidated until the date when such control ceases. The financial statements of the subsidiaries are prepared for the same reporting period as the Company. All significant intercompany balances and transactions are eliminated upon consolidation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i> </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Business Combinations <b>– </b></i>The Company accounts for business combinations under the acquisition method of accounting. Under this method, acquired assets, including separately identifiable intangible assets, and any assumed liabilities are recorded at their acquisition date estimated fair value. Determining the fair value of assets acquired and liabilities assumed involves the use of significant estimates and assumptions. The excess of purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents the goodwill amount resulting from the acquisition.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i> </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Use of Estimates – </i>The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the (i) impairment of long-lived assets and goodwill, (ii) valuation allowances for deferred income tax assets and (iii) estimates of accrued liabilities. Actual results could differ from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i> </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Revenue Recognition – </i>Post-harvest and midstream services revenue is typically determined based on volumes processed at agreed-upon contractual prices and is recognized at the point in time when performance obligations under the terms of a contract with our customers are satisfied. This occurs when control of the product is transferred to our customers upon completion of our processing.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>Rental revenue is recognized based on the contractual cash rental payments for the period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Cash – </i>The Company maintains its deposits of cash in financial institutions, which may at times exceed amounts covered by insurance provided by the U.S. Federal Deposit Insurance Corporation (“FDIC”). The Company has not experienced any losses related to amounts in excess of FDIC limits.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Inventories</i> – Inventories consist of processed hemp product and are stated at the lower of cost or net realizable value. Cost, which includes the cost of raw materials, labor and overhead, is determined using the first-in, first-out method. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable cost of completion, disposal and transportation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Property and Equipment – </i><span style="text-transform: uppercase">P</span>roperty and equipment is stated at cost and depreciated using the straight-line method over the estimated useful lives of assets. Upon disposition, the cost and accumulated depreciation are removed and any gain or loss on the disposal is reflected in the statements of operations. The cost of maintenance and repairs is charged to income as incurred; significant renewals and improvements are capitalized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Leases</i> – The Company’s lease arrangements are operating leases which are capitalized on the balance sheet as right-of-use (“ROU”) assets and obligations. Right of use (“ROU”) assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. These are recognized at the lease commencement date based on the present value of payments over the lease term. If leases do not provide for an implicit rate, we use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term as the lease payments. Lease expense is recognized on a straight-line basis over the lease term.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Intangible Assets</i> – Finite-lived intangible assets are amortized and are tested for impairment when an event occurs or circumstances change that indicate it is more likely than not that an impairment exists. Intangible assets consist of customer relationships and non-compete agreements acquired in the acquisition of certain assets of Halcyon. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Impairment of Long-Lived Assets</i> – We review long-lived assets for potential impairment when events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. In this assessment, future pre-tax cash flows (undiscounted) resulting from the use of the asset and its eventual disposal are estimated. If the undiscounted future cash flows are less than the carrying amount of the asset, an impairment loss is recognized for the difference between its carrying value and estimated fair value.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i> </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Noncontrolling Interest</i> – Noncontrolling interests represent the portion of net assets in consolidated entities that are not owned by the Company. As of December 31, 2022 and 2021, minority investors owned approximately 6% of EHR.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i> </i></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Stock-based Compensation – </i>We account for stock-based compensation using the fair value method. Compensation cost for equity incentive awards is based on the fair value of the equity instrument generally on the date of grant and is recognized over the requisite service period. Forfeitures are recognized as they occur.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Income Taxes – </i>Income taxes are accounted for using a balance sheet approach. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. In assessing the realizability of deferred tax assets, management considers whether it is more-likely-than-not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax asset (including the impact of available carryback and carryforward periods), projected future taxable income, and tax-planning strategies in making this assessment. A valuation allowance for deferred tax assets is recorded when it is more likely than not that the benefit from the deferred tax asset will not be realized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which a change in judgment occurs. The Company had no material uncertain tax positions as of December 31, 2022 or 2021. Income tax returns we file may be routinely examined by tax authorities. The statute of limitations is currently open for tax returns filed after 2018.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>The Company is subject to the Texas margin tax; however, tax expense was zero for the years ended December 31, 2022 and 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Discontinued Operations – </i>In connection with the Transaction, management determined to fully divest of EHR’s oil and gas activities. As such, these activities are presented as discontinued operations for each of the periods presented.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>The Company follows the successful efforts method of accounting for its oil and gas properties. Costs to acquire mineral interests in oil and gas properties and to drill and equip new development wells and related asset retirement costs are capitalized. In 2019, the Company’s oil and gas properties became fully impaired and the carrying amount of the properties was expensed to the market decline and the Company’s determination to exit the oil and gas business. The oil &amp; gas properties have limited production and operations for which the Company recognizes its share as a non-operating working interest owner. Oil &amp; gas revenue is recognized for discontinued operations based on delivered quantities in the amount of the consideration to which the Company is entitled.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>The Company records a liability for the plugging, abandonment and remediation of its properties at the end of their productive lives. The Company computes the liability for asset retirement obligations by calculating the present value of estimated future cash flows related to each property. This requires the Company to use significant assumptions, including current estimates of plugging and abandonment costs, annual inflation of these costs, the productive lives of wells and its risk-adjusted interest rate. Changes in any of these assumptions can result in significant revisions to the estimated asset retirement obligations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>Asset retirement obligations are recorded as a liability at their estimated present value at the asset’s inception, with an offsetting increase to producing properties in the accompanying balance sheet which is amortized to expense on a unit-of-production basis. Periodic accretion of the discount on asset retirement obligations is recorded as expense.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i> </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Fair Value Measurements – </i>Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The three levels related to fair value measurements are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 —</span>   </td> <td style="width: 92%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observable inputs such as quoted prices in active markets for identical assets or liabilities.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 —</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 —</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>The estimated fair values of cash, accounts receivable, accounts payable and indebtedness approximate their carrying amounts due to the relatively short maturity of these instruments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Earnings (loss) per Share – </i>Basic earnings (loss) per share amounts are calculated by dividing income available to common shareholders, after deducting preferred stock dividends, by the weighted average number of shares of common stock outstanding. Diluted earnings per share amounts are calculated by dividing net income by the weighted average number of shares of common stock and common stock equivalents outstanding. Common stock equivalents represent shares issuable upon the assumed conversion of preferred stock, outstanding convertible notes and the assumed exercise of common stock options and warrants outstanding.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Major Customer and Concentration of Credit Risk <b>– </b></i>We estimate an allowance for doubtful accounts based on an analysis of specific customers, taking into consideration the age of past due accounts and an assessment of the customer’s ability to pay. An allowance for doubtful accounts was not needed as of December 31, 2022 or 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>During 2022, one customer accounted for approximately 96% of our post-harvest and midstream services revenue. Amounts due from this customer represented all of our accounts receivable at December 31, 2022. During 2021, one customer accounted for approximately 91% of our post-harvest and midstream services revenue. No amounts were due from this customer at December 31, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>Our rental revenue is derived from a single lessee on a commercial warehouse owned by the Company. There were no amounts due from this customer at December 31, 2022 or 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Recent Accounting Pronouncements – </i>In December 2019, the FASB issued ASU 2019-12, <i>Income Taxes</i>, which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. We adopted this standard in the first quarter of 2021. Adoption of this ASU did not have a significant impact on our consolidated financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>In August 2020, the FASB issued ASU 2020-06, <i>Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40)</i>. The new standard reduces the number of accounting models for convertible debt instruments and convertible preferred stock and amends the guidance for the derivatives scope exception for contracts in an entity’s own equity. The standard also amends and makes targeted improvements to the related earnings per share guidance. The ASU is effective for fiscal years beginning after December 15, 2021. The standard allows for either modified or full retrospective transition methods. The Company adopted this standard on January 1, 2022. The adoption of this ASU did not have a significant impact on our consolidated financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><span style="font-family: Times New Roman, Times, Serif"> </span> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">There are no other new accounting pronouncements that are expected to have a material impact on the consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Basis of Presentation <b>– </b></i>The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and U.S. Securities and Exchange Commission regulations. The consolidated financial statements comprise the financial statements of the Company, its wholly-owned subsidiaries, and subsidiaries that it controls due to ownership of a majority voting interest. Subsidiaries are fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continue to be consolidated until the date when such control ceases. The financial statements of the subsidiaries are prepared for the same reporting period as the Company. All significant intercompany balances and transactions are eliminated upon consolidation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Business Combinations <b>– </b></i>The Company accounts for business combinations under the acquisition method of accounting. Under this method, acquired assets, including separately identifiable intangible assets, and any assumed liabilities are recorded at their acquisition date estimated fair value. Determining the fair value of assets acquired and liabilities assumed involves the use of significant estimates and assumptions. The excess of purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents the goodwill amount resulting from the acquisition.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Use of Estimates – </i>The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the (i) impairment of long-lived assets and goodwill, (ii) valuation allowances for deferred income tax assets and (iii) estimates of accrued liabilities. Actual results could differ from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Revenue Recognition – </i>Post-harvest and midstream services revenue is typically determined based on volumes processed at agreed-upon contractual prices and is recognized at the point in time when performance obligations under the terms of a contract with our customers are satisfied. This occurs when control of the product is transferred to our customers upon completion of our processing.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>Rental revenue is recognized based on the contractual cash rental payments for the period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Cash – </i>The Company maintains its deposits of cash in financial institutions, which may at times exceed amounts covered by insurance provided by the U.S. Federal Deposit Insurance Corporation (“FDIC”). The Company has not experienced any losses related to amounts in excess of FDIC limits.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Inventories</i> – Inventories consist of processed hemp product and are stated at the lower of cost or net realizable value. Cost, which includes the cost of raw materials, labor and overhead, is determined using the first-in, first-out method. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable cost of completion, disposal and transportation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Property and Equipment – </i><span style="text-transform: uppercase">P</span>roperty and equipment is stated at cost and depreciated using the straight-line method over the estimated useful lives of assets. Upon disposition, the cost and accumulated depreciation are removed and any gain or loss on the disposal is reflected in the statements of operations. The cost of maintenance and repairs is charged to income as incurred; significant renewals and improvements are capitalized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Leases</i> – The Company’s lease arrangements are operating leases which are capitalized on the balance sheet as right-of-use (“ROU”) assets and obligations. Right of use (“ROU”) assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. These are recognized at the lease commencement date based on the present value of payments over the lease term. If leases do not provide for an implicit rate, we use our incremental borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term as the lease payments. Lease expense is recognized on a straight-line basis over the lease term.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Intangible Assets</i> – Finite-lived intangible assets are amortized and are tested for impairment when an event occurs or circumstances change that indicate it is more likely than not that an impairment exists. Intangible assets consist of customer relationships and non-compete agreements acquired in the acquisition of certain assets of Halcyon. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Impairment of Long-Lived Assets</i> – We review long-lived assets for potential impairment when events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. In this assessment, future pre-tax cash flows (undiscounted) resulting from the use of the asset and its eventual disposal are estimated. If the undiscounted future cash flows are less than the carrying amount of the asset, an impairment loss is recognized for the difference between its carrying value and estimated fair value.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Noncontrolling Interest</i> – Noncontrolling interests represent the portion of net assets in consolidated entities that are not owned by the Company. As of December 31, 2022 and 2021, minority investors owned approximately 6% of EHR.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i> </i></p> 0.06 0.06 <p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Stock-based Compensation – </i>We account for stock-based compensation using the fair value method. Compensation cost for equity incentive awards is based on the fair value of the equity instrument generally on the date of grant and is recognized over the requisite service period. Forfeitures are recognized as they occur.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Income Taxes – </i>Income taxes are accounted for using a balance sheet approach. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. In assessing the realizability of deferred tax assets, management considers whether it is more-likely-than-not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax asset (including the impact of available carryback and carryforward periods), projected future taxable income, and tax-planning strategies in making this assessment. A valuation allowance for deferred tax assets is recorded when it is more likely than not that the benefit from the deferred tax asset will not be realized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which a change in judgment occurs. The Company had no material uncertain tax positions as of December 31, 2022 or 2021. Income tax returns we file may be routinely examined by tax authorities. The statute of limitations is currently open for tax returns filed after 2018.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>The Company is subject to the Texas margin tax; however, tax expense was zero for the years ended December 31, 2022 and 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Discontinued Operations – </i>In connection with the Transaction, management determined to fully divest of EHR’s oil and gas activities. As such, these activities are presented as discontinued operations for each of the periods presented.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>The Company follows the successful efforts method of accounting for its oil and gas properties. Costs to acquire mineral interests in oil and gas properties and to drill and equip new development wells and related asset retirement costs are capitalized. In 2019, the Company’s oil and gas properties became fully impaired and the carrying amount of the properties was expensed to the market decline and the Company’s determination to exit the oil and gas business. The oil &amp; gas properties have limited production and operations for which the Company recognizes its share as a non-operating working interest owner. Oil &amp; gas revenue is recognized for discontinued operations based on delivered quantities in the amount of the consideration to which the Company is entitled.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>The Company records a liability for the plugging, abandonment and remediation of its properties at the end of their productive lives. The Company computes the liability for asset retirement obligations by calculating the present value of estimated future cash flows related to each property. This requires the Company to use significant assumptions, including current estimates of plugging and abandonment costs, annual inflation of these costs, the productive lives of wells and its risk-adjusted interest rate. Changes in any of these assumptions can result in significant revisions to the estimated asset retirement obligations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>Asset retirement obligations are recorded as a liability at their estimated present value at the asset’s inception, with an offsetting increase to producing properties in the accompanying balance sheet which is amortized to expense on a unit-of-production basis. Periodic accretion of the discount on asset retirement obligations is recorded as expense.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i> </i></p> 0.50 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Fair Value Measurements – </i>Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The three levels related to fair value measurements are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 —</span>   </td> <td style="width: 92%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observable inputs such as quoted prices in active markets for identical assets or liabilities.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 —</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 —</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>The estimated fair values of cash, accounts receivable, accounts payable and indebtedness approximate their carrying amounts due to the relatively short maturity of these instruments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Earnings (loss) per Share – </i>Basic earnings (loss) per share amounts are calculated by dividing income available to common shareholders, after deducting preferred stock dividends, by the weighted average number of shares of common stock outstanding. Diluted earnings per share amounts are calculated by dividing net income by the weighted average number of shares of common stock and common stock equivalents outstanding. Common stock equivalents represent shares issuable upon the assumed conversion of preferred stock, outstanding convertible notes and the assumed exercise of common stock options and warrants outstanding.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Major Customer and Concentration of Credit Risk <b>– </b></i>We estimate an allowance for doubtful accounts based on an analysis of specific customers, taking into consideration the age of past due accounts and an assessment of the customer’s ability to pay. An allowance for doubtful accounts was not needed as of December 31, 2022 or 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>During 2022, one customer accounted for approximately 96% of our post-harvest and midstream services revenue. Amounts due from this customer represented all of our accounts receivable at December 31, 2022. During 2021, one customer accounted for approximately 91% of our post-harvest and midstream services revenue. No amounts were due from this customer at December 31, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>Our rental revenue is derived from a single lessee on a commercial warehouse owned by the Company. There were no amounts due from this customer at December 31, 2022 or 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p> 0.96 0.91 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Recent Accounting Pronouncements – </i>In December 2019, the FASB issued ASU 2019-12, <i>Income Taxes</i>, which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as tax basis step-up in goodwill obtained in a transaction that is not a business combination, ownership changes in investments, and interim-period accounting for enacted changes in tax law. We adopted this standard in the first quarter of 2021. Adoption of this ASU did not have a significant impact on our consolidated financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>In August 2020, the FASB issued ASU 2020-06, <i>Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40)</i>. The new standard reduces the number of accounting models for convertible debt instruments and convertible preferred stock and amends the guidance for the derivatives scope exception for contracts in an entity’s own equity. The standard also amends and makes targeted improvements to the related earnings per share guidance. The ASU is effective for fiscal years beginning after December 15, 2021. The standard allows for either modified or full retrospective transition methods. The Company adopted this standard on January 1, 2022. The adoption of this ASU did not have a significant impact on our consolidated financial statements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><span style="font-family: Times New Roman, Times, Serif"> </span> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">There are no other new accounting pronouncements that are expected to have a material impact on the consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>3. Property and Equipment</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">Property and equipment consisted of the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Useful</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Life (yrs)</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Land</td><td style="width: 1%"> </td> <td style="text-align: center; width: 11%"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">96,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">96,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Warehouse</td><td> </td> <td style="text-align: center">30</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">916,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">916,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Leasehold Improvements</td><td> </td> <td style="text-align: center">3</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">473,601</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">473,601</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Machinery and equipment</td><td> </td> <td style="text-align: center">5-7</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,506,447</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,506,447</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Vehicles</td><td> </td> <td style="text-align: center">4</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">149,440</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">149,440</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Computer equipment and software</td><td> </td> <td style="text-align: center">3</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,825</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,825</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Office furniture and equipment</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">3-5</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,294</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,294</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Subtotal</td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,206,107</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,206,107</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,044,155</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(625,445</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left; padding-bottom: 4pt">Total property and equipment, net</td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: center"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,161,952</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,580,662</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Useful</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Life (yrs)</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Land</td><td style="width: 1%"> </td> <td style="text-align: center; width: 11%"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">96,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">96,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Warehouse</td><td> </td> <td style="text-align: center">30</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">916,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">916,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Leasehold Improvements</td><td> </td> <td style="text-align: center">3</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">473,601</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">473,601</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Machinery and equipment</td><td> </td> <td style="text-align: center">5-7</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,506,447</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,506,447</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Vehicles</td><td> </td> <td style="text-align: center">4</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">149,440</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">149,440</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Computer equipment and software</td><td> </td> <td style="text-align: center">3</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,825</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,825</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Office furniture and equipment</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">3-5</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,294</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,294</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Subtotal</td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,206,107</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,206,107</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,044,155</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(625,445</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left; padding-bottom: 4pt">Total property and equipment, net</td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: center"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,161,952</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,580,662</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 96000 96000 P30Y 916500 916500 P3Y 473601 473601 P5Y P7Y 1506447 1506447 P4Y 149440 149440 P3Y 46825 46825 P3Y P5Y 17294 17294 3206107 3206107 1044155 625445 2161952 2580662 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>4. Intangible and Other Assets</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">The following table summarizes information related to finite-lived intangible assets:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Gross</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Gross</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Carrying</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Carrying</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left">Customer relationships</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,612,649</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,362,311</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,250,338</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,612,649</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(796,858</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,815,791</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left">Non-competition agreements</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">63,176</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(42,116</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,060</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">63,176</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(21,059</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">42,117</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,675,825</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1,404,427</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,271,398</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,675,825</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(817,917</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,857,908</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">Future amortization expense for intangible assets in each of the next five years are expected to be $419 thousand for 2023, $278 thousand for 2024, $194 thousand for 2025, $130 thousand for 2026 and $86 thousand for 2027.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">Other assets included $407,000 at December 31, 2021 for the Company’s option to purchase the facility located in Hopkinsville, Kentucky leased from Halcyon. Under this agreement, the Company had the option to purchase the facility on or before August 25, 2022, as amended, for a purchase price of $993 thousand. This agreement was not renewed upon its expiration. Impairment expense totaling $407 thousand was recognized in the third quarter of 2022 as a result.</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Gross</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Gross</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Carrying</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Carrying</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left">Customer relationships</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,612,649</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,362,311</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,250,338</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,612,649</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(796,858</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,815,791</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left">Non-competition agreements</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">63,176</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(42,116</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,060</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">63,176</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(21,059</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">42,117</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,675,825</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1,404,427</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,271,398</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,675,825</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(817,917</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,857,908</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> 2612649 -1362311 1250338 2612649 -796858 1815791 63176 -42116 21060 63176 -21059 42117 2675825 -1404427 1271398 2675825 -817917 1857908 419000 278000 194000 130000 86000 407000 the Company’s option to purchase the facility located in Hopkinsville, Kentucky leased from Halcyon. Under this agreement, the Company had the option to purchase the facility on or before August 25, 2022, as amended, for a purchase price of $993 thousand. 407000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>5. Notes Payable – Related Parties</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Notes payable – related parties consisted of the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Subordinated Promissory Note to CEO</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">523,551</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">523,551</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Convertible Promissory Note to CEO</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,107,069</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">410,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Secured Promissory Note to Coventry Asset Management, LTD.</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Subordinated Promissory Note to Investor</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">200,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Promissory Note to Investment Hunter, LLC</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">492,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-125">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Total notes payable – related parties</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,322,620</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,183,551</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Subordinated Promissory Note to CEO – </i>Our CEO made advances to the Company during 2020 under a subordinated promissory note in the amount of $524 thousand initially due September 30, 2021. This note was amended to a new maturity date of January 1, 2023. The note bore interest at 10% per annum. Accrued interest on this subordinated promissory note totaled $60 thousand at December 31, 2022. In January 2023, the amounts due under this note were restructured and rolled into a new Secured Promissory Note from our CEO (see Note 15).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Convertible Promissory Note to CEO</i> – In 2021, our CEO made advances totaling $410 thousand to the Company under a convertible promissory note. Additional advances made in 2022 totaled $697 thousand. The convertible note initially matured on January 1, 2022 but was subsequently amended to extend the maturity date to January 1, 2023. The note bore interest at 10%. The principal and interest due on the convertible note were convertible, at the option of the holder, into restricted shares of the Company’s common stock at an initial conversion price of $0.50 per share but that was lowered in July 2022 to $0.30 per share. Accrued interest on this convertible promissory note totaled $107 thousand at December 31, 2022. In January 2023, the amounts due under this note were restructured and rolled into a new Secured Promissory Note from our CEO (see Note 15).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><i>Secured Promissory Note and Warrants to Coventry Asset Management, LTD. – </i>On December 30, 2020, the Company received proceeds from issuance of a secured promissory note in principal amount of $1 million to Coventry Asset Management, LTD, a Company stockholder. The promissory note is secured by the property acquired in the acquisition of certain assets of Halcyon. The unpaid balance of the secured promissory note bears <span>interest at a rate of 14% per annum. The promissory note has been extended seven times including the issuance of 20,000 restricted common shares as extension fees each for the first five extensions and the issuance of 50,000 restricted common shares for the last two extensions. The maturity date of the promissory note is December 31, 2023, as amended. If before December 31, 2023, the Company raises new equity capital of $5 million or more, then the full amount outstanding under the promissory note is due within five days. As amended, principal payments of $250 thousand each are due June 1, 2023 and August 31, 2023. Accrued interest on this secured note totaled $200 thousand at December 31, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><span> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><span><i>Subordinated Promissory Note and Warrants to Investor – </i>On December 30, 2020, the Company issued a subordinated promissory note in principal amount of $500 thousand to an accredited investor who is a</span>lso a Company stockholder. The Company previously made principal payment totaling $300 thousand. The unpaid balance of the Subordinated Note bears interest at a rate of 10% per annum. The subordinated note principal together with accrued and unpaid interest was due, as previously amended, on March 31, 2022 but was extended to June 30, 2022. On March 1, 2023, the Company paid $240 thousand in full repayment of this note and accrued interest thereon.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The holder of the subordinated note received a warrant to purchase 500 thousand shares of common stock exercisable for cash at an exercise price of $0.352 per share. As consideration for the April 2022 extension, the term of this warrant was extended by one year to December 30, 2023. The Company recognized $69 thousand of interest expense in 2022 for the modification related to this extension of the warrant term.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><i>Promissory Note to Investment Hunter, LLC</i> – In 2022, Investment Hunter, LLC, a Texas LLC controlled by our CEO, made advances totaling $492 thousand to the Company under a promissory note due January 1, 2023, as amended. If the Company raises new equity capital of $3 million or more, then the full amount outstanding under the note is due within five days. The note bears interest at 10% per annum. Accrued interest on this subordinated promissory note totaled $43 thousand at December 31, 2022.</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Subordinated Promissory Note to CEO</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">523,551</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">523,551</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Convertible Promissory Note to CEO</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,107,069</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">410,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Secured Promissory Note to Coventry Asset Management, LTD.</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Subordinated Promissory Note to Investor</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">200,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Promissory Note to Investment Hunter, LLC</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">492,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-125">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Total notes payable – related parties</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,322,620</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,183,551</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 523551 523551 1107069 410000 1000000 1000000 200000 250000 492000 3322620 2183551 524000 2021-09-30 2023-01-01 0.10 60000 410000 697000 The convertible note initially matured on January 1, 2022 but was subsequently amended to extend the maturity date to January 1, 2023. 0.10 0.5 0.3 107000 1000000 0.14 20000 50000 2023-12-31 5000000 250000 250000 200000 500000 300000 0.10 subordinated note principal together with accrued and unpaid interest was due, as previously amended, on March 31, 2022 but was extended to June 30, 2022. 240000 500000 0.352 P1Y 2023-12-30 69000 492000 2023-01-01 3000000 0.10 43000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>6. Other Indebtedness</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><i>Mortgage Payable and Operating Lease</i> –The Company is obligated under a mortgage payable dated September 15, 2014 secured by its warehouse property located in Denver, Colorado. The note has been amended a number of times to a maturity date of October 1, 2023. In the latest extension, the Company made a principal payment of $25 thousand plus accrued interest in January 2023 and agreed to make seven additional monthly principal payments of $25 thousand plus accrued interest each beginning on March 1, 2023. A final payment of $50 thousand plus accrued interest is due at maturity. The interest rate on the mortgage payable is 12%. If before the final maturity of the mortgage payable, the Company raises new equity capital of $5 million or more, then the full amount outstanding is due within ten days.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">The Company leases the Denver warehouse property to a tenant under an operating lease which was renewed with a new tenant and extended to August 1, 2023 for a monthly rent of $7.5 thousand. The lease requires a true-up with the tenant for property taxes and insurance paid by the Company and requires the tenant to maintain the interior and exterior of the warehouse (except for the roof). The lease provides for a rent abatement in the first and last month of the contracted extension. Minimum future rents for 2023 are $52 thousand.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span><i>Paycheck Protection Program Loan –</i> Congress created the Paycheck Protection Program (“PPP”) under the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) to provide forgivable loans to eligible small businesses facing economic hardship to retain U.S. employees on their payroll during the Coronavirus Disease 2019 (“COVID-19”) pandemic. PPP loan recipients may be eligible to have their loans forgiven if the funds were used for eligible expenses. On April 29, 2020, we received disbursement of an approved PPP loan in the amount of $25 thousand. The Company received notice that the PPP Loan principal and interest thereon was fully forgiven on April 20, 2021.</span></p> The note has been amended a number of times to a maturity date of October 1, 2023. In the latest extension, the Company made a principal payment of $25 thousand plus accrued interest in January 2023 and agreed to make seven additional monthly principal payments of $25 thousand plus accrued interest each beginning on March 1, 2023. 50000 0.12 5000000 7500 52000 25000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>7. Leases</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><i>Office Space – </i>The Company leases office space in Fort Worth, Texas for managerial offices. This lease requires monthly payments of $2 thousand and is month-to-month. Lease expense for this facility totaled $24 thousand for 2022 and $22 thousand for 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Hemp Processing Operating Facility</i> – The Company leases its operating facility in Kentucky from Oz Capital, LLC, a related party, under a lease expiring May 31, 2024. The lease provides for monthly payments of $10 thousand. Oz Capital, LLC is responsible for all taxes and maintenance under the lease. Lease expense for this facility totaled $123 thousand for 2022 and $119 thousand for 2021. A right-of-use asset and lease liability is recorded for this lease. As the lease does not provide an implicit rate, the Company used its estimated incremental borrowing rate of 10% in determining the present value of the lease payments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Future Bitcoin Mining Premises</i> – In 2022, the Company entered a five-year commercial lease for land and premises in Arkansas. We expect to use these premises as a future Bitcoin mining location because of its favorable power rates and land availability. The lease commences once the Company begins receiving power for its operations conducted at the location. The monthly rent will vary from a minimum of $1 thousand per megawatt of power usage monthly up to $4 thousand per megawatt monthly depending on the average power usage over a trailing 90-day period and the price of bitcoin. We anticipate commencing operations at the leased premises in 2023.</p> 2000 24000 22000 10000 123000 119000 0.10 1000 4000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>8. Commitments and Contingencies</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Litigation – </i>From time to time, we are subject to various litigation and other claims in the normal course of business. Below is a discussion of specific matters. We cannot estimate the ultimate outcome of these matters.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="text-decoration:underline">Evergreen Sustainable Enterprises, Inc. (formerly Generation Hemp, Inc.) v. Colorado Mill Equipment, LLC</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">The defendant sold to the Company a faulty piece of equipment for $16 thousand and will not refund to the Company the purchase price after repeated attempts to return their equipment. An original lawsuit filed by the Company against Colorado Mill Equipment in January 2022 in Dallas County was subsequently dismissed due to jurisdiction. A second lawsuit was subsequently filed in El Paso County, Colorado and is currently pending.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="text-decoration:underline">Halcyon Thruput, LLC, Plaintiff v. United National Insurance Company, Defendant, United States District Court for the Northern District of Texas, Dallas Division, Case No. 3:21-CV-3136-K</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Halcyon Thruput, LLC (Halcyon) obtained an all-risks commercial insurance policy, including an Equipment Breakdown Endorsement (Policy) from United National Insurance Company (UNIC) to provide substantial coverages for Halcyon Thruput LLC’s (Halcyon) $1.2 million hemp processing dryer (Dryer) at its facility in Hopkinsville, Kentucky. During the Policy period, the Dryer caught fire due to the Dryer being defectively designed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">While UNIC has paid a number of Halcyon’s claims, Halcyon’s claim for the cost of the replacement Dryer of $1.5 million was denied as described below.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Buyer, a wholly owned subsidiary of the Company, pursuant to an Asset Purchase Agreement as twice amended, then acquired all the assets of Halcyon, except for the right to the proceeds of UNIC’s insurance policy since the Policy prohibited assignment. Halcyon and Buyer agreed that Buyer’s principal, Gary C. Evans, had the right to control the litigation, engage counsel for Halcyon and make all decisions relating to any proceeds received in the litigation by settlement or otherwise.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Halcyon’s suit against UNIC, which was removed to federal court, seeks over $1 million plus statutory interest on that sum from August 10, 2020 for violating the Texas Insurance Code’s requirement that claims be promptly paid, additional statutory penalties, and attorneys’ fees. Certain documents have been executed between the Company, Halcyon and legal counsel, which provide for a sharing of costs and expenses and awards, if any, against UNIC. Mediation of the case was held in April 2022 where no agreement was reached by the parties. Depositions of the Company’s expert witnesses were completed in July 2022 and of UNIC’s representatives in September 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">In August 2022, the Company received a second payment from UNIC of $357 thousand as a partial settlement of this claim, which amount was reported as other income in the consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="text-decoration:underline">JDONE, LLC v. Grand Traverse Holdings, LLC and John Gallegos, Denver District Court Case No. 2019CV33723</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; ">JDONE, LLC (“JDONE”), a wholly owned subsidiary of the Company and landlord of a commercial warehouse building in Denver, brought suit against Grand Traverse Holdings, LLC for default of its commercial lease of the warehouse from JDONE. This case settled in October 2022 and the Company received $122 thousand from the defendant, which amount was reported as other income in the consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="text-decoration:underline">KBSIII Tower at Lake Carolyn, LLC and Prime US-Tower at Lake Carolyn, LLC (collectively – “KBSIII”) v. Energy Hunter Resources, Inc.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; ">Plaintiff/Counterdefendant KBSIII was seeking lost rent on office space for periods after EHR vacated office premises located in Las Colinas, Texas. EHR filed a counter suit alleging specific damages due to uninhabitable premises of the office space due to the intolerable conduct of other tenants located on the same floor. On December 23, 2020, the trial court entered a summary judgment against EHR for $231 thousand. The judgment provides for post-judgment interest at a rate of 5% per annum until paid and further provides for additional amounts owed should EHR pursue unsuccessful appeals to higher courts. At December 31, 2022, the Company had accrued $253 thousand for this judgment, which is exclusively an EHR obligation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; "><span style="text-decoration:underline">Ogborn-Mihm, LLP v. Evergreen Sustainable Enterprises, Inc. (formerly Generation Hemp, Inc.), JDONE, LLC and Gary C. Evans</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; ">The Company was recently made aware of litigation filed against it in the District Court of Denver from a law firm which was previously engaged by the Company. While none of the parties have been officially served, the alleged amount being sought from the Company is less than $50,000. </p> 16000 1200000 1500000 Halcyon’s suit against UNIC, which was removed to federal court, seeks over $1 million plus statutory interest on that sum from August 10, 2020 for violating the Texas Insurance Code’s requirement that claims be promptly paid, additional statutory penalties, and attorneys’ fees. Certain documents have been executed between the Company, Halcyon and legal counsel, which provide for a sharing of costs and expenses and awards, if any, against UNIC. 357000 122000 231000 0.05 253000 50000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>9. Income Taxes</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>No amounts were recorded for income tax expense during the years ended December 31, 2022 or 2021. A reconciliation of the expected statutory federal tax and the total income tax expense from continuing operations was as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Federal statutory rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,462,067</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(2,056,480</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">State income taxes, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(141,438</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(198,940</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,630,110</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,655,210</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Change in state tax rates</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-126">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(178,644</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">True-up of prior year deferred items</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-127">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(929,450</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left">Other, net</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(26,605</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(291,696</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt; padding-left: 14pt">Total income tax expense</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-128">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-129">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>The tax effect of temporary differences that gave rise to significant components of deferred tax assets and liabilities consisted of the following:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">Assets:</td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-left: 7pt">Net operating loss carryforwards</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,471,098</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4,960,487</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt">Stock-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,142,362</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,046,464</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7pt">Property and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(24,310</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,803</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 7pt">Intangible assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">216,726</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">135,012</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 14pt">Subtotal</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,805,876</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,175,766</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left">Valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,805,876</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,175,766</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left">Net deferred tax asset</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-130">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-131">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>The Company has federal net operating loss (“NOL”) carryforwards of approximately $23.8 million at December 31, 2022, of which approximately $6.5 million begin to expire in 2034 and the remainder have no expiration. The Company estimates that a majority of its NOL carryforwards are subject to annual limitations under Internal Revenue Code Section 382 as a result of ownership changes at various times including in the Transaction. These NOL carryforwards may never be utilized by the Company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>The Company is delinquent in filing its 2021 Federal and state tax returns.</span></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December 31,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Federal statutory rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,462,067</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(2,056,480</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">State income taxes, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(141,438</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(198,940</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in valuation allowance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,630,110</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,655,210</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Change in state tax rates</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-126">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(178,644</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">True-up of prior year deferred items</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-127">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(929,450</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left">Other, net</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(26,605</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(291,696</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt; padding-left: 14pt">Total income tax expense</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-128">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-129">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p> -1462067 -2056480 -141438 -198940 1630110 3655210 -178644 -929450 -26605 -291696 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">Assets:</td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-left: 7pt">Net operating loss carryforwards</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,471,098</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4,960,487</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt">Stock-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,142,362</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,046,464</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7pt">Property and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(24,310</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,803</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 7pt">Intangible assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">216,726</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">135,012</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 14pt">Subtotal</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,805,876</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,175,766</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left">Valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,805,876</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,175,766</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left">Net deferred tax asset</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-130">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-131">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p> 5471098 4960487 2142362 1046464 -24310 33803 216726 135012 7805876 6175766 7805876 6175766 23800000 6500000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>10. Equity</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Series A Preferred Stock <b>– </b></i>Our Series A Preferred Stock was originally issued in connection with HTF’s acquisition of EHR in 2019. On September 8, 2021, holders of the Company’s Series A Preferred Stock elected to convert such shares into shares of the Company’s common stock. As a result, 6,328,948 shares of Series A Preferred Stock were converted into 75,947,376 shares of common stock, with each share of Series A Preferred Stock converting into 12 shares of restricted common stock pursuant to the applicable Certificate of Designations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><i>Series B Preferred Stock Units – </i>On December 30, 2020, the Company sold to certain accredited investors, including Gary C. Evans, our Chief Executive Officer, an aggregate of 135 preferred stock units comprised of (i) one share of Series B Redeemable Convertible Preferred Stock, no par value, and (ii) one warrant exercisable for 50 thousand shares of common stock of the Company until December 30, 2022 at an exercise price of $0.352 per share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">The sale of the preferred stock units for $10 thousand each resulted in aggregate gross proceeds of approximately $1.35 million, before deducting estimated offering expenses payable by the Company. Substantially all of the proceeds raised in the offering were used to fund the acquisition of assets of Halcyon, expenses related thereto and for general corporate purposes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">Each share of Series B Preferred Stock is initially convertible into 25,000 shares of common stock, subject to adjustment. Holders of Series B Preferred Stock are entitled to receive dividends of 6.00% per annum based on the stated value equal to $10 thousand per share. Except as otherwise required by law, the Series B Preferred Stock does not have voting rights. However, as long as any shares of Series B Preferred Stock are outstanding, the Company will not, without the affirmative vote of the holders of a majority of the then outstanding shares of the Series B Preferred Stock, (a) alter or change adversely the powers, preferences or rights given to the Series B Preferred Stock, (b) alter or amend the related certificate of designation, (c) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of Series B Preferred Stock, (d) repay, repurchase or offer to repay, repurchase or otherwise acquire more than a de minimis number of shares of its common stock, (e) enter into any agreement with respect to any of the foregoing, or (f) pay cash dividends or distributions on any equity securities of the Company other than pursuant to the terms of the outstanding Series B Preferred Stock. The Series B Preferred Stock does not have a preference upon any liquidation, dissolution or winding-up of the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">Any or all of the Series B Preferred Stock may be converted, at their holder’s option, into 25,000 shares of common stock, as adjusted for any stock dividends, splits, combinations or similar events.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">At any time after the occurrence of a “Qualifying Event,” the Company, upon 5-day written notice, shall have the right to cause each share of Series B Preferred Stock (and all accrued in-kind dividends with respect thereto) to be converted into common stock. For purposes of this automatic conversion of the Series B Preferred Stock, a “Qualifying Event” shall have occurred if (A) (1) the rolling five-trading day volume-weighted average trading price of shares of the common stock exceeds $1.00, and (2) there shall be an effective registration statement under the Securities Act of 1933, as amended covering all of the shares of common stock which would be issuable upon conversion of all of the outstanding shares of Series B Preferred Stock or (B) the Company closes a firm commitment underwriting of the common stock on a Form S-1 Registration Statement with aggregate gross proceeds of at least $5 million at a price per share equal to or greater than $1.00. In each instance, a conversion may not be made unless the Company has filed an amendment to its Articles of Incorporation effecting an increase in its authorized common stock so that the Company has a sufficient number of authorized and unissued shares of common stock so as to permit the conversion of all outstanding shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">The Series B Preferred Stock may be redeemed by the Company for its stated value, plus accrued and unpaid dividends, at any time. Initially, redemption payments of 12.5% each of the total amount of Series B Preferred Stock then outstanding plus accrued dividends were due from the Company to each Holder of Series B Preferred Stock at the end of each calendar quarter of 2021. The first required redemption payments totaling $137 thousand were made in April 2021. In May, June and October of 2021, the three holders of the Series B Preferred Stock, including the Company’s chief executive officer, entered into transactions in which they accepted the mandatory redemption payment required pursuant to the Series B Preferred Stock certificate of designation in a number of Series B Units to effectively waive the redemption requirement. All other terms of the Series B Units remain unchanged and the holders’ ownership interest in the Series B Preferred Units remains the same as it was before such transactions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><i>Common Stock – </i>At December 31, 2022, the Company had 113,204,002 common shares outstanding. Following is a discussion of common stock issuances during the periods presented:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Acquisition of Certain Assets of Halcyon </i>– In January 2021, the Company issued 6,250,000 shares of common stock valued at $2.5 million ($0.40 per share; restricted from trading for a period of up to one year) in the acquisition. </span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2021 First Quarter Issuances of Common Stock Units</i> – In the first quarter of 2021, the Company issued 800,000 common stock units for total proceeds of $400,000. Each common stock unit consisted of one share of common stock and a warrant for the purchase of two shares of common stock for $0.50 each. Each warrant is exercisable any time before its expiration on the second anniversary of its issuance. The Company allocated the total proceeds based on the relative fair values of the common stock and warrants. The fair value of the warrants was determined using an options valuation model with key assumptions including a risk-free interest rate of 0.11% and historical volatility of 272%. A total of $263 thousand was allocated to the warrants and reported in additional paid-in capital.  </span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrant Exercises </i>– In the first quarter of 2021, the Company received approximately $3 million for the exercise of 8,428,976 outstanding warrants. In the fourth quarter of 2021, the Company received $375 thousand for the exercise of 1,065,340 outstanding warrants.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>●</i></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Issuances for Exchange or Conversion of Debt </i>– The Company issued a total of 1,618,660 common shares for the exchange or conversion of outstanding indebtedness totaling $2.2 million in the first quarter of 2021. </span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Issuance to Vendor for Services </i>– In the third quarter of 2021, the Company issued 125,000 common shares valued at $117.5 thousand to a vendor for services performed.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Issuance for Extension of Secured Note </i>– The Company issued 20,000 common shares valued at $18 thousand as consideration to extend the maturity of a senior note in the third quarter of 2021.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Issuance for Conversion of Series A Preferred Stock </i>– As noted above, in the third quarter of 2021, the Company issued 75,947,376 common shares for the conversion of all outstanding shares of its Series A Preferred Stock.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2021 Fourth Quarter Issuances of Common Stock Units</i> – In the fourth quarter of 2021, the Company issued 958,333 common stock units to accredited investors for total proceeds of $575 thousand. Each common stock unit consists of one share of common stock and a warrant for the purchase of one share of common stock for $0.60 each. Each warrant is exercisable any time before its expiration on the second anniversary of its issuance. The Company allocated the total proceeds based on the relative fair values of the common stock and warrants. The fair value of the warrants was determined using an options valuation model with key assumptions including risk-free interest rates ranging from 0.48% to 0.70% and historical volatility ranging from 237% to 258%. A total of $277 thousand was allocated to the warrants and reported in additional paid-in capital..</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Issuance for Extensions of Secured Note – </i>The Company issued 110,000 common shares valued at $52.6 thousand as consideration for extensions of the maturity of a senior note in 2022. Refer to Note 5.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><i>Common Stock Warrants Outstanding – </i>Following is a summary of warrants outstanding as of December 31, 2022:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><b> </b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"># of<br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price<br/> (each)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Expiration Date</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Method of Exercise</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 48%; text-align: left">Issued in December 2020 with subordinated note to investor <sup>(1)</sup></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">500,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.352</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="white-space: nowrap; width: 15%; text-align: center">December 30, 2023</td><td style="width: 1%"> </td> <td style="text-align: center; width: 11%">Cash</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Issued in Q1 2021 with common stock units <sup>(1)</sup></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,600,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.500</td><td style="text-align: left"> </td><td> </td> <td style="white-space: nowrap; text-align: center">January-February, 2023</td><td> </td> <td style="text-align: center">Cash</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Issued in Q4 2021 with common stock units <sup>(1)</sup></td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">958,333</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.600</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center">October-December, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center">Cash</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; padding-bottom: 4pt; text-align: left">Total warrants outstanding at December 31, 2022</td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">3,058,333</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; white-space: nowrap"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: center"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May be redeemed for $0.0001 per warrant at the Company’s option with 30 days advanced notice should the weighted average market price of common stock exceed $1.00 for any five out of seven consecutive trading days with a minimum average daily trading volume for such seven-day period of at least 25,000 shares of common stock.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">Following is a summary of outstanding stock warrants activity for the periods presented:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center"> </td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"># of<br/> Warrants</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Price</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Warrants as of January 1, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">22,988,632</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.353</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 7pt">Issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,558,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.537</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 7pt">Cancelled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(7,244,316</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.352</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; padding-left: 7pt">Exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,494,316</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.352</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Warrants as of December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,808,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.407</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; padding-left: 7pt">Canceled</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,750,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.354</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Warrants as of December 31, 2022</td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">3,058,333</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left">$</td><td style="padding-bottom: 4pt; text-align: right">0.507</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 6328948 75947376 12 On December 30, 2020, the Company sold to certain accredited investors, including Gary C. Evans, our Chief Executive Officer, an aggregate of 135 preferred stock units comprised of (i) one share of Series B Redeemable Convertible Preferred Stock, no par value, and (ii) one warrant exercisable for 50 thousand shares of common stock of the Company until December 30, 2022 at an exercise price of $0.352 per share. 10000 1350000 25000 0.06 10000 25000 1 5000000 1 0.125 137000 113204002 ●Acquisition of Certain Assets of Halcyon – In January 2021, the Company issued 6,250,000 shares of common stock valued at $2.5 million ($0.40 per share; restricted from trading for a period of up to one year) in the acquisition.     ●2021 First Quarter Issuances of Common Stock Units – In the first quarter of 2021, the Company issued 800,000 common stock units for total proceeds of $400,000. Each common stock unit consisted of one share of common stock and a warrant for the purchase of two shares of common stock for $0.50 each. Each warrant is exercisable any time before its expiration on the second anniversary of its issuance. The Company allocated the total proceeds based on the relative fair values of the common stock and warrants. The fair value of the warrants was determined using an options valuation model with key assumptions including a risk-free interest rate of 0.11% and historical volatility of 272%. A total of $263 thousand was allocated to the warrants and reported in additional paid-in capital.      ●Warrant Exercises – In the first quarter of 2021, the Company received approximately $3 million for the exercise of 8,428,976 outstanding warrants. In the fourth quarter of 2021, the Company received $375 thousand for the exercise of 1,065,340 outstanding warrants.    ●Issuances for Exchange or Conversion of Debt – The Company issued a total of 1,618,660 common shares for the exchange or conversion of outstanding indebtedness totaling $2.2 million in the first quarter of 2021.     ●Issuance to Vendor for Services – In the third quarter of 2021, the Company issued 125,000 common shares valued at $117.5 thousand to a vendor for services performed.    ●Issuance for Extension of Secured Note – The Company issued 20,000 common shares valued at $18 thousand as consideration to extend the maturity of a senior note in the third quarter of 2021.    ●Issuance for Conversion of Series A Preferred Stock – As noted above, in the third quarter of 2021, the Company issued 75,947,376 common shares for the conversion of all outstanding shares of its Series A Preferred Stock.    ●2021 Fourth Quarter Issuances of Common Stock Units – In the fourth quarter of 2021, the Company issued 958,333 common stock units to accredited investors for total proceeds of $575 thousand. Each common stock unit consists of one share of common stock and a warrant for the purchase of one share of common stock for $0.60 each. Each warrant is exercisable any time before its expiration on the second anniversary of its issuance. The Company allocated the total proceeds based on the relative fair values of the common stock and warrants. The fair value of the warrants was determined using an options valuation model with key assumptions including risk-free interest rates ranging from 0.48% to 0.70% and historical volatility ranging from 237% to 258%. A total of $277 thousand was allocated to the warrants and reported in additional paid-in capital..    ●Issuance for Extensions of Secured Note – The Company issued 110,000 common shares valued at $52.6 thousand as consideration for extensions of the maturity of a senior note in 2022. Refer to Note 5. <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"># of<br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price<br/> (each)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Expiration Date</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Method of Exercise</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 48%; text-align: left">Issued in December 2020 with subordinated note to investor <sup>(1)</sup></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">500,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.352</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="white-space: nowrap; width: 15%; text-align: center">December 30, 2023</td><td style="width: 1%"> </td> <td style="text-align: center; width: 11%">Cash</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Issued in Q1 2021 with common stock units <sup>(1)</sup></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,600,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.500</td><td style="text-align: left"> </td><td> </td> <td style="white-space: nowrap; text-align: center">January-February, 2023</td><td> </td> <td style="text-align: center">Cash</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Issued in Q4 2021 with common stock units <sup>(1)</sup></td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">958,333</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.600</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center">October-December, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center">Cash</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; padding-bottom: 4pt; text-align: left">Total warrants outstanding at December 31, 2022</td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">3,058,333</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; white-space: nowrap"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: center"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May be redeemed for $0.0001 per warrant at the Company’s option with 30 days advanced notice should the weighted average market price of common stock exceed $1.00 for any five out of seven consecutive trading days with a minimum average daily trading volume for such seven-day period of at least 25,000 shares of common stock.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p> 500000 0.352 December 30, 2023 Cash 1600000 0.5 January-February, 2023 Cash 958333 0.6 October-December, 2023 Cash 3058333 0.0001 1 25000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center"> </td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"># of<br/> Warrants</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Price</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Warrants as of January 1, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">22,988,632</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.353</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 7pt">Issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,558,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.537</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 7pt">Cancelled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(7,244,316</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.352</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; padding-left: 7pt">Exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,494,316</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.352</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Warrants as of December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,808,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.407</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; padding-left: 7pt">Canceled</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,750,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.354</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Warrants as of December 31, 2022</td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">3,058,333</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left">$</td><td style="padding-bottom: 4pt; text-align: right">0.507</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 22988632 0.353 2558333 0.537 -7244316 0.352 -9494316 0.352 8808333 0.407 -5750000 0.354 3058333 0.507 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>11. Stock-Based Compensation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">We award restricted stock or stock options as incentive compensation to employees and compensation to our Board of Directors for services. Generally, these awards include vesting periods of up to three years from the date of grant.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">The 2021 Omnibus Incentive Plan (“2021 Plan”) was adopted by our Board on July 1, 2021. The 2021 Plan provides for the initial reservation of 15 million shares of common stock for issuance, and provides that the maximum number of shares that may be issued pursuant to the exercise of ISOs is 15 million. On the one-year anniversary date of the 2021 Plan, the number of shares of common stock reserved for issuance automatically increased to 20% of the fully diluted common shares outstanding, including shares issuable upon the conversion of preferred shares, as calculated on an as-converted basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">In the first quarter of 2021, the Company issued 500,000 restricted shares valued at $155 thousand as incentive compensation to two executives who joined the Company. Compensation expense related to these awards totaled $155 thousand for 2021. These awards became fully vested in January 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">In the fourth quarter of 2021, the Company awarded options for 13,850,000 shares of the Company’s common stock as incentive compensation to management and the Board of Directors. One-third of the awarded options vested immediately with the remaining options vesting in two equal annual tranches over the next two years. Vested options may be exercised at any time until their expiration after 10 years at an exercise price of $0.76 per share. Unvested options are forfeited upon termination of service. The fair value of the awards at the date of grant of $10.5 million was determined using the Black-Scholes option pricing model. Key assumptions included a risk-free interest rate ranging from 1.18% to 1.28%, historical volatility ranging from 331% to 643% and an expected life of the stock options ranging from five to six years.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">In the third quarter of 2022, the Company awarded options for 1,915,000 shares of the Company’s common stock as incentive compensation to its CEO and board of directors. The awarded options vest over the next three years. Vested options may be exercised at any time until their expiration ranging from eight to 10 years at their exercise prices ranging from $0.30 to $0.33 per share. Unvested options are forfeited upon termination of service. The fair value of the awards at the date of grant of $576 thousand was determined using the Black-Scholes option pricing model. Key assumptions included a risk-free interest rate ranging from 2.87% to 3.03%, historical volatility ranging from 251% to 408% and an expected life of the stock options ranging from four to seven years.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">We recognized $4.7 million of compensation expense in 2022 and $1.4 million in 2021 for option awards. As of December 31, 2022, there was $2.0 million of total unrecognized compensation cost related to options to be recognized over a remaining weighted average period of 17 months.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">The following table summarizes options outstanding, as well as activity for the periods presented:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted <br/> Average<br/> Grant Date<br/> Fair Value</b></span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times NewRoman, Times, Serif; font-size: 10pt"><b>Weighted <br/> Average<br/> Exercise</b> </span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate<br/> Intrinsic<br/> Value</b></span></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%">Outstanding at January 1, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-132">   -</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-133">   -</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-134">   -</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-135">     -</div></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; padding-left: 7pt">Granted</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,850,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.76</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.76</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-136">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,850,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-137">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; padding-left: 7pt">Granted</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,915,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.30</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.31</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-138">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Outstanding at December 31, 2022</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">15,765,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left">$</td><td style="padding-bottom: 4pt; text-align: right">0.70</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left">$</td><td style="padding-bottom: 4pt; text-align: right">0.71</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-139">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The remaining weighted average contractual life of exercisable options at December 31, 2022 was nine years.</p> 15000000 15000000 0.20 500000 155000 155 13850000 P10Y 0.76 10500000 0.0118 0.0128 3.31 6.43 P5Y P6Y 1915000 P3Y P8Y P10Y 0.3 0.33 576000 0.0287 0.0303 2.51 4.08 P4Y P7Y 4700000 1400000 2000000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted <br/> Average<br/> Grant Date<br/> Fair Value</b></span></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times NewRoman, Times, Serif; font-size: 10pt"><b>Weighted <br/> Average<br/> Exercise</b> </span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate<br/> Intrinsic<br/> Value</b></span></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%">Outstanding at January 1, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-132">   -</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-133">   -</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-134">   -</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-135">     -</div></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; padding-left: 7pt">Granted</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,850,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.76</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.76</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-136">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,850,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-137">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; padding-left: 7pt">Granted</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,915,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.30</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.31</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-138">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Outstanding at December 31, 2022</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">15,765,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left">$</td><td style="padding-bottom: 4pt; text-align: right">0.70</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left">$</td><td style="padding-bottom: 4pt; text-align: right">0.71</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-139">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p> 13850000 0.76 0.76 13850000 0.76 0.76 1915000 0.3 0.31 15765000 0.7 0.71 P9Y <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>12. Discontinued Operations</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In 2019, management determined to fully divest of EHR’s oil and gas activities. As such, these activities are presented as discontinued operations for each of the periods presented. The following is a summary of the carrying amounts of major classes of assets and liabilities of the discontinued operations to assets and liabilities held for sale:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td>Assets:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-left: 7pt">Oil and natural gas properties held for sale, at cost</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,874,849</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,874,849</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 7pt">Accumulated DD&amp;A</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,874,849</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,874,849</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left; padding-left: 7pt">Total assets of discontinued operations held for sale</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-140">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-141">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt">Accrued liabilities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">61,701</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">48,997</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7pt">Asset retirement obligations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">52,368</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">52,368</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 7pt">Revenue payable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">52,117</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">52,117</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 21pt">Current liabilities of discontinued operations held for sale</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">166,186</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">153,482</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt">Asset retirement obligations -</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 21pt">Long-term liabilities of discontinued operations held for sale</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">207,197</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">162,948</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-align: left; padding-left: 7pt">Total liabilities of discontinued operations held for sale</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">373,383</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">316,430</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following is a summary of the major classes of line items constituting loss on discontinued operations shown in the consolidated statements of operations:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td>Revenue -</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-left: 7pt">Oil and gas sales</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">147,828</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">116,710</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Costs and Expenses:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt">Lease operating expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">163,352</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">134,590</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 7pt">Accretion of asset retirement obligations</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">44,249</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,333</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 14pt">Total costs and expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">207,601</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">148,923</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left; padding-left: 7pt">Loss from discontinued operations</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(59,773</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(32,213</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td>Assets:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-left: 7pt">Oil and natural gas properties held for sale, at cost</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,874,849</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,874,849</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 7pt">Accumulated DD&amp;A</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,874,849</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,874,849</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left; padding-left: 7pt">Total assets of discontinued operations held for sale</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-140">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-141">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt">Accrued liabilities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">61,701</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">48,997</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7pt">Asset retirement obligations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">52,368</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">52,368</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 7pt">Revenue payable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">52,117</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">52,117</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 21pt">Current liabilities of discontinued operations held for sale</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">166,186</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">153,482</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt">Asset retirement obligations -</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 21pt">Long-term liabilities of discontinued operations held for sale</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">207,197</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">162,948</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-align: left; padding-left: 7pt">Total liabilities of discontinued operations held for sale</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">373,383</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">316,430</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 1874849 1874849 -1874849 -1874849 61701 48997 52368 52368 52117 52117 166186 153482 207197 162948 373383 316430 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td>Revenue -</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-left: 7pt">Oil and gas sales</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">147,828</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">116,710</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Costs and Expenses:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt">Lease operating expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">163,352</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">134,590</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 7pt">Accretion of asset retirement obligations</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">44,249</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,333</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 14pt">Total costs and expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">207,601</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">148,923</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left; padding-left: 7pt">Loss from discontinued operations</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(59,773</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(32,213</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> </table> 147828 116710 163352 134590 44249 14333 207601 148923 -59773 -32213 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>13. Supplemental Cash Flow Information</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Cash paid for interest</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">68,321</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">138,736</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Cash paid for taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-142">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-143">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Noncash investing and financing activities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7pt">Acquisition of certain assets of Halcyon Thruput, LLC</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 14pt">- issuance of common shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-144">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,500,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 14pt">- issuance of subordinated note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-145">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">850,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 14pt">- assumption of Halcyon bank note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-146">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">995,614</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7pt">Series B preferred stock dividend payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">80,002</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">58,312</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt">Issuance of common stock units previously subscribed</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-147">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7pt">Issuances of common shares for exchange or conversion of debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-148">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,160,269</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt">Conversion of Series A preferred stock into common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,975,503</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Cash paid for interest</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">68,321</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">138,736</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Cash paid for taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-142">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-143">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Noncash investing and financing activities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7pt">Acquisition of certain assets of Halcyon Thruput, LLC</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 14pt">- issuance of common shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-144">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,500,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 14pt">- issuance of subordinated note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-145">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">850,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 14pt">- assumption of Halcyon bank note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-146">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">995,614</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7pt">Series B preferred stock dividend payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">80,002</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">58,312</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt">Issuance of common stock units previously subscribed</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-147">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7pt">Issuances of common shares for exchange or conversion of debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-148">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,160,269</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt">Conversion of Series A preferred stock into common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,975,503</td><td style="text-align: left"> </td></tr> </table> 68321 138736 2500000 850000 995614 80002 58312 50000 2160269 4975503 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>14. Earnings (Loss) per Share</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following is the computation of earnings (loss) per basic and diluted share:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td>Amounts attributable to Generation Hemp:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td>Numerator</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-left: 7pt">Loss from continuing operations attributable to common stockholders</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(6,975,740</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(9,792,532</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt">Income (loss) from discontinued operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(56,031</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(30,196</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 7pt">Less: preferred stock dividends</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(80,002</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(74,812</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-align: left; padding-left: 7pt">Net loss attributable to common stockholders</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(7,111,773</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(9,897,540</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Denominator</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt">Weighted average shares used to compute basic EPS</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">113,163,591</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">57,159,659</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7pt">Dilutive effect of convertible note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,164,773</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,164,773</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt">Dilutive effect of preferred stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,950,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">55,075,900</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7pt">Dilutive effect of common stock options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">229,762</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">709,981</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 7pt">Dilutive effect of common stock warrants</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,320,951</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,022,542</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left; padding-left: 7pt">Weighted average shares used to compute diluted EPS</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">118,829,077</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">125,132,855</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Earnings (loss) per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7pt">Loss from continuing operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 14pt">Basic</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.06</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.17</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 14pt">Diluted</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.06</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.17</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt">Loss from discontinued operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 14pt">Basic</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-149">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-150">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 14pt">Diluted</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-151">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-152">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 7pt">Earnings (loss) per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 14pt">Basic</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.06</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.17</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 14pt">Diluted</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.06</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.17</td><td style="text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The computation of diluted earnings per common share excludes the assumed conversion of the Series B Preferred Stock and outstanding convertible notes and exercise of common stock options and warrants in periods when we report a loss. The dilutive effect of the assumed exercise of outstanding options and warrants was calculated using the treasury stock method.</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td>Amounts attributable to Generation Hemp:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td>Numerator</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-left: 7pt">Loss from continuing operations attributable to common stockholders</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(6,975,740</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(9,792,532</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt">Income (loss) from discontinued operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(56,031</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(30,196</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 7pt">Less: preferred stock dividends</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(80,002</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(74,812</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-align: left; padding-left: 7pt">Net loss attributable to common stockholders</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(7,111,773</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(9,897,540</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Denominator</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt">Weighted average shares used to compute basic EPS</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">113,163,591</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">57,159,659</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7pt">Dilutive effect of convertible note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,164,773</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,164,773</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt">Dilutive effect of preferred stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,950,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">55,075,900</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7pt">Dilutive effect of common stock options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">229,762</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">709,981</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 7pt">Dilutive effect of common stock warrants</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,320,951</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,022,542</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left; padding-left: 7pt">Weighted average shares used to compute diluted EPS</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">118,829,077</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">125,132,855</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Earnings (loss) per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 7pt">Loss from continuing operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 14pt">Basic</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.06</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.17</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 14pt">Diluted</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.06</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.17</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 7pt">Loss from discontinued operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 14pt">Basic</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-149">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-150">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 14pt">Diluted</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-151">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-152">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 7pt">Earnings (loss) per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 14pt">Basic</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.06</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.17</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 14pt">Diluted</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.06</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.17</td><td style="text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> -6975740 -9792532 -56031 -30196 -80002 -74812 -7111773 -9897540 113163591 57159659 1164773 1164773 2950000 55075900 229762 709981 1320951 11022542 118829077 125132855 -0.06 -0.17 -0.06 -0.17 -0.06 -0.17 -0.06 -0.17 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>15. Subsequent Events</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Issuance of common stock options </i>– In January 2023, the Company issued options for the purchase of 100,000 shares of common stock each to our three directors as board fees for the year. The exercise price of the options is $0.30 and they have a ten year term. One-third of the options vested immediately. The remaining options vest in equal tranches over the next two years.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i> </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Commencement of Bitcoin Operations and Acquisition of Toro Energía Sociedad Anonima</i> – In January 2023, the Company announced a new strategic direction into sustainable energy projects, starting with bitcoin mining. The Company’s name was changed to Evergreen Sustainable Enterprises, Inc. (“EGSE”) in March 2023. The Company’s existing operations will continue to be maintained as a fully operating wholly-owned subsidiary.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On January 9, 2023, the Company purchased 80% of Toro Energía Sociedad Anonima (“Toro”), a Costa Rican corporation with ownership of a hydroelectric dam in Costa Rica. The source of approximately one megawatt of power produced from the hydroelectric dam (six generators) will be used to power new Bitcoin mining machines at an extremely low cost. The transaction included seller-financed debt of $985 thousand. The seller-financed debt has a term of 10 years and a 9.5% per annum variable interest rate (based on the prime rate) with straight line amortization. The seller-financed debt is secured by pledge of the Toro Dam.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The purchase price for 80% of Toro’s equity was $1.4 million. These amounts were paid in cash from proceeds of a Secured Promissory Note (“Secured Note”) with the Gary C. Evans, CEO of the Company (‘Evans”). Under the terms of the Secured Note, (a) the Company and Evans restructured (i) the Subordinated Promissory Note dated November 20, 2020 and (ii) Convertible Promissory Note dated July 20, 2021, such that all accrued and unpaid interest on each note were rolled into a new Secured Note, (b) Evans lent the Company $500 thousand on January 9, 2023 and $969 thousand on January 10, 2023. The Secured Note has a maturity date of July 15, 2023 and bears interest at the rate of 10.00% per annum. The Secured Note has a conversion feature which permits Evans to convert at the Maturity Date then outstanding principal and interest at a conversion price of $0.275 (the closing price of the Company’s stock on January 9, 2023).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Toro Dam is located approximately 25 miles from San Jose between two volcano craters. The site generates all its energy from green resources with a proven 98% run time over the years and has a full-time staff in place under a new Operating &amp; Maintenance Agreement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Hydroelectric power is a clean and renewable energy source that is used to generate electricity by harnessing the energy of falling water and can provide a reliable and a very cost-effective source of energy for bitcoin mining operations. Hydroelectric power can help reduce the carbon footprint of cryptocurrency mining, as many cryptocurrencies are produced using fossil fuels, which continues to contribute to greenhouse gas emissions and climate change. By using hydroelectric power, bitcoin mining can be made more environmentally friendly and sustainable and can help improve the stability and reliability of cryptocurrency networks. Hydroelectric power is a relatively stable and reliable source of energy, compared to other sources such as coal or fossil fuels, which can be prone to price fluctuations and supply disruptions. The Company has committed to acquire 240 new Bitmain S19J Pro+ ASIC miners that will be deployed at the Toro Dam in the first half of 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><i>Subordinated Promissory Note and Warrants to Investor – </i>As discussed in Note 5, on March 1, 2023, the Company paid $240 thousand in full repayment of this note and accrued interest thereon.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><i> </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><i>Hemp Processing Operating Facility</i> – The Company’s lease of its operating facility in Kentucky from Oz Capital, LLC, a related party, was amended in January 2023. As amended, the lease payment was increased to $20.5 thousand monthly beginning in March 2023. The lease expiration date of May 31, 2024 was not changed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><i>Issuance of Series C Preferred Units</i> – In the first quarter of 2023, the Company issued six Series C Preferred Units in a private placement for total proceeds of $300 thousand. Each unit consists of one share of 8.50% Series C Redeemable Convertible Preferred Stock and 5,000 warrants to acquire one share of common stock. Cumulative dividends at 8.5% of the stated value of the Series C Redeemable Convertible Preferred Stock are payable each calendar quarter end in cash or additional shares of Series C Redeemable Convertible Preferred Stock, at the Company’s option.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">Each share of Series C Redeemable Convertible Preferred Stock is convertible, at the holder’s option, into 100 thousand shares of our common stock at any time. It is subject to automatic conversion if (a) the rolling five (5)-trading day volume-weighted average trading price of shares of our common stock exceeds $0.75 and (b) there shall be an effective registration statement under the Securities Act of 1933. The conversion ratio may be adjusted for certain dilutive issuances or in the event a dividend is paid on our common stock. The Series C Redeemable Convertible Preferred Stock is redeemable at any time at the Company’s option.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">The warrants are exercisable for a cash exercise price of $0.50 per share and expire in three years. The warrants may be redeemed at the Company’s option if after one year from issuance, the trading price of the Company’s common stock exceeds $0.875 over a ten consecutive day trading period having a minimum trading volume of 25 thousand shares daily.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><i>Promissory Note to Investment Hunter, LLC</i> – In the first quarter of 2023, Investment Hunter, LLC, a Texas LLC controlled by our CEO, made advances totaling $300 thousand to the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><span>Secured Promissory Note to a Director and our CEO – On April 19, 2023, Razorback I, LLC, a wholly-owned subsidiary of the Company, borrowed $300 thousand under a secured promissory note from one of our directors and our CEO. Proceeds from the note are expected to be utilized in the acquisition of land in Arkansas to expand bitcoin mining operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><span> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><span>The promissory note matures on April 15, 2024. Interest accrues at 12% per annum and is due quarterly beginning on July 15, 2023. The holders have the option to convert the outstanding principal and interest into restricted shares at a conversion price of $0.30 per share of common stock.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><span> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><span>The secured promissory note is collateralized by a pledge of 100% of the ownership interest of Razorback I, LLC and has been guaranteed by the Company as well.</span></p> 100000 0.3 0.80 985000 P10Y 0.095 0.80 1400000 500000 969000 0.10 0.00275 The Toro Dam is located approximately 25 miles from San Jose between two volcano craters. The site generates all its energy from green resources with a proven 98% run time over the years and has a full-time staff in place under a new Operating & Maintenance Agreement.  240000 20500 300000 8.5 5000 0.085 100000 0.75 0.5 P3Y 0.875 25 300000 300 0.12 0.3 1 false FY false 0001527102 May be redeemed for $0.0001 per warrant at the Company’s option with 30 days advanced notice should the weighted average market price of common stock exceed $1.00 for any five out of seven consecutive trading days with a minimum average daily trading volume for such seven-day period of at least 25,000 shares of common stock. EXCEL 72 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 73 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 74 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 75 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 144 397 1 true 48 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.genhempinc.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://www.genhempinc.com/role/ConsolidatedBalanceSheet Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations Sheet http://www.genhempinc.com/role/ConsolidatedIncomeStatement Consolidated Statements of Operations Statements 4 false false R5.htm 004 - Statement - Statements of Changes in Stockholders??? Equity (Deficit) Sheet http://www.genhempinc.com/role/ShareholdersEquityType2or3 Statements of Changes in Stockholders??? Equity (Deficit) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows Sheet http://www.genhempinc.com/role/ConsolidatedCashFlow Consolidated Statements of Cash Flows Statements 6 false false R7.htm 006 - Statement - Consolidated Statements of Cash Flows (Parentheticals) Sheet http://www.genhempinc.com/role/ConsolidatedCashFlow_Parentheticals Consolidated Statements of Cash Flows (Parentheticals) Statements 7 false false R8.htm 007 - Disclosure - Business Sheet http://www.genhempinc.com/role/Business Business Notes 8 false false R9.htm 008 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.genhempinc.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 009 - Disclosure - Property and Equipment Sheet http://www.genhempinc.com/role/PropertyandEquipment Property and Equipment Notes 10 false false R11.htm 010 - Disclosure - Intangible and Other Assets Sheet http://www.genhempinc.com/role/IntangibleandOtherAssets Intangible and Other Assets Notes 11 false false R12.htm 011 - Disclosure - Notes Payable ??? Related Parties Notes http://www.genhempinc.com/role/NotesPayableRelatedParties Notes Payable ??? Related Parties Notes 12 false false R13.htm 012 - Disclosure - Other Indebtedness Sheet http://www.genhempinc.com/role/OtherIndebtedness Other Indebtedness Notes 13 false false R14.htm 013 - Disclosure - Leases Sheet http://www.genhempinc.com/role/Leases Leases Notes 14 false false R15.htm 014 - Disclosure - Commitments and Contingencies Sheet http://www.genhempinc.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 15 false false R16.htm 015 - Disclosure - Income Taxes Sheet http://www.genhempinc.com/role/IncomeTaxes Income Taxes Notes 16 false false R17.htm 016 - Disclosure - Equity Sheet http://www.genhempinc.com/role/Equity Equity Notes 17 false false R18.htm 017 - Disclosure - Stock-Based Compensation Sheet http://www.genhempinc.com/role/StockBasedCompensation Stock-Based Compensation Notes 18 false false R19.htm 018 - Disclosure - Discontinued Operations Sheet http://www.genhempinc.com/role/DiscontinuedOperations Discontinued Operations Notes 19 false false R20.htm 019 - Disclosure - Supplemental Cash Flow Information Sheet http://www.genhempinc.com/role/SupplementalCashFlowInformation Supplemental Cash Flow Information Notes 20 false false R21.htm 020 - Disclosure - Earnings (Loss) Per Share Sheet http://www.genhempinc.com/role/EarningsLossPerShare Earnings (Loss) Per Share Notes 21 false false R22.htm 021 - Disclosure - Subsequent Events Sheet http://www.genhempinc.com/role/SubsequentEvents Subsequent Events Notes 22 false false R23.htm 022 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.genhempinc.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://www.genhempinc.com/role/SummaryofSignificantAccountingPolicies 23 false false R24.htm 023 - Disclosure - Property and Equipment (Tables) Sheet http://www.genhempinc.com/role/PropertyandEquipmentTables Property and Equipment (Tables) Tables http://www.genhempinc.com/role/PropertyandEquipment 24 false false R25.htm 024 - Disclosure - Intangible and Other Assets (Tables) Sheet http://www.genhempinc.com/role/IntangibleandOtherAssetsTables Intangible and Other Assets (Tables) Tables http://www.genhempinc.com/role/IntangibleandOtherAssets 25 false false R26.htm 025 - Disclosure - Notes Payable ??? Related Parties (Tables) Notes http://www.genhempinc.com/role/NotesPayableRelatedPartiesTables Notes Payable ??? Related Parties (Tables) Tables http://www.genhempinc.com/role/NotesPayableRelatedParties 26 false false R27.htm 026 - Disclosure - Income Taxes (Tables) Sheet http://www.genhempinc.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.genhempinc.com/role/IncomeTaxes 27 false false R28.htm 027 - Disclosure - Equity (Tables) Sheet http://www.genhempinc.com/role/EquityTables Equity (Tables) Tables http://www.genhempinc.com/role/Equity 28 false false R29.htm 028 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.genhempinc.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.genhempinc.com/role/StockBasedCompensation 29 false false R30.htm 029 - Disclosure - Discontinued Operations (Tables) Sheet http://www.genhempinc.com/role/DiscontinuedOperationsTables Discontinued Operations (Tables) Tables http://www.genhempinc.com/role/DiscontinuedOperations 30 false false R31.htm 030 - Disclosure - Supplemental Cash Flow Information (Tables) Sheet http://www.genhempinc.com/role/SupplementalCashFlowInformationTables Supplemental Cash Flow Information (Tables) Tables http://www.genhempinc.com/role/SupplementalCashFlowInformation 31 false false R32.htm 031 - Disclosure - Earnings (Loss) Per Share (Tables) Sheet http://www.genhempinc.com/role/EarningsLossPerShareTables Earnings (Loss) Per Share (Tables) Tables http://www.genhempinc.com/role/EarningsLossPerShare 32 false false R33.htm 032 - Disclosure - Business (Details) Sheet http://www.genhempinc.com/role/BusinessDetails Business (Details) Details http://www.genhempinc.com/role/Business 33 false false R34.htm 033 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.genhempinc.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details 34 false false R35.htm 034 - Disclosure - Property and Equipment (Details) - Schedule of property and equipment Sheet http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable Property and Equipment (Details) - Schedule of property and equipment Details http://www.genhempinc.com/role/PropertyandEquipmentTables 35 false false R36.htm 035 - Disclosure - Intangible and Other Assets (Details) Sheet http://www.genhempinc.com/role/IntangibleandOtherAssetsDetails Intangible and Other Assets (Details) Details http://www.genhempinc.com/role/IntangibleandOtherAssetsTables 36 false false R37.htm 036 - Disclosure - Intangible and Other Assets (Details) - Schedule of finite-lived intangible assets Sheet http://www.genhempinc.com/role/ScheduleoffinitelivedintangibleassetsTable Intangible and Other Assets (Details) - Schedule of finite-lived intangible assets Details http://www.genhempinc.com/role/IntangibleandOtherAssetsTables 37 false false R38.htm 037 - Disclosure - Notes Payable ??? Related Parties (Details) Notes http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails Notes Payable ??? Related Parties (Details) Details http://www.genhempinc.com/role/NotesPayableRelatedPartiesTables 38 false false R39.htm 038 - Disclosure - Notes Payable ??? Related Parties (Details) - Schedule of notes payable ??? related parties Notes http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable Notes Payable ??? Related Parties (Details) - Schedule of notes payable ??? related parties Details http://www.genhempinc.com/role/NotesPayableRelatedPartiesTables 39 false false R40.htm 039 - Disclosure - Other Indebtedness (Details) Sheet http://www.genhempinc.com/role/OtherIndebtednessDetails Other Indebtedness (Details) Details http://www.genhempinc.com/role/OtherIndebtedness 40 false false R41.htm 040 - Disclosure - Leases (Details) Sheet http://www.genhempinc.com/role/LeasesDetails Leases (Details) Details http://www.genhempinc.com/role/Leases 41 false false R42.htm 041 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.genhempinc.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.genhempinc.com/role/CommitmentsandContingencies 42 false false R43.htm 042 - Disclosure - Income Taxes (Details) Sheet http://www.genhempinc.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.genhempinc.com/role/IncomeTaxesTables 43 false false R44.htm 043 - Disclosure - Income Taxes (Details) - Schedule of reconciliation of the expected statutory federal tax Sheet http://www.genhempinc.com/role/ScheduleofreconciliationoftheexpectedstatutoryfederaltaxTable Income Taxes (Details) - Schedule of reconciliation of the expected statutory federal tax Details http://www.genhempinc.com/role/IncomeTaxesTables 44 false false R45.htm 044 - Disclosure - Income Taxes (Details) - Schedule of deferred tax assets and liabilities Sheet http://www.genhempinc.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable Income Taxes (Details) - Schedule of deferred tax assets and liabilities Details http://www.genhempinc.com/role/IncomeTaxesTables 45 false false R46.htm 045 - Disclosure - Equity (Details) Sheet http://www.genhempinc.com/role/EquityDetails Equity (Details) Details http://www.genhempinc.com/role/EquityTables 46 false false R47.htm 046 - Disclosure - Equity (Details) - Schedule of warrants outstanding Sheet http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable Equity (Details) - Schedule of warrants outstanding Details http://www.genhempinc.com/role/EquityTables 47 false false R48.htm 047 - Disclosure - Equity (Details) - Schedule of outstanding stock warrants activity Sheet http://www.genhempinc.com/role/ScheduleofoutstandingstockwarrantsactivityTable Equity (Details) - Schedule of outstanding stock warrants activity Details http://www.genhempinc.com/role/EquityTables 48 false false R49.htm 048 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.genhempinc.com/role/StockBasedCompensationDetails Stock-Based Compensation (Details) Details http://www.genhempinc.com/role/StockBasedCompensationTables 49 false false R50.htm 049 - Disclosure - Stock-Based Compensation (Details) - Schedule of summarizes options outstanding Sheet http://www.genhempinc.com/role/ScheduleofsummarizesoptionsoutstandingTable Stock-Based Compensation (Details) - Schedule of summarizes options outstanding Details http://www.genhempinc.com/role/StockBasedCompensationTables 50 false false R51.htm 050 - Disclosure - Discontinued Operations (Details) - Schedule of discontinued operations to assets and liabilities held for sale Sheet http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable Discontinued Operations (Details) - Schedule of discontinued operations to assets and liabilities held for sale Details http://www.genhempinc.com/role/DiscontinuedOperationsTables 51 false false R52.htm 051 - Disclosure - Discontinued Operations (Details) - Schedule of discontinued operations shown in the consolidated statements of operations Sheet http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable Discontinued Operations (Details) - Schedule of discontinued operations shown in the consolidated statements of operations Details http://www.genhempinc.com/role/DiscontinuedOperationsTables 52 false false R53.htm 052 - Disclosure - Supplemental Cash Flow Information (Details) - Schedule of supplemental cash flow information Sheet http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable Supplemental Cash Flow Information (Details) - Schedule of supplemental cash flow information Details http://www.genhempinc.com/role/SupplementalCashFlowInformationTables 53 false false R54.htm 053 - Disclosure - Earnings (Loss) Per Share (Details) - Schedule of earnings (loss) per basic and diluted share Sheet http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable Earnings (Loss) Per Share (Details) - Schedule of earnings (loss) per basic and diluted share Details http://www.genhempinc.com/role/EarningsLossPerShareTables 54 false false R55.htm 054 - Disclosure - Subsequent Events (Details) Sheet http://www.genhempinc.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.genhempinc.com/role/SubsequentEvents 55 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesCurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. f10k2022_evergreen.htm 4442, 4443 [dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesCurrentAndNoncurrent in us-gaap/2022 used in 10 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. f10k2022_evergreen.htm 5797, 5798, 5801, 5802, 5805, 5806, 5809, 5810, 5813, 9418 [dq-0542-Deprecated-Concept] Concept NotesPayableRelatedPartiesCurrentAndNoncurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. f10k2022_evergreen.htm 5817, 5818 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:DocumentTransitionReport - f10k2022_evergreen.htm 9448 f10k2022_evergreen.htm f10k2022ex10-49_evergreen.htm f10k2022ex10-50_evergreen.htm f10k2022ex10-51_evergreen.htm f10k2022ex10-52_evergreen.htm f10k2022ex21_evergreen.htm f10k2022ex3-5_evergreen.htm f10k2022ex31-1_evergreen.htm f10k2022ex32-1_evergreen.htm f10k2022ex4-5_evergreen.htm genh-20221231.xsd genh-20221231_cal.xml genh-20221231_def.xml genh-20221231_lab.xml genh-20221231_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 78 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f10k2022_evergreen.htm": { "axisCustom": 0, "axisStandard": 15, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 604, "http://xbrl.sec.gov/dei/2022": 35 }, "contextCount": 144, "dts": { "calculationLink": { "local": [ "genh-20221231_cal.xml" ] }, "definitionLink": { "local": [ "genh-20221231_def.xml" ] }, "inline": { "local": [ "f10k2022_evergreen.htm" ] }, "labelLink": { "local": [ "genh-20221231_lab.xml" ] }, "presentationLink": { "local": [ "genh-20221231_pre.xml" ] }, "schema": { "local": [ "genh-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd" ] } }, "elementCount": 559, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 110, "http://www.genhempinc.com/20221231": 43, "http://xbrl.sec.gov/dei/2022": 4, "total": 157 }, "keyCustom": 108, "keyStandard": 289, "memberCustom": 22, "memberStandard": 23, "nsprefix": "genh", "nsuri": "http://www.genhempinc.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.genhempinc.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - Property and Equipment", "menuCat": "Notes", "order": "10", "role": "http://www.genhempinc.com/role/PropertyandEquipment", "shortName": "Property and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - Intangible and Other Assets", "menuCat": "Notes", "order": "11", "role": "http://www.genhempinc.com/role/IntangibleandOtherAssets", "shortName": "Intangible and Other Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - Notes Payable \u2013 Related Parties", "menuCat": "Notes", "order": "12", "role": "http://www.genhempinc.com/role/NotesPayableRelatedParties", "shortName": "Notes Payable \u2013 Related Parties", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MortgageNotesPayableDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - Other Indebtedness", "menuCat": "Notes", "order": "13", "role": "http://www.genhempinc.com/role/OtherIndebtedness", "shortName": "Other Indebtedness", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MortgageNotesPayableDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - Leases", "menuCat": "Notes", "order": "14", "role": "http://www.genhempinc.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "15", "role": "http://www.genhempinc.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "16", "role": "http://www.genhempinc.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - Equity", "menuCat": "Notes", "order": "17", "role": "http://www.genhempinc.com/role/Equity", "shortName": "Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - Stock-Based Compensation", "menuCat": "Notes", "order": "18", "role": "http://www.genhempinc.com/role/StockBasedCompensation", "shortName": "Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - Discontinued Operations", "menuCat": "Notes", "order": "19", "role": "http://www.genhempinc.com/role/DiscontinuedOperations", "shortName": "Discontinued Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://www.genhempinc.com/role/ConsolidatedBalanceSheet", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - Supplemental Cash Flow Information", "menuCat": "Notes", "order": "20", "role": "http://www.genhempinc.com/role/SupplementalCashFlowInformation", "shortName": "Supplemental Cash Flow Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - Earnings (Loss) Per Share", "menuCat": "Notes", "order": "21", "role": "http://www.genhempinc.com/role/EarningsLossPerShare", "shortName": "Earnings (Loss) Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "22", "role": "http://www.genhempinc.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - Accounting Policies, by Policy (Policies)", "menuCat": "Policies", "order": "23", "role": "http://www.genhempinc.com/role/AccountingPoliciesByPolicy", "shortName": "Accounting Policies, by Policy (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - Property and Equipment (Tables)", "menuCat": "Tables", "order": "24", "role": "http://www.genhempinc.com/role/PropertyandEquipmentTables", "shortName": "Property and Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - Intangible and Other Assets (Tables)", "menuCat": "Tables", "order": "25", "role": "http://www.genhempinc.com/role/IntangibleandOtherAssetsTables", "shortName": "Intangible and Other Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "genh:ScheduleOfNotesPayableRelatedPartiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - Notes Payable \u2013 Related Parties (Tables)", "menuCat": "Tables", "order": "26", "role": "http://www.genhempinc.com/role/NotesPayableRelatedPartiesTables", "shortName": "Notes Payable \u2013 Related Parties (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "genh:ScheduleOfNotesPayableRelatedPartiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - Income Taxes (Tables)", "menuCat": "Tables", "order": "27", "role": "http://www.genhempinc.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "genh:ScheduleOfWarrantsOutstandingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - Equity (Tables)", "menuCat": "Tables", "order": "28", "role": "http://www.genhempinc.com/role/EquityTables", "shortName": "Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "genh:ScheduleOfWarrantsOutstandingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - Stock-Based Compensation (Tables)", "menuCat": "Tables", "order": "29", "role": "http://www.genhempinc.com/role/StockBasedCompensationTables", "shortName": "Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "5", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Consolidated Balance Sheets (Parentheticals)", "menuCat": "Statements", "order": "3", "role": "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals", "shortName": "Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "5", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "genh:ScheduleOfDiscontinuedOperationsToAssetsAndLiabilitiesHeldForSaleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - Discontinued Operations (Tables)", "menuCat": "Tables", "order": "30", "role": "http://www.genhempinc.com/role/DiscontinuedOperationsTables", "shortName": "Discontinued Operations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "genh:ScheduleOfDiscontinuedOperationsToAssetsAndLiabilitiesHeldForSaleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - Supplemental Cash Flow Information (Tables)", "menuCat": "Tables", "order": "31", "role": "http://www.genhempinc.com/role/SupplementalCashFlowInformationTables", "shortName": "Supplemental Cash Flow Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - Earnings (Loss) Per Share (Tables)", "menuCat": "Tables", "order": "32", "role": "http://www.genhempinc.com/role/EarningsLossPerShareTables", "shortName": "Earnings (Loss) Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c40", "decimals": "0", "first": true, "lang": null, "name": "genh:SquareFootFacility", "reportCount": 1, "unique": true, "unitRef": "usdPersqft", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - Business (Details)", "menuCat": "Details", "order": "33", "role": "http://www.genhempinc.com/role/BusinessDetails", "shortName": "Business (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c40", "decimals": "0", "first": true, "lang": null, "name": "genh:SquareFootFacility", "reportCount": 1, "unique": true, "unitRef": "usdPersqft", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "p", "genh:NoncontrollingInterestsPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": "2", "first": true, "lang": null, "name": "genh:NoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "033 - Disclosure - Summary of Significant Accounting Policies (Details)", "menuCat": "Details", "order": "34", "role": "http://www.genhempinc.com/role/SummaryofSignificantAccountingPoliciesDetails", "shortName": "Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "genh:NoncontrollingInterestsPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": "2", "first": true, "lang": null, "name": "genh:NoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "034 - Disclosure - Property and Equipment (Details) - Schedule of property and equipment", "menuCat": "Details", "order": "35", "role": "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable", "shortName": "Property and Equipment (Details) - Schedule of property and equipment", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "035 - Disclosure - Intangible and Other Assets (Details)", "menuCat": "Details", "order": "36", "role": "http://www.genhempinc.com/role/IntangibleandOtherAssetsDetails", "shortName": "Intangible and Other Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "036 - Disclosure - Intangible and Other Assets (Details) - Schedule of finite-lived intangible assets", "menuCat": "Details", "order": "37", "role": "http://www.genhempinc.com/role/ScheduleoffinitelivedintangibleassetsTable", "shortName": "Intangible and Other Assets (Details) - Schedule of finite-lived intangible assets", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeTaxExaminationInterestAccrued", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "037 - Disclosure - Notes Payable \u2013 Related Parties (Details)", "menuCat": "Details", "order": "38", "role": "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "shortName": "Notes Payable \u2013 Related Parties (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeTaxExaminationInterestAccrued", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "genh:ScheduleOfNotesPayableRelatedPartiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "038 - Disclosure - Notes Payable \u2013 Related Parties (Details) - Schedule of notes payable \u2013 related parties", "menuCat": "Details", "order": "39", "role": "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable", "shortName": "Notes Payable \u2013 Related Parties (Details) - Schedule of notes payable \u2013 related parties", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "genh:ScheduleOfNotesPayableRelatedPartiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "genh:PostharvestAndMidstreamServices", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Consolidated Statements of Operations", "menuCat": "Statements", "order": "4", "role": "http://www.genhempinc.com/role/ConsolidatedIncomeStatement", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "genh:PostharvestAndMidstreamServices", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "genh:MortgagePayableDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "039 - Disclosure - Other Indebtedness (Details)", "menuCat": "Details", "order": "40", "role": "http://www.genhempinc.com/role/OtherIndebtednessDetails", "shortName": "Other Indebtedness (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "genh:MortgagePayableDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040 - Disclosure - Leases (Details)", "menuCat": "Details", "order": "41", "role": "http://www.genhempinc.com/role/LeasesDetails", "shortName": "Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": "-3", "lang": null, "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireMachineryAndEquipment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041 - Disclosure - Commitments and Contingencies (Details)", "menuCat": "Details", "order": "42", "role": "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails", "shortName": "Commitments and Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireMachineryAndEquipment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042 - Disclosure - Income Taxes (Details)", "menuCat": "Details", "order": "43", "role": "http://www.genhempinc.com/role/IncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "043 - Disclosure - Income Taxes (Details) - Schedule of reconciliation of the expected statutory federal tax", "menuCat": "Details", "order": "44", "role": "http://www.genhempinc.com/role/ScheduleofreconciliationoftheexpectedstatutoryfederaltaxTable", "shortName": "Income Taxes (Details) - Schedule of reconciliation of the expected statutory federal tax", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "044 - Disclosure - Income Taxes (Details) - Schedule of deferred tax assets and liabilities", "menuCat": "Details", "order": "45", "role": "http://www.genhempinc.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable", "shortName": "Income Taxes (Details) - Schedule of deferred tax assets and liabilities", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PreferredStockConvertibleSharesIssuable", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "045 - Disclosure - Equity (Details)", "menuCat": "Details", "order": "46", "role": "http://www.genhempinc.com/role/EquityDetails", "shortName": "Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PreferredStockConvertibleSharesIssuable", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "genh:ScheduleOfWarrantsOutstandingTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "046 - Disclosure - Equity (Details) - Schedule of warrants outstanding", "menuCat": "Details", "order": "47", "role": "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable", "shortName": "Equity (Details) - Schedule of warrants outstanding", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "genh:ScheduleOfWarrantsOutstandingTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "genh:ScheduleOfOutstandingStockWarrantsActivityTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c4", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "047 - Disclosure - Equity (Details) - Schedule of outstanding stock warrants activity", "menuCat": "Details", "order": "48", "role": "http://www.genhempinc.com/role/ScheduleofoutstandingstockwarrantsactivityTable", "shortName": "Equity (Details) - Schedule of outstanding stock warrants activity", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "genh:ScheduleOfOutstandingStockWarrantsActivityTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c14", "decimals": "INF", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": "2", "first": true, "lang": null, "name": "genh:CommonSharesDiluted", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "048 - Disclosure - Stock-Based Compensation (Details)", "menuCat": "Details", "order": "49", "role": "http://www.genhempinc.com/role/StockBasedCompensationDetails", "shortName": "Stock-Based Compensation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": "2", "first": true, "lang": null, "name": "genh:CommonSharesDiluted", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c8", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Statements of Changes in Stockholders\u2019 Equity (Deficit)", "menuCat": "Statements", "order": "5", "role": "http://www.genhempinc.com/role/ShareholdersEquityType2or3", "shortName": "Statements of Changes in Stockholders\u2019 Equity (Deficit)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c8", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c4", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "049 - Disclosure - Stock-Based Compensation (Details) - Schedule of summarizes options outstanding", "menuCat": "Details", "order": "50", "role": "http://www.genhempinc.com/role/ScheduleofsummarizesoptionsoutstandingTable", "shortName": "Stock-Based Compensation (Details) - Schedule of summarizes options outstanding", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c3", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "genh:ScheduleOfDiscontinuedOperationsToAssetsAndLiabilitiesHeldForSaleTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c122", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "050 - Disclosure - Discontinued Operations (Details) - Schedule of discontinued operations to assets and liabilities held for sale", "menuCat": "Details", "order": "51", "role": "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable", "shortName": "Discontinued Operations (Details) - Schedule of discontinued operations to assets and liabilities held for sale", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "genh:ScheduleOfDiscontinuedOperationsToAssetsAndLiabilitiesHeldForSaleTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c122", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c124", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "051 - Disclosure - Discontinued Operations (Details) - Schedule of discontinued operations shown in the consolidated statements of operations", "menuCat": "Details", "order": "52", "role": "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable", "shortName": "Discontinued Operations (Details) - Schedule of discontinued operations shown in the consolidated statements of operations", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c124", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestPaid", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "052 - Disclosure - Supplemental Cash Flow Information (Details) - Schedule of supplemental cash flow information", "menuCat": "Details", "order": "53", "role": "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable", "shortName": "Supplemental Cash Flow Information (Details) - Schedule of supplemental cash flow information", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestPaid", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "genh:NetLossFromContinuingOperationsAttributableToCommonStockholders", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "053 - Disclosure - Earnings (Loss) Per Share (Details) - Schedule of earnings (loss) per basic and diluted share", "menuCat": "Details", "order": "54", "role": "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable", "shortName": "Earnings (Loss) Per Share (Details) - Schedule of earnings (loss) per basic and diluted share", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "genh:NetLossFromContinuingOperationsAttributableToCommonStockholders", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "genh:OperatingMaintenanceAgreementDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "054 - Disclosure - Subsequent Events (Details)", "menuCat": "Details", "order": "55", "role": "http://www.genhempinc.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "genh:OperatingMaintenanceAgreementDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://www.genhempinc.com/role/ConsolidatedCashFlow", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": "0", "lang": null, "name": "us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAcquiredFromAcquisition", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "006 - Statement - Consolidated Statements of Cash Flows (Parentheticals)", "menuCat": "Statements", "order": "7", "role": "http://www.genhempinc.com/role/ConsolidatedCashFlow_Parentheticals", "shortName": "Consolidated Statements of Cash Flows (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAcquiredFromAcquisition", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - Business", "menuCat": "Notes", "order": "8", "role": "http://www.genhempinc.com/role/Business", "shortName": "Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "9", "role": "http://www.genhempinc.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "f10k2022_evergreen.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 48, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r493", "r494", "r495" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r493", "r494", "r495" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r493", "r494", "r495" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r493", "r494", "r495" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r497" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r498" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r493", "r494", "r495" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r491" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "genh_AccruedAndUnpaidInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued and unpaid interest.", "label": "Accrued And Unpaid Interest", "terseLabel": "Accrued and unpaid interest" } } }, "localname": "AccruedAndUnpaidInterest", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "genh_AccruedInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of accrued interest.", "label": "Accrued Interest", "terseLabel": "Accrued interest" } } }, "localname": "AccruedInterest", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/OtherIndebtednessDetails" ], "xbrltype": "monetaryItemType" }, "genh_AcquisitionOfCertainAssetsOfHalcyonThruputLlcAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisition Of Certain Assets Of Halcyon Thruput Llc Abstract", "terseLabel": "Acquisition of certain assets of Halcyon Thruput, LLC" } } }, "localname": "AcquisitionOfCertainAssetsOfHalcyonThruputLlcAbstract", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable" ], "xbrltype": "stringItemType" }, "genh_AdditionalAdvances": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of additional advances.", "label": "Additional Advances", "terseLabel": "Additional advances" } } }, "localname": "AdditionalAdvances", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "genh_AdvancesTotal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of advances total.", "label": "Advances Total", "terseLabel": "Advances total" } } }, "localname": "AdvancesTotal", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "genh_AdvancesTotaling": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Advances totaling.", "label": "Advances Totaling", "terseLabel": "Advances totaling" } } }, "localname": "AdvancesTotaling", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "genh_AggregateGrossProceeds": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of proceeds from the gross.", "label": "Aggregate Gross Proceeds", "terseLabel": "Aggregate gross proceeds (in Dollars)" } } }, "localname": "AggregateGrossProceeds", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "monetaryItemType" }, "genh_AggregateIntrinsicValueGranted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Number of aggregate intrinsic value granted.", "label": "Aggregate Intrinsic Value Granted", "terseLabel": "Aggregate Intrinsic Value Granted (in Dollars)" } } }, "localname": "AggregateIntrinsicValueGranted", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsummarizesoptionsoutstandingTable" ], "xbrltype": "monetaryItemType" }, "genh_AssetsAbstract0": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets Abstract0", "terseLabel": "Assets:" } } }, "localname": "AssetsAbstract0", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "stringItemType" }, "genh_AssumptionOfHalcyonBankNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Assumption of Halcyon bank note.", "label": "Assumption Of Halcyon Bank Note", "terseLabel": "assumption of Halcyon bank note" } } }, "localname": "AssumptionOfHalcyonBankNote", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable" ], "xbrltype": "monetaryItemType" }, "genh_BorrowingRatePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Borrowing rate percentage.", "label": "Borrowing Rate Percentage", "terseLabel": "Borrowing rate percentage" } } }, "localname": "BorrowingRatePercentage", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/LeasesDetails" ], "xbrltype": "percentItemType" }, "genh_BusinessDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business (Details) [Line Items]" } } }, "localname": "BusinessDetailsLineItems", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "stringItemType" }, "genh_BusinessDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business (Details) [Table]" } } }, "localname": "BusinessDetailsTable", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "stringItemType" }, "genh_ChangeInCommonStockParValueDueToChangeInCorporateDomicile": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of change in common stock par value due to change in corporate domicile.", "label": "Change In Common Stock Par Value Due To Change In Corporate Domicile", "terseLabel": "Change in common stock par value due to change in corporate domicile" } } }, "localname": "ChangeInCommonStockParValueDueToChangeInCorporateDomicile", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "genh_CommitmentsandContingenciesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies (Details) [Line Items]" } } }, "localname": "CommitmentsandContingenciesDetailsLineItems", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "genh_CommitmentsandContingenciesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies (Details) [Table]" } } }, "localname": "CommitmentsandContingenciesDetailsTable", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "genh_CommonSharesDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common shares diluted.", "label": "Common Shares Diluted", "terseLabel": "Diluted common shares outstanding percentage" } } }, "localname": "CommonSharesDiluted", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "genh_CommonStockExceedsPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share of common stock exceeds.", "label": "Common Stock Exceeds Per Share", "terseLabel": "Common stock exceeds, per share (in Dollars per share)" } } }, "localname": "CommonStockExceedsPerShare", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "perShareItemType" }, "genh_CommonStockForIssuance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock for issuance.", "label": "Common Stock For Issuance", "terseLabel": "common stock for issuance" } } }, "localname": "CommonStockForIssuance", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "genh_CommonStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock Units Member", "terseLabel": "Common stock units [Member]" } } }, "localname": "CommonStockUnitsMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "domainItemType" }, "genh_CommonStockValueOne": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock Value One", "terseLabel": "Common stock, shares" } } }, "localname": "CommonStockValueOne", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "genh_ConversionOfSeriesAPreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount conversion of preferred stock.", "label": "Conversion Of Series APreferred Stock", "terseLabel": "Conversion of Series A preferred stock" } } }, "localname": "ConversionOfSeriesAPreferredStock", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "genh_ConversionOfSeriesAPreferredStockIntoCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Conversion Of Series APreferred Stock Into Common Stock", "terseLabel": "Conversion of Series A preferred stock into common stock" } } }, "localname": "ConversionOfSeriesAPreferredStockIntoCommonStock", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable" ], "xbrltype": "monetaryItemType" }, "genh_ConversionOfSeriesAPreferredStockinShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of conversion of series A preferred stock.", "label": "Conversion Of Series APreferred Stockin Shares", "terseLabel": "Conversion of Series A preferred stock (in Shares)" } } }, "localname": "ConversionOfSeriesAPreferredStockinShares", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "genh_ConvertibleConversionPriceOne": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Convertible Conversion Price One", "terseLabel": "Conversion price" } } }, "localname": "ConvertibleConversionPriceOne", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "genh_ConvertiblePromissoryNoteToCEOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Promissory Note To CEOMember", "terseLabel": "Convertible Promissory Note to CEO [Member]" } } }, "localname": "ConvertiblePromissoryNoteToCEOMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "domainItemType" }, "genh_CumulativeDividendsPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage cumulative dividends.", "label": "Cumulative Dividends Percentage", "terseLabel": "Cumulative dividends, percentage" } } }, "localname": "CumulativeDividendsPercentage", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "genh_CurrentLiabilitiesOfDiscontinuedOperationsHeldForSale": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Current liabilities of discontinued operations held for sale.", "label": "Current Liabilities Of Discontinued Operations Held For Sale", "terseLabel": "Current liabilities of discontinued operations held for sale" } } }, "localname": "CurrentLiabilitiesOfDiscontinuedOperationsHeldForSale", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "genh_DailySharesValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of daily share.", "label": "Daily Shares Value", "terseLabel": "Shares value" } } }, "localname": "DailySharesValue", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "genh_DecemberTwoThousandTwentyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "December Two Thousand Twenty Member", "terseLabel": "Issued in December 2020 [Member]" } } }, "localname": "DecemberTwoThousandTwentyMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "domainItemType" }, "genh_DecemberTwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "December Two Thousand Twenty One Member", "terseLabel": "Issued in Q4 2021 [Member]" } } }, "localname": "DecemberTwoThousandTwentyOneMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "domainItemType" }, "genh_DeferredTaxAssetsPropertyPlantsAndEquipment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.", "label": "Deferred Tax Assets Property Plants And Equipment", "terseLabel": "Property and equipment" } } }, "localname": "DeferredTaxAssetsPropertyPlantsAndEquipment", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "genh_DenominatorAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Denominator Abstract", "terseLabel": "Denominator" } } }, "localname": "DenominatorAbstract", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "stringItemType" }, "genh_DescriptionOfBusinessDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description Of Business Description", "terseLabel": "Description of business, description" } } }, "localname": "DescriptionOfBusinessDescription", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "stringItemType" }, "genh_DescriptionOfSuitAgainstUNIC": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of Suit against UNIC.", "label": "Description Of Suit Against UNIC", "terseLabel": "Description of suit against UNIC" } } }, "localname": "DescriptionOfSuitAgainstUNIC", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "genh_DilutiveEffectOfCommonStockOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dilutive effect of common stock options.", "label": "Dilutive Effect Of Common Stock Options", "terseLabel": "Dilutive effect of common stock options" } } }, "localname": "DilutiveEffectOfCommonStockOptions", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "sharesItemType" }, "genh_DilutiveEffectOfCommonStockWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dilutive effect of common stock warrants.", "label": "Dilutive Effect Of Common Stock Warrants", "terseLabel": "Dilutive effect of common stock warrants" } } }, "localname": "DilutiveEffectOfCommonStockWarrants", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "sharesItemType" }, "genh_DilutiveEffectOfConvertibleNote": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dilutive effect of convertible note.", "label": "Dilutive Effect Of Convertible Note", "terseLabel": "Dilutive effect of convertible note" } } }, "localname": "DilutiveEffectOfConvertibleNote", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "sharesItemType" }, "genh_DilutiveEffectOfPreferredStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dilutive effect of preferred stock.", "label": "Dilutive Effect Of Preferred Stock", "terseLabel": "Dilutive effect of preferred stock" } } }, "localname": "DilutiveEffectOfPreferredStock", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "sharesItemType" }, "genh_DiscontinuedOperationsDetailsScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discontinued Operations (Details) - Schedule of discontinued operations to assets and liabilities held for sale [Line Items]" } } }, "localname": "DiscontinuedOperationsDetailsScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleLineItems", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "stringItemType" }, "genh_DiscontinuedOperationsDetailsScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discontinued Operations (Details) - Schedule of discontinued operations to assets and liabilities held for sale [Table]" } } }, "localname": "DiscontinuedOperationsDetailsScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "stringItemType" }, "genh_DisposaGroupIncludingDiscontinuedOperationAccumulatedDDA": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable": { "order": 2.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accumulated DD&A.", "label": "Disposa Group Including Discontinued Operation Accumulated DDA", "terseLabel": "Accumulated DD&A" } } }, "localname": "DisposaGroupIncludingDiscontinuedOperationAccumulatedDDA", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "monetaryItemType" }, "genh_DisposalGroupIncludingDiscontinuedOperationAccretion": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable": { "order": 2.0, "parentTag": "genh_DisposalGroupIncludingDiscontinuedOperationCostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal group including discontinued pperation accretion.", "label": "Disposal Group Including Discontinued Operation Accretion", "terseLabel": "Accretion of asset retirement obligations" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccretion", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable" ], "xbrltype": "monetaryItemType" }, "genh_DisposalGroupIncludingDiscontinuedOperationCostsAndExpenses": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs and expenses.", "label": "Disposal Group Including Discontinued Operation Costs And Expenses", "totalLabel": "Total costs and expenses" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCostsAndExpenses", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable" ], "xbrltype": "monetaryItemType" }, "genh_DocumentAndEntityInformationAbstract": { "auth_ref": [], "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.genhempinc.com/20221231", "xbrltype": "stringItemType" }, "genh_EarningsLossPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Loss Per Share Abstract", "terseLabel": "Earnings (loss) per share" } } }, "localname": "EarningsLossPerShareAbstract", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "genh_EarningsLossPerShareAbstract0": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Loss Per Share Abstract0", "terseLabel": "Earnings (loss) per share:" } } }, "localname": "EarningsLossPerShareAbstract0", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "stringItemType" }, "genh_EarningsLossPerShareAbstract1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Loss Per Share Abstract1", "terseLabel": "Earnings (loss) per share" } } }, "localname": "EarningsLossPerShareAbstract1", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "stringItemType" }, "genh_EnergyHunterResourcesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Energy Hunter Resources Inc Member", "terseLabel": "Energy Hunter Resources, Inc. [Member]" } } }, "localname": "EnergyHunterResourcesIncMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "domainItemType" }, "genh_EquityDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity description.", "label": "Equity Description", "terseLabel": "Equity, description" } } }, "localname": "EquityDescription", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "stringItemType" }, "genh_EquityDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity (Details) [Line Items]" } } }, "localname": "EquityDetailsLineItems", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "stringItemType" }, "genh_EquityDetailsScheduleofwarrantsoutstandingLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity (Details) - Schedule of warrants outstanding [Line Items]" } } }, "localname": "EquityDetailsScheduleofwarrantsoutstandingLineItems", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "stringItemType" }, "genh_EquityDetailsScheduleofwarrantsoutstandingTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity (Details) - Schedule of warrants outstanding [Table]" } } }, "localname": "EquityDetailsScheduleofwarrantsoutstandingTable", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "stringItemType" }, "genh_EquityDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity (Details) [Table]" } } }, "localname": "EquityDetailsTable", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "stringItemType" }, "genh_EquityTotalAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of total equity.", "label": "Equity Total Amount", "terseLabel": "Equity total Amount" } } }, "localname": "EquityTotalAmount", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "genh_ExercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price per share.", "label": "Exercise Price Per Share", "terseLabel": "Exercise price per share (in Dollars per share)" } } }, "localname": "ExercisePricePerShare", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "perShareItemType" }, "genh_ExtensionDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension date.", "label": "Extension Date", "terseLabel": "Extension date" } } }, "localname": "ExtensionDate", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "dateItemType" }, "genh_FinancingObligations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of financing obligations.", "label": "Financing Obligations", "terseLabel": "Financing obligations" } } }, "localname": "FinancingObligations", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "monetaryItemType" }, "genh_FinancingObligationsTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financing obligations terms.", "label": "Financing Obligations Terms", "terseLabel": "Financing obligations terms" } } }, "localname": "FinancingObligationsTerms", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "durationItemType" }, "genh_GainLossChangeInFairValueOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Change in fair value of marketable securities.", "label": "Gain Loss Change In Fair Value Of Marketable Securities", "negatedLabel": "Change in fair value of marketable securities" } } }, "localname": "GainLossChangeInFairValueOfMarketableSecurities", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "genh_GrandTraverseHoldingsLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Grand Traverse Holdings LLCMember", "terseLabel": "Grand Traverse Holdings, LLC [Member]" } } }, "localname": "GrandTraverseHoldingsLLCMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "genh_HalcyonThruputLLCsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Halcyon Thruput LLCs Member", "terseLabel": "Halcyon Thruput LLC\u2019s [Member]" } } }, "localname": "HalcyonThruputLLCsMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "genh_InsuranceSettlementsReceivables": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy.", "label": "Insurance Settlements Receivables", "terseLabel": "Insurance claim for replacement" } } }, "localname": "InsuranceSettlementsReceivables", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "genh_InterestExpenses": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest expense.", "label": "Interest Expenses", "terseLabel": "Interest expense" } } }, "localname": "InterestExpenses", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "genh_InterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate.", "label": "Interest Rate", "terseLabel": "Interest rate" } } }, "localname": "InterestRate", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/OtherIndebtednessDetails" ], "xbrltype": "percentItemType" }, "genh_InvestmentOwnershipPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Investment Ownership Percentage", "terseLabel": "Ownership percentage" } } }, "localname": "InvestmentOwnershipPercentage", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "genh_IssuanceOfCommonShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common shares.", "label": "Issuance Of Common Shares", "terseLabel": "issuance of common shares" } } }, "localname": "IssuanceOfCommonShares", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable" ], "xbrltype": "monetaryItemType" }, "genh_IssuanceOfCommonSharesForExtensionOfSecuredNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of issuance of common shares for extension of secured note.", "label": "Issuance Of Common Shares For Extension Of Secured Note", "terseLabel": "Issuance of common shares for extension of secured note" } } }, "localname": "IssuanceOfCommonSharesForExtensionOfSecuredNote", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "genh_IssuanceOfCommonSharesForExtensionOfSecuredNoteinShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares of issuance for common shares for extension of secured note.", "label": "Issuance Of Common Shares For Extension Of Secured Notein Shares", "terseLabel": "Issuance of common shares for extension of secured note (in Shares)" } } }, "localname": "IssuanceOfCommonSharesForExtensionOfSecuredNoteinShares", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "genh_IssuanceOfCommonStockUnits": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Issuance of common stock units.", "label": "Issuance Of Common Stock Units", "terseLabel": "Issuance of common stock units" } } }, "localname": "IssuanceOfCommonStockUnits", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "genh_IssuanceOfCommonStockUnitsPreviouslySubscribed": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common stock units previously subscribed.", "label": "Issuance Of Common Stock Units Previously Subscribed", "terseLabel": "Issuance of common stock units previously subscribed" } } }, "localname": "IssuanceOfCommonStockUnitsPreviouslySubscribed", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable" ], "xbrltype": "monetaryItemType" }, "genh_IssuanceOfSubordinatedNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of subordinated note", "label": "Issuance Of Subordinated Note", "terseLabel": "issuance of subordinated note" } } }, "localname": "IssuanceOfSubordinatedNote", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable" ], "xbrltype": "monetaryItemType" }, "genh_IssuancesOfCommonSharesForExchangeOrConversionOfDebt": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuances of common shares for exchange or conversion of debt.", "label": "Issuances Of Common Shares For Exchange Or Conversion Of Debt", "terseLabel": "Issuances of common shares for exchange or conversion of debt" } } }, "localname": "IssuancesOfCommonSharesForExchangeOrConversionOfDebt", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable" ], "xbrltype": "monetaryItemType" }, "genh_LeaseAndRentalExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lease and rental expenses.", "label": "Lease And Rental Expenses", "terseLabel": "Lease and rental expense" } } }, "localname": "LeaseAndRentalExpenses", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/OtherIndebtednessDetails" ], "xbrltype": "monetaryItemType" }, "genh_LeasesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases (Details) [Line Items]" } } }, "localname": "LeasesDetailsLineItems", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/LeasesDetails" ], "xbrltype": "stringItemType" }, "genh_LeasesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases (Details) [Table]" } } }, "localname": "LeasesDetailsTable", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/LeasesDetails" ], "xbrltype": "stringItemType" }, "genh_LessPreferredStockDividends": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Less: preferred stock dividends.", "label": "Less Preferred Stock Dividends", "terseLabel": "Less: preferred stock dividends" } } }, "localname": "LessPreferredStockDividends", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "monetaryItemType" }, "genh_LitigationSettlementInterestPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Litigation Settlement interest percentage.", "label": "Litigation Settlement Interest Percentage", "terseLabel": "Litigation settlement interest percentage" } } }, "localname": "LitigationSettlementInterestPercentage", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "percentItemType" }, "genh_LongtermLiabilitiesOfDiscontinuedOperationsHeldForSale": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long-term liabilities of discontinued operations held for sale.", "label": "Longterm Liabilities Of Discontinued Operations Held For Sale", "terseLabel": "Long-term liabilities of discontinued operations held for sale" } } }, "localname": "LongtermLiabilitiesOfDiscontinuedOperationsHeldForSale", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "monetaryItemType" }, "genh_LossFromContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loss From Continuing Operations Abstract", "terseLabel": "Loss from continuing operations" } } }, "localname": "LossFromContinuingOperationsAbstract", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "stringItemType" }, "genh_LossFromDiscontinuedOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loss From Discontinued Operations Abstract", "terseLabel": "Loss from discontinued operations" } } }, "localname": "LossFromDiscontinuedOperationsAbstract", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "stringItemType" }, "genh_MarchTwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "March Two Thousand Twenty One Member", "terseLabel": "Issued in Q1 2021 [Member]" } } }, "localname": "MarchTwoThousandTwentyOneMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "domainItemType" }, "genh_ModificationOfWarrantsForExtensionOfPromissoryNoteToInvestor": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of modification of warrants for extension of promissory note to investor.", "label": "Modification Of Warrants For Extension Of Promissory Note To Investor", "terseLabel": "Modification of warrants for extension of promissory note to investor" } } }, "localname": "ModificationOfWarrantsForExtensionOfPromissoryNoteToInvestor", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "genh_MonthlyRent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Monthly rent.", "label": "Monthly Rent", "terseLabel": "Monthly rent" } } }, "localname": "MonthlyRent", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "genh_MortgagePayableDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of mortgage payable.", "label": "Mortgage Payable Description", "terseLabel": "Mortgage payable, description" } } }, "localname": "MortgagePayableDescription", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/OtherIndebtednessDetails" ], "xbrltype": "stringItemType" }, "genh_NetAcquiredCash": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of net acquired cash.", "label": "Net Acquired Cash", "terseLabel": "Acquisition of certain assets of Halcyon Thruput, LLC, net of acquired cash of $224,530" } } }, "localname": "NetAcquiredCash", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "genh_NetLossFromContinuingOperationsAttributableToCommonStockholders": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Loss from continuing operations attributable to common stockholders.", "label": "Net Loss From Continuing Operations Attributable To Common Stockholders", "terseLabel": "Loss from continuing operations attributable to common stockholders" } } }, "localname": "NetLossFromContinuingOperationsAttributableToCommonStockholders", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "monetaryItemType" }, "genh_NewEquityCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "New equity capital.", "label": "New Equity Capital", "terseLabel": "New equity capital" } } }, "localname": "NewEquityCapital", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "genh_NoncashInvestingAndFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing And Financing Activities Abstract", "terseLabel": "Noncash investing and financing activities:" } } }, "localname": "NoncashInvestingAndFinancingActivitiesAbstract", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable" ], "xbrltype": "stringItemType" }, "genh_NoncompetitionAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncompetition Agreements Member", "terseLabel": "Non-competition agreements [Member]" } } }, "localname": "NoncompetitionAgreementsMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleoffinitelivedintangibleassetsTable" ], "xbrltype": "domainItemType" }, "genh_NoncontrollingInterest": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Noncontrolling Interest.", "label": "Noncontrolling Interest", "terseLabel": "Noncontrolling interest" } } }, "localname": "NoncontrollingInterest", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "genh_NoncontrollingInterestsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Noncontrolling Interests Policy Text Block.", "label": "Noncontrolling Interests Policy Text Block", "terseLabel": "Noncontrolling Interests Policy Text Block" } } }, "localname": "NoncontrollingInterestsPolicyTextBlock", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "genh_NotesPayableRelatedPartiesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable \u2013 Related Parties (Details) [Line Items]" } } }, "localname": "NotesPayableRelatedPartiesDetailsLineItems", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "genh_NotesPayableRelatedPartiesDetailsScheduleofnotespayablerelatedpartiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable \u2013 Related Parties (Details) - Schedule of notes payable \u2013 related parties [Line Items]" } } }, "localname": "NotesPayableRelatedPartiesDetailsScheduleofnotespayablerelatedpartiesLineItems", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "stringItemType" }, "genh_NotesPayableRelatedPartiesDetailsScheduleofnotespayablerelatedpartiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable \u2013 Related Parties (Details) - Schedule of notes payable \u2013 related parties [Table]" } } }, "localname": "NotesPayableRelatedPartiesDetailsScheduleofnotespayablerelatedpartiesTable", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "stringItemType" }, "genh_NotesPayableRelatedPartiesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable \u2013 Related Parties (Details) [Table]" } } }, "localname": "NotesPayableRelatedPartiesDetailsTable", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "genh_NumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares.", "label": "Number Of Shares", "terseLabel": "Number of shares" } } }, "localname": "NumberOfShares", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "genh_NumeratorAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Numerator Abstract", "terseLabel": "Numerator" } } }, "localname": "NumeratorAbstract", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "stringItemType" }, "genh_OperatingLeasesFutureMinimumPaymentsRentTwoYears": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating Leases Future Minimum Payments Rent Two Years.", "label": "Operating Leases Future Minimum Payments Rent Two Years", "terseLabel": "Minimum future rents" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsRentTwoYears", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/OtherIndebtednessDetails" ], "xbrltype": "monetaryItemType" }, "genh_OperatingMaintenanceAgreementDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating & maintenance agreement description.", "label": "Operating Maintenance Agreement Description", "terseLabel": "Operating & maintenance agreement description" } } }, "localname": "OperatingMaintenanceAgreementDescription", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "genh_OptionToPurchaseDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Option to purchase description.", "label": "Option To Purchase Description", "terseLabel": "Option to purchase, description" } } }, "localname": "OptionToPurchaseDescription", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/IntangibleandOtherAssetsDetails" ], "xbrltype": "stringItemType" }, "genh_OtherIndebtednessCurrent": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other indebtedness - current.", "label": "Other Indebtedness Current", "terseLabel": "Other indebtedness - current" } } }, "localname": "OtherIndebtednessCurrent", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "genh_OwnsApproximatelysPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Owns approximately Percentage.", "label": "Owns Approximatelys Percent", "terseLabel": "Percentage of common stock" } } }, "localname": "OwnsApproximatelysPercent", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "percentItemType" }, "genh_OzCapitalLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Oz Capital LLCMember", "terseLabel": "Oz Capital, LLC [Member]" } } }, "localname": "OzCapitalLLCMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/LeasesDetails" ], "xbrltype": "domainItemType" }, "genh_PaymentOfMortgagePayable": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of The fair value of transfer of mortgage payable in financing activities.", "label": "Payment Of Mortgage Payable", "negatedLabel": "Payment of mortgage payable" } } }, "localname": "PaymentOfMortgagePayable", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "genh_PostharvestAndMidstreamServices": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Post-harvest and midstream services.", "label": "Postharvest And Midstream Services", "terseLabel": "Post-harvest and midstream services" } } }, "localname": "PostharvestAndMidstreamServices", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "genh_PppLoanAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "PPP loan amount.", "label": "Ppp Loan Amount", "terseLabel": "Loan amount" } } }, "localname": "PppLoanAmount", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/OtherIndebtednessDetails" ], "xbrltype": "monetaryItemType" }, "genh_PreferredStockStatedValues": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Preferred stock, Stated Value.", "label": "Preferred Stock Stated Values", "terseLabel": "Preferred stock, stated Value (in Dollars)", "verboseLabel": "Stated value per share (in Dollars)" } } }, "localname": "PreferredStockStatedValues", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "monetaryItemType" }, "genh_PrincipalPayments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Principal payments.", "label": "Principal Payments", "terseLabel": "Principal payments" } } }, "localname": "PrincipalPayments", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "genh_ProceedsFromSaleOfInvestmentInCommonStock": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from sale of investment in common stock.", "label": "Proceeds From Sale Of Investment In Common Stock", "terseLabel": "Proceeds from sale of investment in common stock" } } }, "localname": "ProceedsFromSaleOfInvestmentInCommonStock", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "genh_PromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Promissory Note Member", "terseLabel": "Promissory Note [Member]" } } }, "localname": "PromissoryNoteMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "genh_PromissoryNoteToInvestmentHunterLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Promissory Note To Investment Hunter LLCMember", "terseLabel": "Promissory Note to Investment Hunter, LLC [Member]" } } }, "localname": "PromissoryNoteToInvestmentHunterLLCMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "domainItemType" }, "genh_PropertyAndEquipmentUsefulLifeyrs": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Property and equipment, Useful Life.", "label": "Property And Equipment Useful Lifeyrs", "terseLabel": "Property and equipment, useful Life (years)" } } }, "localname": "PropertyAndEquipmentUsefulLifeyrs", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "durationItemType" }, "genh_PurchaseOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Numbro of shares purchase of common stock.", "label": "Purchase Of Common Stock", "terseLabel": "Purchase of common stock (in Shares)" } } }, "localname": "PurchaseOfCommonStock", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "genh_RedemptionsOfSeriesBPreferredStock": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of Redemptions preferred stock.", "label": "Redemptions Of Series BPreferred Stock", "negatedLabel": "Redemptions of Series B preferred stock" } } }, "localname": "RedemptionsOfSeriesBPreferredStock", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "genh_Rental": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of rental.", "label": "Rental", "terseLabel": "Rental" } } }, "localname": "Rental", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "genh_RepaymentAccruedInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of repayment accrued interest.", "label": "Repayment Accrued Interest", "terseLabel": "Repayment accrued interest" } } }, "localname": "RepaymentAccruedInterest", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "genh_RepaymentOfSubordinatedNotes": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of subordinated notes.", "label": "Repayment Of Subordinated Notes", "negatedLabel": "Repayment of subordinated notes" } } }, "localname": "RepaymentOfSubordinatedNotes", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "genh_RestrictedCommonShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted common shares.", "label": "Restricted Common Shares", "terseLabel": "Restricted common shares (in Shares)" } } }, "localname": "RestrictedCommonShares", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "sharesItemType" }, "genh_RevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue Abstract", "terseLabel": "Revenue -" } } }, "localname": "RevenueAbstract", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable" ], "xbrltype": "stringItemType" }, "genh_SaleOfPreferredStockUnits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of preffered stock units.", "label": "Sale Of Preferred Stock Units", "terseLabel": "Sale of preferred stock units (in Dollars)" } } }, "localname": "SaleOfPreferredStockUnits", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "monetaryItemType" }, "genh_ScheduleOfDeferredTaxAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Deferred Tax Assets And Liabilities Abstract" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesAbstract", "nsuri": "http://www.genhempinc.com/20221231", "xbrltype": "stringItemType" }, "genh_ScheduleOfDiscontinuedOperationsShownInTheConsolidatedStatementsOfOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Discontinued Operations Shown In The Consolidated Statements Of Operations Abstract" } } }, "localname": "ScheduleOfDiscontinuedOperationsShownInTheConsolidatedStatementsOfOperationsAbstract", "nsuri": "http://www.genhempinc.com/20221231", "xbrltype": "stringItemType" }, "genh_ScheduleOfDiscontinuedOperationsToAssetsAndLiabilitiesHeldForSaleAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Discontinued Operations To Assets And Liabilities Held For Sale Abstract" } } }, "localname": "ScheduleOfDiscontinuedOperationsToAssetsAndLiabilitiesHeldForSaleAbstract", "nsuri": "http://www.genhempinc.com/20221231", "xbrltype": "stringItemType" }, "genh_ScheduleOfDiscontinuedOperationsToAssetsAndLiabilitiesHeldForSaleTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Discontinued operations to assets and liabilities held for sale [Table Text Block].", "label": "Schedule Of Discontinued Operations To Assets And Liabilities Held For Sale Table Text Block", "terseLabel": "Schedule of discontinued operations to assets and liabilities held for sale" } } }, "localname": "ScheduleOfDiscontinuedOperationsToAssetsAndLiabilitiesHeldForSaleTableTextBlock", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/DiscontinuedOperationsTables" ], "xbrltype": "textBlockItemType" }, "genh_ScheduleOfEarningsLossPerBasicAndDilutedShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Earnings Loss Per Basic And Diluted Share Abstract" } } }, "localname": "ScheduleOfEarningsLossPerBasicAndDilutedShareAbstract", "nsuri": "http://www.genhempinc.com/20221231", "xbrltype": "stringItemType" }, "genh_ScheduleOfFiniteLivedIntangibleAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Finite Lived Intangible Assets Abstract" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsAbstract", "nsuri": "http://www.genhempinc.com/20221231", "xbrltype": "stringItemType" }, "genh_ScheduleOfNotesPayableRelatedPartiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Notes Payable Related Parties Abstract" } } }, "localname": "ScheduleOfNotesPayableRelatedPartiesAbstract", "nsuri": "http://www.genhempinc.com/20221231", "xbrltype": "stringItemType" }, "genh_ScheduleOfNotesPayableRelatedPartiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes payable related parties [Text Block].", "label": "Schedule Of Notes Payable Related Parties Table Text Block", "terseLabel": "Schedule of notes payable \u2013 related parties" } } }, "localname": "ScheduleOfNotesPayableRelatedPartiesTableTextBlock", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesTables" ], "xbrltype": "textBlockItemType" }, "genh_ScheduleOfOutstandingStockWarrantsActivityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Outstanding Stock Warrants Activity Abstract" } } }, "localname": "ScheduleOfOutstandingStockWarrantsActivityAbstract", "nsuri": "http://www.genhempinc.com/20221231", "xbrltype": "stringItemType" }, "genh_ScheduleOfOutstandingStockWarrantsActivityTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Outstanding Stock Warrants Activity Text Block", "terseLabel": "Schedule of outstanding stock warrants activity" } } }, "localname": "ScheduleOfOutstandingStockWarrantsActivityTextBlock", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "genh_ScheduleOfPropertyAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Property And Equipment Abstract" } } }, "localname": "ScheduleOfPropertyAndEquipmentAbstract", "nsuri": "http://www.genhempinc.com/20221231", "xbrltype": "stringItemType" }, "genh_ScheduleOfReconciliationOfTheExpectedStatutoryFederalTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Reconciliation Of The Expected Statutory Federal Tax [Abstract]" } } }, "localname": "ScheduleOfReconciliationOfTheExpectedStatutoryFederalTaxAbstract", "nsuri": "http://www.genhempinc.com/20221231", "xbrltype": "stringItemType" }, "genh_ScheduleOfSummarizesOptionsOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Summarizes Options Outstanding Abstract" } } }, "localname": "ScheduleOfSummarizesOptionsOutstandingAbstract", "nsuri": "http://www.genhempinc.com/20221231", "xbrltype": "stringItemType" }, "genh_ScheduleOfSupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Supplemental Cash Flow Information [Abstract]" } } }, "localname": "ScheduleOfSupplementalCashFlowInformationAbstract", "nsuri": "http://www.genhempinc.com/20221231", "xbrltype": "stringItemType" }, "genh_ScheduleOfWarrantsOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Warrants Outstanding Abstract" } } }, "localname": "ScheduleOfWarrantsOutstandingAbstract", "nsuri": "http://www.genhempinc.com/20221231", "xbrltype": "stringItemType" }, "genh_ScheduleOfWarrantsOutstandingTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Warrants Outstanding Text Block", "terseLabel": "Schedule of warrants outstanding" } } }, "localname": "ScheduleOfWarrantsOutstandingTextBlock", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "genh_SecuredPromissoryNoteAndWarrantsToCoventryAssetManagementLTDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Secured Promissory Note And Warrants To Coventry Asset Management LTDMember", "terseLabel": "Secured Promissory Note and Warrants to Coventry Asset Management, LTD. [Member]" } } }, "localname": "SecuredPromissoryNoteAndWarrantsToCoventryAssetManagementLTDMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "genh_SecuredPromissoryNoteToCoventryAssetManagementLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Secured Promissory Note To Coventry Asset Management Ltd Member", "terseLabel": "Secured Promissory Note to Coventry Asset Management, LTD. [Member]" } } }, "localname": "SecuredPromissoryNoteToCoventryAssetManagementLtdMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "domainItemType" }, "genh_SellerFinancedDebtTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seller financed debt term.", "label": "Seller Financed Debt Term", "terseLabel": "Seller financed debt term" } } }, "localname": "SellerFinancedDebtTerm", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "durationItemType" }, "genh_SellerfinancedDebt": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of seller financed debt.", "label": "Sellerfinanced Debt", "terseLabel": "Seller-financed debt" } } }, "localname": "SellerfinancedDebt", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "genh_SeriesBPreferredStockDividendPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Series B preferred stock dividend payable.", "label": "Series BPreferred Stock Dividend Payable", "terseLabel": "Series B preferred stock dividend payable" } } }, "localname": "SeriesBPreferredStockDividendPayable", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable" ], "xbrltype": "monetaryItemType" }, "genh_SeriesBRedeemablePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series BRedeemable Preferred Stock Member", "terseLabel": "Series B Redeemable Preferred Stock" } } }, "localname": "SeriesBRedeemablePreferredStockMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "genh_SeriesCRedeemableConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series CRedeemable Convertible Preferred Stock Member", "terseLabel": "Series C Redeemable Convertible Preferred Stock [Member]" } } }, "localname": "SeriesCRedeemableConvertiblePreferredStockMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "genh_ServiceRevenuePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Service revenue percentage.", "label": "Service Revenue Percentage", "terseLabel": "Service revenue percentage" } } }, "localname": "ServiceRevenuePercentage", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "genh_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareCancelledInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants cancelled.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Share Cancelled In Period", "terseLabel": "Number of Warrants, Warrants Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardShareCancelledInPeriod", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofoutstandingstockwarrantsactivityTable" ], "xbrltype": "sharesItemType" }, "genh_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareExercisedInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants Exercised.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Share Exercised In Period", "terseLabel": "Number of Warrants, Warrants Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardShareExercisedInPeriod", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofoutstandingstockwarrantsactivityTable" ], "xbrltype": "sharesItemType" }, "genh_ShareBasedCompensationArrangementByShareBasedPaymentAwardShareIssuedInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants Issued.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Share Issued In Period", "terseLabel": "Number of Warrants, Warrants Issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardShareIssuedInPeriod", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofoutstandingstockwarrantsactivityTable" ], "xbrltype": "sharesItemType" }, "genh_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWeightedAverageExercisePriceGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Weighted Average Exercise Price Granted", "terseLabel": "Weighted Average Exercise Price Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardWeightedAverageExercisePriceGranted", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsummarizesoptionsoutstandingTable" ], "xbrltype": "perShareItemType" }, "genh_SharesOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares of Common stock.", "label": "Shares Of Common Stock", "terseLabel": "Shares of Common stock" } } }, "localname": "SharesOfCommonStock", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "sharesItemType" }, "genh_SquareFootFacility": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Square Foot Facility", "label": "Square Foot Facility", "terseLabel": "Square foot facility (in Dollars per Square Foot)" } } }, "localname": "SquareFootFacility", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "perUnitItemType" }, "genh_StockBasedCompensationDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock-Based Compensation (Details) [Line Items]" } } }, "localname": "StockBasedCompensationDetailsLineItems", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "genh_StockBasedCompensationDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock-Based Compensation (Details) [Table]" } } }, "localname": "StockBasedCompensationDetailsTable", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "genh_StockIssuedDuringPeriodValueIssuanceofCommonSharesForSeniorSecuredPromissoryShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of common shares for Senior Secured Promissory Note (in Shares)", "label": "Stock Issued During Period Value Issuanceof Common Shares For Senior Secured Promissory Shares", "terseLabel": "Issuance of common shares for Senior Secured Promissory Note (in Shares)" } } }, "localname": "StockIssuedDuringPeriodValueIssuanceofCommonSharesForSeniorSecuredPromissoryShares", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "genh_StockIssuedDuringSharesOfIssuanceOfCommonSharesForConvertiblePromissoryNote": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during shares of Issuance of common shares for Convertible Promissory Note.", "label": "Stock Issued During Shares Of Issuance Of Common Shares For Convertible Promissory Note", "terseLabel": "Issuance of common shares for Convertible Promissory Note (in Shares)" } } }, "localname": "StockIssuedDuringSharesOfIssuanceOfCommonSharesForConvertiblePromissoryNote", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "genh_StockIssuedDuringThePeriodValueIssuanceOfCommonSharesForSeniorSecuredPromissoryNotes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common shares for Senior Secured Promissory Note", "label": "Stock Issued During The Period Value Issuance Of Common Shares For Senior Secured Promissory Notes", "terseLabel": "Issuance of common shares for Senior Secured Promissory Note" } } }, "localname": "StockIssuedDuringThePeriodValueIssuanceOfCommonSharesForSeniorSecuredPromissoryNotes", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "genh_SubordinatedNoteToInvestorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subordinated Note To Investor Member", "terseLabel": "Subordinated note to investor [Member]" } } }, "localname": "SubordinatedNoteToInvestorMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "domainItemType" }, "genh_SubordinatedPromissoryNoteAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Subordinated promissory note amount.", "label": "Subordinated Promissory Note Amount", "terseLabel": "Subordinated promissory note amount" } } }, "localname": "SubordinatedPromissoryNoteAmount", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "genh_SubordinatedPromissoryNoteAndWarrantsToInvestorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subordinated Promissory Note And Warrants To Investor Member", "terseLabel": "Subordinated Promissory Note and Warrants to Investor [Member]" } } }, "localname": "SubordinatedPromissoryNoteAndWarrantsToInvestorMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "genh_SubordinatedPromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subordinated Promissory Note Member", "terseLabel": "Subordinated Promissory Note to Investor [Member]" } } }, "localname": "SubordinatedPromissoryNoteMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "domainItemType" }, "genh_SubordinatedPromissoryNoteToCEOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subordinated Promissory Note To CEOMember", "terseLabel": "Subordinated Promissory Note to CEO [Member]" } } }, "localname": "SubordinatedPromissoryNoteToCEOMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "domainItemType" }, "genh_SubordinatedPromissouryNoteDueDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subordinated promissoury note due date.", "label": "Subordinated Promissoury Note Due Date", "terseLabel": "Subordinated promissory note due date" } } }, "localname": "SubordinatedPromissouryNoteDueDate", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "dateItemType" }, "genh_SubsequentEventsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsDetailsLineItems", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "genh_SubsequentEventsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Table]" } } }, "localname": "SubsequentEventsDetailsTable", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "genh_SubsidiaryOwnershipPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Subsidiary Ownership Percentage", "terseLabel": "Qwnership, percentage" } } }, "localname": "SubsidiaryOwnershipPercentage", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "genh_ToroEnergaSociedadAnonimaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Toro Energa Sociedad Anonima Member", "terseLabel": "Toro Energ\u00eda Sociedad Anonima [Member]" } } }, "localname": "ToroEnergaSociedadAnonimaMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "genh_TotalProceeds": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of total proceeds.", "label": "Total Proceeds", "terseLabel": "Total proceeds" } } }, "localname": "TotalProceeds", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "genh_TotalUnrecognizedCompensationCost": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total unrecognized compensation cost.", "label": "Total Unrecognized Compensation Cost", "terseLabel": "Total unrecognized compensation cost" } } }, "localname": "TotalUnrecognizedCompensationCost", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "genh_TwoThousandTwentyOnePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two Thousand Twenty One Plan Member", "terseLabel": "2021 Plan [Member]" } } }, "localname": "TwoThousandTwentyOnePlanMember", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "genh_WarrantToPurchaseOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant to purchase of common stock.", "label": "Warrant To Purchase Of Common Stock", "terseLabel": "Warrant to purchase shares of common stock (in Shares)" } } }, "localname": "WarrantToPurchaseOfCommonStock", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "sharesItemType" }, "genh_WarrantsAndRightsOutstandingMaturityDateDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified.", "label": "Warrants And Rights Outstanding Maturity Date Description", "terseLabel": "Expiration Date" } } }, "localname": "WarrantsAndRightsOutstandingMaturityDateDescription", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "stringItemType" }, "genh_WarrantsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants shares.", "label": "Warrants Shares", "terseLabel": "Warrants shares (in Shares)" } } }, "localname": "WarrantsShares", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "genh_WeightedAveragePriceExceed": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "weighted average price exceed.", "label": "Weighted Average Price Exceed", "terseLabel": "Weighted average market price of common stock exceed (in Dollars per share)" } } }, "localname": "WeightedAveragePriceExceed", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "perShareItemType" }, "genh_warrantExpire": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "warrant expire", "label": "warrant Expire", "terseLabel": "Warrant expire" } } }, "localname": "warrantExpire", "nsuri": "http://www.genhempinc.com/20221231", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "durationItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r284", "r285", "r286", "r287", "r326", "r426", "r453", "r465", "r466", "r484", "r485", "r490", "r526", "r542", "r543", "r544", "r545", "r546", "r547" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/LeasesDetails", "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable", "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r284", "r285", "r286", "r287", "r326", "r426", "r453", "r465", "r466", "r484", "r485", "r490", "r526", "r542", "r543", "r544", "r545", "r546", "r547" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/LeasesDetails", "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable", "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r284", "r285", "r286", "r287", "r324", "r326", "r353", "r354", "r355", "r425", "r426", "r453", "r465", "r466", "r484", "r485", "r490", "r522", "r526", "r543", "r544", "r545", "r546", "r547" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/LeasesDetails", "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable", "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r284", "r285", "r286", "r287", "r324", "r326", "r353", "r354", "r355", "r425", "r426", "r453", "r465", "r466", "r484", "r485", "r490", "r522", "r526", "r543", "r544", "r545", "r546", "r547" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/LeasesDetails", "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable", "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r327", "r514" ], "lang": { "en-us": { "role": { "label": "Forecast [Member]", "terseLabel": "Forecast [Member]" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r222", "r327", "r500", "r514" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r222", "r327", "r500", "r501", "r514" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "srt_WarehouseMember": { "auth_ref": [ "r548", "r549" ], "lang": { "en-us": { "role": { "label": "Warehouse [Member]", "terseLabel": "Warehouse [Member]" } } }, "localname": "WarehouseMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r36", "r489" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r266", "r267" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r39" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r99", "r180" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less accumulated depreciation and amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r31", "r489" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r361", "r362", "r363", "r511", "r512", "r513", "r535" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss from continuing operations to net cash from operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r58", "r68", "r139", "r303" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of debt discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r68", "r95" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 }, "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "terseLabel": "Impairment expense" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow", "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r144", "r157", "r184", "r206", "r254", "r257", "r261", "r269", "r288", "r289", "r291", "r292", "r293", "r294", "r295", "r297", "r298", "r389", "r393", "r399", "r489", "r524", "r525", "r540" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets", "verboseLabel": "Assets:" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r175", "r192", "r206", "r269", "r288", "r289", "r291", "r292", "r293", "r294", "r295", "r297", "r298", "r389", "r393", "r399", "r489", "r524", "r525", "r540" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r0", "r1", "r20", "r96", "r101", "r173", "r174" ], "calculation": { "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Assets, Current", "totalLabel": "Total assets of discontinued operations held for sale" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AuctionMarketPreferredSecuritiesStockSeriesSharesAuthorized": { "auth_ref": [ "r29", "r112" ], "lang": { "en-us": { "role": { "documentation": "The number of shares of a preferred security the entity has authorized through an auction process.", "label": "Auction Market Preferred Securities, Stock Series, Shares Authorized", "terseLabel": "Shares of preferred stock" } } }, "localname": "AuctionMarketPreferredSecuritiesStockSeriesSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r77" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r128" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business Combinations Policy [Policy Text Block]", "terseLabel": "Business Combinations" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_Capital": { "auth_ref": [ "r450" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of total capital as defined by regulatory framework.", "label": "Banking Regulation, Total Capital, Actual", "terseLabel": "New equity capital" } } }, "localname": "Capital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Cash": { "auth_ref": [ "r459", "r460", "r489", "r502" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash for its operating activities" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAcquiredFromAcquisition": { "auth_ref": [ "r59" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).", "label": "Cash Acquired from Acquisition", "terseLabel": "Net of acquired cash" } } }, "localname": "CashAcquiredFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow_Parentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r70", "r178", "r468" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r71" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r65", "r70", "r75" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash, end of period", "periodStartLabel": "Cash, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r65", "r138" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowSupplementalDisclosuresTextBlock": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Cash Flow, Supplemental Disclosures [Text Block]", "terseLabel": "Supplemental Cash Flow Information" } } }, "localname": "CashFlowSupplementalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SupplementalCashFlowInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": { "auth_ref": [ "r19", "r65" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Cash Provided by (Used in) Operating Activities, Discontinued Operations", "terseLabel": "Net cash from operating activities \u2013 discontinued operations" } } }, "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r185", "r186", "r187", "r206", "r225", "r226", "r233", "r235", "r243", "r244", "r269", "r288", "r291", "r292", "r293", "r297", "r298", "r306", "r307", "r310", "r314", "r321", "r399", "r467", "r499", "r507", "r515" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.genhempinc.com/role/EquityDetails", "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r115", "r117" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Price (each)", "verboseLabel": "Exercise price, per share (in Dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable", "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Number of Warrants" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "periodEndLabel": "Number of Warrants, Warrants ending", "periodStartLabel": "Number of Warrants, Warrants beginning" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofoutstandingstockwarrantsactivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of reason for issuing warrant or right.", "label": "Warrant or Right, Reason for Issuance, Description", "terseLabel": "Method of Exercise" } } }, "localname": "ClassOfWarrantOrRightReasonForIssuingToNonemployees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r44", "r149", "r162" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r106", "r282", "r283", "r461", "r523" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r511", "r512", "r535" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock", "verboseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails", "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in Dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r30", "r111" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r30", "r489" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.00001 par value; 200,000,000 shares authorized, 113,204,002 and 113,094,002 shares issued and outstanding at December 31, 2022 and 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computer equipment and software\t[Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r156", "r247" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Major Customer and Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": { "auth_ref": [ "r28", "r29", "r112", "r113", "r317" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.", "label": "Convertible Preferred Stock, Shares Issued upon Conversion", "terseLabel": "Converting into shares of restricted common stock" } } }, "localname": "ConvertiblePreferredStockSharesIssuedUponConversion", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r54", "r206", "r269", "r288", "r289", "r291", "r292", "r293", "r294", "r295", "r297", "r298", "r399", "r524" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "terseLabel": "Cost of revenue (exclusive of items shown separately below)" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r52" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total costs and expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Costs and Expenses:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement", "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable" ], "xbrltype": "stringItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer relationships [Member]" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleoffinitelivedintangibleassetsTable" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionOriginalDebtInterestRateOfDebt": { "auth_ref": [ "r73", "r74" ], "lang": { "en-us": { "role": { "documentation": "The rate of interest that was being paid on the original debt issue that is being converted in the noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Original Debt, Interest Rate of Debt", "terseLabel": "Interest rate, percentage" } } }, "localname": "DebtConversionOriginalDebtInterestRateOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Indebtedness [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r108", "r301" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Conversion price per share (in Dollars per share)", "verboseLabel": "Conversion price, per share (in Dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r140", "r141", "r299", "r407", "r480", "r481" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "auth_ref": [ "r508" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.", "label": "Debt Instrument, Increase, Accrued Interest", "terseLabel": "Accrued interest" } } }, "localname": "DebtInstrumentIncreaseAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r41", "r140", "r304", "r407" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Interest accrued, rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r41", "r300" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Bears interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r193", "r479", "r536" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt Instrument, Maturity Date", "terseLabel": "Debt Instrument, Maturity Date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Debt Instrument, Maturity Date, Description", "terseLabel": "Convertible note matured, description" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r155" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Redemption payments percentage" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.", "label": "Deferred Tax Assets, Goodwill and Intangible Assets", "terseLabel": "Intangible assets" } } }, "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r373" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "terseLabel": "Subtotal" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r533" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "terseLabel": "Net deferred tax asset" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r127", "r534" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration", "terseLabel": "Federal net operating loss not expiration" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration", "terseLabel": "Federal net operating loss expiration" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r127", "r534" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost", "terseLabel": "Stock-based compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r374" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r68", "r97" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r68", "r252" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeMaturityDates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date the derivative contract matures, in YYYY-MM-DD format.", "label": "Derivative, Maturity Date", "terseLabel": "Maturity date" } } }, "localname": "DerivativeMaturityDates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r330", "r357", "r358", "r359", "r364", "r486" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Payment Arrangement [Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DisclosureTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "DisclosureTextBlockAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": { "auth_ref": [ "r6", "r7", "r8", "r9", "r10", "r17", "r50", "r165" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax", "terseLabel": "Income (loss) from discontinued operations" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share", "terseLabel": "Basic (in Dollars per share)", "verboseLabel": "Basic" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement", "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "perShareItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share", "terseLabel": "Diluted (in Dollars per share)", "verboseLabel": "Diluted" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement", "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "perShareItemType" }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discontinued Operations [Abstract]" } } }, "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable", "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent": { "auth_ref": [ "r0", "r1", "r20", "r96", "r101" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current", "terseLabel": "Accrued liabilities" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": { "auth_ref": [ "r18", "r174" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold", "terseLabel": "Oil and gas sales" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent": { "auth_ref": [ "r0", "r1", "r20", "r96", "r101" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as deferred revenue attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Deferred Revenue, Current", "terseLabel": "Revenue payable" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": { "auth_ref": [ "r18" ], "calculation": { "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable": { "order": 1.0, "parentTag": "genh_DisposalGroupIncludingDiscontinuedOperationCostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Operating Expense", "terseLabel": "Lease operating expense" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets": { "auth_ref": [ "r0", "r1", "r20", "r96", "r101" ], "calculation": { "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable": { "order": 1.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Other Assets, Current", "terseLabel": "Oil and natural gas properties held for sale, at cost" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPostretirementPlanBenefitObligationCurrent": { "auth_ref": [ "r1", "r20", "r101" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as defined benefit non-pension postretirement plan obligations attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Postretirement Plan Benefit Obligation, Current", "terseLabel": "Asset retirement obligations" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationPostretirementPlanBenefitObligationCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "auth_ref": [ "r26", "r105" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]", "terseLabel": "Discontinued Operations" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/DiscontinuedOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_DividendsPreferredStock": { "auth_ref": [ "r114", "r154" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Preferred Stock", "negatedLabel": "Series B preferred stock dividend" } } }, "localname": "DividendsPreferredStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r36", "r290", "r291", "r292", "r296", "r297", "r298", "r419", "r510" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties, Current", "terseLabel": "Payables to related parties" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r148", "r163", "r290", "r291", "r292", "r296", "r297", "r298", "r419", "r510" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.", "label": "Due to Related Parties", "terseLabel": "Total" } } }, "localname": "DueToRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings (loss) per common share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r201", "r214", "r215", "r216", "r217", "r218", "r223", "r225", "r233", "r234", "r235", "r239", "r397", "r398", "r447", "r451", "r475" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic (in Dollars per share)", "verboseLabel": "Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement", "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r201", "r214", "r215", "r216", "r217", "r218", "r225", "r233", "r234", "r235", "r239", "r397", "r398", "r447", "r451", "r475" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted (in Dollars per share)", "verboseLabel": "Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement", "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r78", "r79" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Earnings (loss) per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r236", "r237", "r238", "r240" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings (Loss) per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EarningsLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Income tax, percentage" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for employee benefit and equity-based compensation.", "label": "Employee Benefits and Share-Based Compensation", "terseLabel": "Compensation expense related to awards" } } }, "localname": "EmployeeBenefitsAndShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r111", "r171", "r197", "r198", "r199", "r209", "r210", "r211", "r213", "r219", "r221", "r242", "r270", "r323", "r361", "r362", "r363", "r378", "r379", "r396", "r400", "r401", "r402", "r403", "r404", "r405", "r415", "r454", "r455", "r456" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails", "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable", "http://www.genhempinc.com/role/ShareholdersEquityType2or3", "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r68", "r109" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "negatedLabel": "Change in fair value of marketable security" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurement" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [ "r410", "r413" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "Finance Lease, Principal Payments", "terseLabel": "Principal payments" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r182", "r279" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "terseLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleoffinitelivedintangibleassetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r91" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "Future amortization expense for intangible assets 2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/IntangibleandOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r91" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "Future amortization expense for intangible assets 2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/IntangibleandOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r91" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "Future amortization expense for intangible assets 2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/IntangibleandOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r91" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "Future amortization expense for intangible assets 2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/IntangibleandOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r91" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "Future amortization expense for intangible assets 2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/IntangibleandOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r277", "r278", "r279", "r280", "r432", "r433" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleoffinitelivedintangibleassetsTable" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r90", "r433" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Gross Carrying Amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleoffinitelivedintangibleassetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleoffinitelivedintangibleassetsTable" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r87", "r89" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleoffinitelivedintangibleassetsTable" ], "xbrltype": "domainItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r68" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedLabel": "Loss on disposal of property and equipment" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r56" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 4.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r181", "r276", "r446", "r478", "r489", "r520", "r521" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r68", "r92" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.", "label": "Impairment of Intangible Assets (Excluding Goodwill)", "terseLabel": "Impairment expense" } } }, "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/IntangibleandOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r93", "r104" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperations": { "auth_ref": [ "r53", "r69", "r132", "r214", "r215", "r216", "r217", "r231", "r235" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "totalLabel": "Net loss from continuing operations" } } }, "localname": "IncomeLossFromContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Loss from continuing operations" } } }, "localname": "IncomeLossFromContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r49", "r143", "r151", "r168", "r254", "r256", "r260", "r262", "r448", "r477" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "terseLabel": "Loss from continuing operations" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "auth_ref": [ "r48", "r150", "r152", "r164", "r201", "r212", "r214", "r215", "r216", "r217", "r225", "r233", "r234", "r398", "r447" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Basic Share", "terseLabel": "Basic (in Dollars per share)", "verboseLabel": "Basic" } } }, "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement", "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "auth_ref": [ "r48", "r164", "r167", "r201", "r212", "r214", "r215", "r216", "r217", "r225", "r233", "r234", "r235", "r398", "r447", "r451" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Diluted Share", "terseLabel": "Diluted (in Dollars per share)", "verboseLabel": "Diluted" } } }, "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement", "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": { "auth_ref": [ "r6", "r7", "r8", "r9", "r10", "r22", "r165", "r174", "r384" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Loss from discontinued operations" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": { "auth_ref": [ "r6", "r7", "r8", "r9", "r10", "r17", "r22", "r133" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent", "terseLabel": "Loss from discontinued operations" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent [Abstract]", "terseLabel": "Loss from discontinued operations" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "auth_ref": [ "r1", "r11", "r12", "r13", "r14", "r15", "r16", "r21", "r23", "r24", "r25", "r102", "r103" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r207", "r370", "r371", "r376", "r380", "r382", "r385", "r386", "r387" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationInterestAccrued": { "auth_ref": [ "r532" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of estimated interest accrued as of the balance sheet date arising from income tax examinations.", "label": "Income Tax Examination, Interest Accrued", "terseLabel": "Accrued interest" } } }, "localname": "IncomeTaxExaminationInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r208", "r220", "r221", "r253", "r368", "r381", "r383", "r452" ], "calculation": { "http://www.genhempinc.com/role/ScheduleofreconciliationoftheexpectedstatutoryfederaltaxTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "totalLabel": "Total income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofreconciliationoftheexpectedstatutoryfederaltaxTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r196", "r366", "r367", "r371", "r372", "r375", "r377" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r531" ], "calculation": { "http://www.genhempinc.com/role/ScheduleofreconciliationoftheexpectedstatutoryfederaltaxTable": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "terseLabel": "Change in valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofreconciliationoftheexpectedstatutoryfederaltaxTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r365", "r369" ], "calculation": { "http://www.genhempinc.com/role/ScheduleofreconciliationoftheexpectedstatutoryfederaltaxTable": { "order": 4.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.", "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount", "terseLabel": "Change in state tax rates" } } }, "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofreconciliationoftheexpectedstatutoryfederaltaxTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r369" ], "calculation": { "http://www.genhempinc.com/role/ScheduleofreconciliationoftheexpectedstatutoryfederaltaxTable": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "terseLabel": "Federal statutory rate" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofreconciliationoftheexpectedstatutoryfederaltaxTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "auth_ref": [ "r531" ], "calculation": { "http://www.genhempinc.com/role/ScheduleofreconciliationoftheexpectedstatutoryfederaltaxTable": { "order": 6.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount", "terseLabel": "Other, net" } } }, "localname": "IncomeTaxReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofreconciliationoftheexpectedstatutoryfederaltaxTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": { "auth_ref": [ "r531" ], "calculation": { "http://www.genhempinc.com/role/ScheduleofreconciliationoftheexpectedstatutoryfederaltaxTable": { "order": 5.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount", "terseLabel": "True-up of prior year deferred items" } } }, "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofreconciliationoftheexpectedstatutoryfederaltaxTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r531" ], "calculation": { "http://www.genhempinc.com/role/ScheduleofreconciliationoftheexpectedstatutoryfederaltaxTable": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount", "terseLabel": "State income taxes, net" } } }, "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofreconciliationoftheexpectedstatutoryfederaltaxTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r72" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r67" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r67" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "auth_ref": [ "r67" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.", "label": "Increase (Decrease) in Interest Payable, Net", "terseLabel": "Other income - PPP Loan forgiveness" } } }, "localname": "IncreaseDecreaseInInterestPayableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r67" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r67" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InsuranceSettlementsReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy.", "label": "Insurance Settlements Receivable", "terseLabel": "Amount received from defendant" } } }, "localname": "InsuranceSettlementsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r281" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]", "terseLabel": "Intangible and Other Assets" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/IntangibleandOtherAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r89", "r428", "r429", "r430", "r432", "r471" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]", "terseLabel": "Intangible Assets" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r86", "r88" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r58", "r302", "r305", "r482", "r483" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "terseLabel": "Interest expenses" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/OtherIndebtednessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense classified as other.", "label": "Interest Expense, Other", "terseLabel": "Interest expense" } } }, "localname": "InterestExpenseOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r506" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.", "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestReceivableAndOtherAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest receivable and assets classified as other.", "label": "Interest Receivable and Other Assets", "terseLabel": "Accrued interest" } } }, "localname": "InterestReceivableAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r189", "r469", "r489" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r177", "r188", "r241", "r271", "r272", "r273", "r427", "r472" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentInterestRate": { "auth_ref": [ "r517", "r518" ], "lang": { "en-us": { "role": { "documentation": "Rate of interest on investment.", "label": "Investment Interest Rate", "terseLabel": "Interest rate per annum" } } }, "localname": "InvestmentInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "auth_ref": [ "r68" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.", "label": "Issuance of Stock and Warrants for Services or Claims", "terseLabel": "Common shares issued to vendor for services" } } }, "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]", "terseLabel": "Land [Member]" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r98" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_LegalFees": { "auth_ref": [ "r55" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.", "label": "Legal Fees", "terseLabel": "Amount accrued for judgment" } } }, "localname": "LegalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r412" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r38", "r206", "r269", "r288", "r289", "r291", "r292", "r293", "r294", "r295", "r297", "r298", "r390", "r393", "r394", "r399", "r476", "r524", "r540", "r541" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r35", "r146", "r160", "r489", "r509", "r519", "r537" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Equity (Deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r40", "r176", "r206", "r269", "r288", "r289", "r291", "r292", "r293", "r294", "r295", "r297", "r298", "r390", "r393", "r394", "r399", "r489", "r524", "r540", "r541" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r0", "r1", "r20", "r101", "r173", "r174" ], "calculation": { "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Liabilities", "totalLabel": "Total liabilities of discontinued operations held for sale" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r0", "r1", "r20", "r96", "r101", "r173", "r174" ], "calculation": { "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current", "terseLabel": "Current liabilities of discontinued operations held for sale" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent": { "auth_ref": [ "r0", "r1", "r20", "r94", "r101", "r173", "r174" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent", "terseLabel": "Long-term liabilities of discontinued operations held for sale" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid": { "auth_ref": [ "r85" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of life insurance premiums anticipated to be paid to keep the life settlement contracts accounted for under the investment method in force.", "label": "Life Settlement Contracts, Investment Method, Premiums to be Paid", "terseLabel": "Partial settlement claim" } } }, "localname": "LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount awarded from other party in judgment or settlement of litigation.", "label": "Litigation Settlement, Amount Awarded from Other Party", "terseLabel": "Amount of summary judgment" } } }, "localname": "LitigationSettlementAmountAwardedFromOtherParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r43", "r107" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "domainItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and equipment [Member]" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_MalpracticeInsuranceAnnualCoverageLimit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Annual coverage limit provided by the insurance arrangement for malpractice claims.", "label": "Malpractice Insurance, Annual Coverage Limit", "terseLabel": "Substantial coverages" } } }, "localname": "MalpracticeInsuranceAnnualCoverageLimit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r47", "r145", "r159", "r206", "r269", "r288", "r291", "r292", "r293", "r297", "r298", "r399" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_MortgageNotesPayableDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for mortgage notes payable.", "label": "Mortgage Notes Payable Disclosure [Text Block]", "terseLabel": "Other Indebtedness" } } }, "localname": "MortgageNotesPayableDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/OtherIndebtedness" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r203" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash from financing activities \u2013 continuing operations" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows From Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r203" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash from investing activities \u2013 continuing operations" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash Flows From Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r65", "r66", "r69" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows From Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": { "auth_ref": [ "r65", "r66", "r69" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations", "totalLabel": "Net cash from operating activities \u2013 continuing operations" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r51", "r69", "r153", "r166", "r174", "r194", "r195", "r199", "r206", "r212", "r214", "r215", "r216", "r217", "r220", "r221", "r231", "r254", "r256", "r260", "r262", "r269", "r288", "r289", "r291", "r292", "r293", "r294", "r295", "r297", "r298", "r398", "r399", "r477", "r524" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net loss attributable to Evergreen Sustainable Enterprises" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r134", "r136", "r194", "r195", "r220", "r221", "r505" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Less: net income (loss) attributable to noncontrolling interests" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r224", "r227", "r228", "r229", "r230", "r232", "r235" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "terseLabel": "Net loss attributable to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from discontinued operations available to common shareholders.", "label": "Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic", "terseLabel": "Income (loss) from discontinued operations" } } }, "localname": "NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r130", "r323", "r511", "r512", "r513" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interest" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r57" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other expense (income)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r37" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes Payable, Current", "terseLabel": "Notes payable \u2013 related parties" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r142", "r163", "r510" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties.", "label": "Notes Payable, Related Parties", "terseLabel": "Total notes payable \u2013 related parties" } } }, "localname": "NotesPayableRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r254", "r256", "r260", "r262", "r477" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r538" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Lease expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r409" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Operating lease liability - related party" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r409" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liability - related party, net of current portion" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r411", "r413" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Lease payment" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/LeasesDetails", "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r408" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r27", "r137" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Business" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/Business" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r191", "r489" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r183" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet", "http://www.genhempinc.com/role/IntangibleandOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherBorrowings": { "auth_ref": [ "r147" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.", "label": "Other Borrowings", "terseLabel": "borrowing" } } }, "localname": "OtherBorrowings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncome": { "auth_ref": [ "r169" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue and income classified as other.", "label": "Other Income", "terseLabel": "Other income" } } }, "localname": "OtherIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIntangibleAssetsNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.", "label": "Other Intangible Assets, Net", "terseLabel": "Net" } } }, "localname": "OtherIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleoffinitelivedintangibleassetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other expense (income):" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_PaymentsForCapitalImprovements": { "auth_ref": [ "r60" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for acquisition of or capital improvements to properties held for investment (operating, managed, leased) or for use.", "label": "Payments for Capital Improvements", "negatedLabel": "Capital expenditures" } } }, "localname": "PaymentsForCapitalImprovements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock": { "auth_ref": [ "r63" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Preferred Stock and Preference Stock", "negatedLabel": "Series B preferred stock dividends paid" } } }, "localname": "PaymentsOfDividendsPreferredStockAndPreferenceStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMachineryAndEquipment": { "auth_ref": [ "r60" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for acquisition of machinery and equipment.", "label": "Payments to Acquire Machinery and Equipment", "terseLabel": "Purchase price of equipment" } } }, "localname": "PaymentsToAcquireMachineryAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockConvertibleConversionPrice": { "auth_ref": [ "r308" ], "lang": { "en-us": { "role": { "documentation": "Per share conversion price of preferred stock.", "label": "Preferred Stock, Convertible, Conversion Price", "terseLabel": "Redeemable Convertible Preferred Stock (in Dollars per share)" } } }, "localname": "PreferredStockConvertibleConversionPrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockConvertibleSharesIssuable": { "auth_ref": [ "r308" ], "lang": { "en-us": { "role": { "documentation": "Number of common shares issuable upon conversion of preferred stock.", "label": "Preferred Stock, Convertible, Shares Issuable", "terseLabel": "Converted into shares of common stock" } } }, "localname": "PreferredStockConvertibleSharesIssuable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockDividendRatePercentage": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "The percentage rate used to calculate dividend payments on preferred stock.", "label": "Preferred Stock, Dividend Rate, Percentage", "terseLabel": "Dividends percentage" } } }, "localname": "PreferredStockDividendRatePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "percentItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Series A Preferred Stock" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r29", "r306" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in Dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockRedemptionAmount": { "auth_ref": [ "r45", "r110" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The redemption (or callable) amount of currently redeemable preferred stock. Includes amounts representing dividends not currently declared or paid but which will be payable under the redemption features or for which ultimate payment is solely within the control of the issuer.", "label": "Preferred Stock, Redemption Amount", "terseLabel": "Redemption payments total (in Dollars)" } } }, "localname": "PreferredStockRedemptionAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r29", "r306" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r29", "r489" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.00001 par value; 200,000,000 shares authorized, none outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r190", "r274", "r275", "r470" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r61" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "terseLabel": "Proceeds from warrant exercises" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r62" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from Notes Payable", "terseLabel": "Proceeds from notes payable - related parties" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSubordinatedShortTermDebt": { "auth_ref": [ "r62" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from an obligation which places a lender in a lien position behind debt having a higher priority of repayment (senior loan) in liquidation of the entity's assets scheduled to be repaid within one year or in the normal operating cycle of the entity, if longer.", "label": "Proceeds from Subordinated Short-Term Debt", "terseLabel": "Proceeds from subordinated notes" } } }, "localname": "ProceedsFromSubordinatedShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r174", "r194", "r195", "r202", "r206", "r212", "r220", "r221", "r254", "r256", "r260", "r262", "r269", "r288", "r289", "r291", "r292", "r293", "r294", "r295", "r297", "r298", "r388", "r391", "r392", "r398", "r399", "r448", "r477", "r487", "r488", "r505", "r524" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow", "http://www.genhempinc.com/role/ConsolidatedIncomeStatement", "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r105", "r462", "r463", "r464" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/PropertyandEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r98", "r179" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Subtotal" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r100", "r161", "r449", "r489" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net", "verboseLabel": "Total property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet", "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r100", "r462", "r463" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of property and equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/PropertyandEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r98" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r325", "r418", "r419" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails", "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails", "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r170", "r418", "r419", "r539" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/LeasesDetails", "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r170" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/LeasesDetails", "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable \u2013 Related Parties [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r325", "r418", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r539" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails", "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails", "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r416", "r417", "r419", "r420", "r421" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Notes Payable \u2013 Related Parties" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedParties" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r64" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of Related Party Debt", "negatedLabel": "Repayments of notes payable - related parties" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfShortTermDebt": { "auth_ref": [ "r64" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Repayments of Short-Term Debt", "negatedLabel": "Repayment of Halcyon bank note" } } }, "localname": "RepaymentsOfShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r78" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted Shares [Member]", "verboseLabel": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.", "label": "Restricted Stock, Shares Issued Net of Shares for Tax Withholdings", "terseLabel": "Restricted shares, issued" } } }, "localname": "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.", "label": "Restricted Stock, Value, Shares Issued Net of Tax Withholdings", "terseLabel": "Restricted shares, value" } } }, "localname": "RestrictedStockValueSharesIssuedNetOfTaxWithholdings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r32", "r114", "r158", "r457", "r458", "r489" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r171", "r209", "r210", "r211", "r213", "r219", "r221", "r270", "r361", "r362", "r363", "r378", "r379", "r396", "r454", "r456" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r473", "r474" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligationPercentage": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Percentage", "terseLabel": "Midstream service revenue" } } }, "localname": "RevenueRemainingPerformanceObligationPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r200", "r206", "r250", "r251", "r255", "r258", "r259", "r263", "r264", "r265", "r269", "r288", "r289", "r291", "r292", "r293", "r294", "r295", "r297", "r298", "r399", "r448", "r524" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "totalLabel": "Total revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenue:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Warrant per share (in Dollars per share)" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.", "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "terseLabel": "Schedule of supplemental cash flow information" } } }, "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SupplementalCashFlowInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r126" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of deferred tax assets and liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "auth_ref": [ "r1", "r11", "r12", "r13", "r14", "r15", "r16", "r21", "r23", "r24", "r25", "r102", "r103" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]", "terseLabel": "Schedule of discontinued operations shown in the consolidated statements of operations" } } }, "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/DiscontinuedOperationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of earnings (loss) per basic and diluted share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EarningsLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r125" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of reconciliation of the expected statutory federal tax" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r87", "r89", "r432" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleoffinitelivedintangibleassetsTable" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r87", "r89" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of finite-lived intangible assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/IntangibleandOtherAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r118", "r121", "r123" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of summarizes options outstanding" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDiscontinuedOperationsMember": { "auth_ref": [ "r2", "r3", "r4", "r5" ], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of or classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.", "label": "Discontinued Operations [Member]", "terseLabel": "Discontinued Operations [Member]" } } }, "localname": "SegmentDiscontinuedOperationsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable", "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r503", "r504", "r527" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]", "terseLabel": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r503", "r504", "r527" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]", "terseLabel": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r67" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Awarded options vest over year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Volatility ranging" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum", "terseLabel": "Risk free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "terseLabel": "Risk free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period", "terseLabel": "Compensation expense" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r530" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofoutstandingstockwarrantsactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Shares Granted (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsummarizesoptionsoutstandingTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r348" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsummarizesoptionsoutstandingTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r334", "r335" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Shares Ending (in Shares)", "periodStartLabel": "Shares Beginning (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsummarizesoptionsoutstandingTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease": { "auth_ref": [ "r530" ], "lang": { "en-us": { "role": { "documentation": "The increase or decrease in number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding, including vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Period Increase (Decrease)", "terseLabel": "Common stock incentive compensation" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r334", "r335" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price Ending", "periodStartLabel": "Weighted Average Exercise Price Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsummarizesoptionsoutstandingTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofoutstandingstockwarrantsactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Issued" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofoutstandingstockwarrantsactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationForfeituresPolicyTextBlock": { "auth_ref": [ "r328", "r329", "r360" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy election for determining cost for share-based payment arrangement by either estimating forfeiture expected to occur or by recognizing effect of forfeiture upon occurrence.", "label": "Share-Based Payment Arrangement, Forfeiture [Policy Text Block]", "terseLabel": "Stock-based Compensation" } } }, "localname": "ShareBasedCompensationForfeituresPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable", "terseLabel": "Exercise price per share" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Price per share (in Dollars per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding", "periodEndLabel": "Aggregate Intrinsic Value Ending (in Dollars)", "periodStartLabel": "Aggregate Intrinsic Value Beginning (in Dollars)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsummarizesoptionsoutstandingTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Stock options range" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r124" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted average contractual life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Grant Date Fair Value Ending", "periodStartLabel": "Weighted Average Grant Date Fair Value Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsummarizesoptionsoutstandingTable" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "auth_ref": [ "r349" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value", "terseLabel": "Grant value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r119" ], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price, Warrants ending", "periodStartLabel": "Weighted Average Exercise Price, Warrants beginning" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofoutstandingstockwarrantsactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance (in Shares)", "periodStartLabel": "Balance (in Shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r77", "r204" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r185", "r186", "r187", "r206", "r225", "r226", "r233", "r235", "r243", "r244", "r269", "r288", "r291", "r292", "r293", "r297", "r298", "r306", "r307", "r310", "r314", "r321", "r399", "r467", "r499", "r507", "r515" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.genhempinc.com/role/EquityDetails", "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r46", "r111", "r171", "r197", "r198", "r199", "r209", "r210", "r211", "r213", "r219", "r221", "r242", "r270", "r323", "r361", "r362", "r363", "r378", "r379", "r396", "r400", "r401", "r402", "r403", "r404", "r405", "r415", "r454", "r455", "r456" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails", "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable", "http://www.genhempinc.com/role/ShareholdersEquityType2or3", "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r209", "r210", "r211", "r242", "r431" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r29", "r30", "r114" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Acquisition of Certain Assets of Halcyon Thruput, LLC (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": { "auth_ref": [ "r29", "r30", "r111", "r112", "r114" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Stock Issued During Period, Shares, Conversion of Units", "terseLabel": "Series B preferred stock redemptions (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Common shares issued to vendor for services (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r29", "r30", "r111", "r114" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuances of common stock units (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r29", "r30", "r111", "r114" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r29", "r30", "r111", "r114", "r339" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "terseLabel": "Warrant exercises (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r46", "r111", "r114" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Acquisition of Certain Assets of Halcyon Thruput, LLC" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r46", "r111", "r114" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Issuance of common shares for Convertible Promissory Note" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": { "auth_ref": [ "r46", "r111", "r114" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Stock Issued During Period, Value, Conversion of Units", "terseLabel": "Series B preferred stock redemptions" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "terseLabel": "Common shares issued to vendor for services" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r29", "r30", "r111", "r114" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuances of common stock units" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Value, Other", "terseLabel": "Modification of warrants for extension of promissory note to investor" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r29", "r30", "r114", "r122" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r46", "r111", "r114" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Warrant exercises" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionExercisePriceIncrease": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement.", "label": "Stock Option, Exercise Price, Increase", "terseLabel": "exercise price (in Dollars per share)" } } }, "localname": "StockOptionExercisePriceIncrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r30", "r33", "r34", "r83", "r489", "r509", "r519", "r537" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Evergreen Sustainable Enterprises equity (deficit)" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Equity (Deficit):" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r130", "r131", "r135", "r171", "r172", "r198", "r209", "r210", "r211", "r213", "r219", "r270", "r323", "r361", "r362", "r363", "r378", "r379", "r396", "r400", "r401", "r405", "r415", "r455", "r456", "r509", "r519", "r537" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total equity (deficit)" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet", "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r116", "r205", "r307", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r318", "r319", "r320", "r323", "r395" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/Equity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubordinatedBorrowingDueDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date the payments are due on subordinated debt, in YYYY-MM-DD format.", "label": "Subordinated Borrowing, Due Date", "terseLabel": "Due date" } } }, "localname": "SubordinatedBorrowingDueDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "dateItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r406", "r423" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r406", "r423" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r406", "r423" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract] [Standard Label]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r422", "r424" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r288", "r291", "r292", "r293", "r297", "r298" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "terseLabel": "Series B redeemable preferred stock, no par value, $10,000 stated value, 300 shares authorized, 118 shares issued and outstanding at December 31, 2022 and 2021" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r80", "r81", "r82", "r245", "r246", "r248", "r249" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_VehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment used primarily for road transportation.", "label": "Vehicles [Member]", "terseLabel": "Vehicles [Member]" } } }, "localname": "VehiclesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails", "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r536" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Warrant term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r224", "r235" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average shares used to compute diluted EPS" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r223", "r235" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average shares used to compute basic EPS" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21564-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.13,16)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(3),(4))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(20))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.4)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721491-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=2122178", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(m)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32059-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721501-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.27(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)(1)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=117337116&loc=SL5958568-112826", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(13))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r491": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r492": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r493": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r494": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r495": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r496": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r497": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r498": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721503-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(14))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r523": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.13)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "230", "URI": "https://asc.fasb.org/topic&trid=2134446", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "3B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "325", "URI": "https://asc.fasb.org/extlink&oid=73718008&loc=d3e42708-111610", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2510-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 79 0001213900-23-041268-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-23-041268-xbrl.zip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�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end